0000203527-20-000008.txt : 20200211 0000203527-20-000008.hdr.sgml : 20200211 20200211165854 ACCESSION NUMBER: 0000203527-20-000008 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 102 CONFORMED PERIOD OF REPORT: 20200103 FILED AS OF DATE: 20200211 DATE AS OF CHANGE: 20200211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VARIAN MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000203527 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 942359345 STATE OF INCORPORATION: DE FISCAL YEAR END: 1002 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-07598 FILM NUMBER: 20597871 BUSINESS ADDRESS: STREET 1: 3100 HANSEN WAY STREET 2: BUILDING 4A CITY: PALO ALTO STATE: CA ZIP: 94304-1038 BUSINESS PHONE: 650-493-4000 MAIL ADDRESS: STREET 1: 3100 HANSEN WAY STREET 2: BUILDING 4A CITY: PALO ALTO STATE: CA ZIP: 94304-1038 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN ASSOCIATES INC /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN DELAWARE INC DATE OF NAME CHANGE: 19761123 10-Q 1 var-20200103.htm 10-Q var-20200103
false2020Q1000020352710/0290,665,845911P5Y0P1Ysix years, six monthsSUBSEQUENT EVENTS {OPEN}fifteen months721.917.527.625.76.7542.02.8000002035272019-09-282020-01-03xbrli:shares00002035272020-01-31iso4217:USD0000203527us-gaap:ProductMember2019-09-282020-01-030000203527us-gaap:ProductMember2018-09-292018-12-280000203527us-gaap:ServiceMember2019-09-282020-01-030000203527us-gaap:ServiceMember2018-09-292018-12-2800002035272018-09-292018-12-28iso4217:USDxbrli:shares00002035272020-01-0300002035272019-09-2700002035272018-09-2800002035272018-12-280000203527us-gaap:CommonStockMember2019-09-270000203527us-gaap:AdditionalPaidInCapitalMember2019-09-270000203527us-gaap:RetainedEarningsMember2019-09-270000203527us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-270000203527us-gaap:ParentMember2019-09-270000203527us-gaap:NoncontrollingInterestMember2019-09-270000203527us-gaap:RetainedEarningsMember2019-09-282020-01-030000203527us-gaap:ParentMember2019-09-282020-01-030000203527us-gaap:NoncontrollingInterestMember2019-09-282020-01-030000203527us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-282020-01-030000203527us-gaap:CommonStockMember2019-09-282020-01-030000203527us-gaap:AdditionalPaidInCapitalMember2019-09-282020-01-030000203527us-gaap:CommonStockMember2020-01-030000203527us-gaap:AdditionalPaidInCapitalMember2020-01-030000203527us-gaap:RetainedEarningsMember2020-01-030000203527us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-030000203527us-gaap:ParentMember2020-01-030000203527us-gaap:NoncontrollingInterestMember2020-01-030000203527us-gaap:CommonStockMember2018-09-280000203527us-gaap:AdditionalPaidInCapitalMember2018-09-280000203527us-gaap:RetainedEarningsMember2018-09-280000203527us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-09-280000203527us-gaap:ParentMember2018-09-280000203527us-gaap:NoncontrollingInterestMember2018-09-280000203527us-gaap:RetainedEarningsMember2018-09-292018-12-280000203527us-gaap:ParentMember2018-09-292018-12-280000203527us-gaap:NoncontrollingInterestMember2018-09-292018-12-280000203527us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-09-292018-12-280000203527us-gaap:CommonStockMember2018-09-292018-12-280000203527us-gaap:AdditionalPaidInCapitalMember2018-09-292018-12-280000203527us-gaap:CommonStockMember2018-12-280000203527us-gaap:AdditionalPaidInCapitalMember2018-12-280000203527us-gaap:RetainedEarningsMember2018-12-280000203527us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-280000203527us-gaap:ParentMember2018-12-280000203527us-gaap:NoncontrollingInterestMember2018-12-28var:cancer_center0000203527country:IN2019-09-282020-01-03var:specialty_hospital0000203527country:LK2019-09-282020-01-0300002035272020-01-042020-01-0300002035272020-10-032020-01-0300002035272021-10-022020-01-0300002035272022-10-012020-01-030000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2020-01-030000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2020-01-030000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2020-01-030000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2020-01-030000203527us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-01-030000203527us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-01-030000203527us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-01-030000203527us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-01-030000203527var:MPTCSubordinatedBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-01-030000203527var:MPTCSubordinatedBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-01-030000203527var:MPTCSubordinatedBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-01-030000203527var:MPTCSubordinatedBondsMemberus-gaap:FairValueMeasurementsRecurringMember2020-01-030000203527var:APTCSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-01-030000203527var:APTCSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-01-030000203527var:APTCSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-01-030000203527var:APTCSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-01-030000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-01-030000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-01-030000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-01-030000203527us-gaap:FairValueMeasurementsRecurringMember2020-01-030000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2019-09-270000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2019-09-270000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2019-09-270000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2019-09-270000203527us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2019-09-270000203527us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-09-270000203527us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2019-09-270000203527us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2019-09-270000203527var:MPTCSubordinatedBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2019-09-270000203527var:MPTCSubordinatedBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-09-270000203527var:MPTCSubordinatedBondsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2019-09-270000203527var:MPTCSubordinatedBondsMemberus-gaap:FairValueMeasurementsRecurringMember2019-09-270000203527var:APTCSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2019-09-270000203527var:APTCSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-09-270000203527var:APTCSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2019-09-270000203527var:APTCSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2019-09-270000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2019-09-270000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-09-270000203527us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2019-09-270000203527us-gaap:FairValueMeasurementsRecurringMember2019-09-270000203527srt:MinimumMember2019-09-282020-01-030000203527srt:MaximumMember2019-09-282020-01-030000203527us-gaap:FairValueMeasurementsRecurringMembervar:ContingentConsiderationMember2019-09-270000203527us-gaap:FairValueMeasurementsRecurringMembervar:ContingentConsiderationMember2019-09-282020-01-030000203527us-gaap:FairValueMeasurementsRecurringMembervar:ContingentConsiderationMember2020-01-030000203527var:TermLoanMembervar:CPTCMember2020-01-030000203527us-gaap:NotesReceivableMember2020-01-030000203527us-gaap:NotesReceivableMember2019-09-270000203527var:OncologySystemsMember2019-09-270000203527us-gaap:AllOtherSegmentsMember2019-09-270000203527var:OncologySystemsMember2019-09-282020-01-030000203527us-gaap:AllOtherSegmentsMember2019-09-282020-01-030000203527var:OncologySystemsMember2020-01-030000203527us-gaap:AllOtherSegmentsMember2020-01-030000203527var:ProtonSolutionsMember2020-01-030000203527var:ProtonSolutionsMember2019-09-270000203527us-gaap:TechnologyBasedIntangibleAssetsMember2020-01-030000203527us-gaap:TechnologyBasedIntangibleAssetsMember2019-09-270000203527us-gaap:CustomerRelatedIntangibleAssetsMember2020-01-030000203527us-gaap:CustomerRelatedIntangibleAssetsMember2019-09-270000203527us-gaap:TradeNamesMember2020-01-030000203527us-gaap:TradeNamesMember2019-09-270000203527us-gaap:OtherIntangibleAssetsMember2020-01-030000203527us-gaap:OtherIntangibleAssetsMember2019-09-270000203527us-gaap:SegmentContinuingOperationsMember2019-09-282020-01-030000203527us-gaap:SegmentContinuingOperationsMember2018-09-292018-12-280000203527us-gaap:RevolvingCreditFacilityMember2020-01-03xbrli:pure0000203527us-gaap:RevolvingCreditFacilityMember2019-09-270000203527us-gaap:RevolvingCreditFacilityMember2019-11-012019-11-010000203527us-gaap:RevolvingCreditFacilityMember2019-10-310000203527us-gaap:RevolvingCreditFacilityMember2019-11-010000203527us-gaap:RevolvingCreditFacilityMembervar:MultiCurrencyBorrowingsMember2019-11-010000203527us-gaap:LetterOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-10-310000203527us-gaap:LetterOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-11-010000203527var:SwingLineLoansMemberus-gaap:RevolvingCreditFacilityMember2019-11-010000203527srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMember2019-09-282020-01-030000203527srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMember2019-09-282020-01-030000203527us-gaap:FederalFundsEffectiveSwapRateMemberus-gaap:RevolvingCreditFacilityMember2019-09-282020-01-030000203527var:EurodollarPlus1Memberus-gaap:RevolvingCreditFacilityMember2019-09-282020-01-030000203527var:EurodollarPlus1Membersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2019-09-282020-01-030000203527var:EurodollarPlus1Membersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2019-09-282020-01-030000203527us-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMember2019-09-282020-01-030000203527srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2019-09-282020-01-030000203527srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2019-09-282020-01-03iso4217:JPY0000203527var:SumitomoCreditFacilityMember2020-01-030000203527var:SumitomoCreditFacilityMember2019-09-282020-01-030000203527us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-030000203527us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-09-270000203527us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2020-01-030000203527us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2019-09-270000203527us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-030000203527us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-09-270000203527us-gaap:ForeignExchangeForwardMembercurrency:EURus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-01-030000203527us-gaap:ForeignExchangeForwardMembercurrency:EURus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2019-09-270000203527us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMembercurrency:JPY2020-01-030000203527us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMembercurrency:JPY2019-09-270000203527us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2020-01-030000203527us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2019-09-270000203527us-gaap:ForeignExchangeForwardMember2019-09-282020-01-030000203527us-gaap:ForeignExchangeForwardMember2018-09-292018-12-280000203527us-gaap:SalesRevenueNetMember2019-09-282020-01-030000203527us-gaap:SalesRevenueNetMember2018-09-292018-12-280000203527us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ShortMember2020-01-030000203527us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:ShortMember2019-09-270000203527us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:LongMember2020-01-030000203527us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:LongMember2019-09-270000203527us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NonoperatingIncomeExpenseMember2019-09-282020-01-030000203527us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NonoperatingIncomeExpenseMember2018-09-292018-12-280000203527srt:MinimumMember2020-01-030000203527srt:MaximumMember2020-01-030000203527us-gaap:OtherNoncurrentAssetsMember2020-01-030000203527us-gaap:AccruedLiabilitiesMember2020-01-030000203527var:LongTermLeaseLiabilitiesMember2020-01-030000203527us-gaap:PropertyPlantAndEquipmentMember2020-01-030000203527us-gaap:OtherNoncurrentLiabilitiesMember2020-01-030000203527us-gaap:EquipmentMember2020-01-030000203527us-gaap:EquipmentMember2019-09-27var:patent0000203527us-gaap:ThreatenedLitigationMembervar:BestMedicalInternationalInc.LitigationMember2018-10-162018-10-160000203527us-gaap:ThreatenedLitigationMembervar:BestMedicalInternationalInc.LitigationMember2020-01-030000203527us-gaap:PensionPlansDefinedBenefitMember2019-09-282020-01-030000203527us-gaap:PensionPlansDefinedBenefitMember2018-09-292018-12-280000203527var:November2016Member2016-11-300000203527var:November2016Member2020-01-030000203527us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2019-09-270000203527us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2019-09-270000203527us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2019-09-270000203527us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2019-09-270000203527us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2019-09-282020-01-030000203527us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2019-09-282020-01-030000203527us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2019-09-282020-01-030000203527us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2019-09-282020-01-030000203527us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-01-030000203527us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-01-030000203527us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-01-030000203527us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2020-01-030000203527us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2018-09-280000203527us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2018-09-280000203527us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2018-09-280000203527us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2018-09-292018-12-280000203527us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2018-09-292018-12-280000203527us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2018-09-292018-12-280000203527us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2018-12-280000203527us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2018-12-280000203527us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2018-12-280000203527us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2019-09-282020-01-030000203527us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2018-09-292018-12-280000203527us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-09-282020-01-030000203527us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2018-09-292018-12-280000203527var:CostOfRevenuesProductMember2019-09-282020-01-030000203527var:CostOfRevenuesProductMember2018-09-292018-12-280000203527var:CostOfRevenuesServiceMember2019-09-282020-01-030000203527var:CostOfRevenuesServiceMember2018-09-292018-12-280000203527us-gaap:ResearchAndDevelopmentExpenseMember2019-09-282020-01-030000203527us-gaap:ResearchAndDevelopmentExpenseMember2018-09-292018-12-280000203527us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-09-282020-01-030000203527us-gaap:SellingGeneralAndAdministrativeExpensesMember2018-09-292018-12-280000203527us-gaap:EmployeeStockOptionMember2019-09-282020-01-030000203527us-gaap:EmployeeStockOptionMember2018-09-292018-12-280000203527var:EmployeeStockPurchasePlanMember2019-09-282020-01-030000203527var:EmployeeStockPurchasePlanMember2018-09-292018-12-280000203527us-gaap:EmployeeStockOptionMember2020-01-030000203527us-gaap:StockAppreciationRightsSARSMember2020-01-030000203527us-gaap:StockAppreciationRightsSARSMember2019-09-282020-01-030000203527var:RestrictedStockRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsMember2020-01-030000203527var:RestrictedStockRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsMember2019-09-282020-01-030000203527us-gaap:LoansReceivableMembervar:MMProtonILLCMember2020-01-030000203527us-gaap:LoansReceivableMembervar:MMProtonILLCMember2019-09-270000203527us-gaap:LoansReceivableMembervar:RPTCSecuritiesMember2020-01-030000203527us-gaap:LoansReceivableMembervar:RPTCSecuritiesMember2019-09-270000203527us-gaap:LoansReceivableMembervar:ProtonInternationalMember2020-01-030000203527us-gaap:LoansReceivableMembervar:ProtonInternationalMember2019-09-270000203527us-gaap:LoansReceivableMember2020-01-030000203527us-gaap:LoansReceivableMember2019-09-270000203527var:MPTCSubordinatedRevenueBondsMember2020-01-030000203527var:MPTCSubordinatedRevenueBondsMember2019-09-270000203527var:MPTCSubordinatedBondsMember2020-01-030000203527var:MPTCSubordinatedBondsMember2019-09-270000203527var:APTCSecuritiesMember2020-01-030000203527var:APTCSecuritiesMember2019-09-270000203527var:RevolvingLoanMembervar:CPTCMember2020-01-030000203527var:RevolvingLoanMembervar:CPTCMember2019-09-270000203527var:TermLoanMembervar:CPTCMember2019-09-270000203527var:CPTCMember2020-01-030000203527var:CPTCMember2019-09-270000203527var:APTCSecuritiesMember2017-12-012017-12-31iso4217:EUR0000203527var:ProtonCenterMunichMemberus-gaap:LoansReceivableMember2017-07-012017-07-310000203527var:RPTCSecuritiesMember2017-07-310000203527var:RPTCSecuritiesMember2020-01-030000203527var:RPTCSecuritiesMember2019-09-270000203527us-gaap:LoansReceivableMembervar:MMProtonILLCMember2015-07-310000203527var:MMProtonILLCMembervar:SeniorFirstLienLoanMember2016-06-300000203527us-gaap:SeniorSubordinatedLoansMembervar:MMProtonILLCMember2015-07-310000203527us-gaap:SeniorSubordinatedLoansMembervar:MMProtonILLCMember2019-05-010000203527us-gaap:SeniorSubordinatedLoansMembervar:MMProtonILLCMember2020-01-030000203527var:NewYorkProtonCenterMember2020-01-030000203527var:NewYorkProtonCenterMember2019-09-270000203527us-gaap:AvailableforsaleSecuritiesMembervar:MPTCSeriesB2BondsMember2020-01-030000203527us-gaap:AvailableforsaleSecuritiesMembervar:MPTCSeriesB2BondsMembersrt:ScenarioForecastMember2022-01-010000203527us-gaap:AvailableforsaleSecuritiesMembervar:MPTCSeriesB1BondsMember2020-01-030000203527us-gaap:AvailableforsaleSecuritiesMembersrt:ScenarioForecastMembervar:MPTCSeriesB1BondsMember2022-01-010000203527var:MarylandProtonTherapyCenterMPTCMember2020-01-030000203527var:MarylandProtonTherapyCenterMPTCMember2019-09-270000203527var:VarianMedicalSystemsInc.Membervar:CPTCMember2017-03-310000203527var:CPTCMember2016-10-012017-09-290000203527var:CPTCMember2017-12-060000203527us-gaap:LoansReceivableMembervar:CPTCMember2017-12-060000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:CPTCMember2017-12-06var:tranche0000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:TrancheALoansMembervar:CPTCMember2017-12-060000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:TrancheBLoansMembervar:CPTCMember2017-12-060000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:CPTCMembervar:TrancheCLoansMember2017-12-060000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:TrancheDLoansMembervar:CPTCMember2017-12-060000203527var:TermLoanMembervar:CPTCMember2017-12-062017-12-060000203527us-gaap:LoansReceivableMembervar:RevolvingLoanMembervar:CPTCMember2019-09-282020-01-030000203527var:VarianMedicalSystemsInc.Memberus-gaap:LoansReceivableMembervar:RevolvingLoanMembervar:CPTCMember2019-09-282020-01-030000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:CPTCMember2020-01-030000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:TrancheBLoansMembervar:CPTCMember2020-01-030000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:TrancheALoansMembervar:CPTCMember2019-09-282020-01-030000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:TrancheDLoansMembervar:CPTCMember2019-09-282020-01-030000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:CPTCMembervar:TrancheCLoansMember2019-09-282020-01-030000203527var:VarianMedicalSystemsInc.Membervar:TermLoanMembervar:TrancheBLoansMembervar:CPTCMember2019-09-282020-01-030000203527us-gaap:SeniorSubordinatedLoansMembervar:MMProtonILLCMember2015-07-312015-07-31var:segment0000203527us-gaap:OperatingSegmentsMembervar:OncologySystemsMember2019-09-282020-01-030000203527us-gaap:OperatingSegmentsMembervar:OncologySystemsMember2018-09-292018-12-280000203527var:ProtonSolutionsMemberus-gaap:OperatingSegmentsMember2019-09-282020-01-030000203527var:ProtonSolutionsMemberus-gaap:OperatingSegmentsMember2018-09-292018-12-280000203527us-gaap:OperatingSegmentsMember2019-09-282020-01-030000203527us-gaap:OperatingSegmentsMember2018-09-292018-12-280000203527us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2019-09-282020-01-030000203527us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2018-09-292018-12-280000203527us-gaap:CorporateMember2019-09-282020-01-030000203527us-gaap:CorporateMember2018-09-292018-12-280000203527var:OncologySystemsMembervar:HardwareMember2019-09-282020-01-030000203527var:OncologySystemsMembervar:HardwareMember2018-09-292018-12-280000203527var:ProtonSolutionsMembervar:HardwareMember2019-09-282020-01-030000203527var:ProtonSolutionsMembervar:HardwareMember2018-09-292018-12-280000203527us-gaap:AllOtherSegmentsMembervar:HardwareMember2019-09-282020-01-030000203527us-gaap:AllOtherSegmentsMembervar:HardwareMember2018-09-292018-12-280000203527var:HardwareMember2019-09-282020-01-030000203527var:HardwareMember2018-09-292018-12-280000203527var:OncologySystemsMembervar:SoftwareMember2019-09-282020-01-030000203527var:OncologySystemsMembervar:SoftwareMember2018-09-292018-12-280000203527var:ProtonSolutionsMembervar:SoftwareMember2019-09-282020-01-030000203527var:ProtonSolutionsMembervar:SoftwareMember2018-09-292018-12-280000203527var:SoftwareMember2019-09-282020-01-030000203527var:SoftwareMember2018-09-292018-12-280000203527var:OncologySystemsMembervar:ServiceExcludingSoftwareMember2019-09-282020-01-030000203527var:OncologySystemsMembervar:ServiceExcludingSoftwareMember2018-09-292018-12-280000203527var:ProtonSolutionsMembervar:ServiceExcludingSoftwareMember2019-09-282020-01-030000203527var:ProtonSolutionsMembervar:ServiceExcludingSoftwareMember2018-09-292018-12-280000203527var:ServiceExcludingSoftwareMember2019-09-282020-01-030000203527var:ServiceExcludingSoftwareMember2018-09-292018-12-280000203527var:OncologySystemsMembersrt:AmericasMember2019-09-282020-01-030000203527var:OncologySystemsMembersrt:AmericasMember2018-09-292018-12-280000203527var:ProtonSolutionsMembersrt:AmericasMember2019-09-282020-01-030000203527var:ProtonSolutionsMembersrt:AmericasMember2018-09-292018-12-280000203527us-gaap:AllOtherSegmentsMembersrt:AmericasMember2019-09-282020-01-030000203527us-gaap:AllOtherSegmentsMembersrt:AmericasMember2018-09-292018-12-280000203527srt:AmericasMember2019-09-282020-01-030000203527srt:AmericasMember2018-09-292018-12-280000203527var:OncologySystemsMemberus-gaap:EMEAMember2019-09-282020-01-030000203527var:OncologySystemsMemberus-gaap:EMEAMember2018-09-292018-12-280000203527var:ProtonSolutionsMemberus-gaap:EMEAMember2019-09-282020-01-030000203527var:ProtonSolutionsMemberus-gaap:EMEAMember2018-09-292018-12-280000203527us-gaap:AllOtherSegmentsMemberus-gaap:EMEAMember2019-09-282020-01-030000203527us-gaap:AllOtherSegmentsMemberus-gaap:EMEAMember2018-09-292018-12-280000203527us-gaap:EMEAMember2019-09-282020-01-030000203527us-gaap:EMEAMember2018-09-292018-12-280000203527srt:AsiaPacificMembervar:OncologySystemsMember2019-09-282020-01-030000203527srt:AsiaPacificMembervar:OncologySystemsMember2018-09-292018-12-280000203527var:ProtonSolutionsMembersrt:AsiaPacificMember2019-09-282020-01-030000203527var:ProtonSolutionsMembersrt:AsiaPacificMember2018-09-292018-12-280000203527us-gaap:AllOtherSegmentsMembersrt:AsiaPacificMember2019-09-282020-01-030000203527us-gaap:AllOtherSegmentsMembersrt:AsiaPacificMember2018-09-292018-12-280000203527srt:AsiaPacificMember2019-09-282020-01-030000203527srt:AsiaPacificMember2018-09-292018-12-280000203527var:OncologySystemsMembersrt:NorthAmericaMember2019-09-282020-01-030000203527var:OncologySystemsMembersrt:NorthAmericaMember2018-09-292018-12-280000203527var:ProtonSolutionsMembersrt:NorthAmericaMember2019-09-282020-01-030000203527var:ProtonSolutionsMembersrt:NorthAmericaMember2018-09-292018-12-280000203527us-gaap:AllOtherSegmentsMembersrt:NorthAmericaMember2019-09-282020-01-030000203527us-gaap:AllOtherSegmentsMembersrt:NorthAmericaMember2018-09-292018-12-280000203527srt:NorthAmericaMember2019-09-282020-01-030000203527srt:NorthAmericaMember2018-09-292018-12-280000203527var:OncologySystemsMembervar:InternationalExcludingNorthAmericaMember2019-09-282020-01-030000203527var:OncologySystemsMembervar:InternationalExcludingNorthAmericaMember2018-09-292018-12-280000203527var:ProtonSolutionsMembervar:InternationalExcludingNorthAmericaMember2019-09-282020-01-030000203527var:ProtonSolutionsMembervar:InternationalExcludingNorthAmericaMember2018-09-292018-12-280000203527us-gaap:AllOtherSegmentsMembervar:InternationalExcludingNorthAmericaMember2019-09-282020-01-030000203527us-gaap:AllOtherSegmentsMembervar:InternationalExcludingNorthAmericaMember2018-09-292018-12-280000203527var:InternationalExcludingNorthAmericaMember2019-09-282020-01-030000203527var:InternationalExcludingNorthAmericaMember2018-09-292018-12-280000203527us-gaap:TransferredAtPointInTimeMembervar:OncologySystemsMember2019-09-282020-01-030000203527us-gaap:TransferredAtPointInTimeMembervar:OncologySystemsMember2018-09-292018-12-280000203527us-gaap:TransferredAtPointInTimeMemberus-gaap:AllOtherSegmentsMember2019-09-282020-01-030000203527us-gaap:TransferredAtPointInTimeMemberus-gaap:AllOtherSegmentsMember2018-09-292018-12-280000203527us-gaap:TransferredAtPointInTimeMember2019-09-282020-01-030000203527us-gaap:TransferredAtPointInTimeMember2018-09-292018-12-280000203527var:OncologySystemsMemberus-gaap:TransferredOverTimeMember2019-09-282020-01-030000203527var:OncologySystemsMemberus-gaap:TransferredOverTimeMember2018-09-292018-12-280000203527var:ProtonSolutionsMemberus-gaap:TransferredOverTimeMember2019-09-282020-01-030000203527var:ProtonSolutionsMemberus-gaap:TransferredOverTimeMember2018-09-292018-12-280000203527us-gaap:TransferredOverTimeMember2019-09-282020-01-030000203527us-gaap:TransferredOverTimeMember2018-09-292018-12-280000203527var:EmbolicsMicrospheresBusinessMember2019-08-012019-08-310000203527var:CancerTreatmentServicesInternationalMember2019-06-012019-06-280000203527var:CancerTreatmentServicesInternationalMember2019-06-280000203527var:CancerTreatmentServicesInternationalMember2019-09-282020-01-030000203527var:EndocareandAliconMember2019-06-012019-06-280000203527var:EndocareandAliconMember2019-06-280000203527var:EndocareandAliconMember2019-09-282020-01-030000203527var:EndocareandAliconMember2019-06-292019-09-270000203527var:EndocareandAliconMember2020-01-030000203527var:PrivatelyheldCompanyMember2019-03-302019-06-280000203527var:PrivatelyheldCompanyMember2019-06-280000203527var:PrivatelyheldSoftwareCompanyMember2018-09-292018-12-280000203527var:PrivatelyheldSoftwareCompanyMember2019-09-27


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ____________________________________________________________
FORM 10-Q
 ____________________________________________________________
☒QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended January 3, 2020
or
☐TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number 1-7598
  _________________________________________________ 
VARIAN MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
 ____________________________________________________________ 
Delaware94-2359345
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
3100 Hansen Way, Palo Alto, California
94304-1038
(Address of principal executive offices)(Zip Code)
(650) 493-4000
(Registrant’s telephone number, including area code)
___________________________________________________________ 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $1 par value VARNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes  ý    No  ¨
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.  
Large Accelerated Filer ☒  Accelerated filer☐
Non-Accelerated filer ☐  Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No ☒
As of January 31, 2020, the registrant had 90,665,845 shares of common stock, par value $1 per share, outstanding.

1

VARIAN MEDICAL SYSTEMS, INC.
FORM 10-Q for the Quarter Ended January 3, 2020
INDEX
 
Part I.
Item 1.
 
 
 
 
 
Item 2.
Item 3.
Item 4.
Part II.
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.

2

PART I
FINANCIAL INFORMATION

Item 1. Unaudited Financial Statements

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(Unaudited)

 Three Months Ended
 January 3,December 28,
(In millions, except per share amounts)20202018
Revenues:
Product$421.0  $400.2  
Service407.9  340.8  
Total revenues828.9  741.0  
Cost of revenues:   
Product271.9  266.6  
Service190.2  158.3  
Total cost of revenues462.1  424.9  
Gross margin366.8  316.1  
Operating expenses:   
Research and development67.1  60.9  
Selling, general and administrative177.0  141.1  
Acquisition-related expenses12.7  2.4  
Total operating expenses256.8  204.4  
Operating earnings110.0  111.7  
Interest income3.0  3.9  
Interest expense(4.7) (1.2) 
Other income, net4.4  23.0  
Earnings before taxes112.7  137.4  
Taxes on earnings23.8  33.5  
Net earnings88.9  103.9  
Less: Net earnings attributable to noncontrolling interests0.7  0.7  
Net earnings attributable to Varian$88.2  $103.2  
Net earnings per share - basic$0.97  $1.13  
Net earnings per share - diluted$0.96  $1.12  
Shares used in the calculation of net earnings per share:
Weighted average shares outstanding - basic90.9  91.0  
Weighted average shares outstanding - diluted91.7  92.0  

See accompanying notes to the condensed consolidated financial statements.
3

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS
(Unaudited)
 
 Three Months Ended
 January 3,December 28,
(In millions)20202018
Net earnings$88.9  $103.9  
Other comprehensive earnings (loss), net of tax:
Defined benefit pension and post-retirement benefit plans:
Amortization of prior service cost included in net periodic benefit cost, net of tax benefit of $0.0* and $0.0*, respectively
(0.2) (0.2) 
Amortization of net actuarial loss included in net periodic benefit cost, net of tax expense of $(0.2) and $(0.1), respectively
0.9  0.5  
 0.7  0.3  
Derivative instruments:      
Change in unrealized loss, net of tax benefit of $0.0* and $0.0, respectively
(0.1) —  
Reclassification adjustments, net of tax benefit of $0.2 and $0.0, respectively
(0.6) —  
(0.7) —  
Currency translation adjustment5.1  (4.0) 
Other comprehensive earnings (loss)5.1  (3.7) 
Comprehensive earnings94.0  100.2  
Less: Comprehensive earnings attributable to noncontrolling interests0.7  0.7  
Comprehensive earnings attributable to Varian$93.3  $99.5  
 
* Tax expense or benefit related to the periods presented are not material.

See accompanying notes to the condensed consolidated financial statements.
4

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
 January 3,September 27,
(In millions, except par values)20202019
Assets  
Current assets:  
Cash and cash equivalents$721.9  $531.4  
Trade and unbilled receivables, net of allowance for doubtful accounts of $47.0 and $46.5 at January 3, 2020 and September 27, 2019, respectively
1,079.2  1,106.3  
Inventories597.4  551.5  
Prepaid expenses and other current assets248.5  206.2  
Total current assets2,647.0  2,395.4  
Property, plant and equipment, net330.3  311.5  
Operating lease right-of-use assets114.1  —  
Goodwill612.4  612.2  
Intangible assets290.9  300.7  
Deferred tax assets85.7  84.7  
Other assets370.3  397.2  
Total assets$4,450.7  $4,101.7  
Liabilities and Equity
Current liabilities:
Accounts payable$215.3  $248.5  
Accrued liabilities471.2  459.5  
Deferred revenues817.9  766.0  
Short-term borrowings542.0  410.0  
Total current liabilities2,046.4  1,884.0  
Long-term lease liabilities93.7  —  
Other long-term liabilities453.3  440.1  
Total liabilities2,593.4  2,324.1  
Commitments and contingencies (Note 8)
Equity:      
Varian stockholders' equity:
Preferred stock of $1 par value: 1.0 shares authorized; none issued and outstanding
—  —  
Common stock of $1 par value: 189.0 shares authorized; 90.7 and 90.8 shares issued and outstanding at January 3, 2020 and September 27, 2019, respectively
90.7  90.8  
Capital in excess of par value870.4  845.6  
Retained earnings983.2  934.0  
Accumulated other comprehensive loss(97.0) (102.1) 
Total Varian stockholders' equity1,847.3  1,768.3  
Noncontrolling interest10.0  9.3  
Total equity1,857.3  1,777.6  
Total liabilities and equity$4,450.7  $4,101.7  

See accompanying notes to the condensed consolidated financial statements.
5

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 Three Months Ended
 January 3,December 28,
(In millions)20202018
Cash flows from operating activities:  
Net earnings$88.9  $103.9  
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Share-based compensation expense14.9  10.5  
Depreciation15.0  12.8  
Amortization of intangible assets and inventory step-up10.2  4.7  
Gain on sale of equity investments(1.4) (22.0) 
Change in fair value of contingent consideration8.8  —  
Other, net2.7  3.7  
Changes in assets and liabilities, net of effects of acquisitions:   
Trade and unbilled receivables29.5  2.9  
Inventories(44.9) (32.4) 
Prepaid expenses and other assets6.3  8.6  
Accounts payable(32.7) 13.5  
Accrued liabilities and other long-term liabilities(42.1) (12.5) 
Deferred revenues57.4  47.2  
Net cash provided by operating activities112.6  140.9  
Cash flows from investing activities:      
Purchases of property, plant and equipment(22.6) (14.0) 
Acquisitions, net of cash acquired(1.7) (25.5) 
Sale of equity investments9.2  29.9  
Other, net—  (3.5) 
Net cash used in investing activities(15.1) (13.1) 
Cash flows from financing activities:      
Repurchases of common stock(43.8) (34.8) 
Proceeds from issuance of common stock to employees19.7  22.0  
Tax withholdings on vesting of equity awards(3.6) (4.4) 
Borrowings under credit facility agreement11.0  —  
Repayments under credit facility agreement (11.0) —  
Net borrowings under the credit facility agreements with maturities less than 90 days132.0  —  
Other(0.9) —  
Net cash provided by (used in) financing activities103.4  (17.2) 
Effects of exchange rate changes on cash, cash equivalents, and restricted cash(2.8) 1.7  
Net increase in cash, cash equivalents, and restricted cash198.1  112.3  
Cash, cash equivalents, and restricted cash at beginning of period 544.1  516.4  
Cash, cash equivalents, and restricted cash at end of period $742.2  $628.7  

See accompanying notes to the condensed consolidated financial statements.
6

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(Unaudited)
 Common Stock    
(In millions)SharesAmountCapital in Excess of Par ValueRetained EarningsAccumulated Other Comprehensive LossTotal Varian Stockholders' EquityNoncontrolling InterestsTotal Equity
Balance at September 27, 201990.8  $90.8  $845.6  $934.0  $(102.1) $1,768.3  $9.3  $1,777.6  
Net earnings—  —  —  88.2  —  88.2  0.7  88.9  
Other comprehensive earnings—  —  —  —  5.1  5.1  —  5.1  
Issuance of common stock0.3  0.3  20.7  —  —  21.0  —  21.0  
Tax withholdings on vesting of equity awards—  —  (3.6) —  —  (3.6) —  (3.6) 
Share-based compensation expense—  —  14.7  —  —  14.7  —  14.7  
Repurchases of common stock(0.4) (0.4) (7.0) (39.0) —  (46.4) —  (46.4) 
Balances at January 3, 202090.7  $90.7  $870.4  $983.2  $(97.0) $1,847.3  $10.0  $1,857.3  

Balances at September 28, 201891.2  $91.2  $778.1  $780.4  $(65.3) $1,584.4  $4.3  $1,588.7  
Net earnings—  —  —  103.2  —  103.2  0.7  103.9  
Other comprehensive loss—  —  —  —  (3.7) (3.7) —  (3.7) 
Issuance of common stock0.3  0.3  21.7  —  —  22.0  —  22.0  
Tax withholdings on vesting of equity awards—  —  (4.4) —  —  (4.4) —  (4.4) 
Share-based compensation expense—  —  10.5  —  —  10.5  —  10.5  
Repurchases of common stock(0.3) (0.3) (6.6) (27.9) —  (34.8) —  (34.8) 
Other—  —  —  (0.2) —  (0.2) —  (0.2) 
Balances at December 28, 201891.2  $91.2  $799.3  $855.5  $(69.0) $1,677.0  $5.0  $1,682.0  

See accompanying notes to the condensed consolidated financial statements.

7

VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business
The long-term growth and value creation strategy of Varian Medical Systems, Inc. (“VMS”) and subsidiaries (collectively, the “Company”) is to transform the Company from the global leader in radiation therapy to the global leader in multi-disciplinary, integrated cancer care solutions that leverages its clinical experience and strengths in technology development and new product innovation. The Company offers solutions in radiation therapy and medical oncology, as well as interventional oncology, an emerging area of cancer care. The Company designs, manufactures, sells and services hardware and software products for treating cancer with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, and offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolization. Software solutions include treatment planning, informatics, clinical knowledge exchange, patient care management, practice management and decision support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices. The Company also develops, designs, manufactures, sells and services proton therapy products and systems for cancer treatment.

The Company has expanded its services offerings to include clinical practice services that assist within the clinical workflow. These services focus on decision support and/or cancer care knowledge augmentation aimed at facilitating improved accessibility and affordability to care while maintaining a fundamental level of clinical quality. Further, the Company operates ten multi-disciplinary cancer centers and one specialty hospital in India and one multi-disciplinary cancer center in Sri Lanka.
Basis of Presentation
The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of September 27, 2019, was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2019 (the “2019 Annual Report”).

In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s financial position as of January 3, 2020, and September 27, 2019, results of operations and statements of comprehensive earnings for the three months ended January 3, 2020, and December 28, 2018, statements of cash flows for the three months ended January 3, 2020, and December 28, 2018, and statements of equity for the three months ended January 3, 2020, and December 28, 2018. The results of operations for the three months ended January 3, 2020, are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period.
Reclassifications
Certain reclassifications have been made to the amounts in the prior year in order to conform to the current year's presentation.
Fiscal Year
The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September 30. Fiscal year 2020 was the 53-week period ending October 2, 2020. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. The fiscal quarter ended January 3, 2020 was a 14-week period, and the fiscal quarter ended December 28, 2018, was a 13-week period.
Principles of Consolidation
The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation.
8
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
Consolidation of Variable Interest Entities
For entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities, and results of operations of the variable interest entity will be included in the Company’s condensed consolidated financial statements. At January 3, 2020 and September 27, 2019, the Company consolidated its non-controlling interest in a joint venture, included within its Oncology Systems business, related to the Cancer Treatment Services International ("CTSI") operations.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Significant Accounting Policies
With the exception of the change for the accounting of leases as a result of the adoption of Accounting Standard Codification Topic 842, there have been no material changes to the Company's significant accounting policies provided in Note 1, "Summary of Significant Accounting Policies," within Item 8 of the Company's Annual Report on Form 10-K for the year ended September 27, 2019.

Leases

The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represents the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate ("IBR"). The Company recognizes operating leases with lease terms of more than twelve months in operating lease right-of-use assets, accrued liabilities, and long-term lease liabilities on its Condensed Consolidated Balance Sheets.

The Company’s finance leases primarily represent certain sale and leaseback-sublease arrangements. The Company has entered into sale-leaseback arrangements with a third-party finance company for certain equipment and simultaneously subleased the equipment to certain qualified customers. The Company’s leaseback arrangements have been accounted for as finance leases as they meet one or more of the finance lease classification criteria. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets.

For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.

The Company generally does not have adequate information to determine the implicit rate in a lease, therefore the Company uses an estimated IBR. The Company does not maintain a public credit rating and its debt arrangements are unsecured, thus requiring significant judgment to calculate the IBR. The Company uses different data sets to estimate the IBR, including: (i) an estimated indicative credit rating of the Company; (ii) yields on comparable credit rating composite curves; (iii) foreign exchange rates; and (iv) an estimated adjustment for collateral. The Company also applies adjustments to account for considerations related to (i) tenor; and (ii) country credit rating that may not be fully incorporated by the aforementioned data sets.

Certain of the Company’s lease arrangements include variable lease payments. Variable lease payments, not dependent on an index or discount rate, are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments generally include common area maintenance, utilities, maintenance charges, property taxes, insurance, and contingent rent payments. Certain of the Company's arrangements contain clauses that provide for contingent rent payments based on a percentage of revenue share and/or earnings before interest, taxes, depreciation, and amortization.


9
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
The Company combines lease and non-lease components as a single lease component for both its operating and finance leases. In addition, the Company does not record operating and finance lease assets and liabilities for short-term leases, which have an initial term of twelve months or less.

Recently Adopted Accounting Pronouncements
In the first quarter of fiscal year 2020, the Company adopted the Financial Accounting Standards Board ("FASB") standard on accounting for leases, "Leases." The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record ROU assets and corresponding lease liabilities on the balance sheet. The Company adopted this standard under the optional transition method, which applies the standard on the effective date, rather than the earliest comparative period presented in the financial statements. The Company elected: (1) the "package of practical expedients," which does not require the Company to reassess its prior conclusions about lease identification, lease classification, and initial direct costs under the new standard; (2) not to separate non-lease components from lease components; and (3) not to recognize ROU assets and lease liabilities for short-term leases. The Company has implemented internal controls and key system functionalities to enable the preparation of financial information. The primary impact for the Company was the balance sheet recognition of ROU assets and lease liabilities for operating leases as a lessee. See Note 8, "Commitments and Contingencies," for more information on the impact of this adoption on the Company's condensed consolidated financial statements.
In the first quarter of fiscal year 2020, the Company adopted FASB guidance that added the Overnight Index Swap rate based on the Secured Overnight Financing Rate ("SOFR") as a benchmark interest rate for hedge accounting purposes. The amendment recognizes SOFR as a likely LIBOR replacement and supports the marketplace transition by adding the new reference rate as a benchmark interest rate. The Company has not executed interest rate hedges but adopted the amendment prospectively as the Company may consider interest rate hedges in the future. The Company is monitoring the LIBOR to SOFR migration and will coordinate the transition of outstanding LIBOR based debt and any related interest rate derivatives with counterparties when the market is liquid to ensure an orderly and efficient transition.
In the first quarter of fiscal year 2020, the Company adopted FASB guidance that allows companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The impact of adopting this amendment on the Company's condensed consolidated financial statements was not material.
Recent Accounting Standards or Updates Not Yet Effective
In December 2019, the FASB issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the current guidance, and improving the consistent application of and simplification of other areas of the guidance. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.
In August 2018, the FASB amended its guidance for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new standard also requires customers to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. This new standard becomes effective for the Company in the first quarter of fiscal year 2021, with early adoption permitted. This new standard can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements for employers that have sponsor defined benefit pension or other post-retirement plans by removing and adding certain disclosures for these plans. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.

In August 2018, the FASB issued guidance which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures. The standard is effective for the Company beginning in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.

10
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
In June 2016, the FASB issued an amendment to its accounting guidance related to the impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses, rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021, with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
2. OTHER FINANCIAL INFORMATION 
Contracts with Customers
The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers:
(In millions)January 3,
2020		September 27,
2019
Unbilled receivables - current$315.8  $346.7  
Unbilled receivables - long-term (1)
42.7  35.1  
Deferred revenues - current(817.9) (766.0) 
Deferred revenues - long-term (2)
(78.9) (73.1) 
Total net unbilled receivables (deferred revenues)$(538.3) $(457.3) 
(1)Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2)Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.
During the three months ended January 3, 2020, unbilled receivables decreased by $23.3 million, primarily due to the timing of billings in Oncology Systems, and deferred revenues increased by $57.7 million primarily due to the contractual timing of billings occurring before the revenues were recognized.
During the three months ended January 3, 2020 and December 28, 2018, the Company recognized revenues of $314.5 million, and $263.4 million, which were included in the deferred revenues balances at September 27, 2019 and September 28, 2018, respectively.
Unfulfilled Performance Obligations
The following table represents the Company's unfulfilled performance obligations as of January 3, 2020, and the estimated revenues expected to be recognized in the future related to these unfulfilled performance obligations:
Fiscal Years of Revenue Recognition
(In millions)Remainder of 202020212022Thereafter
Unfulfilled Performance Obligations$1,884.1  $2,003.2  $787.7  $2,122.9  
The table above includes both product and service unfulfilled performance obligations, which includes a component of service performance obligations that have not been invoiced. The fiscal years presented reflect management’s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers’ facilities for installation, installation requirements, and availability of products or customer acceptance terms.
Cash, Cash Equivalents, and Restricted Cash
The following table summarizes the Company's cash, cash equivalents and restricted cash:
(In millions)January 3,
2020		September 27,
2019
Cash and cash equivalents$721.9  $531.4  
Restricted cash - current (1)
3.7  4.2  
Restricted cash - long-term (2)
16.6  8.5  
  Total cash, cash equivalents, and restricted cash$742.2  $544.1  
(1)Included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets.
11
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
(2)Included in other assets on the Company's Condensed Consolidated Balance Sheets.
Inventories
The following table summarizes the Company's inventories:
(In millions)January 3,
2020		September 27,
2019
Raw materials and parts$399.8  $376.5  
Work-in-process75.6  71.8  
Finished goods122.0  103.2  
Total inventories$597.4  $551.5  
Other Long-Term Liabilities
The following table summarizes the Company's other long-term liabilities:
(In millions)January 3,
2020		September 27,
2019
Income taxes payable$180.8  $180.3  
Deferred income taxes78.1  75.3  
Deferred revenues78.9  73.1  
Contingent consideration42.5  42.3  
Defined benefit pension plan30.4  31.1  
Other42.6  38.0  
Total other long-term liabilities$453.3  $440.1  
Other Income, Net
The following table summarizes the Company's other income, net:
Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Gain on equity investments$1.4  $22.0  
Net foreign currency exchange gain2.4  1.3  
Other income (loss)0.6  (0.3) 
Total other income, net$4.4  $23.0  

12
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
3. FAIR VALUE
Assets/Liabilities Measured at Fair Value on a Recurring Basis
In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
 Fair Value Measurements at January 3, 2020
Quoted Prices in
Active Markets
for Identical
Instruments		Significant
Other
Observable
Inputs		Significant
Unobservable
Inputs		Total
Type of Instruments(Level 1)(Level 2)(Level 3)Balance
(In millions)    
Assets:    
Cash equivalents:
Money market funds$17.5  $—  $—  $17.5  
Available-for-sale securities:
MPTC Series B-1 Bonds —  27.6  —  27.6  
MPTC Series B-2 Bonds —  25.7  —  25.7  
APTC securities—  6.7  —  6.7  
Derivative assets—  2.3  —  2.3  
Total assets measured at fair value$17.5  $62.3  $—  $79.8  
Liabilities:            
Contingent consideration$—  $—  $(84.3) $(84.3) 
Total liabilities measured at fair value$—  $—  $(84.3) $(84.3) 


Fair Value Measurements at September 27, 2019
Quoted Prices in Active Markets for Identical InstrumentsSignificant
Other
Observable
Inputs		Significant Unobservable InputsTotal
Type of Instruments(Level 1)(Level 2)(Level 3)Balance
(In millions)
Assets:
Cash equivalents:
Money market funds$0.2  $—  $—  $0.2  
Available-for-sale securities:
MPTC Series B-1 Bonds—  27.1  —  27.1  
MPTC Series B-2 Bonds—  25.1  —  25.1  
APTC securities—  6.6  —  6.6  
Derivative assets—  2.8  —  2.8  
Total assets measured at fair value$0.2  $61.6  $—  $61.8  
Liabilities:
Contingent consideration$—  $—  $(75.3) $(75.3) 
Total liabilities measured at fair value$—  $—  $(75.3) $(75.3) 

The Company classifies its money market funds as Level 1 because they have daily liquidity, quoted prices for the underlying investments can be obtained, and there are active markets for the underlying investments. The Company's Level 2 available-for-sale securities consist of bonds for the Maryland Proton Therapy Center ("MPTC") and the Alabama Proton Therapy Center
13
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
(“APTC”). The observable inputs for these securities are comparable bond issues, broker/dealer quotations for the same or similar investments in active markets, and other observable inputs such as yields, credit risks, default rates, and volatility. The Company's available-for-sale securities are included in other assets on the Company's Condensed Consolidated Balance Sheets, except for amounts related to short-term interest receivable. See Note 14, "Proton Solutions Loans and Investments," for further information about the available-for-sale securities. As of January 3, 2020, and September 27, 2019, the carrying amount of the Company's Level 1 money market funds and Level 2 available-for-sale securities approximated their respective fair values.
The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads. The Company’s derivative instruments are generally short-term in nature, typically one month to fifteen months in duration.

The Company generally measures the fair value of its Level 3 contingent consideration liabilities based on Monte Carlo pricing models with key assumptions that include estimated revenues of the acquired business, the probability of completing certain milestone targets during the earn-out period, revenue volatility, and estimated discount rates corresponding to the periods of expected payments. If the estimated revenues or probability of completing certain milestones were to increase or decrease during the respective earn-out period, the fair value of the contingent consideration would increase or decrease, respectively. If the estimated discount rates were to increase or decrease, the fair value of contingent consideration would decrease or increase, respectively. Changes in key assumptions may result in an increase or decrease in the fair value of contingent consideration. The Company's contingent consideration is from its business combinations and is included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets.
The following table presents the reconciliation for liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):
(In millions)Contingent
Consideration
Balance at September 27, 2019$(75.3) 
Adjustments due to the effect of foreign exchange(0.2) 
Change in fair value recognized in earnings(8.8) 
Balance at January 3, 2020$(84.3) 
There were no transfers of assets or liabilities between fair value measurement levels during either the three months ended January 3, 2020, or the three months ended December 28, 2018. Transfers between fair value measurement levels are recognized at the end of the reporting period.
Fair Value of Other Financial Instruments
The fair values of certain of the Company’s financial instruments, including bank deposits included in cash equivalents, trade and unbilled receivables, net of allowance for doubtful accounts, revolving loan to California Proton Therapy Center ("CPTC"), accounts payable, and short-term borrowings approximate their carrying amounts due to their short maturities.
As of January 3, 2020, the fair value of the Term Loan (as defined below) with CPTC approximated its carrying value of $44.0 million. The carrying value is based on the present value of expected future cash payments discounted at a rate reflecting the nature and duration of the loans, risks involved with CPTC, and its industry. As a result, the Term Loan is categorized as Level 3 in the fair value hierarchy. See Note 14, "Proton Solutions Loans and Investments," for further information.
The Company's equity investments in privately-held companies were $56.4 million and $64.2 million at January 3, 2020 and September 27, 2019, respectively.
The fair value of the outstanding long-term notes receivable, including accrued interest, approximated their carrying value of $34.1 million and $33.6 million at January 3, 2020 and September 27, 2019, respectively, because they are based on terms of recent comparable transactions and are categorized as Level 3 in the fair value hierarchy. The fair value is based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks as well as underlying cash flow assumptions. See Note 14, "Proton Solutions Loans and Investments," for information on the long-term notes receivable.

14
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
4. RECEIVABLES
The following table summarizes the Company's trade and unbilled receivables, net, and long-term notes receivable:
(In millions)January 3,
2020		September 27,
2019
Trade and unbilled receivables, gross$1,174.7  $1,193.5  
Allowance for doubtful accounts(47.0) (46.5) 
Trade and unbilled receivables, net$1,127.7  $1,147.0  
Short-term$1,079.2  $1,106.3  
Long-term (1)
$48.5  $40.7  
Long-term notes receivable (1) (2)
$34.1  $33.6  
(1)Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2)Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.
A financing receivable represents a financing arrangement with a contractual right to receive money, on demand or on fixed or determinable dates, and that is recognized as an asset on the Company’s Condensed Consolidated Balance Sheets. The Company’s financing receivables consist of trade receivables with contractual maturities of more than one year and notes receivable. A small portion of the Company's financing trade receivables are included in short-term trade accounts receivable. As of January 3, 2020, and September 27, 2019, the allowance for doubtful accounts is entirely related to short-term trade and unbilled receivables. See Note 14, "Proton Solutions Loans and Investments," for more information on the Company's long-term notes receivable balances.
5. GOODWILL AND INTANGIBLE ASSETS
The following table summarizes the activity of goodwill by reportable operating segment: 
(In millions)Oncology SystemsOther
Total (1)
Balance at September 27, 2019$447.9  $164.3  $612.2  
Business combination0.3  —  0.3  
Measurement period adjustments to business combinations in prior year(0.1) —  (0.1) 
Balance at January 3, 2020$448.1  $164.3  $612.4  
(1)The total carrying value of goodwill at both January 3, 2020, and September 27, 2019 is net of $50.5 million of accumulated impairment charges related to the Company recording an impairment charge for the full value of the Proton Solutions operating segment goodwill in fiscal year 2019.
The following table summarizes the gross carrying amount and accumulated amortization of the Company's intangible assets: 
January 3, 2020September 27, 2019
(In millions)Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Technologies and patents$226.4  $(92.2) $134.2  $226.4  $(85.9) $140.5  
Customer contracts, supplier relationships, and partner relationships121.1  (28.1) 93.0  121.1  (25.7) 95.4  
Trade names55.1  (4.1) 51.0  55.1  (3.0) 52.1  
Other6.1  (6.1) —  6.1  (6.1) —  
Total intangible with finite lives408.7  (130.5) 278.2  408.7  (120.7) 288.0  
In-process research and development with indefinite lives12.7  —  12.7  12.7  —  12.7  
Total intangible assets$421.4  $(130.5) $290.9  $421.4  $(120.7) $300.7  
Amortization expense for intangible assets was $10.1 million and $4.7 million during the three months ended January 3, 2020 and December 28, 2018, respectively.
15
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
As of January 3, 2020, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions):
Fiscal Years:Remaining Amortization Expense  
Remainder of 2020$27.1  
202135.6  
202233.5  
202332.7  
202425.7  
Thereafter123.6  
Total remaining amortization for intangible assets$278.2  

6. BORROWINGS
The following table summarizes the Company's total short-term borrowings:
January 3, 2020September 27, 2019
(In millions, except for percentages)AmountWeighted-Average Interest RateAmountWeighted-Average Interest Rate
Short-term borrowings:
Revolving Credit Facility
$542.0  2.80 %$410.0  3.05 %
Total short-term borrowings$542.0  $410.0  

On November 1, 2019, the Company entered into Amendment No.2 (the "Amendment") to its Credit Agreement dated April 3, 2018, (the "Credit Agreement"), by and among the Company certain lenders party thereto, and Bank of America, N.A., as administrative agent, swing line lender and letter of credit issuer. The Amendment extended the maturity date from April 2023 to November 2024. The Amendment reduced the aggregate principal amount available under Credit Agreement's five-year revolving credit facility (the "Revolving Credit Facility") from $1.8 billion to $1.2 billion, added a $500 million sub-limit for multi-currency borrowings, increased the letter of credit sub-limit from $50.0 million to $225 million, and reduced the commitment fee. In addition, there is a sub-limit for swing line loans of up to $25 million. Under the Revolving Credit Facility, the Company has the right to (i) request to increase the aggregate commitments by an aggregate amount for all such requests of up to $100.0 million and (ii) request an additional increase in the commitments or establish one or more term loans, provided that, in each case, the lenders are willing to provide such new or increased commitments and certain other conditions are met. The proceeds of the Revolving Credit Facility may be used for working capital, capital expenditures, Company share repurchases, permitted acquisitions and other corporate purposes.

Borrowings under the Revolving Credit Facility accrue interest based on either (i) the Eurodollar Rate plus a margin of 1.000% to 1.375% based on a net leverage ratio involving funded indebtedness and EBITDA, or (ii) a base rate of (a) the federal funds rate plus 0.50%, (b) BofA’s announced prime rate, or (c) the Eurodollar Rate plus 1.00%, whichever is highest, plus a margin of 0.000% to 0.375% based on the same leverage ratio, depending upon instructions from the Company. Borrowings under the Eurodollar Rate have a contract repayment date of twelve months, or less. Borrowings under the base rate can be made on an overnight basis and have a final maturity of five years.
The Company must pay a commitment fee on the unused portion of the Revolving Credit Facility at a rate from 0.100% to 0.225% based on a net leverage ratio. The Company may prepay, reduce or terminate the commitments without penalty. Swing line loans under the Revolving Credit Facility will bear interest at the base rate plus the then applicable margin for base rate loans.
The Credit Agreement provides that certain material domestic subsidiaries must guarantee the Revolving Credit Facility, subject to certain limitations on the amount secured. As of January 3, 2020, no subsidiary guarantees were required to be executed under the Credit Agreement.
16
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
The Credit Agreement contains provisions that limit the Company's ability to, among other things, incur future indebtedness, contingent obligations or liens, guarantee indebtedness, make certain investments and capital expenditures, sell stock or assets and pay dividends, and consummate certain mergers or acquisitions.
The Credit Agreement contains affirmative and negative covenants applicable to the Company and its subsidiaries that are typical for credit facilities of this type, and that are subject to materiality and other qualifications, carve-outs, baskets and exceptions. The Company agreed to maintain a financial covenant which requires a maximum consolidated net leverage ratio. The Company was in compliance with all financial covenants under the Credit Agreement for all periods within these condensed consolidated financial statements.
Other Borrowings
VMS’s Japanese subsidiary (“VMS KK”) has an unsecured uncommitted credit agreement with Sumitomo that enables VMS KK to borrow and have outstanding at any given time a maximum of 3.0 billion Japanese Yen (the “Sumitomo Credit Facility”). In February 2019, the Sumitomo Credit Facility was extended and will expire in February 2020. Borrowings under the Sumitomo Credit Facility accrue interest based on the basic loan rate announced by the Bank of Japan plus a margin of 0.5%. As of January 3, 2020, the Company did not have an outstanding principal balance on its Sumitomo Credit Facility.
7. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company measures all derivatives at fair value on the Condensed Consolidated Balance Sheets. The accounting for gains or losses resulting from changes in the fair value of those derivatives depends upon the use of the derivative and whether it qualifies for hedge accounting.
The fair value of derivative instruments reported on the Company's Condensed Consolidated Balance Sheets were as follows:

January 3,
2020		September 27, 2019
(In millions)Balance Sheet
Location		Fair Value
Derivatives designated as hedging instruments:  
Foreign exchange forward contractsPrepaid expenses and other current assets$1.9  $2.8  
Derivatives not designated as hedging instruments:  
Foreign exchange forward contractsPrepaid expenses and other current assets0.4  —  
Total derivatives $2.3  $2.8  
As of September 27, 2019, the fair value of the Company's derivatives not designated as hedging instruments were not material.
Cash Flow Hedging Activities
The Company had the following outstanding foreign currency forward contracts that were entered into to hedge forecasted revenues and designated as cash flow hedges:
January 3, 2020September 27, 2019
(In millions)Notional Value Sold
Euro$52.9  $76.5  
Japanese Yen46.2  56.7  
$99.1  $133.2  

17
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
The following table presents the amounts, before tax, recognized in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets:
Loss Recognized in Other Comprehensive Earnings (Loss)
Three Months Ended
(In millions)January 3, 2020December 28, 2018
Foreign currency forward contracts$(0.1) $—  
As of January 3, 2020, the net unrealized gain on derivatives, before tax, of $1.9 million was included in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets and is expected to be reclassified into net earnings over the next 12 months.
The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings was as follows:
Location and Amount Recognized in Earnings on Cash Flow Hedging Relationships
Three Months Ended
January 3, 2020December 28, 2018
(In millions)Revenues  
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value and cash flow hedges are recorded$828.9  $741.0  
Gain on cash flow hedge relationships:
Foreign currency forward contracts:
Amount of gain reclassified from accumulated other comprehensive loss into net earnings $0.8  $—  
Balance Sheet Hedging Activities
The Company also hedges balance sheet exposures from its various subsidiaries and business units where the U.S. Dollar is the functional currency. For derivative instruments not designated as hedging instruments, changes in their fair values are recognized in other income, net in the Condensed Consolidated Statements of Earnings. Changes in the values of these hedging instruments are offset by changes in the values of foreign-currency-denominated assets and liabilities.

The notional amount of the Company's outstanding foreign currency forward contracts relating to balance sheet hedging activities:
(In millions)January 3,
2020		September 27,
2019
Notional value sold$471.3  $385.0  
Notional value purchased$116.3  $52.3  

The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings related to the foreign currency forward contracts that are not designated as hedging instruments.
Location of Gain (Loss) Recognized in Net Earnings on Derivative InstrumentsAmount of Gain (Loss) Recognized in Net Earnings on Derivative Instruments
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Other income, net$(5.0) $2.8  
The gains (losses) on these derivative instruments were significantly offset by the gains (losses) resulting from the re-measurement of monetary assets and liabilities denominated in currencies other than the U.S. Dollar functional currency.
18
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
8. COMMITMENTS AND CONTINGENCIES
Product Warranty
The following table reflects the changes in the Company’s accrued product warranty:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Accrued product warranty, at beginning of period$43.2  $44.8  
Charged to cost of revenues20.8  13.3  
Actual product warranty expenditures(17.8) (11.8) 
Accrued product warranty, at end of period$46.2  $46.3  
Accrued product warranty was included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets.
Leases
The Company leases its facilities and certain equipment under operating leases. The Company's operating leases have remaining lease terms ranging from less than one year to 19 years. Facilities primarily include general and administrative office space, and space for manufacturing, research and development, and other services. Equipment primarily includes vehicles and various office equipment. The Company's finance leases primarily relate to its sale and leaseback-subleases arrangements for certain equipment and have a remaining lease terms ranging from one year to 8 years.

Lease cost for operating leases is recognized on a straight-line basis over the lease term. Lease cost for finance leases is recognized as amortization of the finance lease ROU asset and interest expense on the finance lease liability over the lease term. The Company also has variable lease cost that primarily relate to its operating leases and include common area maintenance, utilities, maintenance charges, property taxes, insurance, and contingent rent.

The following table summarizes the components of the Company's lease cost:
Three Months Ended
(In millions)January 3, 2020
Operating lease cost$7.8  
Finance lease cost:
Amortization of right-of-use assets0.1  
Interest on lease liabilities0.1  
Variable lease cost4.5  
Total lease cost$12.5  

The following table summarizes the supplemental cash flow information related to the Company's operating leases:
Three Months Ended
(In millions)January 3, 2020
Cash paid for amounts included in the measurement of lease liabilities:
   Operating cash flows for leases$8.8  

19
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
The following table summarizes supplemental balance sheet information related to the Company's operating and finance leases:
(In millions)January 3, 2020
Operating leases:
Operating right-of-use assets$114.1  
Accrued liabilities$24.4  
Long-term lease liabilities93.7  
   Total lease liabilities$118.1  
Finance leases:
Property, plant, and equipment, net$14.3  
Accrued liabilities$3.4  
Other long-term liabilities10.5
Total lease liabilities$13.9  

The following table summarizes the weighted lease term and discount rate by operating and finance leases:
January 3, 2020
Weighted average remaining lease term in years
Operating leases7.0
Finance leases4.8
Weighted average discount rate
Operating leases4.8 %
Finance leases1.5 %

As of January 3, 2020, the future minimum lease payments are as follows:
(In millions)Operating LeasesFinance leases
Remainder of 2020$21.5  $2.9  
202125.8  3.5  
202220.3  2.9  
202315.4  2.9  
202411.8  1.1  
Thereafter51.4  1.1  
  Total minimum lease payments$146.2  $14.4  
Less: imputed interest28.1  0.5  
Total operating lease liability$118.1  $13.9  

At September 27, 2019, the Company was committed to minimum rentals under non-cancellable operating leases (including rent escalation clauses) for fiscal years 2020 through 2024 and thereafter, as determined under the prior accounting guidance of Accounting Standard Codification 840, as follows: $32.5 million, $26.3 million, $20.2 million, $14.5 million, $10.9 million and $49.9 million, respectively.

Lessor Arrangements
The Company leases some of its equipment to certain customers on operating leases generally over a period of 15 years. As of January 3, 2020, the Company had $22.6 million and $6.4 million included in property, plant and equipment and accumulated depreciation, respectively, related to equipment leased to customers. As of September 27, 2019, the Company had $22.5 million and $5.5 million included in property, plant and equipment and accumulated depreciation, respectively, related to equipment
20
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
leased to customers. The Company recorded income of $2.5 million and $2.1 million during the three months ended January 3, 2020 and December 28, 2018, respectively, on these equipment leases.
Contingencies
Environmental Remediation Liabilities
The Company’s operations and facilities, past and present, are subject to environmental laws, including laws that regulate the handling, storage, transport and disposal of hazardous substances. Certain of those laws impose cleanup liabilities on the Company in connection with its past and present operations. Those include facilities sold as part of the Company’s electron devices business in 1995 and thin film systems business in 1997. As a result, the Company oversees various environmental cleanup projects and receives reimbursements from third parties for a portion of the costs of its cleanup activities.

As of January 3, 2020 and September 27, 2019, the Company had accrued $4.7 million and $4.8 million, respectively, net of third parties' indemnification obligations, for environmental remediation liabilities. The Company believes its reserve is adequate; however, as the scope of the Company’s obligations becomes more clearly defined, the Company may modify the reserve, and charge or credit future earnings accordingly. Based on information currently known to management, management believes the costs of these environmental-related matters are not reasonably likely to have a material adverse effect on the consolidated financial statements of the Company in any one fiscal year.
The Company also reimburses certain third parties for cleanup activities. The amount the Company spent on environmental cleanup costs, third-party claim costs, project management costs and legal costs in the three months January 3, 2020 and December 28, 2018, was not material.
Other Matters
On October 16, 2018, Best Medical International, Inc. sued the Company in U.S. District Court in the District of Delaware, alleging infringement of four patents related to treatment planning. The Company intends to defend the suit vigorously. This lawsuit is in the initial stages, and at this time, the Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure. Therefore, no amounts have been accrued as of January 3, 2020.
From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations and other legal matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value). A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. 
In addition to the above, the Company is involved in other legal matters. However, such matters are subject to many uncertainties, and outcomes are not predictable with assurance. The Company is unable to estimate a loss or a range of reasonably possible losses with respect to such matters. There can be no assurances as to whether the Company will become subject to significant additional claims and liabilities with respect to ongoing or future proceedings. If actual liabilities significantly exceed the estimates made, the Company’s consolidated financial position, results of operations or cash flows could be materially adversely affected. Legal expenses relating to legal matters are expensed as incurred.
9. RETIREMENT PLANS
The Company sponsors multiple defined benefit pension plans for regular full-time employees in Germany, Japan, Switzerland and the United Kingdom. The Company also sponsors a post-retirement benefit plan that provides healthcare benefits to certain eligible retirees in the United States.
21
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
The components of net periodic benefit costs were as follows:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Defined Benefit Plans  
Service cost$2.5  $1.8  
Interest cost0.5  0.9  
Expected return on plan assets(1.9) (1.6) 
Amortization of prior service cost(0.2) (0.2) 
Recognized actuarial loss1.1  0.6  
Net periodic benefit cost$2.0  $1.5  

10. INCOME TAXES
The Company’s effective tax rate was 21.0% and 24.4% for the three months ended January 3, 2020 and December 28, 2018, respectively. The Company’s effective tax rate is lower in the three months ended January 3, 2020 as compared to the year-ago period, primarily because the prior period included the tax effect of a change in law due to the enactment of the Tax Cuts and Jobs Act, which was signed into law on December 22, 2017.

The Company’s effective income tax rate differs from the U.S. federal statutory rate primarily because the Company’s foreign earnings are taxed at rates that are, on average, lower than the U.S. federal rate, and because the Company’s domestic earnings are subject to state income taxes. The total amount of unrecognized tax benefits did not materially change during the three months ended January 3, 2020; however, the amount of unrecognized tax benefits has increased as a result of positions taken during the current and prior years and has decreased as the result of the expiration of the statutes of limitation in various jurisdictions.
11. STOCKHOLDERS’ EQUITY
Share Repurchase Program
In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. Share repurchases under the Company's authorizations may be made in open market purchases, in privately negotiated transactions (including accelerated share repurchase programs), or under Rule 10b5-1 share repurchase plans, and may be made from time to time in one or more blocks. All shares that were repurchased under the Company's share repurchase programs have been retired. As of January 3, 2020, approximately 1.9 million shares of VMS common stock remained available for repurchase under the November 2016 authorization.
The Company repurchased shares of VMS common stock during the periods presented as follows:
Three Months Ended
(In millions, except per share amounts)January 3,
2020		December 28,
2018
Number of shares0.3  0.3  
Average repurchase price per share$139.67  $108.90  
Total cost of shares repurchased$46.4  $34.8  
22
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
Accumulated Other Comprehensive Loss
The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:
(In millions)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans		Net
Unrealized
Gains
Cash Flow
Hedging
Instruments		Cumulative
Translation
Adjustment		Accumulated
Other
Comprehensive
Loss
Balance at September 27, 2019$(61.7) $2.1  $(42.5) $(102.1) 
Other comprehensive earnings (loss) before reclassifications—  (0.1) 5.1  5.0  
Amounts reclassified out of other comprehensive earnings (loss)0.9  (0.8) —  0.1  
Tax (expense) benefit(0.2) 0.2  —  —  
Balance at January 3, 2020$(61.0) $1.4  $(37.4) $(97.0) 

(In millions)Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans		Cumulative
Translation
Adjustment		Accumulated
Other
Comprehensive Loss
Balance at September 28, 2018$(35.2) $(30.1) $(65.3) 
Other comprehensive earnings (loss) before reclassifications—  (4.0) (4.0) 
Amounts reclassified out of other comprehensive earnings (loss)0.4  —  0.4  
Tax expense(0.1) —  (0.1) 
Balance at December 28, 2018$(34.9) $(34.1) $(69.0) 

The amounts reclassified, before taxes, out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings, with line item location, during each period were as follows: 

(In millions)Three Months Ended
Comprehensive Earnings (Loss) ComponentsJanuary 3,
2020		December 28,
2018		Line Item in Statements of Earnings
Unrealized loss on defined benefit pension and post-retirement benefit plans$(0.9) $(0.4) Other income, net
Unrealized earnings on cash flow hedging instruments0.8  —  Revenues
Total amounts reclassified out of other comprehensive earnings (loss)$(0.1) $(0.4)  
 
23
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
12. EMPLOYEE STOCK PLANS
The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Cost of revenues - Product$0.8  $0.7  
Cost of revenues - Service1.3  1.1  
Research and development1.2  1.1  
Selling, general and administrative11.6  7.6  
Total share-based compensation expense$14.9  $10.5  
Income tax benefit for share-based compensation$(2.9) $(2.3) 

The fair value of stock options and performance stock options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 Three Months Ended
January 3,
2020		December 28,
2018
Employee Stock Option Plans  
Expected term (in years)3.83.8
Risk-free interest rate1.6 %2.9 %
Expected volatility26.0 %22.2 %
Expected dividend— %— %
Weighted average fair value at grant date (1)
$29.42  $25.87  
(1)Excludes the fair value of the market condition based on a relative total shareholder return for the performance stock options granted during the period.

The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 Three Months Ended
January 3,
2020		December 28,
2018
Employee Stock Purchase Plan  
Expected term (in years)0.50.5
Risk-free interest rate1.6 %2.5 %
Expected volatility26.4 %18.6 %
Expected dividend— %— %
Weighted average fair value at grant date$27.58  $22.82  

24
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
The activity for stock options and performance stock options is summarized as follows: 
 Options Outstanding
(In millions, except per share amounts)Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Term (in years)
Aggregate
Intrinsic
Value (1)
Balance at September 27, 20192.2  $97.66    
Granted0.1  131.34    
Cancelled or expired—  99.35    
Exercised(0.1) 82.03    
Balance at January 3, 20202.2  $101.01  4.6$98.0  
Exercisable at January 3, 20201.1  $82.38  3.4$68.2  
(1)The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of $144.93 as of January 3, 2020, the last trading date of the first quarter of fiscal year 2020, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date..
As of January 3, 2020, there was $20.7 million of total unrecognized compensation expense related to stock options and performance stock options granted under the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of 2.1 years.
As of January 3, 2020 there was $0.6 million of total unrecognized compensation expense related to cash-settled stock appreciation rights granted outside the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of 2.2 years.
The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:
(In millions, except per share amounts)Number of
Shares		Weighted Average
Grant-Date Fair
Value
Balance at September 27, 20190.7  $108.35  
Granted0.1  140.74  
Vested(0.1) 84.99  
Cancelled or expired


(0.1) 117.11  
Balance at January 3, 20200.6  $115.82  

As of January 3, 2020, unrecognized compensation expense totaling $43.7 million was related to awards of restricted stock units, deferred stock units and performance units granted under the Company's employee stock plans. This unrecognized share-based compensation expense is expected to be recognized over a weighted average period of 2.0 years.
25
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
13. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted net earnings per share:
 Three Months Ended
(In millions, except per share amounts)January 3,
2020		December 28,
2018
Net earnings$88.9  $103.9  
Less: Net earnings attributable to noncontrolling interests0.7  0.7  
Net earnings attributable to Varian $88.2  $103.2  
Denominator:
Weighted average shares outstanding - basic90.9  91.0  
Dilutive effect of potential common shares0.8  1.0  
Weighted average shares outstanding - diluted91.7  92.0  
Net earnings per share attributable to Varian - basic$0.97  $1.13  
Net earnings per share attributable to Varian - diluted$0.96  $1.12  
Anti-dilutive employee share-based awards, excluded0.8  0.9  

14. PROTON SOLUTIONS LOANS AND INVESTMENTS
In limited cases, the Company participates, along with other investors and at market terms, in the financing of proton therapy centers. Over time, the Company has divested some of its investments, including investments in CPTC, the New York Proton Center ("NYPC"), the Georgia Proton Treatment Center and the Delray Radiation Therapy Center.
The following table lists the Company's notes receivable, including accrued interest, senior secured debt, available-for-sale securities, loans outstanding and future commitments for funding the development, construction and operation of various proton therapy centers:
January 3, 2020September 27, 2019
(In millions)BalanceCommitment BalanceCommitment
Notes Receivable and Secured Debt: (1)
NYPC loan$32.3  $—  $31.8  $—  
RPTC senior secured debt24.0  —  23.5  —  
Proton International LLC loan1.8  —  1.8  —  
$58.1  $—  $57.1  $—  
Available-For-Sale Securities: (1)
MPTC Series B-1 Bonds  $27.6  $—  $27.1  $—  
MPTC Series B-2 Bonds   25.7  —  25.1  —  
APTC securities  6.7  —  6.6  —  
$60.0  $—  $58.8  $—  
CPTC Loans and Investment:
Short-term revolving loan (2)
$5.3  $1.9  $5.3  $1.9  
Term loan (3)
44.0  —  44.0  —  
$49.3  $1.9  $49.3  $1.9  
(1)Included in other assets at January 3, 2020 and September 27, 2019 on the Company's Condensed Consolidated Balance Sheets, except for amounts related to short-term interest receivable.
(2)Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets.
(3)Included in prepaid and other current assets at January 3, 2020 and other assets at September 27, 2019 on the Company's Condensed Consolidated Balance Sheets.
26
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
Alabama Proton Therapy Center ("APTC") Securities
In December 2017, the Company purchased $6.0 million in Subordinate Revenue Bonds, which financed the APTC. The Subordinate Revenue Bonds carry an interest rate of 8.5% and pay interest semi-annually. The Company is scheduled to start receiving annual principal payments on the Subordinate Revenue Bonds beginning on November 1, 2022. The Subordinate Revenue Bonds will mature on October 1, 2047.
At January 3, 2020 and September 27, 2019, the Company had $3.9 million and $2.1 million, respectively, in long-term unbilled receivables from APTC.
Rinecker Proton Therapy Center ("RPTC") Senior Secured Debt
In July 2017, the Company purchased the outstanding senior secured debt related to the RPTC in Munich, Germany for €21.5 million or $24.5 million. By purchasing the senior secured debt, the Company has a right to approximately 77 million Euros in claims against all of RPTC's assets. In September 2017, the management of RPTC filed for bankruptcy in Germany. In January 2018, the final insolvency proceedings commenced, and in December 2019 the center closed for clinical operations and decommissioning began. Upon finalization of bankruptcy proceedings, the Company believes it is probable it will recover the outstanding senior secured debt balance and trade accounts receivable, net. The Company classified its senior secured debt as long-term other assets because it expects the bankruptcy proceedings to be complete in greater than one year.
At January 3, 2020 and September 27, 2019, the Company had $4.2 million and $4.6 million, respectively, in long-term trade receivables, net, from RPTC, which does not include any unbilled receivables.
New York Proton Center ("NYPC") Loan
In July 2015, the Company committed to loan up to $91.5 million to MM Proton I, LLC. In June 2016, the Company assigned $73.0 million of this loan to Deutsche Bank AG. The remaining balance is comprised of an $18.5 million “Subordinate Loan” with a six-and-a-half-year term at up to 13.5% interest. In December 2019, the interest rate on the loan was reduced to 10%, effective May 1, 2019. As of January 3, 2020, the Subordinate Loan is $32.3 million, including accrued interest. The principal balance and accrued interest on the Subordinate Loan are due in full at maturity in January 2022.
At January 3, 2020 and September 27, 2019, the Company had $18.0 million and $16.6 million, respectively, in trade and unbilled receivables, which included $6.4 million and $6.0 million in unbilled receivables, respectively, from NYPC.
Maryland Proton Treatment Center ("MPTC") Securities
The Company has Subordinate Revenue Bonds ("MPTC Series B-2 Bonds") that carry an interest rate of 8.5% per annum with interest accruing up to the MPTC Series B-2 Bonds face amount of $33.9 million until January 1, 2022 and then will pay cash interest semi-annually. The MPTC Series B-2 Bonds will mature on January 1, 2049. The Company also has Subordinate Revenue Bonds ("MPTC Series B-1 Bonds") that carry an interest rate of 7.5% with interest accruing up to the MPTC Series B-1 Bonds face amount of $32.0 million on January 1, 2022 and then will pay cash interest semi-annually. The MPTC Series B-1 Bonds will mature on January 1, 2048. The MPTC Series B-1 Bonds are senior in right and time to the MPTC Series B-2 Bonds.
At January 3, 2020 and September 27, 2019, the Company had zero net trade and unbilled receivables from MPTC.
Variable Interest Entities
The Company has determined that MM Proton I, LLC and RPTC are variable interest entities and that the Company holds a significant variable interest of each of the entities through its participation in the loan facilities and its agreements to supply and service the proton therapy equipment. The Company has concluded that it is not the primary beneficiary of any of these entities. The Company has no voting rights, has no approval authority or veto rights for these centers' budget, and does not have the power to direct patient recruitment, clinical operations and management of these Centers, which the Company believes are the matters that most significantly affect their economic performance. The Company’s exposure to loss as a result of its
27
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
involvement with MM Proton I, LLC and RPTC is limited to the carrying amounts of the above-mentioned assets on its Condensed Consolidated Balance Sheets.
California Proton Therapy Center ("CPTC") Loans and Investment
Between September 2011 and November 2015, the Company, ORIX and J.P. Morgan (the "Lenders”) funded loans (“Original CPTC Loans”) to the Scripps Proton Therapy Center in San Diego, California. ORIX is the loan agent.
In March 2017, California Proton Treatment Center, LLC ("Original CPTC") filed for bankruptcy and concurrently entered into a Debtor-in-Possession Facility (the "DIP Facility") with the Lenders where the Company's pro-rata share of the DIP Facility was $7.3 million. In September 2017, the Lenders and Scripps signed a Transition Agreement to transition the operations of the center from Scripps to Proton Doctors Professional Corporation. As a result of these events, the Company recorded an impairment charge of $51.4 million to its Original CPTC Loans in fiscal year 2017.
Pursuant to an order of the Bankruptcy Court, the California Proton Treatment Center ("Original CPTC") conducted an auction of the Scripps Proton Therapy Center. On December 6, 2017 (“Closing Date”), the Bankruptcy Court approved the sale of Scripps Proton Therapy Center to California Proton Therapy Center, LLC (“CPTC”), an entity owned by the Lenders. The Lenders purchased all assets and assumed $112.0 million of Original CPTC’s outstanding liabilities. On December 13, 2017, the Bankruptcy Court dismissed the bankruptcy filing of Original CPTC.
On the Closing Date, the Lenders entered into a Credit Agreement with Original CPTC of which the terms of the Original CPTC Loans, DIP Facility and accrued interest (collectively “Former Loans”) have been modified. In addition to the partially satisfied Original CPTC Loans reinstated by the Bankruptcy Court, the Company received a 47.08% equity ownership in CPTC, which it sold for a nominal amount in March 2019. Original CPTC has assigned all its Former Loans to CPTC at an amount of $112.0 million, the partially satisfied loan balance. Per the terms of the Credit Agreement, the Company's portion of the $112.0 million is $53.5 million; the remainder is allocated between ORIX and J.P. Morgan. The $53.5 million is composed of four tranches: Tranche A of $2.0 million, Tranche B of $7.2 million, Tranche C of $15.6 million, and Tranche D of $28.7 million (collectively, the "Term Loan"). The maturity date of the Term Loan is three years from the Closing Date. The Term Loan is secured by the assets of CPTC.
In addition, the Lenders have committed to lend up to $15.0 million in a Revolving Loan with a maturity date of one year from the Closing Date. In the first quarters of fiscal 2019, fiscal 2020 and subsequent to the end of the first quarter of fiscal 2020, as provided in the initial agreement, the Lenders have granted extensions to the term of the Revolving Loan with a current maturity of June 30, 2020. The Company's share of the funding commitment from the Revolving Loan is $7.2 million, and as of January 3, 2020, the Company has funded $5.3 million.
All of the tranches accrue paid-in-kind interest at 7.5% per annum, except the Tranche B and the Revolving Loan, which accrue paid-in-kind interest at 10% per annum. The seniority of these loans is as follows: Revolving Loan, Tranche A, Tranche B, Tranche C and Tranche D. If CPTC is in default, the interest rate of the Tranche A, C and D will increase to 9.5% and the interest rate on the Tranche B and the Revolving Loan will increase to 12.0%.
The Company believes it is probable that it will collect the amounts owed under the Term Loan and Revolving Loan when due based on CPTC’s current operating plan. This plan includes an increase in patient volume, partnership with a significant clinical partner, and maintenance of its current reimbursement structure. In July 2019, the Centers for Medicare and Medicaid Services ("CMS") proposed an alternative payment model (or “APM”) pilot program for radiation oncology. This proposed APM could materially impact the reimbursement to CPTC for its services. CPTC's inability to execute its operating plan, as well as finalization of the proposed APM as currently drafted could negatively impact CPTC's ability to repay or refinance the debt when it comes due, which may result in an impairment of the loan receivable; this impairment could be material.
At January 3, 2020, and September 27, 2019, the Company had $2.9 million and $2.6 million, respectively, in trade receivables, net, from CPTC.
Further, the Company has determined that CPTC is a variable interest entity because of the Company's participation in the loan facilities, and its operations and maintenance agreement. The Company has no special approval authority or veto rights for CPTC’s budget, and does not have the power to direct patient recruitment, clinical operations and management of CPTC, which the Company believes are the matters that most significantly affect their economic performance. Therefore, the Company does not have majority voting rights and no power to direct activities at CPTC, and as a result it is not the primary beneficiary of CPTC.
28
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
15. SEGMENT INFORMATION
The Company has two reportable operating segments: Oncology Systems and Proton Solutions. The Company's Interventional Solutions business is reflected in the "Other" category because it does not meet the criteria for a reportable operating segment. The operating segments were determined based on how the Company’s Chief Executive Officer, its Chief Operating Decision Maker (“CODM”), views and evaluates the Company’s operations. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings.
Description of Segments
The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments such as fixed field intensity-modulated radiation therapy (“IMRT”), image-guided radiation therapy (“IGRT”), volumetric modulated arc therapy ("VMAT"), stereotactic radiosurgery (“SRS”), stereotactic body radiotherapy (“SBRT”) and brachytherapy as well as associated quality assurance equipment.
The Oncology Systems’ hardware products include linear accelerators, brachytherapy afterloaders, treatment accessories, artificial intelligence-powered adaptive delivery systems and quality assurance software. The Oncology Systems’ software solutions include treatment planning, informatics, clinical knowledge exchange, patient care management, practice management and decision support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices.
Oncology Systems’ products enable radiation oncology departments in hospitals and clinics to perform conventional radiotherapy treatments and offer advanced treatments such as IMRT, IGRT, VMAT, SRS and SBRT, and treat patients using brachytherapy techniques, which involve the introduction or temporary insertion of radioactive sources. The Oncology Systems' products are also used by surgeons and radiation oncologists to perform stereotactic radiosurgery and by medical oncology departments to manage patient treatments. Oncology Systems’ customers worldwide include university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices, medical oncology practices, radiotherapy centers and cancer care clinics.
The Oncology Systems segment offers services ranging from hardware phone support, break/fix repair of linear accelerators, obsolescence protection of hardware, software support, software upgrades, hosting as a service, as well as clinical consulting services.

The Oncology Systems segment also provides clinical practice services that assist within the clinical workflow. These services focus on decision support and/or cancer care knowledge augmentation aimed at facilitating improved accessibility and affordability to care while maintaining a fundamental level of clinical quality. Further, the Company operates ten multi-disciplinary cancer centers and one specialty hospital in India and one multi-disciplinary cancer center in Sri Lanka.
The Proton Solutions segment develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams, for the treatment of cancer.
The Other category primarily includes the Interventional Solutions business, which offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolization. Interventional Solutions also provides software and remote services for post treatment dose calculation for Yttrium-90 microspheres used in selective internal radiation therapy. The Other category also includes assets related to the use of radiation in the heart and other forms of radiosurgery for cardiovascular disease.
The following information is provided for the purpose of achieving an understanding of operations but may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.
The Company allocates corporate costs to its operating segments based on the relative revenues of Oncology Systems, Proton Solutions and Interventional Solutions. The Company allocates these costs, excluding certain corporate related costs, transactions or adjustments that the Company's CODM considers to be non-operational, such as restructuring and impairment charges, significant litigation charges or benefits and legal costs, and acquisition-related expenses and in process research and development. Although the Company excludes these amounts from segment operating earnings, they are included in the condensed consolidated operating earnings and included in the reconciliation below.
29
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
The following table summarizes select financial results for each reportable segment:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Revenues  
Oncology Systems$782.4  $702.5  
Proton Solutions27.6  38.5  
Total reportable segments810.0  741.0  
Other 18.9  —  
Total Company$828.9  $741.0  
Earnings from continuing operations before taxes       
Oncology Systems$136.4  $124.1  
Proton Solutions(14.3) (8.8) 
Total reportable segments122.1  115.3  
Other2.8  —  
Unallocated corporate (14.9) (3.6) 
Operating earnings110.0  111.7  
Interest income (expense), net(1.7) 2.7  
Other income, net4.4  23.0  
Total Company$112.7  $137.4  
Disaggregation of Revenues
The Company disaggregates its revenues from contracts by major product categories, geographic region, and by timing of revenue recognition for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.
Revenues by Product Type
Three Months Ended
Total Revenues by Product TypeJanuary 3,December 28,
(In millions)20202018
Hardware
Oncology Systems$320.0  $313.6  
Proton Solutions20.1  33.6  
Other18.9  —  
Total Hardware359.0  347.2  
Software (1)
Oncology Systems148.8  131.2  
Proton Solutions—  —  
Total Software148.8  131.2  
Service
Oncology Systems313.6  257.7  
Proton Solutions7.5  4.9  
Total Service321.1  262.6  
Total Revenues$828.9  $741.0  
(1) Includes software support agreements that are recorded in revenues from service, and software licenses that are recorded in revenues from product in the Condensed Consolidated Statements of Earnings.

30
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
Revenues by Geographical Region
Three Months Ended
Total Revenues by Geographical RegionJanuary 3,December 28,
(In millions)20202018
Americas
Oncology Systems$378.9  $330.8  
Proton Solutions16.9  19.6  
Other6.4  —  
Total Americas402.2  350.4  
EMEA
Oncology Systems259.8  234.5  
Proton Solutions10.3  16.5  
Other2.8  —  
Total EMEA272.9  251.0  
APAC
Oncology Systems143.7  137.2  
Proton Solutions0.4  2.4  
Other9.7  —  
Total APAC153.8  139.6  
Total Revenues$828.9  $741.0  
North America (1)
Oncology Systems$355.2  $309.1  
Proton Solutions16.9  19.6  
Other6.4  —  
Total North America378.5  328.7  
International
Oncology Systems427.2  393.4  
Proton Solutions10.7  18.9  
Other12.5  —  
Total International450.4  412.3  
Total Revenues$828.9  $741.0  
(1)North America primarily includes the United States and Canada.
Revenues by Timing of Revenue Recognition
Three Months Ended
Timing of revenue recognitionJanuary 3,December 28,
(In millions)20202018
Products transferred at a point in time
Oncology Systems$382.0  $366.6  
Other18.9  —  
Total products transferred at a point in time400.9  366.6  
Products and services transferred over time
Oncology Systems400.4  335.9  
Proton Solutions27.6  38.5  
Total products and services transferred over time428.0  374.4  
Total Revenues$828.9  $741.0  

31
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
16. BUSINESS COMBINATIONS
Business Combinations in Fiscal Year 2020
The Company completed an acquisition in its Oncology Systems business that was not material in the first quarter of fiscal year 2020. The acquisition was comprised of goodwill and assets acquired. The purchase accounting from this transaction is not yet finalized.

Business Combinations in Fiscal Year 2019
Assets acquired from Boston Scientific
In August 2019, the Company acquired Boston Scientific's embolics microspheres business, for treating arteriovenous malformations and hypervascular tumors, for a purchase price of $90.0 million in cash consideration. The assets from this purchase are included in the Company's Interventional Solutions business, which is included in the Other category. The purchase accounting from this transaction has been finalized.

Cancer Treatment Services International
In June 2019, the Company acquired CTSI, a privately-held company for a purchase price of $277.0 million, consisting of $262.8 million of cash consideration, $8.2 million of contingent consideration, and $6.0 million of other consideration. The undiscounted range of the contingent consideration payments is zero to $58 million and is based on actual revenues over the 18 months following the acquisition date. There have been no changes this quarter to the fair value of the contingent consideration included in the initial purchase price. The Company has included this acquisition in its Oncology Systems business. The purchase accounting from this transaction is not yet finalized. The Company recorded a measurement period adjustment in the first quarter of fiscal year 2020 that was not material.

Endocare and Alicon
In June 2019, the Company acquired Endocare and Alicon for a combined purchase price of $210.0 million consisting of $197.4 million of cash consideration and $12.6 million of contingent consideration. The undiscounted range of the contingent consideration payments is zero to $40 million and is based on actual revenues through March 2020. Due to better than expected actual and projected financial performance for Endocare and Alicon, as well as a change in the expected mix of products, the Company recorded an $8.8 million increase in the fair value of contingent consideration in the first quarter of fiscal year 2020, in addition to a $18.6 million increase in the fair value of the contingent consideration recorded in the fourth quarter of fiscal year 2019. The Company has recorded a total of $40.0 million in contingent consideration related to the Endocare and Alicon acquisitions, which is expected to be paid in fiscal year 2020. These acquisitions are included in the Company's Interventional Solutions business, which is included in the Other category. The purchase accounting from this transaction is not yet finalized. The Company has not recorded any measurement period adjustments this quarter.

Other Acquisitions in Fiscal Year 2019
In the third quarter of fiscal year 2019, the Company purchased a privately-held company for a cash purchase price of $15.2 million, including a holdback of $3.6 million and contingent consideration. At the closing date, the value of the contingent consideration was zero because none of the milestones were probable to be achieved however, the Company could potentially pay up to approximately $9 million by 2023 if certain milestones were met plus additional payments for achieving revenue targets through 2035. The acquisition was classified as an asset acquisition. This acquisition is included in the Other category.
In the first quarter of fiscal year 2019, the Company acquired a privately-held software company for a purchase price of $28.5 million. The acquisition primarily consisted of $21.9 million in goodwill and $6.5 million in finite-lived intangible assets. The Company integrated this acquisition into its Oncology Systems reporting unit.
Other Information
The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount. The Company believes the factors that contributed to goodwill in its completed acquisitions include synergies not available to market participants, as well as the acquisition of a talented workforce.

The fair value of assets acquired and liabilities assumed has been determined on a preliminary basis for acquisitions completed in the current year and certain acquisitions in the previous fiscal year. The Company will finalize these amounts as it obtains the
32
VARIAN MEDICAL SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(Unaudited)
information necessary to complete the measurement process. Any changes resulting from facts and circumstances that existed as of the date of a business combination may result in certain adjustments. The Company expects to finalize these amounts no later than one year from the date of each business combination.

The condensed consolidated financial statements include the operating results from the date the above businesses were acquired. Pro forma results of operations for the completed acquisitions have not been presented because the effects were not material to the Company's condensed consolidated financial statements.

The Company incurred acquisition transaction costs of $3.9 million and $2.4 million during the three months ended January 3, 2020 and December 28, 2018, respectively.

33

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, which provides a “safe harbor” for statements about future events, products and future financial performance that are based on the beliefs of, estimates made by, and information currently available to the management of Varian Medical Systems, Inc. (“VMS”) and its subsidiaries (collectively “we,” “our” or the “Company”). The outcome of the events described in these forward-looking statements is subject to risks and uncertainties. Actual results and the outcome or timing of certain events may differ significantly from those projected in these forward-looking statements or management’s current expectations due to the factors cited in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”), the Risk Factors listed under Part II, Item 1A of this Quarterly Report on Form 10-Q, and other factors described from time to time in our other filings with the Securities and Exchange Commission (“SEC”), or other reasons. For this purpose, statements concerning: growth strategies; industry or market segment outlook; economic and market conditions; domestic and global trends; development, market acceptance of or transition to new products, technologies, solutions or services; growth drivers; future orders, revenues, operating expenses, tax rate, cash flows, backlog, earnings growth or other financial results; expected capital expenditures; new and potential future tariffs and exclusions therefrom or cross-border trade restrictions; currency fluctuation, changes in political, regulatory, safety or economic conditions; and any statements using the terms “believe,” “expect,” “anticipate,” “can,” “should,” “would,” “could,” “estimate,” “may,” “intended,” “potential,” and “possible” or similar statements are forward-looking statements that involve risks and uncertainties that could cause our actual results and the outcome and timing of certain events to differ materially from those projected or management’s current expectations. By making forward-looking statements, we have not assumed any obligation to, and you should not expect us to, update or revise those statements because of new information, future events or otherwise.
This discussion and analysis of our financial condition and results of operations is based upon and should be read in conjunction with the Condensed Consolidated Financial Statements and the Notes included elsewhere in this Quarterly Report on Form 10-Q and the Consolidated Financial Statements, the Notes to the Consolidated Financial Statements and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended September 27, 2019 (the “2019 Annual Report”), as well as the information contained under Part I, Item 1A "Risk Factors" of the 2019 Annual Report and Part II, Item 1A "Risk Factors" of this Quarterly Report on Form 10-Q , and other information provided from time to time in our other filings with the SEC.
Overview
We, Varian Medical Systems, Inc., are a Delaware corporation originally incorporated in 1948 as Varian Associates, Inc. We are the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy, brachytherapy and proton therapy. Through recent acquisitions, we now operate a hospital and a network of cancer centers in India and Sri Lanka; provide cancer care professional services to healthcare providers worldwide; and are a supplier of a broad portfolio of interventional solutions.

Our vision is a world without fear of cancer. Our mission is to combine the ingenuity of people with the power of data and technology to achieve new victories against cancer. Our long-term growth and value creation strategy is to transform our company from the global leader in radiation therapy (also referred to as radiotherapy) to the global leader in multi-disciplinary, integrated cancer care solutions that leverages our clinical experience and strengths in technology development and new product innovation. To achieve these long-term objectives, we are focused on driving growth through strengthening our leadership in radiation therapy, extending our global footprint and expanding into new markets and therapies.
We have two reportable operating segments: Oncology Systems and Proton Solutions. Our Interventional Solutions business is reflected in the Other category because it does not meet the criteria for a reportable operating segment. The operating segments were determined based on how our Chief Executive Officer, who is our Chief Operating Decision Maker (“CODM”), views and evaluates our operations. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings. We report revenues in three regions. The Americas region includes North America (primarily United States and Canada) and Latin America. The EMEA region includes Europe, Russia, the Middle East, India and Africa. The APAC region primarily includes East and Southeast Asia and Australia.
34

Highlights for the Three Months Ended January 3, 2020
Financial Summary
Three Months Ended  
(In millions, except per share amounts)January 3,
2020		December 28,
2018		Change  
Gross Orders $818.6  $721.7  13 %
Oncology Systems773.8  716.5  8 %
Proton Solutions25.9  5.2  399 %
Other18.9  —  n/m  
Backlog$3,305.3  $3,174.7  4 %
Revenues$828.9  $741.0  12 %
Oncology Systems 782.4  702.5  11 %
Proton Solutions 27.6  38.5  (28)%
Other 18.9  —  n/m  
Gross margin as a percentage of revenues44.2 %42.7 %160 bps  
Effective tax rate21.0 %24.4 %
Net earnings attributable to Varian$88.2  $103.2  (14)%
Diluted net earnings per share$0.96  $1.12  (14)%
Net cash provided by operating activities$112.6  $140.9  (20)%
Number of shares repurchased0.3  0.3  4 %
Total cost of shares repurchased$46.4  $34.8  33 %
n/m - not meaningful

Tariff Measures. Between July 2018 and May 2019, the Trump Administration imposed a series of tariffs, ranging from 5% to 25%, on numerous products imported into the United States from China, including Varian’s radiotherapy systems manufactured in China and certain components used in our manufacturing and service activities. In July and August 2018, China retaliated against the U.S. tariffs by imposing its own series of tariffs, ranging from 10% to 25%, on certain products imported into China from the United States, including Varian’s radiotherapy systems and certain manufacturing and service components.
 
We participated in the Office of the U.S. Trade Representative (“USTR”) process to seek product-specific exclusions from the U.S. tariffs on Chinese imports. To date, USTR has granted tariff exclusions for four products: certain radiotherapy systems manufactured in China, as well as three key components of the radiation therapy systems that we manufacture in the United States -multi-leaf collimators, certain printed circuit board assemblies and tungsten shielding. We submitted an additional U.S. exclusion request in September 2019, in relation to a manufacturing component, which is pending. In December 2019, USTR granted a one-year extension to our exclusion for radiotherapy systems.

In June and July 2019, we submitted formal requests to the Chinese government for exclusions from the Chinese retaliatory tariffs for manufacturing inputs, service parts and radiotherapy systems imported into China from the United States. In September 2019, the Chinese government granted a tariff exclusion for medical linear accelerators, including our radiotherapy systems, with retroactive effect. The other exclusion requests are still pending. The U.S. and Chinese government tariff exclusions are for one-year periods, with anticipated renewal processes. In the aggregate, these tariffs will be referred to as "U.S./China tariffs."
Currency Fluctuation. In order to assist with the assessment of how our underlying businesses performed, we compare the percentage change in revenues and Oncology Systems gross orders from one period to another, excluding the effect of foreign currency fluctuations (i.e., using constant currency exchange rates). To present this information on a constant currency basis, we convert current period revenues and gross orders in currencies other than U.S. Dollars into U.S. Dollars using the comparable prior period’s average exchange rate. Percentage changes in revenues and gross orders are not adjusted for constant currency unless indicated.
35

Currency fluctuations had approximately a $5.4 million and $3.6 million unfavorable impact on total revenues and Oncology Systems gross orders, respectively, for the three months ended January 3, 2020, compared to the year-ago period. We expect that fluctuations of non-U.S. Dollar currencies against the U.S. Dollar may continue to cause variability in our financial performance.
Oncology Systems. Our Oncology Systems business designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiotherapy, and advanced treatments such as fixed field intensity-modulated radiation therapy (“IMRT”), image-guided radiation therapy (“IGRT”), volumetric modulated arc therapy (“VMAT”), stereotactic radiosurgery, stereotactic body radiotherapy and brachytherapy as well as associated quality assurance equipment. Our software solutions include treatment planning, informatics, clinical knowledge exchange, patient care management, practice management and decision support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices. We offer services ranging from hardware phone support, break/fix repair of linear accelerators, obsolescence protection of hardware, software support, software upgrades, hosting as a service, as well as clinical consulting services.

We have expanded our services offerings to include clinical practice services that assist within the clinical workflow. These services focus on decision support and/or cancer care knowledge augmentation aimed to facilitate improved accessibility and affordability to care while maintaining a fundamental level of clinical quality. Further, we operate ten multi-disciplinary cancer centers and one specialty hospital in India and one multi-disciplinary cancer center in Sri Lanka. We also expect to innovate and incubate new solutions such as technology-enabled services, and to develop additional technologies that incorporate artificial intelligence and machine learning capabilities, in an environment of data security and patient privacy integrity.
Our primary goal in the Oncology Systems business is to promote the adoption of more advanced and effective cancer treatments. In our view, the fundamental market forces that drive long-term growth in our Oncology Systems business are the rise in cancer cases; technology advances and product developments that are leading to improvements in patient care and outcomes; customer demand for the more advanced and effective cancer treatments that we enable; competitive conditions among hospitals and clinics to offer such advanced treatments; continued improvement in safety and cost efficiency in delivering radiation therapy; and underserved medical needs outside of the United States. Approximately half of Oncology Systems gross orders and revenues come from international markets, within which certain emerging markets typically can have lower gross margins and longer installation cycles since many of these purchases are for new sites where treatment vaults need to be constructed. We have also been investing a higher portion of our Oncology Systems research and development budget in software and software-related products, which have a higher gross margin than our hardware products.
We believe international markets will be our fastest growing markets. The radiation oncology market in North America is largely characterized by replacements of older machines, with periodic increases in demand driven by the introduction of new technologies. Reimbursement rates in the United States have generally supported a favorable return on investment for the purchase of new radiotherapy equipment and technologies. While we believe that improved product functionality, greater cost-effectiveness and prospects for better clinical outcomes with new capabilities, such as IMRT, IGRT and VMAT, tend to drive demand for radiotherapy products, large changes in reimbursement rates or reimbursement structure can affect customer demand and cause market shifts. We believe that growth of the radiation oncology market in the United States could be impacted as customers’ decision-making processes are complicated by the uncertainties surrounding reimbursement rates and new models for radiotherapy and radiosurgery, such as the alternative payment model pilot program for radiation oncology that was proposed by the Centers for Medicare and Medicaid Services in July 2019. This pilot program is intended to test whether an episode-based payment structure would reduce Medicare expenditures. We believe that this uncertainty will likely continue in future fiscal years and could impact transaction size, timing and purchasing processes, and also contribute to increased quarterly business variability.
In the radiation oncology markets outside of North America, we expect the EMEA and Latin America markets to grow over the long term with varying growth rates across the regions. In APAC, we expect China to lead longer-term regional growth. Overall, we believe the global radiation oncology market can grow over the long term, in constant currencies, in the mid-single-digit range.
Proton Solutions. Our Proton Solutions business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam therapy using proton beams, for the treatment of cancer. Proton therapy is a preferred option for treating certain cancers, particularly tumors near critical structures such as the base of the skull, spine, optic nerve and most pediatric cancers. Although proton therapy has been in clinical use for more than four decades, it has not been widely deployed due to the high capital cost.
36

We are investing resources to drive growth and innovation in this business. Proton therapy facilities are large-scale construction projects that have long lead times and involve significant customer investment and often complex project financing. Consequently, this business is vulnerable to general economic and market conditions, as well as reimbursement rates. Customer decision-making cycles tend to be very long, and orders generally involve many contingencies. Credit markets for proton therapy projects have improved in recent years but the funding environment for large capital projects, such as proton therapy projects, is still challenging. Our current focus is bringing our expertise in traditional radiation therapy to proton therapy to improve its clinical utility, reduce its cost of treatment per patient and drive innovation, so that it is more widely accepted and deployed.
As of January 3, 2020, we had a total of $167.4 million of notes receivable, including accrued interest, senior secured debt, available-for-sale securities, and loans outstanding to Proton Solutions customers. See Note 14, "Proton Solutions Loans and Investments," of the Notes to the Condensed Consolidated Financial Statements for further information.

Other. The Other category includes our Interventional Solutions business that offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolization. We also provide software for post treatment, image-guided dosimetry for Yttrium-90 microspheres used in selective internal radiation therapy. The Other category also includes assets related to the use of radiation in the heart and other forms of radiosurgery for cardiovascular disease.
Critical Accounting Estimates
The preparation of our financial statements and related disclosures in conformity with accounting principles generally accepted in the United States (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on historical experience and on various other factors that we believe are reasonable under the circumstances. Our critical accounting policies that are affected by accounting estimates require us to use judgments, often as a result of the need to make estimates and assumptions regarding matters that are inherently uncertain, and actual results could differ materially from these estimates.

We periodically review our accounting policies, estimates and assumptions and make adjustments when facts and circumstances dictate. During the three months ended January 3, 2020, there were no significant changes to our critical accounting policies and estimates as described in the financial statements contained in Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2019 Annual Report.
Results of Operations
Fiscal Year
Our fiscal year is the 52- or 53-week period ending on the Friday nearest September 30. Fiscal year 2020 was the 53-week period ending October 2, 2020, and fiscal year 2019 was the 52-week period that ended September 27, 2019. The fiscal quarter ended January 3, 2020 was a 14-week period and the fiscal quarter ended December 28, 2018 was a 13-week period.
Discussion of Results of Operations for the Three Months Ended January 3, 2020 Compared to the Three Months Ended December 28, 2018
Total Revenues 
Revenues by sales classificationThree Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent Change
Product$421.0  $400.2  5 %
Service 407.9  340.8  20 %
Total Revenues$828.9  $741.0  12 %
Product as a percentage of total revenues51 %54 % 
Service as a percentage of total revenues49 %46 % 
37

Total product revenues increased in the three months ended January 3, 2020, compared to the year-ago period, due to $18.9 million in revenues from the Other category and an increase in revenues from Oncology Systems, partially offset by a decrease in revenues from Proton Solutions. Total service revenues increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to Oncology Systems, which included approximately $19 million in additional service revenues due to the three months ended January 3, 2020, being a 14-week period and approximately $18 million in service revenues from CTSI.
Revenues by geographical regionThree Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent ChangeConstant Currency
Americas$402.2  $350.4  15 %15 %
EMEA272.9  251.0  9 %11 %
APAC153.8  139.6  10 %10 %
Total Revenues$828.9  $741.0  12 %13 %
North America (1)
$378.5  $328.7  15 %15 %
International450.4  412.3  9 %11 %
Total Revenues$828.9  $741.0  12 %13 %
North America as a percentage of total revenues46 %44 % 
International as a percentage of total revenues54 %56 % 
(1) North America primarily includes the United States and Canada.
The Americas revenues increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in revenues from Oncology Systems and, to a lesser extent, an increase in revenues from the Other category, partially offset by a decrease in revenues from Proton Solutions. EMEA revenues increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase from Oncology Systems, which included approximately $14 million in revenues from CTSI and, to a lesser extent, an increase in revenues from the Other category, partially offset by a decrease in revenues from Proton Solutions. APAC revenues increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in revenues from the Other category and Oncology Systems, partially offset by a decrease in revenues from Proton Solutions.
Oncology Systems Revenues 
Revenues by sales classificationThree Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent ChangeConstant Currency
Product$382.0  $366.6  4 %5 %
Service400.4  335.9  19 %20 %
Total Oncology Systems Revenues$782.4  $702.5  11 %12 %
Product as a percentage of total Oncology Systems revenues49 %52 %
Service as a percentage of total Oncology Systems revenues51 %48 % 
Oncology Systems revenues as a percentage of total revenues95 %95 %
Oncology Systems product revenues increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to higher software sales. In the three months ended December 28, 2018, revenues from hardware products included a negative impact of approximately $8 million from the U.S./China Tariffs, as compared to a benefit of approximately $3 million related to tariff refunds in the three months ended January 3, 2020.
Oncology Systems service revenues, which include performance obligations for installation, training and warranty, increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to the ongoing customer adoption of service contracts as the warranty periods on our TrueBeam systems expire and an increase in the number of customers as the installed base of our products continues to grow. The three months ended January 3, 2020 was a 14-week period, which resulted
38

in approximately $19 million in additional service revenues being recorded. Also, Oncology Systems service revenues include approximately $18 million in revenues from CTSI in the three months ended January 3, 2020.
Revenues by geographical regionThree Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent ChangeConstant Currency
Americas$378.9  $330.8  15 %15 %
EMEA259.8  234.5  11 %13 %
APAC143.7  137.2  5 %4 %
Total Oncology Systems Revenues$782.4  $702.5  11 %12 %
North America$355.2  $309.1  15 %15 %
International427.2  393.4  9 %10 %
Total Oncology Systems Revenues$782.4  $702.5  11 %12 %
North America as a percentage of total Oncology Systems revenues45 %44 % 
International as a percentage of total Oncology Systems revenues 55 %56 % 
Americas Oncology Systems revenues increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in revenues from services and hardware products in North America.
EMEA Oncology Systems revenues increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in revenues from services and software licenses. EMEA Oncology Systems revenues from services include approximately $14 million from CTSI.
APAC Oncology Systems revenues increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in revenues from services, partially offset by a decrease in revenue from hardware products. In the three months ended December 28, 2018, revenues from hardware products included a negative impact of approximately $8 million from the U.S./China Tariffs.
Variations of higher and lower revenues between the North America and international regions are impacted by regional factors influencing our gross orders, which include government spending, philanthropy/donations, economic and political instability in some countries, uncertainty created by U.S. health care policy, such as the excise tax on the sale of most medical devices, Medicare reimbursement rates and consolidation of free standing clinics in the United States, and different technology adoption cycles. See further discussion of orders under “Gross Orders.”
Proton Solutions Revenues
Revenues by sales classificationThree Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent Change
Product$20.1  $33.6  (40)%
Service7.5  4.9  54 %
Total Proton Solutions Revenues$27.6  $38.5  (28)%
Proton Solutions revenues as a percentage of total revenues3 %5 %
Revenues from Proton Solutions decreased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to a decrease in product revenues that resulted from the timing of project completion and stage of progress, partially offset by an increase in service revenues resulting from the increase in proton centers transitioned to service contracts.
39

Other Revenues
Revenues from the Other category was $18.9 million for the three months ended January 3, 2020. Revenues from the Other category are allocated to product revenues and are related to our Interventional Solutions business.
Gross Margin
Dollars by segmentThree Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent Change
Oncology Systems$353.0  $309.8  14 %
Proton Solutions—  6.3  n/m  
Other 13.8  —  n/m  
Gross margin$366.8  $316.1  16 %
Percentage by segment
Oncology Systems45.1 %44.1 %
Proton Solutionsn/m  16.9 %
Other72.8 %— %
Total Company44.2 %42.7 %
Percentage by sales classification
Total Company - Product35.4 %33.4 %
Total Company - Service 53.4 %53.6 %
Oncology Systems - Product36.1 %35.8 %
Oncology Systems - Service53.7 %53.2 %
n/m - not meaningful
Oncology Systems product gross margin percentage increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to certain tariff exclusions. In the three months ended December 28, 2018, the U.S./China tariffs had a negative impact of approximately $11 million, comprised of a negative impact of $8 million in revenues and $3 million in cost of revenues, compared to a total negative impact of approximately $0.8 million in the three months ended January 3, 2020.
Oncology Systems service gross margin percentage increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in service revenues.
Proton Solutions gross margin percentage decreased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to project mix and increased project costs.
Research and Development
 Three Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent Change
Research and development$67.1  $60.9  10 %
Research and development as a percentage of total revenues8 %8 %
Research and development expenses increased $6.2 million in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in investments in software, Flash technology, adaptive radiotherapy and other strategic programs.
40

Selling, General and Administrative and Acquisition-related expenses
 Three Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent Change
Selling, general and administrative$177.0  $141.1  25 %
Acquisition-related expenses$12.7  $2.4  419 %
Selling, general and administrative as a percentage of total revenues21 %19 %
Acquisition-related expenses as a percentage of total revenues2 %— %
Selling, general and administrative expenses increased $35.9 million in the three months ended January 3, 2020, compared to the year-ago period, as we continue to invest in scaling our operations to support growth, including an increase in headcount to support sales and marketing for recent acquisitions and investments in product management for treatment planning in Oncology Systems. Also contributing to the increase in the three months ended January 3, 2020, was $5.3 million in additional amortization of intangible assets and approximately $3 million in additional costs due to the three months ended January 3, 2020 being a 14-week period.

Acquisition-related expenses increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an $8.8 million increase in the fair value of contingent consideration related to the Endocare and Alicon acquisitions.
Other Income, Net 
 Three Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent Change
Interest income$3.0  $3.9  (25)%
Interest expense$(4.7) $(1.2) 282 %
Other income, net$4.4  $23.0  (81)%
Interest income decreased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to a decrease in interest income from loans to our Proton Solution customers and available-for-sale securities. Interest expense increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in borrowings. Other income, net, decreased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to a $22.0 million gain on the sale of an equity investment in the three months ended December 28, 2018.
Taxes on Earnings 
 Three Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Change
Taxes on earnings$23.8  $33.5  (29.0)%
Effective tax rate21.0 %24.4 %
Our effective tax rate is lower in the three months ended January 3, 2020, compared to the year-ago period, primarily because the prior year-ago period included the tax effect of a change in law due to the enactment of the Tax Cuts and Jobs Act, which was signed into law on December 22, 2017.
Our effective tax rate is impacted by the percentage of our total earnings that comes from our international regions, the mix of particular tax jurisdictions within our international regions, changes in the valuation of our deferred tax assets or liabilities, and changes in tax laws or interpretations of those laws. We expect that our effective tax rate may experience increased fluctuations from period to period. See Note 10, "Income Taxes," of the Notes to the Consolidated Financial Statements in our 2019 Annual Report.
41

Diluted Net Earnings Per Share
 Three Months Ended
January 3,
2020		December 28,
2018		Percent Change
Diluted net earnings per share$0.96  $1.12  (14)%
n/m - not meaningful

Diluted net earnings per share decreased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to a $22.0 million gain on the sale of an equity investment in the three months ended December 28, 2018, and an $8.8 million increase in the fair value of contingent consideration related to the Endocare and Alicon acquisition in the three months ended January 3, 2020, partially offset by a decrease in the effective tax rate in the three months ended January 3, 2020, as compared to the prior period.
Gross Orders
Gross orders by segmentThree Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent Change
Oncology Systems$773.8  $716.5  8 %
Proton Solutions25.9  5.2  399 %
Other18.9  —  n/m  
Total Gross Orders$818.6  $721.7  13 %
Gross orders are defined as new orders recorded during the period and revisions to previously recorded orders. New orders are recorded for the total contractual amount, excluding certain pass-through items and service items, which are recognized as revenue is recognized, once a written agreement for the delivery of goods or provision of services is in place and, other than Proton Solutions, when shipment of the product is expected to occur within two years, so long as any contingencies are deemed perfunctory. For our Proton Solutions business, we record orders when construction of the related proton therapy treatment center is reasonably expected to start within two years, but only if any contingencies are deemed perfunctory. We will not record Proton Solutions orders if there are financing contingencies, if a substantial portion of the financing for the project is not reasonably assured or if customer board approval contingencies are pending. We perform a quarterly review to verify that outstanding orders remain valid. If an order is no longer expected to ultimately convert to revenue, we record a backlog adjustment, which reduces backlog but does not impact gross orders for the period.
Gross orders in any period may not be directly correlated to the level of revenues in any particular future quarter or period since the timing of revenue recognition will vary significantly based on the delivery requirements of individual orders, acceptance schedules and the readiness of individual customer sites for installation of our products. Moreover, certain types of orders, such as orders for software or newly introduced products in our Oncology Systems segment, typically take more time from order to completion of installation and acceptance than hardware or older products. Because an order for a proton therapy system can be relatively large, an order in one fiscal period will cause gross orders in our Proton Solutions business to vary significantly, making comparisons between fiscal periods more difficult.
42

Oncology Systems Gross Orders
Gross orders by geographical regionThree Months Ended
(Dollars in millions)January 3,
2020		December 28,
2018		Percent ChangeConstant Currency
Americas$359.5  $335.9  7 %7 %
EMEA236.7  218.3  8 %11 %
APAC177.6  162.3  9 %9 %
Total Oncology Systems Gross Orders$773.8  $716.5  8 %9 %
North America$326.8  $313.5  4 %4 %
International447.0  403.0  11 %12 %
Total Oncology Systems Gross Orders$773.8  $716.5  8 %9 %
The Americas Oncology Systems gross orders increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in gross orders from services in North America, partially offset with a decrease in gross orders from hardware products.
EMEA Oncology Systems gross orders increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to an increase in gross orders from services, partially offset by a decrease in gross orders from hardware products. EMEA Oncology Systems gross orders from services include approximately $14 million from CTSI.
APAC Oncology Systems gross orders increased in the three months ended January 3, 2020, compared to the year-ago period, primarily due to a growth in orders across the region, primarily in Greater China, Southeast Asia, and South Korea, for our products and services, partially offset by a decrease in hardware product orders in Japan.
The trailing 12 months' growth in gross orders for Oncology Systems at the end of the first quarter of fiscal year 2020 and at the end of each of the previous three fiscal quarters was:
Trailing 12 Months Ended
January 3,
2020		September 27,
2019		June 28,
2019		March 29,
2019
Americas6%  7%  6%  8%  
EMEA11%  12%  13%  18%  
APAC6%  9%  22%  20%  
North America6%  8%  6%  9%  
International9%  10%  15%  17%  
Total Oncology Systems Gross Orders8%  9%  11%  13%  
Consistent with the historical pattern, we expect that Oncology Systems gross orders will continue to experience regional fluctuations. Over the long-term, we expect international gross orders, specifically from emerging markets, to grow as a percentage of overall orders. Oncology Systems gross orders are affected by foreign currency fluctuations, which could impact the demand for our products. In addition, government programs that stimulate the purchase of healthcare products could affect the demand for our products from period to period, and could therefore make it difficult to compare our financial results.
Proton Solutions Gross Orders
Proton Solutions gross orders increased $20.7 million in the three months ended January 3, 2020, compared to the year-ago period, primarily due to one proton therapy system order in the three months ended January 3, 2020, as compared to none in the prior year period. Also contributing to the increase in gross orders was an increase in service orders.
Other Gross Orders
Other gross orders were $18.9 million in the three months ended January 3, 2020, and was related to our Interventional Solutions business.
43

Backlog
Backlog is the accumulation of all gross orders for which revenues have not been recognized but are still considered valid. Backlog is stated at historical foreign currency exchange rates and revenue is released from backlog at current exchange rates, with any difference recorded as a backlog adjustment. At January 3, 2020, total Company backlog was $3.3 billion, an increase of 4% compared to the backlog at December 28, 2018. Our Oncology Systems backlog at January 3, 2020 was 4% higher than the backlog at December 28, 2018, which reflected an increase of 4% for the both international and North America regions, respectively. Proton Solutions backlog was $220 million at January 3, 2020.
We perform a quarterly review to verify that outstanding orders in the backlog remain valid. Aged orders that are not expected to ultimately convert to revenues are classified as dormant and are reflected as a reduction in the backlog amounts in the period identified. Backlog adjustments are comprised of dormancies, cancellations, foreign currency exchange rate adjustments, backlog acquired from our acquisitions, and other adjustments. Gross orders do not include backlog adjustments. Backlog adjustments totaled net reductions of $74.5 million in the three months ended January 3, 2020, compared to a net addition of $11.0 million in the year-ago period.
Liquidity and Capital Resources
Liquidity is the measurement of our ability to meet potential cash requirements, including ongoing commitments to repay borrowings, acquire businesses or make other investments or loans, repurchase shares of VMS common stock, and fund continuing operations and capital expenditures. Our sources of cash have included operations, borrowings, stock option exercises, and employee stock purchases.
Cash, Cash Equivalents, and Restricted Cash
The following table summarizes our cash, cash equivalents, and restricted cash:
(In millions)January 3,
2020		September 27,
2019		Increase
Cash and cash equivalents $721.9  $531.4  $190.5  
Restricted cash20.3  12.7  7.6  
 Total cash, cash equivalents, and restricted cash$742.2  $544.1  $198.1  
The increase in cash, cash equivalents, and restricted cash in the three months ended January 3, 2020 was primarily due to $132.0 million in net borrowings from our credit facility, $112.6 million of cash provided by operating activities, $19.7 million in proceeds from the issuance of common stock to employees, and $9.2 million in proceeds from the sale of an equity investment, partially offset by $43.8 million used for the repurchase of shares of VMS common stock, $22.6 million used for purchases of property, plant, and equipment, and $3.6 million used for tax withholdings on vesting of equity awards.
At January 3, 2020, we had approximately $29 million, or 4%, of cash and cash equivalents in the United States, which includes approximately $18 million in money market funds, and approximately $693 million, or 96%, of cash and cash equivalents was held abroad. In light of the changes to the U.S. federal taxation of foreign earnings, we no longer consider the earnings of our foreign subsidiaries to be indefinitely reinvested. As a result, we have accrued for the foreign and state income taxes that we expect would be imposed upon a future remittance.
As of January 3, 2020, most of our cash and cash equivalents that were held abroad were in U.S. Dollars and were primarily held as bank deposits. In addition to cash flows generated from operations, a significant portion of which are generated in the United States, we have used our credit facilities to meet our cash needs from time to time and expect to continue to do so in the future. Borrowings under our credit facilities may be used for working capital, capital expenditures, VMS share repurchases, acquisitions and other corporate purposes.
44

Cash Flows
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Net cash flow provided by (used in):  
Operating activities$112.6  $140.9  
Investing activities(15.1) (13.1) 
Financing activities103.4  (17.2) 
Effects of exchange rate changes on cash, cash equivalents and restricted cash(2.8) 1.7  
Net increase in cash, cash equivalents and restricted cash$198.1  $112.3  
Our primary cash inflows and outflows were as follows:
•In the three months ended January 3, 2020, net cash provided by operating activities was $112.6 million compared to $140.9 million in the three months ended December 28, 2018. The $28.3 million decrease in net cash from operating activities was driven by a $53.8 million decrease in the net change from operating assets and liabilities and a $15.0 million decrease in net earnings, partially offset by a $40.5 million increase from non-cash items.
•The major contributors to the net change in operating assets and liabilities, net of effects of acquisitions, in the three months ended January 3, 2020 were as follows:
◦Trade and unbilled receivables decreasing $29.5 million primarily due to a decrease in unbilled receivables in Oncology Systems.
◦Inventory increasing $44.9 million primarily to support a higher volume of orders in Oncology Systems.
◦Accounts payable decreasing $32.7 million primarily due to timing of payments.
◦Accrued liabilities and other long-term liabilities decreasing $42.1 million, primarily due to the timing of payments processed for accrued compensation and payments related to operating leases resulting from the adoption of the lease accounting standard.
◦Deferred revenues increasing $57.4 million primarily due to an increase in billing ahead of revenue recognition resulting from changes in the mix of contractual billing terms.
We expect that cash provided by operating activities may fluctuate in future periods as a result of a number of factors, including fluctuations in our operating results, timing of product shipments, product installation or customer acceptance, trade receivable collections, inventory management, contracts with extended payment terms, and the timing and amount of taxes and other payments. For additional discussion, please refer to the “Risk Factors” in Item 1A herein and in Part I, Item 1A of our 2019 Annual Report.
•In the three months ended January 3, 2020, cash used in investing activities was $15.1 million, compared to $13.1 million in the three months ended December 28, 2018. In the three months ended January 3, 2020, cash used in investing activities primarily included $22.6 million for purchases of property, plant and equipment, partially offset by $9.2 million in proceeds from the sale of an equity investment. In the three months ended December 28, 2018, cash used in investing activities primarily included $25.5 million used for acquisitions and $14.0 million for the purchases of property, plant and equipment, partially offset by $29.9 million in proceeds from the sale of an equity investment.
•In the three months ended January 3, 2020, cash provided by financing activities was $103.4 million, compared to cash used of $17.2 million in the three months ended December 28, 2018. In the three months ended January 3, 2020, cash provided by financing activities primarily included $132.0 million in net borrowings from our credit facility and $19.7 million in proceeds received from stock option exercises and employee stock purchases, partially offset by $43.8 million used for the repurchase of VMS common stock and $3.6 million used for tax withholdings on vesting of equity awards. In the three months ended December 28, 2018, cash used in financing activities primarily included $34.8 million used for the repurchase of VMS common stock and $4.4 million used for tax withholdings on vesting of equity
45

awards, partially offset by $22.0 million in proceeds received from stock option exercises and employee stock purchases.
Revolving Credit Facility
The following table summarizes our short-term borrowings:
(Dollars in millions)
January 3, 2020September 27, 2019
AmountWeighted-Average Interest RateAmountWeighted-Average Interest Rate
Revolving Credit Facility$542.0  2.80%  $410.0  3.05 %
Total short-term borrowings$542.0  $410.0  

See Note 6, "Borrowings," of the Notes to the Condensed Consolidated Financial Statements for further information about our Credit Agreement and other borrowing arrangements.
Our liquidity is affected by many factors, some of which result from the normal ongoing operations of our business and some of which arise from uncertainties and conditions in the United States and global economies. Although our cash requirements will fluctuate as a result of the shifting influences of these factors, we believe that existing cash and cash equivalents, cash to be generated from operations, and current or future credit facilities will be sufficient to satisfy anticipated commitments for capital expenditures, and other cash requirements for at least the next 12 months and into the foreseeable future. We currently anticipate that we will continue to utilize our available liquidity and cash flows from operations, as well as borrowed funds, to make strategic acquisitions, invest in the growth of our business, invest in advancing our systems and processes, repurchase VMS common stock, fund loan commitments and other strategic investments.

Days Sales Outstanding
Our Oncology Systems trade and unbilled receivables days sales outstanding (“DSO”) was 112 days at January 3, 2020, as compared to 111 days at December 28, 2018. Our accounts receivable and DSO are impacted by a number of factors, primarily including: the timing of product shipments, product installation or customer acceptance, collections performance, payment terms, the mix of revenues from different regions, and the effects of economic instability. Proton Solutions' DSO is not meaningful because it is highly variable. As of January 3, 2020, approximately 4% of our net trade and unbilled receivables balance was related to customer contracts with remaining terms of more than one year.
Share Repurchase Program
We repurchased shares of VMS common stock during the periods presented as follows:
Three Months Ended
(In millions, except per share amounts)January 3,
2020		December 28,
2018
Number of shares0.3  0.3  
Average repurchase price per share$139.67  $108.90  
Total cost of shares repurchased$46.4  $34.8  

In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. As of January 3, 2020, approximately 1.9 million shares of VMS common stock remained available for repurchase under the November 2016 authorization.
Stock repurchases may be made in the open market, in privately negotiated transactions (including accelerated share repurchase programs), or under Rule 10b5-1 share repurchase plans, and also may be made from time to time or in one or more larger blocks. All shares that were repurchased under our share repurchase programs have been retired.
Contractual Obligations
Long-term income taxes payable includes the liability for uncertain tax positions, including interest and penalties, and the noncurrent portion of the one-time transition tax on unremitted foreign earnings under the Act. As of January 3, 2020,
46

our liability for uncertain tax positions was $45.6 million, of which we do not anticipate making any payments in the next 12 months. We are unable to reliably estimate the timing of the remainder of future payments related to uncertain tax positions; we believe that existing cash and cash equivalents, cash to be generated from operations, and current or future credit facilities will be sufficient to satisfy any payment obligations that may arise related to our liability for uncertain tax positions. We have elected to pay the one-time transition tax over a period of 8 years as follows: 8% per year for each of the first five years and 15%, 20%, and 25%, in years 6 through 8, respectively. As of January 3, 2020, the noncurrent portion of the one-time transition tax on unremitted foreign earnings was $135.2 million.
See Note 8, "Commitments and Contingencies," of the Notes to the Condensed Consolidated Financial Statements for further information about contractual obligations regarding lease arrangements.
Except for the item discussed above, there has been no significant change to the other contractual obligations we reported in our 2019 Annual Report.
Contingencies
Environmental Remediation Liabilities
For a discussion of environmental remediation liabilities, see Note 8, "Commitments and Contingencies," of the Notes to the Condensed Consolidated Financial Statements, which discussion is incorporated herein by reference.
Other Matters
From time to time, we are a party to or otherwise involved in legal proceedings, claims and government inspections or investigations and other legal matters both inside and outside the United States, arising in the ordinary course of our business or otherwise. Such matters are subject to many uncertainties and outcomes are not predictable with assurance. See Note 8, "Commitments and Contingencies," of the Notes to the Condensed Consolidated Financial Statements, which discussion is incorporated herein by reference.
Off-Balance Sheet Arrangements
In conjunction with the sale of our products in the ordinary course of business, we provide standard indemnification of business partners and customers for losses suffered or incurred for property damages, death and injury and for patent, copyright or any other intellectual property infringement claims by any third parties with respect to our products. The terms of these indemnification arrangements are generally perpetual. Except for losses related to property damages, the maximum potential amount of future payments we could be required to make under these arrangements is unlimited. As of January 3, 2020, we have not incurred any significant costs to defend lawsuits or settle claims related to these indemnification arrangements. As a result, we believe the estimated fair value of these arrangements is minimal.
We have entered into indemnification agreements with our directors and officers and certain of our employees that serve as officers or directors of our foreign subsidiaries that may require us to indemnify our directors and officers and those certain employees against liabilities that may arise by reason of their status or service as directors or officers, and to advance their expenses incurred as a result of any legal proceeding against them as to which they could be indemnified.

From time to time, we are required to provide letters of credit, surety bonds and bank guarantees to support certain obligations that arise in the ordinary course of business and in some cases, in place of pledging cash collateral. There has been no significant change to the balance of these outstanding instruments from what we reported in our 2019 Annual Report.

Recent Accounting Standards or Updates Not Yet Effective
See Note 1, "Summary of Significant Accounting Policies," of the Notes to the condensed consolidated financial statements for a description of recent accounting standards, including the expected dates of adoption and the estimated effects on our consolidated financial statements.
47

Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to three primary types of market risks: credit risk and counterparty risk, foreign currency exchange rate risk and interest rate risk. Our exposures to the three market risks have not changed materially since September 27, 2019. For quantitative and qualitative disclosures about market risk, see Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” of our 2019 Annual Report.
Item 4. Controls and Procedures
(a)Disclosure controls and procedures. Based on the evaluation of our disclosure controls and procedures (as defined in the Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) required by Exchange Act Rules 13a-15(b) or 15d-15(b), as applicable, our principal executive officer and principal financial officer have concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by us in such reports is accumulated and communicated to our management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b)Changes in internal control over financial reporting. There were no changes in our internal control over financial reporting that occurred during the first quarter of fiscal year 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II
OTHER INFORMATION
Item 1. Legal Proceedings
We are subject to various legal proceedings and claims that are discussed in Note 8, "Commitments and Contingencies," to the Condensed Consolidated Financial Statements, which discussion is incorporated by reference into this item.
Item 1A. Risk Factors
There were no material changes during the period covered in this report to the risk factors previously disclosed in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended September 27, 2019, except as follows:

Economic, political and other risks associated with international sales and operations could adversely affect our sales or make them less predictable.
Revenues outside of the United States accounted for approximately 57%, 55%, and 53% of our total revenues during fiscal years 2019, 2018 and 2017, respectively. Correspondingly, we must provide significant service and support globally. We also manufacture many of our products and conduct a significant portion of our research and development outside of the United States. We intend to continue to expand our presence in international markets and expect to expend significant resources in doing so. We cannot assure you that we will be able to recover these investments in international markets.

Our results of operation could be adversely affected by a variety of factors, including, among other things:

•lower sales prices and gross margins usually associated with sales of our products and services in international regions, and in emerging markets in particular;
•the longer payment cycles associated with many foreign customers;
•the typically longer periods from placement of orders to revenue recognition in certain international and emerging markets;
•currency fluctuations;
48

•difficulties in interpreting or enforcing agreements and collecting receivables through the legal systems of many foreign countries;
•unstable regional political and economic conditions or changes in restrictions on trade between the United States and other countries;
•changes in the political, regulatory, safety or economic conditions in a country or region, including as a result of the United Kingdom (the “U.K.”) exit from the European Union (“E.U.”) (“Brexit”);
•the imposition by governments, including the United States, of additional taxes, tariffs, global economic sanctions programs or other restrictions on foreign trade;
•any inability to obtain required export or import licenses or approvals;
•any inability to comply with export or import laws and requirements or any violation of sanctions regulations, which may result in enforcement actions, civil or criminal penalties and restrictions on exportation;
•any increase in the cost of trade compliance functions to comply with changes to regulatory requirements;
•failure to obtain proper business licenses or other documentation, or to otherwise comply with local laws and requirements to conduct business in a foreign jurisdiction;
•the possibility that it may be more difficult to protect our intellectual property in foreign countries;
•natural disasters, outbreaks of pandemic disease, climate change or the fear of such events; and
•difficulties in staffing and managing international operations.

Currently, we provide customer services, manufacture products and conduct research in China. We also sell a significant amount of equipment and services to customers located in China. In December 2019, a novel strain of the coronavirus was first identified in Wuhan, China and has resulted in an outbreak of respiratory illness. While our operations in China are not based in Wuhan, it is possible that the spread of the coronavirus in China could adversely impact our business by, among other things, disrupting or restricting our ability to travel, provide services and manufacture and distribute our products, both within and outside of China, as well as resulting in temporary closures of our facilities or the facilities of our suppliers or customers all of which could adversely affect our revenue. At this point, the extent to which the coronavirus may impact our business is uncertain.

The U.K.'s exit from the E.U. may negatively impact our operations.

The U.K.’s exit from the E.U. on January 31, 2020, commonly referred to as Brexit, has caused, and may continue to cause, uncertainty in the global markets. Political and regulatory responses to the withdrawal are still developing, and we are in the process of assessing the impact that the withdrawal may have on our business as more information becomes available. While we have not experienced any material financial impact from Brexit on our U.K. business to date, sales into the U.K. represented approximately 3% of our total revenues in fiscal year 2019, and we cannot predict the future implications of Brexit. Any impact from Brexit on our business and operations over the long term will depend, in part, on the outcome of tariff, tax treaties, trade, regulatory, and other negotiations the U.K. conducts.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(a)Not applicable
(b)Not applicable
(c)The following table provides information with respect to the shares of common stock repurchased by us during the first quarter of fiscal year 2020 (in millions, except per share amounts):
49

PeriodTotal Number of
Shares Purchased		Average Price
Paid Per Share		Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
Maximum Number
of Shares that May
Yet Be Purchased
Under the Plans or
Programs (1)
September 28, 2019 - October 15, 2019—  $—  —  2.2  
October 26, 2019 - November 22, 2019—  $—  —  2.2  
November 23, 2019 - January 3, 20200.3  $139.67  0.3  1.9  
Total0.3  $139.67  0.3  1.9  
(1)In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. Share repurchases may be made in the open market, in privately negotiated transactions (including accelerated share repurchase programs), or under Rule 10b5-1 share repurchase plans, and also may be made from time to time or in one or more larger blocks. All shares that were repurchased under the Company's share repurchase programs have been retired.
The preceding table excludes an immaterial number of shares of VMS common stock that were withheld by VMS in satisfaction of tax withholding obligations upon the vesting of restricted stock units granted under our employee stock plans.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
50

Item 6. Exhibits
The exhibits listed below are filed or incorporated by reference as part of this Form 10-Q:
Exhibit
No.		  Description
10.1*  
10.2  
   
31.1*    
   
31.2*    
   
32.1**    
   
32.2**    
   
101*  The following financial statements from the Company's Quarterly Report on Form 10-Q for the quarter ended January 3, 2020: (i) Condensed Consolidated Statements of Earnings, (ii) Condensed Consolidated Statements of Comprehensive Earnings, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Cash Flows, (v) Condensed Consolidated Statements of Equity, and (vi) Notes to the Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
   
104*The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended January 3, 2020, formatted in Inline XBRL
*Filed herewith
**Furnished, not filed

51

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
   VARIAN MEDICAL SYSTEMS, INC.
   (Registrant)
 
Dated:February 11, 2020By: /s/ J. MICHAEL BRUFF
   J. Michael Bruff
   Senior Vice President, Finance and
   Chief Financial Officer
   (Duly Authorized Officer and
   Principal Financial Officer)

52
 EX-10.1 2 ex101rsuagreement.htm EX-10.1 Document
U.S. RSU Form (Non-Employee Director)
VARIAN MEDICAL SYSTEMS, INC.
Fifth Amended and Restated 2005 Omnibus Stock Plan
RESTRICTED STOCK UNIT AGREEMENT
Varian Medical Systems, Inc. (the “Company”) hereby awards to the designated member (the “Director”) of the Company’s Board of Directors (the “Board”), Restricted Stock Units under the Company’s Fifth Amended and Restated 2005 Omnibus Stock Plan (the “Plan”). The Restricted Stock Units awarded under this Restricted Stock Unit Agreement (the "Agreement") consist of the right to receive shares of common stock of the Company (“Shares”). The Grant Date is set forth below. Subject to the provisions of Appendix A of this Agreement ("Appendix A") (attached) and of the Plan, the principal features of this award are as follows:
Grant Date:   [DATE]
Total Number of Restricted Stock Units:   [NUMBER A]
Scheduled Vesting Date(s):
Number of Restricted Stock Units
[The earlier of (i) the one-year anniversary of the
Grant Date or (ii) the next Annual Meeting of
Stockholders that occurs after the Grant Date]		[100% of NUMBER A]

Your signature below (or otherwise any acceptance of the Restricted Stock Units and any Shares hereunder) indicates your agreement and understanding that this award is subject to all of the terms and conditions contained in Appendix A and the Plan. For example, important additional information on vesting and forfeiture of the Restricted Stock Units covered by this award is contained in Paragraphs 2 through 6 of Appendix A. PLEASE BE SURE TO READ ALL OF APPENDIX A, WHICH CONTAINS THE SPECIFIC TERMS AND CONDITIONS OF THIS AGREEMENT. YOU CAN REQUEST A COPY OF THE PLAN BY CONTACTING THE CORPORATE HUMAN RESOURCES OFFICE IN PALO ALTO, CALIFORNIA. TO THE EXTENT ANY CAPITALIZED TERMS USED IN APPENDIX A ARE NOT DEFINED HEREIN, THEY WILL HAVE THE MEANING ASCRIBED TO THEM IN THE PLAN.


        





VARIAN MEDICAL SYSTEMS, INC.DIRECTOR
By:
Title:[NAME]


        A-2

APPENDIX A
TERMS AND CONDITIONS OF RESTRICTED STOCK UNITS
1.Award. The Company hereby awards to the Director under the Plan as a separate incentive in connection with his or her service on the Board, and not in lieu of any other compensation for his or her services, an award of [NUMBER A] Restricted Stock Units on the date hereof, subject to all of the terms and conditions in this Agreement and the Plan.
2. Vesting Schedule. Except as provided in Paragraphs 2, 3, 5 and 6, the Restricted Stock Units subject to this Agreement shall vest as to one-hundred percent (100%) of the Shares covered by this Award on the earlier of (i) the one-year anniversary of the Grant Date or (ii) the next Annual Meeting of Stockholders that occurs after the Grant Date, but in no event shall vesting occur later than March 15 of the calendar year following the calendar year of the Grant Date (the "Vesting Date(s)"). The Restricted Stock Units shall not vest in accordance with any of the provisions of Paragraph 2 unless the Director (a) shall have continuously served on the Board through the Vesting Date(s) or (b) shall have had a Termination of Service due to Retirement or Disability at any time following the Grant Date, in which case, vesting and settlement shall accelerate to the date of Retirement or Disability.
3. Committee Discretion. The Committee, in its absolute discretion, may accelerate the vesting and settlement of the balance, or some lesser portion of the balance, of the unvested Restricted Stock Units at any time. If so accelerated, such Restricted Stock Units shall be considered as having vested as of the date specified by the Committee.
4. Forfeiture. Except as provided in Paragraphs 2, 3, 5 and 6 and notwithstanding any contrary provision of this Agreement, the balance of the Restricted Stock Units which have not vested at the time of the Director’s Termination of Service shall thereupon be forfeited.
5. Death of Director. In the event of the Director's death, the Vesting Date(s) of the Restricted Stock Units subject to this Agreement shall fully accelerate and all of the Restricted Stock Units subject to this Agreement shall be settled at the time of the Director's death. Any distribution or delivery to be made to the Director under this Agreement shall, if the Director is then deceased, be made to the Director’s designated beneficiary, or if either no beneficiary survives the Director or the Committee does not permit beneficiary designations, to the administrator or executor of the Director’s estate. Any designation of a beneficiary by the Director shall be effective only if such designation is made in a form and manner acceptable to the Committee. Any transferee must furnish the Company with (a) written notice of his or her status as transferee, and (b) evidence satisfactory to the Company to establish the validity of the transfer and compliance with any laws or regulations pertaining to said transfer.
6. Change in Control. In the event of a Change in Control, the Vesting Date(s) of the Restricted Stock Units subject to this Agreement shall fully accelerate and all of the Restricted Stock Units subject to this Agreement shall be settled at the time of the Change in Control, provided the Director is serving on the Board immediately prior to the Change in Control. A “Change in Control” shall be deemed to have occurred as of the date of the first to occur of the following events:



(a) Any Person or Group (other than a Person or Group who effectively controls the Company within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(vi)) acquires stock of the Company that, together with stock held by such Person or Group, constitutes more than 50% of the total fair market value or total voting power of the stock of the Company. However, if any Person or Group is considered to own more than 50% of the total fair market value or total voting power of the stock of the Company, the acquisition of additional stock by the same Person or Group is not considered to cause a Change in Control. An increase in the percentage of stock owned by any Person or Group as a result of a transaction in which the Company acquires its stock in exchange for property will be treated as an acquisition of stock for purposes of this subsection. This subsection applies only when there is a transfer of stock of the Company (or issuance of stock of the Company) and stock in the Company remains outstanding after the transaction;
(b) Any Person or Group acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such Person or Group) ownership of stock of the Company possessing 35% or more of the total voting power of the stock of the Company. However, if any Person or Group is considered to effectively control the Company within the meaning of Treasury Regulation Section 1.409A-3(i)(5)(vi), the acquisition of additional stock by the same Person or Group is not considered to cause a Change in Control;
(c) A majority of members of the Company’s Board is replaced during any 12-month period by Directors whose appointment or election is not endorsed by a majority of the members of the Company’s Board prior to the date of the appointment or election; or
(d) Any Person or Group acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such Person or Group) assets from the Company that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions. For this purpose, gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. However, no Change in Control shall be deemed to occur under this subsection (d) as a result of a transfer to an entity that is controlled by the shareholders of the Company immediately after the transfer as follows:
i. A shareholder of the Company (immediately before the asset transfer) in exchange for or with respect to its stock;
ii. An entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company;
iii. A Person or Group that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding stock of the Company; or
iv. An entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a person described in clause (iii) above.
For purposes of clauses (ii), (iii), and (iv) above, a Person’s or a Group’s status is determined immediately after the transfer of assets.



For these purposes, the term “Person” shall mean an individual, Company, association, joint stock company, business trust or other similar organization, partnership, limited liability company, joint venture, trust, unincorporated organization or government or agency, instrumentality or political subdivision thereof or any other person, in each case, to the extent consistent with Treasury Regulation Section 1.409A-3(i)(5). The term “Group” shall have the meaning set forth in Treasury Regulation Section 1.409A-3(i)(5), or any successor thereto in effect at the time a determination of whether a Change of Control has occurred is being made.

7.  Settlement of Restricted Stock Units; Dividend Equivalents.
(1)  Status as a Creditor. Unless and until Restricted Stock Units have vested in accordance with Paragraph 2, 3, 5 or 6 above, the Director will have no settlement right with respect to any Restricted Stock Units. Prior to settlement of any vested Restricted Stock Units, the vested Restricted Stock Units will represent an unfunded and unsecured obligation of the Company, payable (if at all) only from the general assets of the Company. The Director is an unsecured general creditor of the Company, and settlement of Restricted Stock Units is subject to the claims of the Company’s creditors.
(1) Form and Timing of Settlement. Restricted Stock Units will automatically be settled in the form of Shares upon the applicable vesting of the Restricted Stock Units pursuant to Paragraph 2, 3, 5 or 6 above but in no event later than March 15 of the calendar year following the calendar year of the Grant Date. Fractional Shares will not be issued upon the vesting of Restricted Stock Units. Where a fractional Share would be owed to the Director upon the vesting of Restricted Stock Units, a cash payment equivalent will be paid in place of any such fractional Share using the Fair Market Value on the relevant settlement date.
(1) Dividend Equivalents. Restricted Stock Units will accrue dividend equivalents in the event cash dividends are paid with respect to the Shares having a record date on or after the Grant Date and prior to the date on which the Restricted Stock Units are settled. Such dividend equivalents will be converted into cash and paid, if at all, at the same time and otherwise under the same terms and conditions as apply to the underlying Restricted Stock Units.
8. Tax Liability and Withholding. The Company or one of its Affiliates may assess any applicable tax liability and requirements (including any social contributions, required deductions, or other payments) in connection with the Director’s participation in the Plan, including, without limitation, any tax liability associated with the grant or vesting of the Restricted Stock Units or sale of the underlying shares (the “Tax Liability”). These requirements may change from time to time as laws or interpretations change. Regardless of the Company’s or the Affiliate’s actions in this regard, the Director hereby acknowledges and agrees that any Tax Liability shall be the Director’s responsibility and liability. Prior to the relevant taxable event, the Director hereby acknowledges and agrees that the Company (and any Subsidiary or Affiliate) may satisfy all its obligations related to the Tax Liability, if any, by withholding all or a portion of any Shares that otherwise would be issued to the Director upon settlement of the vested Restricted Stock Units; provided that amounts withheld shall not exceed the amount necessary to satisfy the Company’s tax withholding obligations. Such withheld Shares shall be valued based on the Fair Market Value as of the date the withholding obligations are satisfied. Furthermore, the Director agrees to pay the Company or the Affiliate any Tax Liability that cannot be satisfied by


the foregoing methods. The Director further acknowledges and agrees that he solely is responsible for filing all relevant documentation that may be required in relation to the Restricted Stock Units or any Tax Liability (other than filings or documentation that is the specific obligation of the Company or any Subsidiary or Affiliate pursuant to applicable law) such as but not limited to personal income tax returns or reporting statements in relation to the grant or vesting of the Restricted Stock Units, the holding of Shares or any bank or brokerage account, the subsequent sale of Shares, and the receipt of any dividends or dividend equivalents. The Director further acknowledges that the Company makes no representations or undertakings regarding the treatment of any Tax Liability and does not commit to and is under no obligation to structure the terms or any aspect of the Restricted Stock Unit to reduce or eliminate the Director’s Tax Liability or achieve any particular tax result. The Director also understands that applicable law may require varying Restricted Stock Unit or Share valuation methods for purposes of calculating any Tax Liability, and the Company assumes no responsibility or liability in relation to any such valuation or for any calculation or reporting of income or Tax Liability that may be required of the Director under applicable law. Further, if the Director has become subject to Tax Liability in more than one jurisdiction, the Director acknowledges that the Company or any Subsidiary or Affiliate may be required to withhold or account for Tax Liability in more than one jurisdiction.
9. Rights as Stockholder. Neither the Director nor any person claiming under or through the Director shall have any of the rights or privileges of a stockholder of the Company in respect of any Restricted Stock Units (whether vested or unvested) unless and until such Restricted Stock Units are settled in Shares and certificates representing such Shares shall have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to the Director. After such issuance, recordation and delivery, the Director shall have all the rights of a stockholder of the Company with respect to voting such Shares and receipt of dividends and distributions on such Shares.
10. Acknowledgments. The Director acknowledges and agrees to the following:
•The Plan is discretionary in nature and the Committee may amend, suspend, or terminate it at any time;
•The grant of the Restricted Stock Units is voluntary and occasional and does not create any contractual or other right to receive future grants of Restricted Stock Units, or benefits in lieu of the Restricted Stock Units even if the Restricted Stock Units have been granted repeatedly in the past;
•All determinations with respect to such future Restricted Stock Units, if any, including but not limited to, the times when the Restricted Stock Units shall be granted or when the Restricted Stock Units shall vest, will be at the sole discretion of the Committee;
•The Director’s participation in the Plan is voluntary;
•The value of the Restricted Stock Units is an extraordinary item of compensation, which is outside the scope of the Director’s service contract (if any), except as may otherwise be explicitly provided in the Director’s service contract (if any);
•The Restricted Stock Units are not part of normal or expected compensation for any purpose;
•The future value of the Shares is unknown and cannot be predicted with certainty; further, neither the Company nor any Subsidiary or Affiliate is


responsible for any foreign exchange fluctuation between local currency and the United States Dollar or the selection by the Company or any Subsidiary or Affiliate in its sole discretion of an applicable foreign currency exchange rate that may affect the value of the Restricted Stock Units or Shares (or the calculation of income or Tax Liability thereunder).
•Any cross-border cash remittance made to pay any Tax Liability in relation to the Restricted Stock Units or transfer proceeds received upon the sale of Shares must be made through a locally authorized financial institution or registered foreign exchange agency and may require the Director to provide to such entity certain information regarding the transaction.
•No claim or entitlement to compensation or damages arises from the termination of the Award or diminution in value of the Restricted Stock Units or Shares, and the Director irrevocably releases the Company and its Affiliates from any such claim that may arise;
•Neither the Plan nor the Restricted Stock Units shall be construed to create a service relationship where such relationship did not otherwise already exist; and
•The Company is not obligated, and will have no liability for failure to issue or deliver any Shares upon vesting of the Restricted Stock Units unless such issuance or delivery would comply with applicable laws.
•The Company reserves the right to impose other requirements on the Director’s participation in the Plan, on the Restricted Stock Units and the Shares, and on any other award or Shares acquired under the Plan, or take any other action, to the extent the Company determines it is necessary or advisable in order to comply with applicable laws or facilitate the administration of the Plan. The Director agrees to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. Furthermore, the applicable laws of the country in which the Director is residing or providing services in at the time of grant or vesting of the Restricted Stock Units or duirng the ownership or sale of Shares received pursuant to the Restricted Stock Units (including any rules or regulations governing securities, foreign exchange, tax, labor, or other matters) may subject the Director to additional procedural or regulatory requirements that he solely is and will be responsible for and must fulfill. Such requirements may be outlined in but are not limited to the Country-Specific Addendum (the “Addendum”) attached hereto, which forms part of the Restricted Stock Unit Agreement and Appendix A. Notwithstanding any provision herein, the Director’s participation in the Plan shall be subject to any applicable special terms and conditions or disclosures as set forth in the Addendum. The Director also understands and agrees that if he works, resides, moves to, or otherwise is or becomes subject to applicable laws or company policies of another jurisdiction at any time, certain country-specific notices, disclaimers and/or terms and conditions may apply to him as from the date of grant, unless otherwise determined by the Company in its sole discretion.
11. Changes in Stock. In the event that as a result of a stock dividend, stock split, reclassification, recapitalization, combination of Shares or the adjustment in capital stock of the Company or otherwise, or as a result of a merger, consolidation, spin-off or other


reorganization, the Company’s common stock shall be increased, reduced or otherwise changed, the Restricted Stock Units shall, subject to Section 409A of the Code, be properly adjusted.
12. Address for Notices. Any notice to be given to the Company under the terms of this Agreement shall be addressed to the Company, in care of its Secretary, at 3100 Hansen Way, Palo Alto, California 94304, or at such other address as the Company may hereafter designate in writing.
13. Restrictions on Transfer. Except as provided in Paragraph 5 above, this award and the rights and privileges conferred hereby shall not be transferred, assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to sale under execution, attachment or similar process. Upon any attempt to transfer, assign, pledge, hypothecate or otherwise dispose of this award, or of any right or privilege conferred hereby, or upon any attempted sale under any execution, attachment or similar process, this award and the rights and privileges conferred hereby immediately shall become null and void. Regardless of whether the transfer or issuance of the Shares to be issued pursuant to this Agreement has been registered under the Securities Act of 1933, as amended (the "1933 Act") or has been registered or qualified under the securities laws of any state, the Company may impose additional restrictions upon the sale, pledge, or other transfer of the Shares (including the placement of appropriate legends on stock certificates and the issuance of stop-transfer instructions to the Company’s transfer agent) if, in the judgment of the Company and the Company’s counsel, such restrictions are necessary in order to achieve compliance with the provisions of the 1933 Act, the securities laws of any state, or any other law. Stock certificates evidencing the Shares issued pursuant to this Agreement, if any, may bear such restrictive legends as the Company and the Company’s counsel deem necessary under applicable laws or pursuant to this Agreement.
14. Binding Agreement. Subject to the limitation on the transferability of this award contained herein, this Agreement shall be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
15. Conditions for Issuance of Certificates for Stock. The Shares deliverable to the Director upon settlement of vested Restricted Stock Units may be either previously authorized but unissued Shares or issued Shares which have been reacquired by the Company. Subject to Section 409A of the Code, the Company shall not be required to issue any certificate or certificates for Shares hereunder prior to fulfillment of all the following conditions: (a) the admission of such Shares to listing on all stock exchanges on which such class of stock is then listed; (b) the completion of any registration or other qualification of such Shares under any state or federal law or under the rulings or regulations of the Securities and Exchange Commission or any other governmental regulatory body, which the Committee shall, in its absolute discretion, deem necessary or advisable; (c) the approval or other clearance from any state or federal governmental regulatory body, which the Committee shall, in its absolute discretion, determine to be necessary or advisable; and (d) the lapse of such reasonable period of time following the Vesting Date(s) as the Committee may establish from time to time for reasons of administrative convenience.
16. Plan Governs. This Agreement is subject to all terms and provisions of the Plan. In the event of a conflict between one or more provisions of this Agreement and one or more provisions of the Plan, the provisions of the Plan shall govern.
17. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California, without reference to its principles of conflicts of law. For purposes of litigating any dispute that may arise directly or indirectly from this


Agreement, the parties hereby submit and consent to the exclusive jurisdiction of the State of California and agree that any such litigation shall be conducted only in the courts of California or the federal courts of the United States located in California and no other courts.
18. Committee Authority. The Committee shall have the power to interpret the Plan and this Agreement, and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee in good faith shall be final and binding upon the Director, the Company and all other interested persons. No member of the Committee shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Agreement. In its absolute discretion, the Board may at any time and from time to time exercise any and all rights and duties of the Committee under the Plan and this Agreement.
19. Captions. Captions provided herein are for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.
20. Severability. In the event that any provision in this Agreement shall be held invalid or unenforceable, such provision shall be severable from, and such invalidity or unenforceability shall not be construed to have any effect on, the remaining provisions of this Agreement.
21. Modifications to the Agreement. This Agreement constitutes the entire understanding of the parties on the subjects covered. The Director expressly warrants that he or she is not executing this Agreement in reliance on any promises, representations, or inducements other than those contained herein. Modifications to this Agreement or the Plan can be made only in an express written contract executed by a duly authorized officer of the Company.
22. Amendment, Suspension or Termination of the Plan. By accepting this award, the Director expressly warrants that he or she has received a right to an equity based award under the Plan, and has received, read, and understood a description of the Plan. The Director understands that the Plan is discretionary in nature and may be modified, suspended, or terminated by the Company at any time.
23. Authorization to Release and Transfer Necessary Personal Information. The Director hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of his or her personal data by and among, as applicable, the Company and the Affiliates for the exclusive purpose of implementing, administering and managing the Director’s participation in the Plan. The Director understands that the Company and the Affiliates may hold certain personal information about the Director including, but not limited to, the Director’s name, home address and telephone number, date of birth, social security number (or any other social or national identification number), compensation, nationality, number of Shares held and the details of all Restricted Stock Units or any other entitlement to Shares awarded, cancelled, vested, unvested or outstanding for the purpose of implementing, administering and managing the Director’s participation in the Plan (the “Data”). The Director understands that the Data may be transferred to the Company or any of the Affiliates, or to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Director’s country or elsewhere, and that the recipients’ country may have different data privacy laws and protections than the Director’s country. The Director understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. The Director authorizes the recipients to receive, possess, use, retain and transfer the Data, in


electronic or other form, for the sole purpose of implementing, administering and managing his or her participation in the Plan, including any requisite transfer of such Data to a broker or other third party assisting with the administration of Restricted Stock Units under the Plan or with whom Shares acquired pursuant to the vesting of the Restricted Stock Units or cash from the sale of such Shares may be deposited. Furthermore, the Director acknowledges and understands that the transfer of the Data to the Company or the Affiliates or to any third parties is necessary for his or her participation in the Plan. The Director understands that Data will be held only as long as is necessary to implement, administer and manage his or her participation in the Plan. The Director understands that he or she may, at any time, view the Data, request additional information about the storage and processing of the Data, require any necessary amendments to the Data or refuse or withdraw the consents herein by contacting his or her local human resources representative in writing. The Director further acknowledges that withdrawal of consent may affect his or her ability to vest in or realize benefits from the Restricted Stock Units, and his or her ability to participate in the Plan. For more information on the consequences of refusal to consent or withdrawal of consent, the Director understands that he or she may contact his or her local human resources representative.
24. [Electronic Delivery: By executing this Agreement or otherwise accepting the Restricted Stock Units in accordance with procedures established by the Company, the Director consents to the electronic delivery of the Plan documents and this Agreement.] To the extent the Director has been provided with a copy of the Restricted Stock Unit Agreement, the Plan, or any other documents relating to this grant in a language other than English, the English language documents will prevail in case of any ambiguities or divergences as a result of translation.
25. [Execution of this Agreement: Execution of this Agreement, whether in writing or electronic, shall have the same binding effect and shall fully bind the Director and the Company to all of the terms and conditions set forth in this Agreement and the Plan.]


o 0 o
COUNTRY-SPECIFIC ADDENDUM

This Addendum includes additional country-specific notices, disclaimers, and/or terms and conditions that apply to individuals who work or reside in the countries listed below and that may be material to their participation in the Plan. Such notices, disclaimers, and/or terms and conditions may also apply, as from the date of grant, if the recipient of Restricted Stock Units moves to or otherwise is or becomes subject to the applicable laws or company policies of the country listed. However, because foreign exchange regulations and other local laws are subject to frequent change, the Director is advised to seek advice from his own personal legal and tax advisor prior to accepting the Restricted Stock Unit or exercising anor holding or selling Shares acquired under the Plan. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Director’s acceptance of the Restricted Stock Unit or participation in the Plan. Unless otherwise noted below, capitalized terms shall have the same meaning assigned to them under the Plan and the Restricted Stock Unit Agreement, including Appendix A. This Addendum forms part of the Restricted Stock Unit Agreement and Appendix A and should be read in conjunction with the Plan.



Securities Law Notice: Unless otherwise noted, neither the Company nor the Shares are registered with any local stock exchange or under the control of any local securities regulator outside the United States. The Restricted Stock Unit Agreement, Appendix A (of which this Addendum is a part), the Plan, and any other communications or materials that may be received regarding participation in the Plan do not constitute advertising or an offering of securities outside the United States, and the issuance of securities described in any Plan-related documents is not intended for public offering or circulation in the Director’s jurisdiction.

Singapore
Securities Law Notice
This offer and Shares to be issued hereunder shall be made available only to an employee, director, or other “qualifying person” of the Company or its Subsidiary or Affiliate, in reliance on the prospectus exemption set out in Section 273(1)(f) of the Securities and Futures Act (Chapter 289) of Singapore (“the SFA”). This offer is not made with a view to the Shares being subsequently offered for sale or sold to any other party in Singapore.  In accepting this offer, the Director understands and acknowledge that this Agreement and/or any other document or material in connection with this offer and the Shares hereunder have not been and will not be lodged, registered or reviewed by the Monetary Authority of Singapore. Any and all Shares to be issued hereunder shall therefore be subject to the general resale restriction under Section 257 of the SFA, and the Director undertakes not to make any subsequent sale in Singapore, or any offer of sale in Singapore, of any of the Shares (received upon vesting) unless that sale or offer  in Singapore is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) other than Section 280 of the SFA.

Director Reporting
If the Director is a director or shadow director of a Singapore-incorporated Subsidiary or Affiliate of the Company, he may be subject to special reporting requirements with regard to the acquisition of Shares or rights over Shares. The Director should contact his personal legal advisor for further details if he is a director or shadow director of a Singapore Subsidiary or Affiliate.

Exit Tax / Deemed Exercise Rule
If the Director has received Restricted Stock Units in relation to employment or service in Singapore, please note that if, prior to the vesting of the Restricted Stock Units, he is 1) a permanent resident of Singapore and leaves Singapore permanently or is transferred out of Singapore; or 2) neither a Singapore citizen nor permanent resident and either ceases employment in Singapore or leaves Singapore for any period exceeding 3 months, it is possible he may be taxed on the unvested RSUs on a “deemed exercise” basis, even though the RSUs have not yet vested.  The Director should discuss the relevant tax treatment with his personal tax advisor. 



 EX-31.1 3 exhibit311-2020q1.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, Dow R. Wilson, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Varian Medical Systems, Inc. (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonable likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Dated: February 11, 2020/s/Dow R. Wilson
  Dow R. Wilson
  President
  and Chief Executive Officer




 EX-31.2 4 exhibit312-2020q1.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002
I, J. Michael Bruff, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Varian Medical Systems, Inc. (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonable likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: February 11, 2020/s/J. Michael Bruff
  J. Michael Bruff
  Senior Vice President and
  Chief Financial Officer




 EX-32.1 5 exhibit321-2020q1.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report of Varian Medical Systems, Inc. (the “Company”), on Form 10-Q for the quarter ended January 3, 2020 (the “Report”), I, Dow R. Wilson, President and Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:
(1)the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:February 11, 2020/s/Dow R. Wilson
  Dow R. Wilson
  President
  and Chief Executive Officer


 EX-32.2 6 exhibit322-2020q1.htm EX-32.2 Document

Exhibit 32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report of Varian Medical Systems, Inc. (the “Company”), on Form 10-Q for the quarter ended January 3, 2020 (the “Report”), I, J. Michael Bruff, Senior Vice President and Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:
(1)the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:February 11, 2020/s/J. Michael Bruff
  J. Michael Bruff
  Senior Vice President and
  Chief Financial Officer


 EX-101.SCH 7 var-20200103.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EQUITY Statement link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details) link:presentationLink link:calculationLink link:definitionLink 2104102 - Disclosure - OTHER FINANCIAL INFORMATION link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - OTHER FINANCIAL INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - OTHER FINANCIAL INFORMATION - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - OTHER FINANCIAL INFORMATION - Unfulfilled Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - OTHER FINANCIAL INFORMATION - Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - OTHER FINANCIAL INFORMATION - Components of Inventories (Detail) link:presentationLink link:calculationLink link:definitionLink 2410406 - Disclosure - OTHER FINANCIAL INFORMATION - Components of Other Long-Term Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 2411407 - Disclosure - OTHER FINANCIAL INFORMATION - Other Income, Net (Details) link:presentationLink link:calculationLink link:definitionLink 2112103 - Disclosure - FAIR VALUE link:presentationLink link:calculationLink link:definitionLink 2313302 - Disclosure - FAIR VALUE (Tables) link:presentationLink link:calculationLink link:definitionLink 2414408 - Disclosure - FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) link:presentationLink link:calculationLink link:definitionLink 2415409 - Disclosure - FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail) link:presentationLink link:calculationLink link:definitionLink 2416410 - Disclosure - FAIR VALUE - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2117104 - Disclosure - RECEIVABLES link:presentationLink link:calculationLink link:definitionLink 2318303 - Disclosure - RECEIVABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 2419411 - Disclosure - RECEIVABLES (Details) link:presentationLink link:calculationLink link:definitionLink 2419411 - Disclosure - RECEIVABLES (Details) link:presentationLink link:calculationLink link:definitionLink 2120105 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2321304 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2422412 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail) link:presentationLink link:calculationLink link:definitionLink 2423413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail) link:presentationLink link:calculationLink link:definitionLink 2424414 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2425415 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2126106 - Disclosure - BORROWINGS link:presentationLink link:calculationLink link:definitionLink 2327305 - Disclosure - BORROWINGS (Tables) link:presentationLink link:calculationLink link:definitionLink 2428416 - Disclosure - BORROWINGS - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2429417 - Disclosure - BORROWINGS - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2130107 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES link:presentationLink link:calculationLink link:definitionLink 2331306 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2432418 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Instruments Reported on the Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 2433419 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedging Activities (Details) link:presentationLink link:calculationLink link:definitionLink 2434420 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Pre-tax amounts Recognized in AOCI on the Balance Sheet (Details) link:presentationLink link:calculationLink link:definitionLink 2435421 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail) link:presentationLink link:calculationLink link:definitionLink 2436422 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail) link:presentationLink link:calculationLink link:definitionLink 2437423 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail) link:presentationLink link:calculationLink link:definitionLink 2138108 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2339307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2440424 - Disclosure - COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail) link:presentationLink link:calculationLink link:definitionLink 2441425 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2441425 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2442426 - Disclosure - COMMITMENTS AND CONTINGENCIES - Lessor Arrangements (Details) link:presentationLink link:calculationLink link:definitionLink 2443427 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2144109 - Disclosure - RETIREMENT PLANS link:presentationLink link:calculationLink link:definitionLink 2345308 - Disclosure - RETIREMENT PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 2446428 - Disclosure - RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail) link:presentationLink link:calculationLink link:definitionLink 2147110 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 2448429 - Disclosure - INCOME TAXES - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2149111 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 2350309 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 2451430 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2452431 - Disclosure - STOCKHOLDERS' EQUITY - Shares Repurchased During Period (Details) link:presentationLink link:calculationLink link:definitionLink 2453432 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail) link:presentationLink link:calculationLink link:definitionLink 2454433 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail) link:presentationLink link:calculationLink link:definitionLink 2155112 - Disclosure - EMPLOYEE STOCK PLANS link:presentationLink link:calculationLink link:definitionLink 2356310 - Disclosure - EMPLOYEE STOCK PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 2457434 - Disclosure - EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail) link:presentationLink link:calculationLink link:definitionLink 2458435 - Disclosure - EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail) link:presentationLink link:calculationLink link:definitionLink 2459436 - Disclosure - EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail) link:presentationLink link:calculationLink link:definitionLink 2460437 - Disclosure - EMPLOYEE STOCK PLANS - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2461438 - Disclosure - EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail) link:presentationLink link:calculationLink link:definitionLink 2162113 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2363311 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2464439 - Disclosure - EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail) link:presentationLink link:calculationLink link:definitionLink 2165114 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 2366312 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2467440 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS - Loans and Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 2468441 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2169115 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 2370313 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2471442 - Disclosure - SEGMENT INFORMATION - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 2472443 - Disclosure - SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail) link:presentationLink link:calculationLink link:definitionLink 2473444 - Disclosure - SEGMENT INFORMATION - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2174116 - Disclosure - BUSINESS COMBINATIONS link:presentationLink link:calculationLink link:definitionLink 2475445 - Disclosure - BUSINESS COMBINATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 2176117 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - OTHER FINANCIAL INFORMATION - Unfulfilled Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 var-20200103_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 var-20200103_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 var-20200103_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cumulative Translation Adjustment Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Business combination Goodwill acquired Goodwill, Acquired During Period Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Statistical Measurement [Domain] Statistical Measurement [Domain] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Tranche B loan Tranche B Loans [Member] Tranche B loans. Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Hardware Hardware [Member] Hardware [Member] Number of specialty hospitals Number of Specialty Hospitals Number of Specialty Hospitals Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Liabilities assumed by lenders Debtor in Possession, Financing, Liabilities Assumed by Lenders Debtor in Possession, Financing, Liabilities Assumed by Lenders Amount accrued for environmental remediation expense Accrual for Environmental Loss Contingencies, Component Amount Future Minimum Operating Lease Payments [Abstract] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Income Statement Location [Domain] Income Statement Location [Domain] Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments Derivatives Not Designated as Hedging Instruments [Table Text Block] Legal Entity [Axis] Legal Entity [Axis] Accounting Policies [Abstract] Accounting Policies [Abstract] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Unrecognized compensation expense related to outstanding stock awards Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Impairment charges Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale Other comprehensive earnings (loss) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Fair Value of Derivative Instruments Reported on the Balance Sheet Fair Value, by Balance Sheet Grouping [Table Text Block] Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Operating expenses: Operating Expenses [Abstract] Number of cancer centers Number of Cancer Centers Number of Cancer Centers Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Other income, net Other Operating Income (Expense), Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Estimated litigation accrual Estimated Litigation Liability Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets MPTC loans (1) Maryland Proton Therapy Center (MPTC) [Member] Maryland Proton Therapy Center (MPTC) [Member] Capital in Excess of Par Value Additional Paid-in Capital [Member] Borrowings under credit facility agreement Proceeds from Issuance of Long-term Debt Depreciation Depreciation Total liabilities measured at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Line Of Credit Facility [Table] Line of Credit Facility [Table] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] 2024 Lessee, Operating Lease, Liability, Payments, Due Year Five Repurchases of common stock Payments for Repurchase of Common Stock Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Net borrowings under the credit facility agreements with maturities less than 90 days Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Accounts receivable, includes unbilled accounts receivable Accounts Receivable From Variable Interest Entity Accounts receivable from variable interest entity. Unallocated corporate Corporate Segment [Member] Goodwill Balance, beginning Balance, ending Goodwill Unbilled receivables - long-term Contract with Customer, Asset, Net, Noncurrent Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Hedging Relationship [Axis] Hedging Relationship [Axis] Property Subject to or Available for Operating Lease, by Major Property Class [Table] Property Subject to or Available for Operating Lease, by Major Property Class [Table] Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Recognized revenue included in deferred revenue balance Contract with Customer, Liability, Revenue Recognized Accrued liabilities Finance Lease, Liability, Current Property, plant and equipment, net Property, Plant and Equipment, Net Notional Value Purchased Long [Member] Balance at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Debt Instrument [Axis] Debt Instrument [Axis] Other Financial Information [Abstract] Other Financial Information [Abstract] Other Financial Information [Abstract] Significant Other Observable Inputs Fair Value, Inputs, Level 2 [Member] Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Schedule Of Goodwill [Table] Schedule of Goodwill [Table] Defined benefit pension plan Liability, Defined Benefit Pension Plan, Noncurrent Adjustments due to the effect of foreign exchange Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments Due to Effect of Foreign Exchange Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments Due to Effect of Foreign Exchange Unrealized loss on derivatives, before tax, expected to be reclassified over the next 12 months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Employee Stock Option Plans Stock options Share-based Payment Arrangement, Option [Member] Hedging Relationship [Domain] Hedging Relationship [Domain] Tax on increase (decrease) in unrealized gain on derivative instruments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax Expected term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Statement [Table] Statement [Table] Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Charged to cost of revenues Standard Product Warranty Accrual, Increase for Warranties Issued Foreign exchange forward contracts Foreign Exchange Forward [Member] New York Proton Center New York Proton Center [Member] New York Proton Center [Member] Receivables [Abstract] Receivables [Abstract] Measurement Frequency Measurement Frequency [Axis] Weighted-Average Interest Rate (as a percent) Debt, Weighted Average Interest Rate Equity investments in privately-held companies Equity Securities without Readily Determinable Fair Value, Amount Gain on equity investments Realized and Unrealized Gain on Investments Realized and Unrealized Gain on Investments Changes in assets and liabilities, net of effects of acquisitions: Increase (Decrease) in Operating Capital [Abstract] 2022 Lessee, Operating Lease, Liability, Payments, Due Year Three Total lease expense Lease, Cost Retained earnings Retained Earnings (Accumulated Deficit) Cost of revenues - Product Cost Of Revenues Product [Member] Cost of Revenues - Product [Member] BORROWINGS Debt Disclosure [Text Block] PROTON SOLUTIONS LOANS AND INVESTMENTS Proton Solutions Loans and Investments [Text Block] Proton Solutions Loans and Investments [Text Block] Weighted average remaining discount rate-operating leases (percent) Operating Lease, Weighted Average Discount Rate, Percent Other Assets Other Noncurrent Assets [Member] Option Component of ESPP Shares with Weighted Average Assumptions Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Cost of revenues: Cost of Revenue [Abstract] Document Quarterly Report Document Quarterly Report Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Operating Activities [Axis] Operating Activities [Axis] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Other income, net Nonoperating Income (Expense) [Member] Asset acquisition, holdback amount Asset Acquisition, Holdback Amount Asset Acquisition, Holdback Amount Other income (loss) Other Nonoperating Income (Expense) Position [Domain] Position [Domain] BUSINESS COMBINATIONS Business Combination Disclosure [Text Block] Schedule of Unfulfilled Performance Obligations Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Tax on amortization of net actuarial loss included in net periodic benefit cost Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Federal Funds Rate Fed Funds Effective Rate Overnight Index Swap Rate [Member] Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Reclassification adjustments, net of tax benefit of $0.2 and $0.0, respectively Amount of gain reclassified from accumulated other comprehensive loss into net earnings Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax Weighted average shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Net Carrying Amount Finite-Lived Intangible Assets, Net Prepaid Expenses and Other Current Assets Prepaid Expenses and Other Current Assets [Member] Number of patents allegedly infringed Loss Contingency, Patents Allegedly Infringed, Number Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Interest income Investment Income, Interest Tranche D Loans Tranche D Loans [Member] Tranche D Loans [Member] Total share-based compensation expense Share-based Payment Arrangement, Expense Major Types of Debt and Equity Securities Financial Instruments [Domain] Lease term Lessor, Operating Lease, Term of Contract Future amortization expense, fiscal year 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Two Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Long-term lease liabilities Operating Lease, Liability, Noncurrent Assets Assets [Abstract] Schedule of Cash Flow Hedging Activities Schedule of Cash Flow Hedging Activities [Table Text Block] Schedule of Cash Flow Hedging Activities [Table Text Block] Americas Americas [Member] Activity of Goodwill by Reportable Operating Segment Schedule of Goodwill [Table Text Block] Consolidation Items Consolidation Items [Domain] Notional value sold Derivative, Notional Amount Statistical Measurement [Axis] Statistical Measurement [Axis] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Derivative assets Derivative Asset Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts payable Increase (Decrease) in Accounts Payable Deferred tax assets Deferred Income Tax Assets, Net Debt instrument, contract repayment date Debt Instrument, Contract Repayment Date Debt Instrument, Contract Repayment Date Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee stock purchase plan. Business Acquisition [Axis] Business Acquisition [Axis] Less: Net earnings attributable to noncontrolling interests Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Raw materials and parts Inventory, Raw Materials and Purchased Parts, Net of Reserves Commitment Remaining Obligation Fund Loan Remaining Obligation Fund Loan RECEIVABLES Loans, Notes, Trade and Other Receivables, Including Financing Receivables Disclosure [Text Block] Loans, Notes, Trade and Other Receivables, Including Financing Receivables Disclosure [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus STOCKHOLDERS’ EQUITY Stockholders' Equity Note Disclosure [Text Block] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Derivative instruments: Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract] Asset acquisition, potential maximum payout of contingent consideration Asset Acquisition, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High Asset Acquisition, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High Equity: Stockholders' Equity Attributable to Parent [Abstract] Scenario [Axis] Scenario [Axis] Schedule Of Employee Stock Ownership Plan E S O P Disclosures [Table] Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization FAIR VALUE Fair Value Disclosures [Text Block] Operating Results Information for Each Business Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Other assets Other Assets, Noncurrent Service Service [Member] Acquisition purchase price Business Combination, Consideration Transferred Property Subject to or Available for Operating Lease [Axis] Property Subject to or Available for Operating Lease [Axis] Entity Current Reporting Status Entity Current Reporting Status Preferred stock, issued (in shares) Preferred Stock, Shares Issued Derivative, term of contract Derivative, Term of Contract Accrued liabilities and other long-term liabilities Increase (Decrease) In Accrued Liabilities And Other Non-current Liabilities Increase (Decrease) In Accrued Liabilities And Other Non-current Liabilities Entity Emerging Growth Company Entity Emerging Growth Company Retained Earnings Retained Earnings [Member] Segments [Domain] Segments [Domain] Long-term Accounts Receivable, after Allowance for Credit Loss, Noncurrent Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Operating Activities [Domain] Operating Activities [Domain] Amount of Gain (Loss) Recognized in Net Earnings on Derivative Instruments Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Maximum lending commitment Maximum Lending Commitment Maximum Lending Commitment Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues Net earnings per share - diluted (in dollars per share) Net earnings per share attributable to Varian - diluted (in dollars per share) Earnings Per Share, Diluted Business Acquisition [Line Items] Business Acquisition [Line Items] Unbilled receivables - current Contract with Customer, Asset, Net, Current Accelerated Share Repurchases, Date [Domain] Accelerated Share Repurchases, Date [Domain] SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Inventories Total inventories Inventory, Net Anti-dilutive employee shared based awards, excluded (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Balance Sheet Location [Axis] Balance Sheet Location [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Receivable Type [Axis] Receivable Type [Axis] Business Combinations [Abstract] Business Combinations [Abstract] 2020 Operating Leases, Future Minimum Payments Due, Next Twelve Months Reclassification Out Of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Service cost Defined Benefit Plan, Service Cost Service Service, Excluding Software [Member] Service, Excluding Software [Member] Endocare and Alicon Endocare and Alicon [Member] Endocare and Alicon [Member] Cash-settled Stock Appreciation Rights Stock Appreciation Rights (SARs) [Member] MPTC Series B-1 Bonds MPTC Series B-1 Bonds [Member] MPTC Series B-1 Bonds [Member] Total minimum lease payments Lessee, Operating Lease, Liability, Payments, Due Property, plant, and equipment, net Property, Plant and Equipment [Member] Remaining performance obligation, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Entity [Domain] Entity [Domain] Computation of Basic and Diluted Net Earnings (Loss) Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Amortization of prior service cost included in net periodic benefit cost, net of tax benefit of $0.0* and $0.0*, respectively Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax 2024 Operating Leases, Future Minimum Payments, Due in Five Years Proton International LLC loan Proton International [Member] Proton International [Member] Entity Address, State or Province Entity Address, State or Province Total short-term borrowings Debt, Current Total equity Balance at beginning of period Balance at end of period Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Activity Under Employee Stock Plans Share-based Payment Arrangement, Option, Activity [Table Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Segments [Axis] Segments [Axis] India INDIA Average repurchase price per share (in dollars per share) Stock Repurchased During Period, Average Cost Per Share Stock Repurchased During Period, Per Share DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Derivative Instruments and Hedging Activities Disclosure [Text Block] Net earnings (loss) Net Income (Loss) Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest Net Income (Loss) Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Share Repurchases Share Repurchases [Table Text Block] Share Repurchases [Table Text Block] Document Transition Report Document Transition Report Goodwill [Line Items] Goodwill [Line Items] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Revenues Revenue Benchmark [Member] Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Components of Lease Expense, Supplemental Cash Flow Information and Supplemental Balance Sheet Information Lease, Cost [Table Text Block] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] MPTC Series B-2 Bonds MPTC Series B-2 Bonds [Member] MPTC Series B-2 Bonds [Member] Line of credit, basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Tax withholdings on vesting of equity awards Payment, Tax Withholding, Share-based Payment Arrangement Payments to acquire available-for-sale securities Payments to Acquire Debt Securities, Available-for-sale Proton Center, Munich Proton Center, Munich [Member] Proton Center, Munich [Member] Short-term borrowings Short-term Debt Total operating expenses Operating Expenses Derivative instruments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Accumulated Other Comprehensive Loss AOCI Including Portion Attributable to Noncontrolling Interest [Member] Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents MPTC Series B-2 Bonds MPTC Subordinated Bonds [Member] MPTC Subordinated Bonds [Member] Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Weighted average fair value at grant date (dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Continuing Operations Continuing Operations [Member] Earnings before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest EMEA EMEA [Member] Balance at end of period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Other, net Payments for (Proceeds from) Other Investing Activities Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Share-based compensation expense Share-based Payment Arrangement, Noncash Expense Other income, net Other Nonoperating Income Technologies and patents Technology-Based Intangible Assets [Member] Other comprehensive earnings (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Cash paid Payments to Acquire Businesses, Gross Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Other Long-term Liabilities Other Noncurrent Liabilities [Member] Dilutive effect of potential common shares (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Operating cash flows for leases Operating Lease, Payments Geographical [Axis] Geographical [Axis] Additional financing Debtor-in-Possession Financing, Amount Arranged Noncontrolling Interests Noncontrolling Interest [Member] Weighted Average Grant-Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Increase in deferred revenue Increase (Decrease) in Deferred Revenue Trade and unbilled receivables Increase (Decrease) in Accounts Receivable Accumulated Other Comprehensive Income Loss [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Interest on lease liabilities Finance Lease, Interest Expense Significant Unobservable Inputs Fair Value, Inputs, Level 3 [Member] Entity Address, City or Town Entity Address, City or Town Deferred income taxes Deferred Income Taxes and Other Tax Liabilities, Noncurrent Loans Receivable Loans Receivable [Member] Income tax benefit for share-based compensation Share-based Payment Arrangement, Expense, Tax Benefit Entity Filer Category Entity Filer Category Notes Receivable Notes Receivable [Member] Future Minimum Payments Due under Topic 840 [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Consolidation Items Consolidation Items [Axis] Equity [Abstract] Equity [Abstract] Amounts reclassified out of other comprehensive earnings (loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Total lease liabilities Finance Lease, Liability Designated as Hedging Instrument Designated as Hedging Instrument [Member] Schedule of Trade and Unbilled Receivables, Net and Notes Receivable Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Sri Lanka SRI LANKA Liability Class [Axis] Liability Class [Axis] Term Loan Term Loan [Member] Term Loan Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Derivative [Table] Derivative [Table] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Comprehensive earnings attributable to Varian Comprehensive Income (Loss), Net of Tax, Attributable to Parent Statement [Line Items] Statement [Line Items] Change in fair value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Number of segments Number of Reportable Segments Long-term notes receivable Financing Receivable, after Allowance for Credit Loss Entity Registrant Name Entity Registrant Name 2022 Finance Lease, Liability, Payments, Due Year Three Payments to acquire outstanding senior debt Payments to Acquire Senior Secured Debt Payments to Acquire Senior Secured Debt Property Subject to or Available for Operating Lease [Line Items] Property Subject to or Available for Operating Lease [Line Items] Asset acquisition, fair value of contingent consideration Asset Acquisition, Contingent Consideration, Liability, Fair Value Asset Acquisition, Contingent Consideration, Liability, Fair Value Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Tranche C Loans Tranche C Loans [Member] Tranche C Loans [Member] Amendment Flag Amendment Flag Euro Euro Member Countries, Euro Unbilled receivables from variable interest entity Unbilled Receivables from Variable Interest Entity Unbilled Receivables from Variable Interest Entity Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Loss) Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] City Area Code City Area Code Entity Central Index Key Entity Central Index Key Cancelled or expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Litigation Case [Domain] Litigation Case [Domain] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Gross Carrying Amount and Accumulated Amortization of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Schedule of Short-term Borrowings and Long-term Debt Schedule of Short-term Debt [Table Text Block] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Loan facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Common stock, shares authorized (in shares) Common Stock, Shares Authorized Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Other long-term liabilities: Other Noncurrent Liabilities [Table Text Block] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] All Currencies [Domain] All Currencies [Domain] Product and Service [Domain] Product and Service [Domain] Modified former loans receivable Term loan Financing Receivable, before Allowance for Credit Loss, Noncurrent Paid-in-kind interest receivable (percent) Paid-in-kind Interest Receivable, Percent Paid-in-kind Interest Receivable, Percent APTC Securities APTC Securities [Member] APTC Securities [Member] Cancer Treatment Services International Cancer Treatment Services International [Member] Cancer Treatment Services International [Member] GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Tax withholdings on vesting of equity awards Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Variable Rate [Domain] Variable Rate [Domain] Accumulated Other Comprehensive Income Loss [Table] Accumulated Other Comprehensive Income (Loss) [Table] Entity Shell Company Entity Shell Company Acquisition-related expenses Business Combination, Acquisition Related Costs Total Varian stockholders' equity Stockholders' Equity Attributable to Parent Finite lived intangible assets, gross Finite-Lived Intangible Assets, Gross Work-in-process Inventory, Work in Process, Net of Reserves 2021 Lessee, Operating Lease, Liability, Payments, Due Year Two Defined benefit pension and post-retirement benefit plans: Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract] Accumulated impairment charges Goodwill, Impaired, Accumulated Impairment Loss Plan Name Plan Name [Axis] Cash Flow Hedging Cash Flow Hedging [Member] Net earnings Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Other Other Sundry Liabilities, Noncurrent Equity Component [Domain] Equity Component [Domain] Maximum lending commitment Loan Facility Maximum Lending Commitment Loan Facility Maximum Lending Commitment Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Exercisable (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Leased equipment Property, Plant and Equipment, Gross Common Stock Common Stock [Member] Derivative [Line Items] Derivative [Line Items] Amortization of net actuarial loss included in net periodic benefit cost, net of tax expense of $(0.2) and $(0.1), respectively Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Geographical [Domain] Geographical [Domain] Exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Receivable [Domain] Receivable [Domain] Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain] Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain] Contingent consideration Contingent Consideration Liability, Fair Value Contingent Consideration Liability, Fair Value Accounts payable Accounts Payable, Current Other Other Intangible Assets [Member] Asset acquisition purchase price Asset Acquisition, Consideration Transferred Asset Acquisition, Consideration Transferred Net Unrealized Gains (Losses) Defined Benefit Pension and Post-Retirement Benefit Plans Unrealized loss on defined benefit pension and post-retirement benefit plans Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Repayments under credit facility agreement Repayments of Long-term Debt Current Fiscal Year End Date Current Fiscal Year End Date Hedging Designation [Axis] Hedging Designation [Axis] Net Unrealized Gains Cash Flow Hedging Instruments Unrealized earnings on cash flow hedging instruments Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member] Total Varian Stockholders' Equity Parent [Member] Equity Award Award Type [Domain] Commitment Remaining Obligation to Fund Bond Remaining Obligation to Fund Bond Weighted Average Remaining Term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Derivative Instruments and Hedging Activities Disclosures [Line Items] Derivative Instruments and Hedging Activities Disclosures [Line Items] Contingent consideration Business Combination, Contingent Consideration, Liability, Noncurrent Short-term Financing Receivable, after Allowance for Credit Loss, Current Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Repurchases of common stock Stock Repurchased and Retired During Period, Value Gain on sale of equity investments Gain on Sale of Investments Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Additional maximum commitment amount Additional Loan Facility Maximum Commitment Amount Additional Loan Facility Maximum Commitment Amount Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Derivative Instrument [Axis] Derivative Instrument [Axis] Finished goods Inventory, Finished Goods, Net of Reserves Revenue projection period for consideration payments Business Combination, Contingent Consideration, Revenue Projection Period Business Combination, Contingent Consideration, Revenue Projection Period Senior First Lien Loan Senior First Lien Loan [Member] Senior First Lien Loan [Member] Quoted Prices in Active Markets for Identical Instruments Fair Value, Inputs, Level 1 [Member] EMPLOYEE STOCK PLANS Share-based Payment Arrangement [Text Block] Long-term income taxes payable Liability for Uncertainty in Income Taxes, Noncurrent November 2016 November 2016 [Member] November 2016 [Member] Products transferred at a point in time Transferred at Point in Time [Member] NYPC loan MM Proton I, LLC [Member] MM Proton I, LLC [Member] Weighted average remaining discount rate-finance leases (percent) Finance Lease, Weighted Average Discount Rate, Percent Cost of revenues - Service Cost Of Revenues Service [Member] Cost Of Revenues Service [Member] Income Statement Location [Axis] Income Statement Location [Axis] Undiscounted range of contingent consideration payments, low Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, Low Available-for-sale Securities Available-for-sale Securities [Member] Debt Security Category [Axis] Debt Security Category [Axis] Cancelled or expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Schedule of Loans and Investments to Fund PT Centers Schedule Of Loans and Investments to Fund PT Centers [Table Text Block] Schedule Of Loans and Investments to Fund PT Centers [Table Text Block] Schedule Of Segment Reporting Information By Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Balance at beginning of period (in shares) Balance at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Interest income (expense), net Interest Income (Expense), Net Thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Tranche A loan Tranche A Loans [Member] Tranche A loans. Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Equity ownership interest (percent) Equity Method Investment, Ownership Percentage Eurodollar Rate plus 1% Eurodollar Plus 1% [Member] Eurodollar Plus 1% [Member] Remainder of 2020 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year Tax on reclassification adjustments on derivative instruments Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Operating earnings Earnings from continuing operations before taxes Operating Income (Loss) Tax (expense) benefit Other Comprehensive Income (Loss), Tax Total lease liabilities Operating Lease, Liability Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Net foreign currency exchange gain Foreign Currency Transaction Gain (Loss), before Tax Weighted average period unrecognized compensation expense is expected to be recognized, years Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Amounts Before Tax Included in AOCI on the Balance Sheet Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss Commitment fee Line of Credit Facility, Commitment Fee Percentage Inventories Increase (Decrease) in Inventories Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Embolics Microspheres Business Embolics Microspheres Business [Member] Embolics Microspheres Business Long-term Lease Liabilities Long-term Lease Liabilities [Member] Long-term Lease Liabilities Balance at beginning of period (in shares) Balance at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Finance Lease, Liability, Payment, Due [Abstract] Finance Lease, Liability, Payment, Due [Abstract] Short-term borrowings: Debt Instrument [Line Items] Proton Solutions Proton Solutions [Member] Proton Solutions [Member] Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Total assets measured at fair value Assets, Fair Value Disclosure Issuance of common stock Stock Issued During Period, Value, New Issues Interest rate (as a percent) Financing Receivable, Stated Rate Financing Receivable, Stated Rate Future amortization expense, fiscal year 2024 Finite-Lived Intangible Assets, Amortization Expense, Year Five Commitments and contingencies (Note 8) Commitments and Contingencies Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Finance Lease Liability Maturity Finance Lease, Liability, Maturity [Table Text Block] Schedule Of Finite Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Cover page. Cover page. Other Proceeds from (Payments for) Other Financing Activities Research and development Research and Development Expense Defined Benefit Plans Pension Plan [Member] Claims filed against assets of Company in bankruptcy Claims Filed Against Assets of Company in Bankruptcy Claims Filed Against Assets of Company in Bankruptcy North America North America [Member] Restricted cash - long-term Restricted Cash, Noncurrent Total liabilities Liabilities 2022 Operating Leases, Future Minimum Payments, Due in Three Years Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Other, net Other Noncash Income (Expense) Trading Symbol Trading Symbol Net earnings per share - basic (in dollars per share) Net earnings per share attributable to Varian - basic (in dollars per share) Earnings Per Share, Basic Recognized actuarial loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Tax on amortization of prior service cost included in net periodic benefit cost Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax Thereafter Finance Lease, Liability, Payments, Due after Year Five Less: Net earnings attributable to noncontrolling interests Less: Comprehensive earnings attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Document Period End Date Document Period End Date Other consideration Business Combination, Consideration Transferred, Other Trade and unbilled receivables, net Accounts Receivable, after Allowance for Credit Loss Effects of exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Other long-term liabilities Finance Lease, Liability, Noncurrent Total net unbilled receivables (deferred revenues) Contract with Customer, Liability 2023 Lessee, Operating Lease, Liability, Payments, Due Year Four OTHER FINANCIAL INFORMATION Supplemental Balance Sheet Disclosures [Text Block] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Fiscal Year Fiscal Period, Policy [Policy Text Block] C P T C C P T C [Member] CPTC Short-term revolving loan Loans Financing Receivable, before Allowance for Credit Loss, Current Revolving Credit Facility Revolving Credit Facility [Member] Litigation Status [Domain] Litigation Status [Domain] Common stock of $1 par value: 189.0 shares authorized; 90.7 and 90.8 shares issued and outstanding at January 3, 2020 and September 27, 2019, respectively Common Stock, Value, Issued Actual product warranty expenditures Standard and Extended Product Warranty Accrual, Decrease for Payments Research and development Research and Development Expense [Member] Cash, Cash Equivalents and Restricted Cash: Schedule of Cash and Cash Equivalents [Table Text Block] Less: imputed interest Finance Lease, Liability, Undiscounted Excess Amount Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Expected dividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Loss Recognized in Other Comprehensive Earnings (Loss) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] In-process research and development with indefinite lives Indefinite-lived Intangible Assets (Excluding Goodwill) Basis of Presentation Basis of Accounting, Policy [Policy Text Block] SUBSEQUENT EVENTS Subsequent Events [Text Block] Scenario [Domain] Scenario [Domain] Defined benefit pension and post-retirement benefit plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Total cost of revenues Cost of Goods and Services Sold Total minimum lease payments Finance Lease, Liability, Payment, Due Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] Other Income (Expense), Net: Schedule of Other Nonoperating Income (Expense) [Table Text Block] Sale of equity investments Proceeds from Sale of Other Investments Share-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Revenues: Revenues [Abstract] Total assets Assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Available-for-sale securities Fair Value Debt Securities, Available-for-sale Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Net earnings Net earnings Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Currency [Axis] Currency [Axis] Finance leases: Lessee Finance Leases [Abstract] Lessee Finance Leases Products and Services transferred over time Transferred over Time [Member] Exercisable (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Plan Name Plan Name [Domain] Accelerated Share Repurchases, Date [Axis] Accelerated Share Repurchases, Date [Axis] Unfulfilled Performance Obligations Revenue, Remaining Performance Obligation, Amount Weighted average remaining lease term-finance leases Finance Lease, Weighted Average Remaining Lease Term Document Fiscal Period Focus Document Fiscal Period Focus Document Type Document Type Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Commitments And Contingencies [Line Items] Commitments And Contingencies [Line Items] Commitments and Contingencies [Line Items] Assets and Liabilities Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Tax Identification Number Entity Tax Identification Number Commitments And Contingencies [Table] Commitments And Contingencies [Table] Commitments and Contingencies [Table] 2024 Finance Lease, Liability, Payments, Due Year Five Accrued Product Warranty Schedule of Product Warranty Liability [Table Text Block] Income Statement [Abstract] Income Statement [Abstract] Other comprehensive earnings (loss) Other comprehensive (loss) earnings Other Comprehensive Income (Loss), Net of Tax Schedule Of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Amortization of prior service cost Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Product Product [Member] Best Medical International, Inc. Litigation Best Medical International, Inc. Litigation [Member] Best Medical International, Inc. Litigation [Member] Effective tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Change in fair value recognized in earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Restricted cash - current Restricted Cash, Current Amortization of intangible assets and inventory step-up Amortization of Intangible Assets Goodwill [Roll Forward] Goodwill [Roll Forward] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Entity Interactive Data Current Entity Interactive Data Current Term (in years) Financing Receivable, Term Financing Receivable, Term MPTC Series B-1 Bonds Corporate Debt Securities [Member] Equipment Equipment [Member] Use of Estimates Use of Estimates, Policy [Policy Text Block] Taxes on earnings Income Tax Expense (Benefit) Senior Subordinated Loans Senior Subordinated Loans [Member] Accrued Expenses Accrued Liabilities [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Total current assets Assets, Current Future Minimum Operating Lease Payments Lessee, Operating Lease, Liability, Maturity [Table Text Block] Hedging Designation [Domain] Hedging Designation [Domain] Swing Line Loans Swing Line Loans [Member] Swing line loans. Deferred revenues - long-term Long-term deferred revenues Contract with Customer, Liability, Noncurrent 2023 Finance Lease, Liability, Payments, Due Year Four Net increase in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Future amortization expense, fiscal year 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Four Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Total current liabilities Liabilities, Current Varian Medical Systems, Inc. Varian Medical Systems, Inc. [Member] Varian Medical Systems, Inc. [Member] Oncology Systems Oncology Systems [Member] Oncology Systems Percentage added to Eurodollar base rate before margin (as a percent) Percentage Added To Eurodollar Base Rate Before Margin Percentage added to Eurodollar base rate before margin. Local Phone Number Local Phone Number Number of Tranches Number of Tranches Number of Tranches Schedule of Net Defined Benefit Costs Schedule of Net Benefit Costs [Table Text Block] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Total liabilities and equity Liabilities and Equity Schedule of Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Earnings (Loss) Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 2021 Operating Leases, Future Minimum Payments, Due in Two Years Reconciliation for Assets Measured and Recorded at Fair Value on Recurring Basis Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Capital in excess of par value Additional Paid in Capital Trade and unbilled receivables, net of allowance for doubtful accounts of $47.0 and $46.5 at January 3, 2020 and September 27, 2019, respectively Short-term Accounts Receivable, after Allowance for Credit Loss, Current Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Equity Components [Axis] Equity Components [Axis] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Variable Rate [Axis] Variable Rate [Axis] Inventories Schedule of Inventory, Current [Table Text Block] Cancelled or expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Fair Value of Employee Stock Option Plans With Weighted Average Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Net earnings attributable to Varian Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Award Type Award Type [Axis] RETIREMENT PLANS Pension and Other Postretirement Benefits Disclosure [Text Block] Intangible assets Total intangible assets, net Intangible Assets, Net (Excluding Goodwill) Counterparty Name [Domain] Counterparty Name [Domain] Operating Segments Operating Segments [Member] Loans and Investments Loans and Investments Loans and Investments Property Subject to or Available for Operating Lease [Domain] Property Subject to or Available for Operating Lease [Domain] Weighted average shares outstanding - diluted (in shares) Weighted average shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Software Software [Member] Software [Member] Decrease in unbilled receivables Increase (Decrease) in Contract with Customer, Asset Trade and unbilled receivables, gross Accounts Receivable, before Allowance for Credit Loss Interest cost Defined Benefit Plan, Interest Cost Common stock, shares issued (in shares) Common Stock, Shares, Issued Operating leases: Lessee Operating Leases [Abstract] Lessee Operating Leases Position [Axis] Position [Axis] Operating lease right-of-use assets Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Thereafter Operating Leases, Future Minimum Payments, Due Thereafter 2021 Finance Lease, Liability, Payments, Due Year Two MPTC Series B-1 Bonds MPTC Subordinated Revenue Bonds [Member] MPTC Subordinated Revenue Bonds [Member] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Subsequent Events [Abstract] Subsequent Events [Abstract] Balance at beginning of period (in dollars per share) Balance at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Letter of Credit Letter of Credit [Member] Other Stockholders' Equity, Other Preferred stock of $1 par value: 1.0 shares authorized; none issued and outstanding Preferred Stock, Value, Issued Property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Assets/Liabilities Measured at Fair Value on a Recurring Basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract] Net earnings attributable to Varian Net Income (Loss) Attributable to Parent Cash paid for amounts included in the measurement of lease liabilities: Cash Paid for Amounts Included in the Measurement for Lease Liabilities [Abstract] Cash Paid for Amounts Included in the Measurement for Lease Liabilities Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Cancelled or expired (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Variable lease cost Variable Lease, Cost Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Revolving Loan Revolving Loan [Member] Revolving Loan [Member] Remainder of 2020 Finance Lease, Liability, Payments, Remainder of Fiscal Year Contingent Consideration Contingent Consideration [Member] Contingent consideration [member] Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Entity Small Business Entity Small Business Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Entity File Number Entity File Number Leases Lessee, Leases [Policy Text Block] Other Other Segments [Member] Rental income Operating Lease, Lease Income Accrued liabilities Operating Lease, Liability, Current Forecast Forecast [Member] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Contingent consideration Business Combination, Contingent Consideration, Liability Credit facility term (in years) Debt Instrument, Term Acquisition-related expenses Acquisition-related Expense (Benefit) and In-process R&D Acquisition-related Expense (Benefit) and In-process R&D Principles of Consolidation Consolidation, Policy [Policy Text Block] Proceeds from issuance of common stock to employees Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised Future amortization expense, fiscal year 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Three Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Tax withholdings on vesting of equity awards (shares) Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Accumulated amortization on equipment leased to customers, included in PP&E Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization Notional Value Sold Short [Member] Accrued liabilities Accrued Liabilities, Current Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Total cost of shares repurchased Stock Repurchased During Period, Value Total derivatives Derivative Asset, Fair Value, Gross Asset Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Share-Based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Shareholders Equity [Table] Shareholders Equity [Table] Shareholders Equity [Table] Counterparty Name [Axis] Counterparty Name [Axis] Privately-held Software Company Privately-held Software Company [Member] Privately-held Software Company [Member] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Customer contracts, supplier relationships, and partner relationships Customer-Related Intangible Assets [Member] Major Types of Debt and Equity Securities Financial Instrument [Axis] Product and Service [Axis] Product and Service [Axis] Property, plant, and equipment, net Finance Lease, Right-of-Use Asset Line Of Credit Facility [Line Items] Line of Credit Facility [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Long-term notes receivable and Available-for-sale Securities [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Equipment leased to customers included in PP&E Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Total other income, net Other income, net Nonoperating Income (Expense) Eurodollar Eurodollar [Member] Schedule of Notional Amounts of Outstanding Derivative Positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Multi-currency Borrowings Multi-currency Borrowings [Member] Multi-currency Borrowings Measurement period adjustments to business combinations in prior year Goodwill, Purchase Accounting Adjustments Deferred revenues Increase (Decrease) in Contract with Customer, Liability Current liabilities: Liabilities, Current [Abstract] Accrued product warranty, at beginning of period Accrued product warranty, at end of period Standard and Extended Product Warranty Accrual Selling, general and administrative Selling, General and Administrative Expenses [Member] International International, Excluding North America [Member] International, Excluding North America [Member] Share price (in dollars per share) Share Price Derivatives Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Selling, general and administrative Selling, General and Administrative Expense Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Liabilities and Equity Liabilities and Equity [Abstract] Notional Value Derivative Asset, Notional Amount Remaining authorization (shares) Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased Balance at beginning of period (in dollars per share) Balance at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Credit Facility [Domain] Credit Facility [Domain] Cash equivalents Cash Equivalents, at Carrying Value Money Market Funds Money Market Funds [Member] Contingent Consideration, beginning balance Contingent Consideration, ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value INCOME TAXES Income Tax Disclosure [Text Block] Litigation Status [Axis] Litigation Status [Axis] Restricted stocks, restricted stock units, deferred stock units and performance units Restricted Stock Restricted Stock Units Deferred Stock Units And Performance Units [Member] Restricted Stock, Restricted Stock Units, Deferred Stock Units And Performance Units [Member] 2023 Operating Leases, Future Minimum Payments, Due in Four Years Segment Reporting [Abstract] Segment Reporting [Abstract] Remainder of 2020 Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Shares used in the calculation of net earnings per share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Interest expense Interest Expense Stockholders’ equity and noncontrolling interests [Line Items] Shareholders Equity [Line Items] Shareholders Equity [Line Items] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Notes receivable and secured debt Notes, Loans and Financing Receivable, Net Notes, Loans and Financing Receivable, Net Weighted average remaining lease term- operating leases Operating Lease, Weighted Average Remaining Lease Term Privately-held Company Privately-held Company [Member] Privately-held Company [Member] Litigation Case [Axis] Litigation Case [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Deferred revenues Deferred revenues - current Contract with Customer, Liability, Current Earnings Per Share [Abstract] Earnings Per Share [Abstract] Number of shares authorized by VMS Board of Directors to be repurchased (in shares) Stock Repurchase Program, Number of Shares Authorized to be Repurchased Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Minimum Minimum [Member] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Change in unrealized loss, net of tax benefit of $0.0* and $0.0, respectively Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Japan, Yen Japan, Yen Repurchases of common stock (in shares) Number of shares (in shares) Stock Repurchased and Retired During Period, Shares Entity Address, Address Line One Entity Address, Address Line One Undiscounted range of contingent consideration payments, high Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High Current assets: Assets, Current [Abstract] Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Schedule Of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Operating lease expense Operating Lease, Cost Credit Facility [Axis] Credit Facility [Axis] Threatened Litigation Threatened Litigation [Member] Derivative Instruments and Hedging Activities Disclosures [Table] Derivative Instruments and Hedging Activities Disclosures [Table] Finance lease cost: Lessee, Finance Lease, Description [Abstract] Finite Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Measurement Frequency [Domain] Measurement Frequency [Domain] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Total revenues Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value and cash flow hedges are recorded Revenues Revenues Other long-term liabilities Total other long-term liabilities Other Liabilities, Noncurrent Gross margin Gross Profit APAC Asia Pacific [Member] EARNINGS PER SHARE Earnings Per Share [Text Block] Trade names Trade Names [Member] Sumitomo Credit Facility Sumitomo Credit Facility [Member] Sumitomo credit facility. RPTC senior secured debt RPTC Securities RPTC Securities [Member] RPTC Securities [Member] Long-term Financing Receivable, after Allowance for Credit Loss, Noncurrent Unbilled Accounts Receivable and Deferred Revenues from Contracts with Customers: Contract with Customer, Asset and Liability [Table Text Block] Interest receivable, default rate (percent) Note Receivable, Default Interest Rate, Percent Note Receivable, Default Interest Rate, Percent Maximum Maximum [Member] Outstanding principal balance Long-term Line of Credit Title of 12(b) Security Title of 12(b) Security EX-101.PRE 11 var-20200103_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 3 Months Ended
Jan. 03, 2020
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of September 27, 2019, was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2019 (the “2019 Annual Report”).
In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s financial position as of January 3, 2020, and September 27, 2019, results of operations and statements of comprehensive earnings for the three months ended January 3, 2020, and December 28, 2018, statements of cash flows for the three months ended January 3, 2020, and December 28, 2018, and statements of equity for the three months ended January 3, 2020, and December 28, 2018. The results of operations for the three months ended January 3, 2020, are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period.
Fiscal Year
Fiscal Year
The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September 30. Fiscal year 2020 was the 53-week period ending October 2, 2020. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. The fiscal quarter ended January 3, 2020 was a 14-week period, and the fiscal quarter ended December 28, 2018, was a 13-week period.
Principles of Consolidation
Principles of Consolidation
The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation.
Consolidation of Variable Interest EntitiesFor entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities, and results of operations of the variable interest entity will be included in the Company’s condensed consolidated financial statements. At January 3, 2020 and September 27, 2019, the Company consolidated its non-controlling interest in a joint venture, included within its Oncology Systems business, related to the Cancer Treatment Services International ("CTSI") operations.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Leases
Leases

The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represents the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate ("IBR"). The Company recognizes operating leases with lease terms of more than twelve months in operating lease right-of-use assets, accrued liabilities, and long-term lease liabilities on its Condensed Consolidated Balance Sheets.

The Company’s finance leases primarily represent certain sale and leaseback-sublease arrangements. The Company has entered into sale-leaseback arrangements with a third-party finance company for certain equipment and simultaneously subleased the equipment to certain qualified customers. The Company’s leaseback arrangements have been accounted for as finance leases as they meet one or more of the finance lease classification criteria. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets.

For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.

The Company generally does not have adequate information to determine the implicit rate in a lease, therefore the Company uses an estimated IBR. The Company does not maintain a public credit rating and its debt arrangements are unsecured, thus requiring significant judgment to calculate the IBR. The Company uses different data sets to estimate the IBR, including: (i) an estimated indicative credit rating of the Company; (ii) yields on comparable credit rating composite curves; (iii) foreign exchange rates; and (iv) an estimated adjustment for collateral. The Company also applies adjustments to account for considerations related to (i) tenor; and (ii) country credit rating that may not be fully incorporated by the aforementioned data sets.

Certain of the Company’s lease arrangements include variable lease payments. Variable lease payments, not dependent on an index or discount rate, are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments generally include common area maintenance, utilities, maintenance charges, property taxes, insurance, and contingent rent payments. Certain of the Company's arrangements contain clauses that provide for contingent rent payments based on a percentage of revenue share and/or earnings before interest, taxes, depreciation, and amortization.

The Company combines lease and non-lease components as a single lease component for both its operating and finance leases. In addition, the Company does not record operating and finance lease assets and liabilities for short-term leases, which have an initial term of twelve months or less.
New Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In the first quarter of fiscal year 2020, the Company adopted the Financial Accounting Standards Board ("FASB") standard on accounting for leases, "Leases." The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record ROU assets and corresponding lease liabilities on the balance sheet. The Company adopted this standard under the optional transition method, which applies the standard on the effective date, rather than the earliest comparative period presented in the financial statements. The Company elected: (1) the "package of practical expedients," which does not require the Company to reassess its prior conclusions about lease identification, lease classification, and initial direct costs under the new standard; (2) not to separate non-lease components from lease components; and (3) not to recognize ROU assets and lease liabilities for short-term leases. The Company has implemented internal controls and key system functionalities to enable the preparation of financial information. The primary impact for the Company was the balance sheet recognition of ROU assets and lease liabilities for operating leases as a lessee. See Note 8, "Commitments and Contingencies," for more information on the impact of this adoption on the Company's condensed consolidated financial statements.
In the first quarter of fiscal year 2020, the Company adopted FASB guidance that added the Overnight Index Swap rate based on the Secured Overnight Financing Rate ("SOFR") as a benchmark interest rate for hedge accounting purposes. The amendment recognizes SOFR as a likely LIBOR replacement and supports the marketplace transition by adding the new reference rate as a benchmark interest rate. The Company has not executed interest rate hedges but adopted the amendment prospectively as the Company may consider interest rate hedges in the future. The Company is monitoring the LIBOR to SOFR migration and will coordinate the transition of outstanding LIBOR based debt and any related interest rate derivatives with counterparties when the market is liquid to ensure an orderly and efficient transition.
In the first quarter of fiscal year 2020, the Company adopted FASB guidance that allows companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The impact of adopting this amendment on the Company's condensed consolidated financial statements was not material.
Recent Accounting Standards or Updates Not Yet Effective
In December 2019, the FASB issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the current guidance, and improving the consistent application of and simplification of other areas of the guidance. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.
In August 2018, the FASB amended its guidance for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new standard also requires customers to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. This new standard becomes effective for the Company in the first quarter of fiscal year 2021, with early adoption permitted. This new standard can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements for employers that have sponsor defined benefit pension or other post-retirement plans by removing and adding certain disclosures for these plans. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.

In August 2018, the FASB issued guidance which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures. The standard is effective for the Company beginning in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.
In June 2016, the FASB issued an amendment to its accounting guidance related to the impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses, rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021, with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
XML 13 R22.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
PROTON SOLUTIONS LOANS AND INVESTMENTS
 3 Months Ended
Jan. 03, 2020
Receivables [Abstract]  
PROTON SOLUTIONS LOANS AND INVESTMENTS PROTON SOLUTIONS LOANS AND INVESTMENTS
In limited cases, the Company participates, along with other investors and at market terms, in the financing of proton therapy centers. Over time, the Company has divested some of its investments, including investments in CPTC, the New York Proton Center ("NYPC"), the Georgia Proton Treatment Center and the Delray Radiation Therapy Center.
The following table lists the Company's notes receivable, including accrued interest, senior secured debt, available-for-sale securities, loans outstanding and future commitments for funding the development, construction and operation of various proton therapy centers:
January 3, 2020September 27, 2019
(In millions)BalanceCommitment BalanceCommitment
Notes Receivable and Secured Debt: (1)
NYPC loan$32.3  $—  $31.8  $—  
RPTC senior secured debt24.0  —  23.5  —  
Proton International LLC loan1.8  —  1.8  —  
$58.1  $—  $57.1  $—  
Available-For-Sale Securities: (1)
MPTC Series B-1 Bonds  $27.6  $—  $27.1  $—  
MPTC Series B-2 Bonds   25.7  —  25.1  —  
APTC securities  6.7  —  6.6  —  
$60.0  $—  $58.8  $—  
CPTC Loans and Investment:
Short-term revolving loan (2)
$5.3  $1.9  $5.3  $1.9  
Term loan (3)
44.0  —  44.0  —  
$49.3  $1.9  $49.3  $1.9  
(1)Included in other assets at January 3, 2020 and September 27, 2019 on the Company's Condensed Consolidated Balance Sheets, except for amounts related to short-term interest receivable.
(2)Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets.
(3)Included in prepaid and other current assets at January 3, 2020 and other assets at September 27, 2019 on the Company's Condensed Consolidated Balance Sheets.
Alabama Proton Therapy Center ("APTC") Securities
In December 2017, the Company purchased $6.0 million in Subordinate Revenue Bonds, which financed the APTC. The Subordinate Revenue Bonds carry an interest rate of 8.5% and pay interest semi-annually. The Company is scheduled to start receiving annual principal payments on the Subordinate Revenue Bonds beginning on November 1, 2022. The Subordinate Revenue Bonds will mature on October 1, 2047.
At January 3, 2020 and September 27, 2019, the Company had $3.9 million and $2.1 million, respectively, in long-term unbilled receivables from APTC.
Rinecker Proton Therapy Center ("RPTC") Senior Secured Debt
In July 2017, the Company purchased the outstanding senior secured debt related to the RPTC in Munich, Germany for €21.5 million or $24.5 million. By purchasing the senior secured debt, the Company has a right to approximately 77 million Euros in claims against all of RPTC's assets. In September 2017, the management of RPTC filed for bankruptcy in Germany. In January 2018, the final insolvency proceedings commenced, and in December 2019 the center closed for clinical operations and decommissioning began. Upon finalization of bankruptcy proceedings, the Company believes it is probable it will recover the outstanding senior secured debt balance and trade accounts receivable, net. The Company classified its senior secured debt as long-term other assets because it expects the bankruptcy proceedings to be complete in greater than one year.
At January 3, 2020 and September 27, 2019, the Company had $4.2 million and $4.6 million, respectively, in long-term trade receivables, net, from RPTC, which does not include any unbilled receivables.
New York Proton Center ("NYPC") Loan
In July 2015, the Company committed to loan up to $91.5 million to MM Proton I, LLC. In June 2016, the Company assigned $73.0 million of this loan to Deutsche Bank AG. The remaining balance is comprised of an $18.5 million “Subordinate Loan” with a six-and-a-half-year term at up to 13.5% interest. In December 2019, the interest rate on the loan was reduced to 10%, effective May 1, 2019. As of January 3, 2020, the Subordinate Loan is $32.3 million, including accrued interest. The principal balance and accrued interest on the Subordinate Loan are due in full at maturity in January 2022.
At January 3, 2020 and September 27, 2019, the Company had $18.0 million and $16.6 million, respectively, in trade and unbilled receivables, which included $6.4 million and $6.0 million in unbilled receivables, respectively, from NYPC.
Maryland Proton Treatment Center ("MPTC") Securities
The Company has Subordinate Revenue Bonds ("MPTC Series B-2 Bonds") that carry an interest rate of 8.5% per annum with interest accruing up to the MPTC Series B-2 Bonds face amount of $33.9 million until January 1, 2022 and then will pay cash interest semi-annually. The MPTC Series B-2 Bonds will mature on January 1, 2049. The Company also has Subordinate Revenue Bonds ("MPTC Series B-1 Bonds") that carry an interest rate of 7.5% with interest accruing up to the MPTC Series B-1 Bonds face amount of $32.0 million on January 1, 2022 and then will pay cash interest semi-annually. The MPTC Series B-1 Bonds will mature on January 1, 2048. The MPTC Series B-1 Bonds are senior in right and time to the MPTC Series B-2 Bonds.
At January 3, 2020 and September 27, 2019, the Company had zero net trade and unbilled receivables from MPTC.
Variable Interest Entities
The Company has determined that MM Proton I, LLC and RPTC are variable interest entities and that the Company holds a significant variable interest of each of the entities through its participation in the loan facilities and its agreements to supply and service the proton therapy equipment. The Company has concluded that it is not the primary beneficiary of any of these entities. The Company has no voting rights, has no approval authority or veto rights for these centers' budget, and does not have the power to direct patient recruitment, clinical operations and management of these Centers, which the Company believes are the matters that most significantly affect their economic performance. The Company’s exposure to loss as a result of its
involvement with MM Proton I, LLC and RPTC is limited to the carrying amounts of the above-mentioned assets on its Condensed Consolidated Balance Sheets.
California Proton Therapy Center ("CPTC") Loans and Investment
Between September 2011 and November 2015, the Company, ORIX and J.P. Morgan (the "Lenders”) funded loans (“Original CPTC Loans”) to the Scripps Proton Therapy Center in San Diego, California. ORIX is the loan agent.
In March 2017, California Proton Treatment Center, LLC ("Original CPTC") filed for bankruptcy and concurrently entered into a Debtor-in-Possession Facility (the "DIP Facility") with the Lenders where the Company's pro-rata share of the DIP Facility was $7.3 million. In September 2017, the Lenders and Scripps signed a Transition Agreement to transition the operations of the center from Scripps to Proton Doctors Professional Corporation. As a result of these events, the Company recorded an impairment charge of $51.4 million to its Original CPTC Loans in fiscal year 2017.
Pursuant to an order of the Bankruptcy Court, the California Proton Treatment Center ("Original CPTC") conducted an auction of the Scripps Proton Therapy Center. On December 6, 2017 (“Closing Date”), the Bankruptcy Court approved the sale of Scripps Proton Therapy Center to California Proton Therapy Center, LLC (“CPTC”), an entity owned by the Lenders. The Lenders purchased all assets and assumed $112.0 million of Original CPTC’s outstanding liabilities. On December 13, 2017, the Bankruptcy Court dismissed the bankruptcy filing of Original CPTC.
On the Closing Date, the Lenders entered into a Credit Agreement with Original CPTC of which the terms of the Original CPTC Loans, DIP Facility and accrued interest (collectively “Former Loans”) have been modified. In addition to the partially satisfied Original CPTC Loans reinstated by the Bankruptcy Court, the Company received a 47.08% equity ownership in CPTC, which it sold for a nominal amount in March 2019. Original CPTC has assigned all its Former Loans to CPTC at an amount of $112.0 million, the partially satisfied loan balance. Per the terms of the Credit Agreement, the Company's portion of the $112.0 million is $53.5 million; the remainder is allocated between ORIX and J.P. Morgan. The $53.5 million is composed of four tranches: Tranche A of $2.0 million, Tranche B of $7.2 million, Tranche C of $15.6 million, and Tranche D of $28.7 million (collectively, the "Term Loan"). The maturity date of the Term Loan is three years from the Closing Date. The Term Loan is secured by the assets of CPTC.
In addition, the Lenders have committed to lend up to $15.0 million in a Revolving Loan with a maturity date of one year from the Closing Date. In the first quarters of fiscal 2019, fiscal 2020 and subsequent to the end of the first quarter of fiscal 2020, as provided in the initial agreement, the Lenders have granted extensions to the term of the Revolving Loan with a current maturity of June 30, 2020. The Company's share of the funding commitment from the Revolving Loan is $7.2 million, and as of January 3, 2020, the Company has funded $5.3 million.
All of the tranches accrue paid-in-kind interest at 7.5% per annum, except the Tranche B and the Revolving Loan, which accrue paid-in-kind interest at 10% per annum. The seniority of these loans is as follows: Revolving Loan, Tranche A, Tranche B, Tranche C and Tranche D. If CPTC is in default, the interest rate of the Tranche A, C and D will increase to 9.5% and the interest rate on the Tranche B and the Revolving Loan will increase to 12.0%.
The Company believes it is probable that it will collect the amounts owed under the Term Loan and Revolving Loan when due based on CPTC’s current operating plan. This plan includes an increase in patient volume, partnership with a significant clinical partner, and maintenance of its current reimbursement structure. In July 2019, the Centers for Medicare and Medicaid Services ("CMS") proposed an alternative payment model (or “APM”) pilot program for radiation oncology. This proposed APM could materially impact the reimbursement to CPTC for its services. CPTC's inability to execute its operating plan, as well as finalization of the proposed APM as currently drafted could negatively impact CPTC's ability to repay or refinance the debt when it comes due, which may result in an impairment of the loan receivable; this impairment could be material.
At January 3, 2020, and September 27, 2019, the Company had $2.9 million and $2.6 million, respectively, in trade receivables, net, from CPTC.
Further, the Company has determined that CPTC is a variable interest entity because of the Company's participation in the loan facilities, and its operations and maintenance agreement. The Company has no special approval authority or veto rights for CPTC’s budget, and does not have the power to direct patient recruitment, clinical operations and management of CPTC, which the Company believes are the matters that most significantly affect their economic performance. Therefore, the Company does not have majority voting rights and no power to direct activities at CPTC, and as a result it is not the primary beneficiary of CPTC.
ZIP 14 0000203527-20-000008-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000203527-20-000008-xbrl.zip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

F#V>'QX^@NE?\/"^\7!FZ#MKA59,(DJM0MP8 MCK2(!-'(HV9"8Q=G8$QZR: M:5WN_X*7W0, [PHMNPDOX)3[J*;4;?7'H^'(]O*SMU!=D%PR#!Z>N_C>XV]G M>!]KPN'=5/$2#'=GDUQQ%!1'ZB:.U'PV@<"1$.8-8DY$Q"E12%.G$ W22)$< M28RNO39X*5ER+W3[K*03/''PN_?040&_!P2_611)A:AD=!%)Y3GB#'#/F(B1 M(5X%'X/$R@/XD1F37@&_$B=Z!#?XB60!5SQ1G2^Q!>\9_2@S IWT1[$WZMAN MI@HZ!B2M ?3!.I'<*!+[O+72VZ97;XUAUI%K-G?""@D_5-B\H>-\H M.->F(H+F"E[G$(5&7+"(7 10]%IC;Y,/AO"UU\LQTE\H"KX<([T$S=&$NW,U MPN9WH6-ZXJIK63'URY1745DW45GSC;=E,+<-X/<,Y%Y"WUD06-I,]<'2X%Y(B62+ID M%>&1$8H!..D*1N1?!G"^'$_@>6>MM2_DY;^LZ.^21)K'J-RX3BKF:@WU:I1N M_+ ?\]/1^9>WM;VCQW2NO^V%#5%6IN'L4]#N._L;6;/7KM'&1Z634XE*Q!/C MB!./D351H$"5LL9'RZW(.QIF&8[1PZVEU0.AU=SP* JD*)"54B!W]!R+ GD8 M!7(Z4R",>LTE0)B*"U"@HKDC>#""L*I'B(9:]H>1[B);M& M2QO@HN+O'+=Z$2K^H7W$)BAJH0\L1AQ!:ZB=3PA92F7 MP3.K):^\1+G*4>#GK.27NG]65$A1(2NE0A[:2RPJY)8J9.8G)DDD38F@@*-" MW":-G-$&E(DCPG&31 XT@I^X#'Z8HD)>M)_XO'<2-WJC#@K3RI_CDV[_-#:9 MA3IJ;#FIA5D*)D*P%_UXT!EUXG"K MF?": &W:*GXWG=5X&U7'V)(WB'Z[@54$KUD1+WWG,."J(^"J#,7@D6IHQ8<42=E3N).2,? $+." M2J9",$E64:B"J,6#..-!_+/:'X'_ALZ7UQ/Y:(^/85Q\_;>O^6"KU?OZ?ZO# MZA?.7;JG+U]]#_^J%^]'_-&0M?FOFP]V>A%-B!IIA?N$K[?^=V&4[L%>K?'TBQW\\N>@/^KW]OH9 M3?N]X1]]>%;;"]N]+[&NSASNPZU^Z_;]Y\?%2;&S-\')G6\'GSYTVW]O??^P M?W34WO_K]&#_/]5UVYMP[/>_^,'??]&#OP\$8%XW_NO=Z8>_PXFC7.Y\?]MI M'[\G!_OM[N[O6P0P[ZC]][^[@*V D?G\(\#9#TV?S\,6%%A0T1 M8<L^"4#&MS M"_+15PR_>,5L]UK=SG$G%_-Y<++!NQX=Q58V"6SOM'5BLU[HG-A1_L5V^[W# MUM?.Z*C5AZ,&K4XE^/W!L 6KH&5'+0",SW'4&L7!,1S?Z5472YV>[?E<$YB) M/*HEE+\?V)/3EH^Y?]]PO;4+*J@U@E=;?( C.VS!&,)=X &'_>.8K]$9#9M; M5VLNWZAIB3K_=;[]FS_WW]07S.-UT!]\;M5KN/6FNG'KI[7VP9]OUGZN#_H] M]@'P[.28_4&TU;4F1^>WS,=MQN[ GK;>V="IQ6>_>9WZN/76.6%[($#:\TKKE$O&9_VWW^D,<%B5@0Y@PGBDGCD= C(:F*I MX8HH(\_BS64:DJZ0/KQD=>_GY=?O=OM?\^*HDRVZG2$LCKE%]H]AJ]>'!=X: M1!\[7_)!\TO*>@_#$*:=-E^UAK'7Z0_@/^!-P \A.OC2?K&=;CX7I?X #<%; MJ ^HW(U7K6Z6SX4"X;R8TG@$EZ@X?3K-JH6SX>OZD/R0(7Z)W?Y)_O%57CM# MF)3:DRO<],L+[.#ZM%>#.,ODP_G'/?J[TXOP*/\DN=Y8AYV>M4,5_?] M]6LGC(Y #D"><.WR-M'FYH&:W]?KW\[X#O6/7*]30R___ M2B;>3)W8@@8O:^;KG::""44RKHD)3R0[< 4V+ZH;_](9P=/[JS< ZRA8NPID MOIL&,JL@X5X3J-R,;O3+-#8_')\L^[WDNKC=BYV911",;(&2;'>.3Z;;PZN6 M-'1O]W]8C"N#4P:G#,X=!F?%BJ*?2)>+O/%<;8N]V#JY4@EW/<;OIY/2>KX= M>L)&2,^T!^QNWGTJ?W[7[C]][\_P36.=W]_>U1EO\)[[7QJ MIYU3?#KER]0T&,=B1#[F]GV11N28M4A*Q[G"7";OUUXSNKX,.I07VL&J8'S! M^!4:F:5@?.H/CFU.I?PV^N5['/2#'1[-Y[>]B\>VD^L1=AT,797HDW/:LA(H M8'\SL,SFQZHCQ7(:%(J$-< M*@4PCS520A!%F[_[_(%=LYJ4!WBP.CHF/@&L622L9 MXMI: #RI$(_&,J>#-&ZI-G/!O()YJS%W-\ \GP.+4>-$HN9,66,3E\(30V!5 M\",(^],0IP*C'1N[N4]_*(]-SJ%8MBM>##T^2> M-RQCV[D8KEB MP-S*P%PQG9>&=[.8J)=,<&P)2LE:Q$,0R!"M$*'.*^*XPA&7/(*">07SKJJ' M,#@H*ZR-(7'#I.$""\RH]-YYH6/)CWT\J)N%14V0DF, N, SU!&%D>')HJB] M<2QAX8(LIEV!N0)S]PYSQ;1;&M[-HJ*$"Y44IBA8R\"5E1;99 *B6/G+D(#>,"- M5Z4U$V45&M-8HCL[2= B> MTR&"4QT]PN#7((X30X;BB)QF,3=5Y6*5TS^*&BEJI*B1YZA&$A/$)Z^P\80; MR8S)-568<>J3I3K\:%N@.!\/HCAF.P*@-R*C3"$64V;!LQPYBA4"OP/T251< M2 [.ARK.1]$:16L4K;'B6J,X'TO3(;-=EN"T3I9$I$.>.(1L-1M)XX:T( M7/BE)M"\;#6R8HGIEZF<)]AH8V/:[O=M?X#VV'XV(;6$[2E7I)+7KSNY\]PR8P3UF =K0S<1ZF)4T8("=]AB9.[;@'> MU!(&0SC;P3,S./>;F_U5?.H;^-2[\\QDEL9@8&J0=CH@+@A&S@B.E PFL$1# MH.!34[4N5\ZA+CA?<+[@_!/%^5L$4$?]'$+-)F:!^YO!_1PO&[9$LRB1) S@ M/GF,C#$1464QX2PJ0\3JAE +XA?$+XC_N/EZWC*NC/< M+SC_1'&^6/9+A/M9_/>L.(UAM&K5( _6#V1B%]>#HZ%U-KA9/..4!O1ZW!1,(77$5)I$RF[)H\ MIK*=IRYDR4P[CZQKO@7 M2X2\V58RM*F 2N>8L M6@[K2$<3B7.>1LVB2+I$SQ\7[F;1$B%O%D&.)# JK$#&JX2X#@XY;;./"QA(> Q> M\&+A+:^"+G2&)UU[FD>]Y(3&:Q!A%B?O 2V>G6SM=/"WRNK9^"BU%E%[ M@C 1$7$)'IXA+B%)E?2>*.TW4\2+ M/++D@D:!$X-XB@3IH!PREF*&O;6,F9(G5%"OH-X5J*=$X,9$::W17"=M)>-2 M$T9B"O E*7'\QP:\F8E7=5)11*/DA$,<&X*L!V//.1%(5-Q+;;.)5PI<"]@5 ML+M7L"LFWO(0;W=FXL&JU#A0B3B5%/&H-'(IDW0;KCW&DFNVU%2-9X]Z-^Y& M]*0HEI97A71;YJ>73>UZLWVR%T+M:I.E43&C2,3<:&]CH I3E[QSEAM<@K"/ MJJ^VYX.P%&:'8:Y1J#AHO$W(!L=1L,E%0JTPE("%#D*PS_*TR%Q@FPE--;41"2I!BTA%D9&>(J&8#LIK+)-:W?2EHDB*(BF* MY#DJ$JP-#MP*@17E4@@=5<#),Q8H5D)"++T2&=N@X]D:_K)J#5.Y? M[E_N_TCW?PBH?0 %%CI?SC[20HGK&32^)DHN0NNU$?D'WLD%O3CWCOJ#$1K% MP7%K$+_TNU_@!5I= .<5:<-YU=-?W'23WJ'I9F&O?EKQM)?*7JVP9C0IF7"P M7+'H?$HN07DKG&"+.4\2=8,AI29!2-/*@*8$#UEZ+=5:2E)>WH5(POF#\ M2\#XL@%RO[@^EXIE26+6$8,,R4Q2V'%D!/=(^V!C%!XKHM=>DW53<+W@>L'U M@NOSN.X32YP'[!T!7"?.!$L)C=8((J3RZKKY4L5V?P",GRO:"%R ^>Z1<)$@ M#H8\TB0W#B;<>)>89R$6V[U@?,'X@O'WCO'%=K]?7)]+7K+*).\]15(;A3CU M&#F.#5*<)THD)]S98KLO)S=I5;;+G_@>SG[>O7G2>S;L#GLVA3/]Z>A%G()F M7"B7&TE%G4QTR66SVG,9HTKWL6_1[O=\<7]NH28/YKK)@G4%ZTI9PV- WEQ47^F$C8P"4:EBN >D8&F@*V5*3<,52;$'5D-B:E-;;ZVLRA MQ<)[&+B;JP4FA!DL =^4\PC$R"/+I$>.4@N3R$+0H5AX!>L*UMT_UA4+;WF0 M-Q?[U83(F)Q R@<&D"1\4$Y],#;_[:F64IE@ M^'420RNWRO;"K/BR\"K=S+ XG(^68\V$H=@A%7*R$&,).<8P4MHH23S8A!*# M+V56,%OH?M;3ZD'4"\\R*HIG-1?*2U<\Q;.]/P4TMW]([,\?'1N\\MPXDA(+>49XA:UQ"X/Q@ZK@3B17'IRB>HGB*XGGA MBJG@.:V] 2X.4Z)@+BV$G'G(S+")R2QM<$KF1AGQ?%9A6W ?XYR L\D MQ7^NY*(:KTXO9 9 1/2<)JFPF$GXYM@.#CN]"8%C]<;++W$0Z_J'-0[TTAH' M,JEQ>(Q2$G.=YSY7^U*-]';/=\7L52O'?RI2Q[UX,HK'+@[JGZC*OQ'3 IR%2[3>](]A$$[_,81/>>*'<'GX M5*T!.X(_?K-=V_.QM7<4X5:O6O&;AROFO(F6/8;A@ML/8K,CNI"NF:$.%U7XGP5X^1,Z^#!QJ/X:V-,X/E+K)V7]UHT?,PHNKIEC[1Z M>"K/C.WZA?;_6I/AVO_7'CYYLHB;6^T6SM;F]MO-OYH[1WL[6_M[+UJ;;??K+_[6UO;L-A6WM7 M ^%3>NWV[O[67FM_M[7_KZW6F]WVYE9[;VLS?]K;_6-[]^PX= ",^"4[+QD.&< R(JN7"EOC<,XIY\Q&G:+V$G.+B0Q> ML\65-*:Q-,ZJP8LSX$K3BG#5LGXX$_LED7 M_M\;Q%4TT9;RQ*E/CA/.K5<.)Z(\I538$#]NYCO! Q!4?V#DJDSJWO@X]$?- M[V<+2OZTIU6T?[^_X?\[[@SBU?WFGGI,IAO_]>[TP]_AQ%$N=[Z_[;2/WY.# M_79W]_S=4APE$7%1*! M:,2Q#,@9PQ$V+#FK$U8$UK2\H#BD!=+7K7"DU]H;YUA&IP>&4>M=_!(!+EJ_ M@=D$'MW7HXX_:B7X#8RE4 E37B+K>>5UL]/=BFLP*EO5$V M M_!OZ82A.B+$Z$MNG/XT5,3:# >!0,+F&-MD+8A(68$-T18&%\0(;TNSHG0 M_U2&^8D]G+5FV+AY'&A1>1S9FZF-VZW=:VF+O*K?]QS,'"SB MZ:(>ID'_^#]VT,E_;#J)]N:.V-WLPZKR,-=[0:QN__^V\X^/-?F#M_YZZ-(S',6*0*'@2'N541: M&HND#%'"0K64)7#CU\FE-L0K@/'A2?0Y^-$]?95-BFX_;\OD4.^XF9>Y4.^P ME6>F,22>#K[>U-=X!U_YSW$PI7MZC*>GU],.K4=]R%L/\65NW+N)&]?K] >U M-P<2F#V&ZXC;2GBV/_3S_CWNGE[IX^5O^^,1&%J]')D%XZP:C6$S&@%&8WY[ M)A^>QRTOWQW <7_TJO4[K.!\T;RC\__\'\TD__52Q(_CL]:[43@:%E7FX>9: M"1.QXF $*# X0]*-XXA5XSAB=0O',4/_Q&D<39S&>MZ;:7_A?N)[NOO71QDU M)RD7O>B\"6^- YVOP>:WS&.J+8]* L:3"ZS\J:,((G 3=5\F?Q4F/ROXD!@% M1>Y1XA:#!#"/3+().>JQ3LP8+11,/K]B\M=;OTV1)4-)QHH+X.2LPS!LV5:5 M )'QQ9Z<#/K?8/I&8"1<'@X(=B$7\D?O>)#*AJK%PAT$ MZ$W7=HZ';SM@HVPLQ;UEPP_NI MTD#_?>LMT'-3YW1.V8%2LHQT%F.KIKI O;< +],? M-K?WH*[S!FZK?P)627[YNH,FB!YH_.]CNS# M&\V]PMP#+2XO%[N=^ 5LBLXH!U?@.)>-Z_QG%=, >[O_!1[M.F: :W9#\W.. M!C; )^\G"1P3L_U5JQ='BT$=F$-XG]3)&[QP[$67!A"8.0,+N[@N>CL>5@\< MOV7W85@]Z\7OGA'$Q3PE)]TXBGDR#@?1CJH7!#NMWXNMTV@'EZ>1K)P_L6+Q M&L]]"('Z%)SFGBM'A<6@&DPDR1E-[QBOV6@$:N:?ORWN^3F4_;0%[OG&Z<[W M;0K/P7$L*"Y\39J)$1+*)$ MN.8R$6JHR;,O;Q>ID!RCT =IZ?= T=4)/*R/,1:&= MZ^'O,]E-SE<^Z \^3[:3I_&']L&?.?Z0T\:?S 8R$6<""V)1GU36RZ@)%E0\ MYN.3_/$FR,*#ESH(Z8AU7&EGK!'!@!F?-XV=J#LNB%N;\CL6_(OQ\1^QLG3> M5 ]\_ P(".^ (N\96.V8^$2DY@B#B8@XXYD_4 "*. 7N(+,!:T 1%/;U&.POY**T9+OPL'?#3(-@L<*,.A6YX)83BQ.8(Y9( MR7STHC)!P."1#!?QN!_Q./C>WO@(#ISCUC DHZ/@U$F>=X3@4W;H./C:(H*) MH=A5:03@M(R..L,:&$!6-B.X'!X$(OO.K8W?:[]A,"FOF7H<:0 RKU+C/^V<_A1@& P&B,RS .@ M*&R0M=$@HP4#KR_20.C::W)1UL!48C*!'\6_SN_,9WU9?4U^!1]V=-2RK6'G M&P+[%5ET9+L)91>O59DN=M3HGYMEE-Q.8$I&R36%(VN;0+#C!C-DI ^(MF%+MSK1V[&F=J$/, M>FMCF/7'13&35^?RAS+09-5S$U4CB0>) &S#F<:%!>,BBYQ%C ,E5%W1Z??: MV8^7T&FWX^CYD&G? 5T.3T'U!,LD=A0CXSQ#G/"$G ,'.8"%RZECBF7)8?0" M+H.92UQ[L57:F?>#<56?,L&=;*?,LM#F(Z-GC[TH,ZV2+#N(K3"N@I1IW.UF M755EF'5&54AZ%H;.Z6DE8'G+@*5B3 LM"&.>PSJT!CQ+YG)3/Q>\$K($+)>P M*+]OG&:6>AI$3!RCO!&'N*%@#U(C4+"6$1E@Q:94V8-7>! WC5(:8KRP3%LO M(R>,F^!EP#S$Y"/5PI8HY7*FO_WUHZ.:@N/.LPX'MQ$@&CD!KJ1@.6RI.*W2 MT(F\69BRV8@"L;@HT#B)3'8F%88K!!TE%_%ZPK.5?4F,/0[:6*0\40B,P)R9 M(!2*OMI3MF J^ES#P)\,=)3IO^[T[_[U45E!<@4" K]0(JYCA$^2H8"Q!H\Q M!AG2CTM8+D:(14BI-C5R9/Y%[5'L@$'6S0MDDBN9=\VKS(GI;L7.#XO>GF:2 MY/Z99*3+BT#J,8 1&,#;MWY#M/X>!F5T!,;[?94S!:P43THE0G/C:6/R?Z+% M1C)E<0REG.DNY.8A3%)O%$=2*M FCE%P#PU!S'@-8V^I4_JR<^Z%-0)' MX:+'A 4=75TM UH)W[ZV\NI2RME?+U@C'7S?^?K1V&@B#A29D!)8LY$CQT W M.:%ML%YDJOBUU^RB"IFI2@()Z'2GCGY3BE:G5QW%7IV@E2OGO!T>75D^=[&@ MG2E:6[@/-XLY6B H_1O"'WD8^)-!BA 93@QC3I2!X>2*40(B3TF0N,#?763W M,P;95;G"GS*"#+8:<8(54XCEX$:A[FJ&?L*Z#UTA>#&MYQHQ'P0E"N4F2# #,\!^6@X(IQCPH4' MY12JL.I5>\"]^T<\=F8.Q36(J. IU.GKU6&!K7JG.2RKI?&3V!LN: M*)L$F+E,2\QY\I8;126AAIL8F;RB \'IOL M_/514\483^!4*PWV,+C6R'F?LPB)3!Y;2[FX&YU;5YX#[?,H MWHNC'X1'CG0V7A(B#F3IM.K:D7!SC^;WU<) M0E5]F[=O*>8"=U/$6[,/SUP"+,5I_5.>/ MQ=DE1TA%>LY,_5XELI\U+#6>OM>B9Y4OW^JTO_5&VLRO+9/AJ\FU5+O?% M=EMV/#KJ5UO'8,%\B?!2]9%5L5%]^;H(:?B/EAN'PYR_7=4;35*VC^R7YJW[ M7W.Y3+\5.K"J1ZT\H#D0"'^ J5\%!5]=6KZT6')5W[>.($ZW8BZL3LJB4Y=L MC?*Q]0@>][/M-Q.,/$555D<^M#-H11CQ_G''YY!,I39Z/BZ,7=7]5?TZS)5# M_6$V"JNDY&&N',M%AW$X[E8/FD7B/+EC(7.\)9FC*F2.AVND/#N$5?\J'K.4J +!@F@3U MGUL)WA4$K5N-X4]-.OLN&&=537D>X7I\IRJWWM9.QFDC!IO; M?TZ_@OM4*)=_:,0#;.'8F+PS$G(PY1$8T^ ,'65[N,&U^2M5Z>LWB9T[PAB+ M1DM/)5=26*V5=B3RH*5E4U8,=@80PO-WB^ M?WBZN_'1,6)H*CQ&*43&"B2G)%_*=#&1JBI6VP!' M4UEG82W 4JN\CM;&Q.VM4&;V?<7^,//D&LEK6"NJ>,[DJG!>L\0V^Q[FO0*H M5,][7E;]P4F_ODR5:S_O9#5.[I?L=2]&CC,)Q2"C9-X]A*\Z@^H9/2R#PWC3 M[2+*P#KRQD>+/=W' MX_S>@]/MZ>/_ >MAXHORH5LNSV:SYUY=^.Q-@*OAJ1O":LFWO]HV@B'YD6W;F .3QX&7G3T& MO&D5B#MM];]F '6G\Q!;QY#NCTKISD9[^HV-=$R'=J!_'N D"6<8M2I1;2JDAR>82-'+UEG=:!*AI7'*><:D[FX3%U4/8 MJSE5?VZ%A,XP\T4U2V3.C 7;MF*[/G/SY^,%[#9=?.;09-$<.F.WOX'/G=&< M$519Y8NJ T9K%J;.&Q]3:^@"%?-JT3B_L/KK)QB.[B2]>%+.# ; ,!=]D:/^Z&BRZKLO=PQ:=2HNBH^G_T4VU;>8,F"U:1N=>8<;[-^1NXJ*L<)HT=6 MB-DRFQ?U2C57.X6CRJ"X73H8E@[;% 65D7,?P*%-*<08N>3,1W4'-?F#"MO? M!Z Z2XTMB.'6U_9?'YV-)(1=S$G7T%!DPZ5$..0CP9XW5Y$>J\=6ED%:% MK9JZVO76GPU%X0(BG\7S5V?C*?W!O,%:A.QI"=GV-Q R*9P!/(M(>Y(+_SF@ M'F8R=[$A@MO$N,0_M+]N6,-/, BPXBHQF'PMI--2"^*=8$D9I'\VM$K8O/$Q(:W#S\";#OCC4+&T\P[Y!72EG.$:=244X/!1/V! MV$P8I_H-X=2E8I"#J/XHWHLH5#4,U\M_;%>&>#_MU[YW ZSD_YDO00YRN(8EI@.,/)(T@1S 59"SA"$?(TFYJBB2 MF-O47&613J3@MYM*0?*:@E%"M6:!,TU,Q!QS0G3@PF#FBA0L00IP^^M'PCT/ MDEJP%@BX)Q& P'EID+>"<\&DH[3::;N<#7DF!6]N*@5:):*I#M$$RH.V!FXF M#2$@>0HK>9\MF)":&0FN@[B2 M;R1;A1-1V+RQ*$@JF<_$Z)YRH8+!.@JO>6*":D-,$84EB ('+](GJF@$BU : ME\T#$I .2:+@O) :"] 1!-2"7K^B)<5"(+<.-:SM9X[)//1K/]?^PI3 *S2U MK_FPZ5'9JOS?A:[QB_+"',"$,8RS7.E(HJ,Q4A>,$-%C>.!I#UV)9H)SUF , MX\$9@W$^4V.[-QP-QCE:DI_JQ4G#7V1WXZ-6U'F"*?*F@@.!D16,(]+CH@G 3U(2TS/;B)G;I5C< M@*FV-!8IP6,N&[HQ);AV--'@A"0Z<0NVMM02#&YA60B.85>MC%Q/IM&=.)GR MQ$WV MH-^MVOI6ZZ7A\CT'H5D/S'B3ME.7&$__:&J1AV,WC/\= M3Y+8JG*P,%&U"]=:N%0F>+55CN673J@V:!NFX$[>>I@5A%T 8(=@_V7X JF+ MO6&5(=?SE?T4_"9 MC>69^]TPQJVLY)1(:X)7G$MK&246+ [B'14T^ *H2UE=APSL$2*-,5A%1&TF M-S8<7!8A C),LNBTR'SI/W)7ZZ2CJ[F-YRL*F[3TF^V):4:3D@D'RQ4\F4_) M1D-JZ\F34]&PNZ1AJ& ML+#@D['H$>@>ATA0R3&963_M991$4T:V5Z"B?3RI*ZYG8=R&7N:,QISDN]RO MP&@33/))2"H2A__7L"J)%]HE%IQM&-J*P-Q!8'8W-]C.UX^26VLP28C%W(0& MQ 9IC17R2GJP8AA8+_3BW@ S>:EMKYKVI['-ZB*%NEJK4]6)IWZWV_\Z_.6< M^$QWB^:V#.;CQ@NA0[!V:Z\_7Q5LSQ"3'7='%[:K2 OR"Y>OK[59TQMU>GX0 M[3#>O'V%!;]-,Q&% ##S%&R.A*-*(42E$_;I!S;?&2'-NGHFEIOU^TSE%5ZD M2.KF=F7>8<>H%@398!3BPE!D,8_(NN"B=39J8:\@U[EP*AEF')Z&,DT#YR%9 M$FP,B5H1DY%1EZE\D*G4V.2M)5!0(4<.F7/(,6N1Y4+0J#@-@M]T*AV@E336 M1 M&A6+&&:=LT$:IW'!-_RBT5:;R=E.9^T^9D!3*^W*(VTB0%MR".E&6O" MV;V*J"B3:U;W.^Z'V&W]!!=L2E(V_MR95J*<=+K]4;[$X< >5W<=V-!I^L[W MLBP=GDZ&<'(?.!_F+KSLI!,C7KGO"U\^_7GW]CVPB MU]50I_G0^"WZ<6[GGF5C82*KF.[76!7?M5(N1>A\M_-)WPO/9Z>C#\\6!IEV M*#0/W8N'MJG1:1ZZ>9"YQQC$3$V:1R.F3CVG^195 _M*#$&F?3^O)I#'B7MY M;$\G-=!YTV.AP+EYQBK5?<:@]VO=(W.^$+IZ1!>G0_N,0C@7LXZ^>KB&4-)@ M)\ 4S]%+3GTP-O_MJ992@?-^/=[1TA'HKMM*HOWI/=_9_PN>?_LK^/-6)*F) M3$@:SD![JH ,20P):PBVE":L5<[-2&.Q 'FQ,"L"7$ M:^%J8NG2&VJYDM#.S/K$*9H[Q@H,DA X^,NP:)$4FA/IL#)19$FX19NH2WK8 MO[DV6>D30-2WXT%FI3B_Y7.6R',2C;*7D79F"\[;\7 :DIHKK;H&V>:K*=OF M.9+(F5$TW7>]A%2SUV_EF:RV:*_%=;E@_2V-Z7*^@'()!)=@@/0'<7&*%]_O MV'ZJAVB!-[1ZU\^7AB%UU+Q,LZ,X97"Y%I_I!2OI8B;-"N0^XH\& M0/W\DBL$FU<3;.I"L%D(-@O!YET)-I\6P>/5KTK$^M69:Q3,DHGSB^,"BXF)VQ%P^SOGL7J\+JWN%F9^B[%:_R/MSFMV[??WYDZ[5] M.K%>V\>[FQL4)/IT9_] [.[_)>#ZXL/^H8!S/AW0+7+P:8?M_KWU]9SU2@_X MSN8!V?FT_:W]Z;-H;W[F.]^[W=W-S_!\[4_9"M[Y[L7!_F^IO7GX+>]%JNC M*(W("A,1YWGSVN0N*2+FOJ;!,M?X'J $8]C(G@-70FO,(T:ZU(K@$)WG5#<9Q[?7>UN]YJ0*"O=U]M[.QO[W;/IMGMRCB%[+'_OBN MBT]); B2BAP45]PP:G2048&0!&MBS!'RI\O]>=;4O-1S'-9R?W:G_S8+ZL;% MGM/,J"K0OYOJQ5?ULZJ?:G5*/Y>_^-Y_9(RSH$1"1F.!N \,P64P,C)*0RB- M)D<-1E_/M[;(T;QF).=BBLU4#W]I[39QSM;>Z7 4CVO3N2$3V\N69?8$SB9O M5D[]EYJ"&%R&Z7'@B Q! (=53@$8[SGB/]@K'._]VK:^9?'3.'YS&SH_Z7^>=BJDC]>:H$U-K MJXK#YC#R;@*C/SN9%;=R]>/N]#:;(.05)^J._9QIY28T:R $,YJU+YWXM1[4 M"#X=8%0<7GCGF=O5##9<95K"GP=SV!\/[4Z3IN]QSD7:M9.XNS( M-&X-@,UL2&8'13OHP7^'UXR^KJ@9<5.>Z$W00X/.R22H/H&=9T( G47JW%*? M2$.(V3D?OLK._CC9:G\&_AK&;G#?J9/;)IP M9+K%*ID[R^"@WD,"C3*#B]DF2]-RI''"PY=\1JBO4"_@X3AGKN4MCV^9O[@3 MNW726B9T/47'<-MNQ7!Q[I+3U;B]\VY_MAI!ZL%9/!Q7J?%7G/3[_$GUSM@H MFYJS.]J!GYQ61W1^6OL/F"MK[/++QSN M^N&T/N?L,^W]-GNF:KP<0/S1Z>2PN?TA.QSV 0OR4_YW;&O*MB$\0H4)L^XN MSV9OY2+9;G!U)K!3&6WV05OY0G:0TR)C-R-?/[=N.3.F.9S0[=M0M769BF5U M#HSQH [^@8]018:ZE61VP6V,,-"HBCUE00GVI-(E(7;A/R %PSE->WZ")JNJ M5@.7O==T[0VGNG?R8K/GS#N'&.-&"N;L0J.@*!#*GR" >Y76:*^-J)*COFSN1 MS\MWTZZG#C96^[S=Z>;K]*;7U45/0%HOF]&I@,9>9>6=>M0## MZLW+W_)W589//FTB0,/6N"J!6EQ1H^B/>IW_CN.T35+3(V.2150/0O76H$HF M;-/P"PSW1#57;U*%EYR9V?*[A0O6BFJVLVPNN7+G$_'H(Q59'H]P?=\!5TUG2-@\\& M4)*58+8,8T556-/Y'Q]G?^YT)AQYY7:^Y+2L?,!A'\[KY3M7>#4<=48U?+QJ M'47;'1W5.1<9PBIT.SDZ'69PZTT?JU^9Q-E8N'2Q7K'")U"0[])([/-9VE<: M6=4:FV6 M'*S@+Q JIVYF9HZRM6%#91F?13MYW^"]5,E972J4K\+%5<_;P. M!9M53]70+4Y)K"?7?C6G-";7GWXS/CG,.X=9#/K#RGRK]D2:IUU(/YFJ#X"7 MO&-2^Q63O)9+N@"^_E\W^.?K)]@B\-+YK-"D*;.<&Y2IFIQ.=+4%EOE"AS43 M;^,-3\^ U?TY=?M?*PP;SIV8^@ !V34[IV)A)?TS:]FYQ333Y79D,3_JG$HRJMLPV2 M=..76-4H3=^J,6S66Q?NT];.9KPB&%6_V\<:.\Z$I#!8[])RSQCEG"JO.4Y< M*B>-A/^%<#\AJ7G^L3?5TS3Y:2\X$K4#U]W [4_O3W<^[7S;V?CH" \\)_U[ M(1/*+7!1SCA"DOG,/B%5)'3M-3AL%R0Q9.Q H3/TG1.0FJSF)P(]IS NCU;6 MV^6CTX\35??H4K(W>:1_391O$95:5')_7DJ2=I1)A"N*4V8R'8ERR"NGJ"&6 M)2FJXOKSHC*=ZZE9D^W?[1Y8;5<+R94H0J-(4EKM;.")86LBE5XZE[.C0% * MBBQ%-#*3I; \:1H3#+0,B"LMD"':(R]%PLDX+C.%U86B\2,4J5J(#3JM/VSO MLWTVR4_9,CD;I)\+YX$R[I^ +7?]P-[,4++D#M"S87R#_#4S0=>^?B%=E^J.;N6LQV_28 MA=ZG&?EY%'ZXI3)QF!L_8B'FVED\>*I=U'YV/$8O))YZW;0.LF) M8;/Y#_W5#+*]$.*5R4Y3>+B[*4;!P/\^=I5 M:,V6Z7 :/YG$+ZIH'7B(G?X7.\P#/\B=5G)QR/K=1^#A%]BSBAW4)=B5@S:) MU]84S5,VGPEFGHP'N=RC:JWNCSJQJA.RO;J8:-IJ!WZ=R^9TXU%5I9%W65U> M+3E\4RV<*:G09!.Q3H6<-B"H]UYC.+.Q"C]E$ OQ)+,(9?S.A.(-2 P7FKJ\ MJB+" 'O#N;Y[EV^!5LWJ.S#,((V+_?IJ4:XNULMIG',O=!QM]DS3N/NLU,?$ M99[M!?NF^6"FG&OBE(L50]-IFF[NUK-8YYC"!X#N<:S&\VQXX]5YLZ)NB'LQ MX"\D!LP]8DTO4#U>158Q435QD.,'0Y#=2H6*Q@(D ,P#]%4:&SWU32&G3.^Z^JS>K6$\TT8LW$T5^R6 M$[P/ZU78_)X?JLX%;FRE;CRL0F'5X]>=D?X[[M3)N6CR=O';26[*7)^1:^ZR M7AX.%V.WC=E6[\UM=$='_?'A8I9U/9#3X9V4$581Q&F8\=PV_JMZH68]W&B[ M:4:&GW:+]O/=HL]?HWGPQ;-S.\M>CBK5(^1B%<2Z3E9T27^^5OJS*>G/)?VY MI#_?-?WYP@S1'V9\GLD09<98SYE*7FNN;&:%PW"H-); !ZFF=!@/EI7LC\"5 MZ\;==#8_>7MF+/YVVOSX@C.53W.F9L MYO$3MQ-GSD.=)3D<'^S*QI#XY;J);Q>F_C67 M6CBA&]/H%SL>]2>G5+5:]3>NZNR;![-K3X;QE\F'7^>P*)]?_]VIW(U?\N" MKWK2M:>_='K5L%3WG2FX==PHN=$ _@F3!VI^7Z]_^^6_7WGR MU3_R=4%O>S)>)U?]*-AMS_WQ(]/KGPRSEV7G_UT#$&L.G,P3 &1?/MU\GUTG/DZ!XNS@FX<=R,8V>?BA5$L8ROV* MA7\'[G(T;&UESMI+AW75%U59JBLH7S]M]R:L <.?KR%:RU^QC0E0F5PG56_> M3FA-WO.I#7?#]=)BKZJ\IVS37V/0[U5"[V$\BWP\E'Q,F]Y3/9$0HI\LXC\ M-O\?GQ).?@EH?&&0X:'G_UT3@G\@)+[9Z#W8RKK0?7UDH_0*M'T(F2L3N_R) M?3D@F:K_/09(+F/"S^Y-GIWZQQNYU1JG__NP U.)QP]&IA:A.@JT0B-SDZ:V M-CJMA0V@_KEVRF";+/$X8"-2I/0:C8(6X_43%;\RE'>W#,4?'1Q_Z^Y^.N0[ M] #O[K\].MC?QA_VX7OZ[T[[[P/1IG^='GS:(NWO!_3#I_>GDW/@7N,/]+V$ MY_D.[R)V_GY[M//I7;?]^]M/!\?;Y,.GS^S#YK\[._OO6?O3A^/V_K_3SBG^ M]L?^UFAG#W_]**/VP1"",.4)\6 3RB26* HB!?.88Y?67BM-U_FYO-"+E<5C M+8S5PXP[6$D/H'0*HA=$OW=$!Q<;3&7NA(^"*TXTHT(RB( M7MRC)Q-#6L:$GTW4O'3JZ7V/XG66R27#^)05BA,N:F.%EL)Q(L%%P$QC$5E, MF(*?4%R$92B4]ILY%\&KP)SS$CF6>Y$D$Y%V'L9?)6H4)CQ&N?::J@M(M.]? MG]QNH:PJO*QX'+6 VOV &LLYB-R*2(D$@RQ9RR)WU&%"H\0X%"MY2: V9R5K M3Z,* 5G!-.).1F2D\IJ!^N8#,'"1S#2G+7:4*RUQ)X;'(G_$3E'43OW MHW;VYL/M-DKN'$74&(:X51@9'"1BAF&3@V?&A+77FN +&OL]=G#F6LMH52%J M-6/Q!0^7B8?*>DU#U!(<6IX4TSY02;U5+%AK@RMF^)+P<&:& QI:[W%"3M&$ M.'8864()82Y.LIHI$HA5W2IE(KV$XSW>Y_1X'_6"' M1P7J[@?J9N9T4)$R;PP2,KLG^_8/K X'?>CB1?SZDF2 MB3ADO%.(4Y.0MHFC8)67#(0@"+'V6M/E>!TEL/52DNZ+HBB*XG)%87GBU!D5 M4P1%0<"14X90K6,,.E!NR@[(DA3%7"*2,RZ(H)&5 2,>:$#6BH2B\RXI%HES MNNR %&_N>>^ +(,/8FO"LUMQ^3;,DYU,X3W'WQU3/[-NVV^Y;]+2-DNNI]#9 M2:;O'^<$JZ>Z6U\ONL<.-%UO3)\\<#V3H'M9'&5Q%*U>"$P*@@ W7+$$)F1@TI%*R45.@L9!K;W6Z[J@7+&C2X)X M(3]9B;%^3/*3HH#NJH"VYNULL*6%5L(C!O]!7%N.G"$6664QYBIX[6*.Y] 5 MC.>\C+RWPH3R;,'QWIE0"CC> SC.K//@P8&*$2,OI$#<.(.L%FMF)4?2")8IOA," MZ]PB%[R/W$K--%M[32^(!CUVMNJJXTL)?+\(@%L20TJ!O7N O9F9K:G6FJ6 MJ+ 4<>H=<@0 4$OGO,]=Z*]HGGNJGG^FC>P M4_#".$D0B2(;V)0B;9)#WL64O+#$ZUPDM*3V.@^PIE85J$J8NX#CO9/+%7"\ M!W"6".Y&T(DAZ&1!GR8!9'B-B23H7G13"Z R.9%T5<"RF>PF$WWK"MP$5 M!W$X:G4JX&K]%+^=Q-XP_ORJU8NC$A!_Z$C1/9CIET2*)C-;:Z2M>EK;<53T MTHWTTOO%Y!--F.,8T1PSX@3S3)5M4632^114%%J 7KI *Y5P40F*/T.H>TR; MNP#[>#>D"<_<&1<<2 M@@GSR-J<19?I3*0.VB0"EC1;P>V]9X-S+\>4?BG<)2O=W++YL;G;=;H\K-80 MKVI3LVN/Z]/7[??NPLSVH]\.^L=O^I-.0KO31D*_57V$ZN/VB"XFKL11<$5!?^_:'+>MK O_%9;VVN=-JD2% $$"L/=1E6(K65HGDN-(2%_[BY5!5)\6H&5T!\F__;@=Y3LXG#<>12OTX;PXA<%!+R%N7+V M*""4BT^;O\&2T!>\+FIUFC[K#CV9+F(*D%0=U#Y+$(Q8O->./; M1ASA6!W!BWX>E.;#>D+IP/W[CXM__K9GFK(/V! M[7\>#-Z\_@#M.WC_[NBO8O^SR=X=_>P/7I]LR.Y&=*1&\H1C74=7I\O0P7'04=:0OHJ%Z M7U;1657:B1E'N)S_I*P*5V]&)ZX\J=39*:@Y/ O4<3-2(XOWC(LAKE("(VD? M#/\UY0E0%K0=H J14^84OV]>/MTL=YHCGVZ;"\^LH_%0Y_5BY2WCN#FQ= AZ#UHW(('?4@EK*JMZ)#Y^"]\*0!2' 47ANZ@$V"1VPM M@L(*J\V-0'B#(DUA#\3R>ZL51Q=G[BX=)O0F9]#NE;QP1XAPU&1<=KA;>._+\\*.3T$F(-ND8?YM M[KAM4/O]5O/=);;4?,G)EDAO^?[6FV__,MGB1'[CSW+[+8FWWKO%YM, MO^+F%: [-T\6W-$D'[[$1EQ"^H<_)3WT"2+#L@GS7@!\@M6AX:Q/*SM8NH&+ MR^^:%/JB*AB'@>Z34 ;D$!5XO7UXRVD=[8*0[=J&.(\[E]@C2)!O,]_X14)Q M\W@MWV1OS%NLV;AL;/]'C2:JNHC2S6])Q'^/!G^O#'N%>!"%>.V,&VI7153< M125Z!%Z7@?UA;Q3!PP>8J+^R1FHEC&C=)(K9N66CYAIBX_H-*Q$]\BUK@<@R M1O3?JK+GJKH+EUP7BK-:H+(N4EMOF_TO8YS[MK*7? WJ3M^,\/N3B^CPHL92 M@7LMR_YFR:V>G.ZUMN:J8.Y>K[[.U3$9\]JF+,F%TXQKJHV5C$IA;)Z[Q-.O M+O_L\A=/I)1E-WWSZUZ*Y2@XS[K_^8_AN^$NW&,'^[_^<[I/_RCV_]Y/__G[ MC^'E4I;](\/>O3>?WOV]R][1_<\'O_Y3O#L:# XHM'FX^_F?7_<^O?ML!__\ M^H^?EK$<)I^Q7\U1?OR+#5:Z%9U]_,&'O1;[-B\S'!NFQS(S,'S&=586?;P\4'B$)V4/@0T"@\7EBP=RD,(XEBDE"96IMFF:* MY%RF/9%>"@0>SA/IDT_',!;&Y)3&2:+SF FM8YVG)I9&"24H.*T'0/ M@>O/JI_ZC,*#GN/]36'D$_05E*0)R93C-DF93(FVAO'<,688> M'>KJ\)%\Q M3Y>S8YYS8\!=Q)GC.F8I5;&TDL;>80R#L0U)-K:)N.9!_&]MI)I=1FO+ 5K6JB-5GIGOF$RFN=9)WN>LEX*;%PO$G!QKFZ2"$!)[&(:8^2R/IY,$L6$XCJ1-I'$R%P3(KF^ W?NRRX> MSIO,,VIZG'I&+=5D'KDASB MSU1IGS&P&N5S+BDQ.6<"WDG[0K-'W*+B:&=VVLKG??;F[7&NLXR)S.$QHR1F M-H'?=&;BW$F;*63UK[DO-+I6:=5-5JYB,?I8E$VFJ3"H3P8!#0^3O M198FF1*IA+\RU^^"M$07SG(N3M/ MSK/]M\<$1D791,>>2@[(Z6TLM7:QELJ9A(H$D'4]TMO/ #G7F\(_1([ECJ.X MC%V3#UWUL3#?M&GR,ZN+>NSWK[<9]759*Q8*/V':)A)/O)7"&:)9DN>::&$A M[&5$Y3JYT]Q23]ON@;;M+02\!SO'W'A%-5>QS5D2LYRS6)G4Q4P3SU.7^BQ+ MEK9%9%^5T(>U3QD%B52I=19^9I[9! (EDF698Y800$?N^N!U.2BXOQB\GA^K M7-@T265,E%0Q4YS&4I@DEB3E*>[YE>$:4YKQ+=ZC8!^B]K59?6W6LOFS9JG3 M/-.Y9)D4DJN$XP931KF4L:SGSTOS'//\^>28<9I;)WV*I2=I#-[= M^9QD*LG$QC;?ROIZA+X&JT>V:SBQET9[FQGO+,M-KHRQ5&>*I\+K).E7*RP) MV=XN<.*#M\<^3UQBK8M58H$36X=T6+G8>>.U<$H[RC:V6;^-8<^!^TJK::75 M%^9N^G*!Y7H793-->:Z$83EC(A6:ZS1UD@B*>[2:GC8W.\=,X %$ M61H+FZ0Q,\S',LFRF%B;I8)[RDPX<(ZL_*D2SZ!0_(^>"_(Y%"V=IP]@Z8'NWBZ^^^A4L3IHE3UB>,941P[E.3Y-Y+;CQ+^L!G:>Y[ M%OA<[.\<4V@Z,8K'22HS"'RDBX7B/C94>\N84Y3IC6U!5_%\D/LQJ]5#JM6< M:NC]3^]_5DNB7Y-X8YY1+;GS#OP/\4IP2:@0SEEA*9-]^+@<__-N(7S$1?2$ M*$$)B77F5W6VF#2T^*ZMQI$XJYX:@ M7G4T/E7P-WQ7.8-F;J-B!+\W[B#R53F,ZF;:;3-2(SM[U@ ^&M7N3D\XJTH[ M,6/\8GSJHE[J3=P.;! M9 A2,N_5SF_1X;O#H]W]P\UH[^#55K1S\#HZ_//GP[W7>W#9[N&- M:KAVW3YX<[1[&!V]B8[^O1N]>G/P>O?@]USM'\,P<[!Z_V M4"I'\,'^[L'1811'/\!%1WL'?^Z^_O'IR..'/T=J8@N L!^OLYA+^-3PZE1* M95C*O1&"<>6T\8E5,I>*P"\YW[CA/J^LMMI(3KUBUC"A"2 NSQ)E)0&JOVA1 M7HH'F2TZV4DEN_O[6FY.M6^Y,ME+!OO'> M6]]*DBU.Y-HUF=*[W_RX@<7]36FM0EG":K5&/FR11.OL[G^?!?$(VRPW#6T[K:!>PT*Y6 /[HEZYT2>BJZU?HD\5P,U"C%Q'V78*\2#*,1K9]Q0NRJBXBXJ MT7N0)^=!(&K?&T7P\ &NL/VQ=P=/CH%BX4T_K$]P6(GH(?O9;->W$V9YU,U[ M(#SV2N5[>_\#4L5>,BM@^X\,$S[\\U2W3+GS!H2W*>6WB^A!JPV_KUFK-4[W M6C5X53!W7[>^SM5_S-(T,XH*0@2#7Y0DECJ5Y8[A-EOY,Z\^'_[U_I_WIQ\. MCOXD[SY_2/\Y>OOIW><]%BK[AN_.W_V]1P_^_L_PX->]]'+UWS]_P_M^?4L. MCOYZ_^;(#@Y>__)^__W)IX//I\4_[W\^???^'8%G)._>6W_P*KGH#@T[>/^! M'6N9<,:ICE.>ZI@)Z6.="A^33!KO4RJ3E&QLIWPYM>??8QRKAQO?44/>HWJ/ MZNN ZB;3V@FI$\ *QKB46N4NP07\5MN,D6=>T[T\5$^FJ/[Y[<6Q8JEGTM X M,8+%S"<\%CYCL15Y9JV0TG,+J)XFRSBSYKFB^O,)T_J=+5B$\%3X5&>E#E:4XM<.Y4.7SSODQ\80ERJL88D89,ZY( M+"Q/X]QZ2@W5)&5X$%N^@JMD5QWB5G.U:P]L]WZX,?>$YCI3B6:.YRIQ@BJ9 M.(\_B.G9^I* ;9ZM)\=>6".MT;%EG -;SU2L$L7CW.>>9U28C#@ -KF,W7N> M*[ ]'[+^Q.=4QJ>N6K64VWTYLF\+I)^@(TM38C,K=6ISQ<"%*989KA.9@S8S20C%$SRDT(Y)1B7G4J;,$7\'@N[+:JC&\*Q/XQ>?755: M59_V:'<_:#=/V^EQKF1*I/,Q<32)6>;S6%!M8ING/L\\ Q]ET7(%)?1ECW@] MI;[3*YTQIRF2>"668=CP%ML^3]-EO5+DL M?W>QP.Z38V9L9JRB<4K2+&8ZSV,-?\=2J3QW29X;Y3>V64*WZ,KEJ9[!OM(] M&CY--"0V)Y:)5#) 1*"4*I&&$)\+K9FU^KEOF[@\-)RR?VAC%EE+M[N_NK&S:JW__ MJKS_^9C[TZZUNY?"^C[67P:[ M?;-8:T>/M:#::D%B*V@>,^%HK'-A8F;3-*=6:675QC;-Y%(*R)]I34J/;.N, M;)(!:G'XER2,B4PJYD@J-,,SK+G.61^W+PG9YN-V>BR=M#QE26R5)KA#N!":.ER MG:9)+EQFO1,]75^&4]L_VAGO%]T9/N;\SQ4 V M"/4B-[D%MT:2K;2O1.EK[WIHN^9XLHREN<(M2;P-Y<0IMSGACIK,*XA]>[Z^ M+&@[>-5!VPE"F\B4\IZ+6!A!8H8E=DII$LN$&LDS123F(DB^%,+^3*'M^1#V M)YY?_^;E,7WJ:8U<6>X]R:S1.O.,I0)=F24T,S37UKX\2_^T MOW.<)E;K1.DX2_,\9L N8LF( ]+N$I(Z915)-[9IGU3OD^H]LEV';!FC@E*> M9I9QYKW2@&^ M:P4TGAB5\V'OWY%P69\E,BM=$[?4=-2S+ AGN4J88\;DEK#4 M$L$(,RXQ,DN-(CSMV?URO-W>(KL_.4Y3FTOO&!'A M OM'/$PD$<;&BG(5X_+!6"H$1>$S;EWNN4FPB)!L)3T>]E'!*N;TUV&)S,[O M.Z]6-O'5OW]5WO]\S/UIU]RM^JE!?6'*/?-;;8QW1.K,>XC[@;UJGP'%I2S/ MA8#/^GA_.?SV[4*\?[!SG#N3L(SK6,M4Q(P:'BN6X:$+Q' A.J)L[(ONEL:MLW'[H!M:*;<^'LC_MJKO^!)EGYM92 MPQ.E>LB_'K?VY2-E/CDDFK)""Q$ \;,RR/(LU M9UG,;>XT,7DF<[NQO8I[-JTZQO4%>,\"V9RS1%H"$2Z33#@ ,>J!H*?$9)X9 MT:]J7QJR+1#VDV-O+=,B<;$"IARS%'XHGMDXS;5W-"=$ISF6%O?(UM/U/L/^ M0(MD^M33^G@RXK4WC'@J*92(S0/4=?CB=[M\#1W^P1>.WB^2>4"\FV?N@'?49HP0Q^/$41:#\[&QS)R/;2X8YU08 M3WQ_CDS/WE<@V;Y&BV16NBJN/S7AP2>6K<_SU&I&F6,R8XHH(8TCU'IM;%L4 MWK/[!_=V9I[=7^SO'#-'C616QA!IV9BQ7 "[SVQ,THQH0JB3)MW8)EFZ@HO@ MGT%1>(^'3Q,/I'F,@$! BD]*;-->9=BE/^T4R2\/#.?:/>$@43[U5 M+#:IPW-D;!(+F69QJH6D+M/@G1 /TU4\_?T9X.'SB0J^(\,CUB8JZ%!KU7)@ M2QNXKW!^JS5^_UK]M8#KS ^$2Q.FB5/6)XQE1'#N4Y/DWDMN?'_FYK+XP"2T*%<,X*2UE_%NG2O,1"%'ER+$S"A,*ZUMPG,>-$Q8HD M,G:6LY3X+,\=W=CFK-]JH8\B5W5NZ2;O9XN/BZ-^Q_%9'-0[Z\(7=G,8%",7 MGS9_DR2 ^4%9C4^CG2'<;E34J4,].5MV@_.M["XMOC08,+[0B1_(C]#RR1FH M11#XRN6([^W]N^/X3CY0#7;EQ M>L10Z.D$/%ENC.8)DTX2YF@.L8_R.>$94]8H8OJTV%("GO<+YUU='.P<6ZIU MYK(\EDF:QLQK'JL\M[&52C":I5RH;&,[S;)^?7J?_.IQO4"95K MZI@P3ECKDIP3X3-)M4K[1-:R<'T^D87[CB1&>F]U[+EA,-I9!9[&WBM68D==*$,RR7,8G_3)?G M]]"VSM F%&5 T;4Q-F<\-1HB?$*\@W@_EZG2/6-?%K0M,/:3XXRP7#FN8T$) MX!OU>,87R>!'[KU(/*:SJ7)$ZR]%<((VZ]-7)(K6SC Z^+-SK'-B3;>^C@+DPHFSV.EN(T317.7 M&I,(F6QLYTO90^N9IIYZ9%MG9$NED=KR5+"$,\.9SAGC-A6$6)MVTZ7]SB./ MAG?SU!WP+IZ=G["J3;UVCGD85R MT#XO]6R7W+LL395SC&<9@*PQ4K@\5;E!S+76]9N +\GM[<_3_,_[.\>2,&Z8 M([%(&<4E=3)6C/M8\,08HTEF+-O83KG8RE8N9?4,%DOT>/@T\3#GQF=&6, Y MQ:BPFCIK#40)WE"69TF?P5\6'LZ% 8B'3#&6VYS'F<&S?I(\B373(DX5)8P8 M3KU- ^I6,J6JST>/MOPX %2/7<<\&6Y2Z/.0P&$%W-8BU5'D,T(K57GGLI-K897M=,YZ M">$[&$JJ",!:Q'FZG0:2TM-K"@,BZ&6:*DWMDG2GP;6U^3U MT';MSO^9(=0+:<%@F'29RI2V7*DDL9IHPGO&OBQHFV?L &U42Y^3@;;G0]B?>([]FQ?.],FG]7%E.569X83E M5N8LRW,I62I2J:26ADK9+V]?DBLSBRS]Y#@Q7#B5T]B95,6,RR36F8&1=SI/ MB-^?T?&97U6 MSJQ'A=Q2$U//LE*<4L>9HHPYKQC@J:0^SYQTJ5(JM=+W/'\Y;F_A,*K/>%1] MJG.1)7G,(]'CY-/$R2W)L4 MX(X;P73F=4X2D5MK3:9-INX2'/1X>"]X.!\& !YJ:QT1>18KKQUN&&)B;40> M*Y)[ZH32G'' 0T*WTAX/^_!@%;/[S^7PW@=,ABUMX&XVV?:;]E5?/+MGM4;W M7G>TOZ_E@W>3Z/ISB_[@W]7@%A_F8ZUD?^>8)!DH,N,QL#D3,\VR6'('/XSF M0 D<*]_WDJD>]/8P7RWFZ/F84?W2UA;(N1=:/Q MBW@A+ U^(\4ZM*&J3HI1&-B\'9WE'[.;;8G+Y^RRR^?LTB^?LSNO5\MJNKQ+ MNQ?=-=FB0=*+IQR?50# %;PY*D9F,+'P[O&IB_X$H'];D1)?2JP2U+,#-S#B]^48QAT,R79;6QW?F;2%]$\"X07%3Z+E]]>5[8\2D>'KV5-$=>=_FKMD'M]UO-=Y?POOF2P[=2 MWOS]K3#=W[O) M_NO3X<'1?][_<_0V_>?O@].#7W\YA?:P=Y_?7NS_^L?[?W[]DUXN^SB@?YV^ M.WI[_N;7=V1_># X> W/HKO)N[]_&?SS^O3]P>L]:/O!AW^._O$'KY*+4/)Q MF'Q^<_0A/28\T0EA-.9:RIBE*8NU,VE,%7=2Y]9S2C>V4T&74O3Q3#?69M & -#D0.JY_E6WJ/Z,RS)NSE,6\U&/]%+5ROQ MMA8A<[_MWS/8&XM0[JAQ(C=)RI3+9,Z8(ES)G$)(0OM8<3FLHIC&BO"NG4_' M&4TS;:B-4X8+U+RRL70DBU-K%.-*")*XI>U?^TPWP.J!;9V!+9%YFG.:>BL] MRXW0-",0+7DFF>9,VG[3OT>%N_D@BAUSGCCATS1.\T3$S-HT%MS)V.5YK@57 M1JNLW_*O#Z-68+9KC;;\.WO J?-^\ZNGX"0E337QPC$@F\R#6R2&*J43[ZQ+ MA7<]^U^*.[Q88/^?CWTF'3=Y$G.;Z9@Q;V.MC8\=<49IY4VJ<.NK)%G!XRN> MP=97/1H^331D*L]3GRHO:,8,1 K2&T:\%CG@8T:?^_F;RT/#N>#@[?FQ2JC2 MCJHX232@89*X6$!$%W-MC!!..$+LJLZP/ ,T?#Y!PS,IM,6=!>!)'POC%D.' M$GKZ3(IM^_?WA;-]X>P:%,X^#CU^PB0XSWW&E3:9IX+QQ.O,*.>4UBQ-L]ST M*8&ED. WAPLI 7+LDHQ)JVVLO1$Q,Q9(L"4T5C!&5GK/G&=-2F#U3@=8=8SK M _]G@6Q)D@LM,I=E:<*8X(I#)&]=:H1Q*N//_;#>Y2';?'A_<9RFB5&<9C$U M L+[7#H$-1^G.U)*>V?[0SW6+^X/7. M^<'YL20YT8PFL98)BQG)\E@2S^),*NVM%X);M[%-^5*2UL^TGJ6'MG6&-N*L M9T(SFW#)'!."\HSP)%$X&9>DKN?KRX*V;O=R@+;D8.)D,YSY0@N9.U/).\)^QHT^HE>NEIS'>M8-OE $Z%/+F?X+(N%I-5Y M+BAQF3 LIT(8;K5+C TGKC#2!U[+82=[\X'7I_VWQ\8[+.+B<09#'[,T\[%. M%(TU23C-A<\-EQO;C(H5W&;C&90+]7CX-/%0)7E.I. MGP$>/I_@H3]'N3_'LC_'\NMS5OTYEOTYRJO!+?878ZWSXTPD0/$2%RN)Z[95 M6*B6FCCQTO-,&DMHUI^CO*+,H_<_O?_I_4]_CO(Z^9^YV);L[QQ+ZH51N8Q= M1K*8V=S%X'AX[ TUW(G4(XR:@[B03&:A%/FKOODYB-G MV]'9_A]=_;1]]9S:8/;'R3%+-[:O'E][5M;AM+H7E1O FS[.'1?[WR_;LW(9 MW>)9\Z+K[E2ZQFI ][+5IV3^$1M73XE>.#+FDFHM_\3@V\\'3LFB0.=_GE8S M8SYQL:Z<^A K#[UZH0;GZJ+>^&FA\^V3,P:O7D,)\>LE]-?.'WL[!]'^[NN] M5SN_18?O#H]V]P\WH[V#5UO1SL'KZ/#/GP_W7N_!9;N'-YZBO';=/GASM'L8 M';V)COZ]&[UZ<_!Z]^!P]S7^=OCFM[W7.T?PQR][!SL'K_90*D?PP?[NP=%A M%$<_P$5'>P=_[K[^\>G(XX<_1VIB\?SP'Z^SF!O.#,>TV[4G9J]R5TF^%;7< M[F 23E2_AV3"(GW[>5+#>^OZ53G4Q2AX@-=%;09E/:G<$;SIYT%I/CPNI4OV M9Y3NP[OW>^F[HS\_O?O\9_+N_=OT'?VEV*= NX[>7AP,__S\S_L_WB/U GHV M^_S/ZYT,J!G]Y^A@ M>/#K?@(TSK]Y;;*#]SL9M"DY.'J7O'E[G#C*I>0RMIYC#2P!&.9:QUJYG*<9 MS7F>-U0;'*FS.[C7GH%OG. $$%]B0;. 45):4;T0../,9&F$U<1O; M/_]YN'>P>W@(MKW_,UCTT1[8>$?V6@6XY'8O.>]FF+[\WL5V)IISQ@WWEA$F M!54Z8RE)N1%2)9GS&S=:%5U-JPHO?E&, =;,7>RL,X)HS@IJW%/LEP*#FNB= M4U6T< 9?!S6/W=/;.<71J<,N00LO8,B'9P,WQFW31I$R_SLI&E*%W2S&=71Y M=72D.Z&,3]4X.E=U-"K'T5"!BRA )KCC&CS>%U4]COYWHBKX',\G]HW(+CJ1 M;478BOD7XJ.P-5518P&2CT[*TIX7@T&H4E)U[;!@"6^HG&UN/YM4YE35^!P# MX@7=/8E\50ZA"45;S]2&OD73S LWAI:,0 $^PS-N&+8;>.QCC^D#:2^1-W* MZVG^HVOU#?W=6=201A%^+NNP6L@40&(*7YAUZ^P-)KPWBG8F)Q.P,1S!S6!S MG4E/)7"E\_]?';FAAC#A-WA 7#<2K84K#>HOSH1N4$ M[E"#9K_8H$AHE*<79Z[ZJ&HS&8 NC2?#LFH?H6:V"09M'-KSO[YFHRJJN4V, M%3QES"4:UYIDA"D+_\N3Z;9](B%Q\TM*;MO;=C09VG+OC])#W:.OI.D&-)7F+?GF'?OGM.WO?BG[71'JOY@WS:%853GHD1"3\O'..2&@RDTLEXH3D M,F8N36-%31HS<%R9U"85A.'J1WX+%&XV&%@'?%EA'>D]Y-WTXF+_Y%@KHC,K M=9RD,H\9XR[6E*>QE4F24FJMM#GH14ZWQ,TN$G3AJHO<_"K]4$PF+O>4>.>9 M\:EVS*"(*.]Y[(.A 909E60"1WPJEBT$QON@UI=$4+%M5EA)A'8VI MKG2KT.O3HU2G^NC<" MP?R!O[WQ;R9CX'JN_A+4_:4&$_=;>=YK;M#%B MD6<\3C7HM+24:P:D"4^BN:JZXW+-T.R!5>O?$+?TNM7JUL'Y,:-*<&M)3(3V M,0,HC"5):6RLS+5(;4)ILK&=W<*ZT&$"@&D5$M"8#A]/(+2MVE*F=E$LX.!M MDV_?I'>74Q>Z^#MF\>PS4Y&YV3KZYO5; M+.9-4Y]K1P!T%"X4RKR)1<*!>]'$IH*K#,8(SYR[/+D6A<&H89@&@_(<@[7Q MI,_*1:?JHVMR0E\%5TS:-!=Y+@3S-M=)ZFQN=&(2GN6,?:$ ?._@ ME^7YPITADH,W_DLP-2-MR?/6O0MP?1F,+@"#C(4F!G0OH3%H6QYKZX0R*LG2 M1&QLCZYQ?":(O6YRC]V4&GC#,,^FBBKZB.[@BQSM%]W_-%.&]3-(MM*=R!BL';:2BH5-8BQ!RDFM_F:$T /[CD^Y*U1FCI MI&6"Y(I)("%2@U#NE8IU(I(X MA9%3GCI.4XB8*;EUWNK;<[7+5)$^5WLWM:!OWAXS(.C&0/QI\QSX(,_S6 F3 MQBDAA$LO*&-X!K'DURPI@1'((;ZD- 4,D4S&4E&((+1)"77 )CP0.$*OV>[R+OG:9>?> M[A>3^MS;*NOO/@8@G&N59B*+F6$0@-B,Q(I;%>.AT9I:Z5A.[RGW]OB4J,^] M+4^W#LZ/M11$")7$+E4T9L[X6.4\BZVQA(%32Y03>';'M^?>QJ<0=IR<1OL* MN'I;0?H:HE[03.W&(2*&(8W$BF,3VB6&B:3U(J[;'F])/OY^E30L[:6]^]P_BZG/$VT]S$P/!4S MDMA8YT [9>IMGA$.0VMPXO>65'4Q,I7#D+5+="SD@6[) =TM+;*)5^(JS' 7 MV)CZ*OT%U=1$Y395X 28R+3+5*Y!JPVG3&G:X7^SFA@5F??ZNP[Z^WD_@6@Z MS8RU5+A8 CA!-,TAKL9\)@>DTEKDQ"D,F\2-&[_?38MO9;U3:.UN+2?5^/1F MG2;R:F9S+ILX#EL;?658GR=<$>X%<=HRC3M#:\S=,R.-LUIQC-F6ALY]S'8I MZ9[LGQ]+K;SB@L%K9^4;:._-#^QUK=%9PU=T7,_BH)=:>.]DMUV"$S]WWY M?8!XG3.>>NH9(THJ29G-X1^6&>-4MPURFB;?'LSB_'Y8OS2G!SR6&LK-%O_">J?HM!Q8 M-!%4DL[FOMU\:)[25#RD^:R#(O^[E6G#M7OU;=0W/3@_-AZD;R"*3RG'^0>C M8NUY'A/"F$RE]4D&]"2]):/\_3KZ\! ?B-#-:>^=<]6YK1P'X%,G);G\-]JD6L WP5:<5:.D4VKP> " M9URBR5E(BYS!HSX5P\ _>H=Q?\SG;OF;8A22]V6?O/]6+\1P#Y. M#2;U-/&)\P3=Y&H()P).H)-JIR6B,81;;CR;G:!)FMVPL\5 U77A"PQ9ZK#7 M!BK]_&5XW^4"NR\'YT^HDNL.F>D;J[RNA(%UZM= C&@I )"0IWEL4H2 NR: M*I)IG0B#IY)>=W1?!VA7+1BT!>P)U+XK FMVJ%E5W?FUW3FGK0"SKR<5H%:W M"J#7%=25Y.#DV"2Y =Z?Q$YI'C-BDE@8CRLPC649#%4J0UG@-7M[S^]FL;!1 MT=?H1*J\R[FG.+_++$]$:JSR&53(5P^&@/=*N#BOHJPU2)Z /Q),F(3HF*56M BH_-8 M\LS$"B(8T*M,2FMP.>;-@-,D_4%/7#PH/@9GWTFZW1)E,8,.7[N3JIETN%J4 M#W')M67YE3LKJY"Y1Y6\(W58T0T2OW8SK(8V[8VF&QC=-(>PJOSH*!2=&-S/ M"\M-+M&8;F':W 2J"MFV&O6G.!G-IJ'0[BK"CUI)[FF3VF7CLSM/K;(_J+RA7TI9M*Q'OJ>>4&-8I* MC8]OQOS2WJ^W[6+=[SQ]^\[3M-]YNM]YNM]Y^GMWGKYV+]XO[JU[:2_>7*2. MD.YN';9;# 2B:#60$*THUF-TI35&8RK,=8U-O2#_>IB=55W4T%X/120P:F M&]F:66@$M.*B?4$H^>D":(6:[-A!,>N7=+2$D&45'D6,E\A^XH# M5%\28F!\NL2U]],5;TUB=[9I\.]5V83.TV?@1CAG;4JM(3?-;..UO#2L[$Q]4(KQY86ODEH#/BK2^0A);=^ U:ZP7UX/DET%O,2@. MQ'-AR!8JTTQ9-P/^-2F:>SB8[WMR-7.S8G\T98:OL!?/-OUR\/G#YS<[QS0Q M&G?)B+7)5,Q4;F/E"(T3+D22P8>Y$E@X<4O>[FMS=?=P0E:O"/>J",G!V^,\ M54Q[Q^/$IC9FPI)82*YCGN246Y=;1_7&-KUM_:X-R?&V"K%RKMOLQ8UPVNT_ M"B"INFBJ@=/-9M,(U)W7P&"&VE7--U3@5P1^@E- 3@#AY.!BZRI0?V7MZO3P M))+D_>E)7Q_#IDN*86\>Q%7SP#<$,7M -%I5WHKVU4@UA1;_Y[\$)?QE'>'I M+Y.Z[I!S!\CN!::#P)W^,N4KKX#0%-/E[W_,*-:;*<6Z3=: M 9'$9!SYR1ABT0BK/3"_W*WR#.K=?G?]FM(0?6+YP71!*W8@Y,D]6L1FY.IQ MJ!O#/>2)E(NF\JL;@@;20(OJDU5Z&G.N ZK<.<58R$*# W%-;S8_:JH M/S0C,!FU 3JJPA:.?+-DN($=O&(\WP)H+*:R@SIUD7W;'@S[;0&1&^@ >#<\ M*T,%P;!5%N]1XDS=H@TX[<;/MO)JY$U-,WU-,3>[G3C653=?,'2#[ZI6WBH,FL #J!T'X'"(CV]D#CIFZ$ M[#1C_B6$:-2^V8RVZ_Y,/1KY XP%">%_02B@@=T-!:#228,9H8EST("/W?W4 M+ML&W1P6C:"Z/A[NOIIUK^R>B.L102!;V,#I$13 E=SF_.@"JH$&(3:]B "B MS^'M]1@G9'&RZB6TT4[@[XM&"\)$5>U.&FN=C%%;7D8.GE$."Q/:V5YDNI&" M9UBL9QRWWY\,2HT9!% >B]^!V@[*,WS@9G>O,L:=A=Q7R&E43>@[7< [ B

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�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end XML 15 R68.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES - Additional Information (Detail)
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Income Tax Disclosure [Abstract]    
Effective tax rate (as a percent) 21.00% 24.40%

XML 16 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Parenthetical) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Statement of Comprehensive Income [Abstract]    
Tax on amortization of prior service cost included in net periodic benefit cost [1] $ 0.0 $ 0.0
Tax on amortization of net actuarial loss included in net periodic benefit cost (0.2) (0.1)
Tax on increase (decrease) in unrealized gain on derivative instruments 0.0 [1] 0.0
Tax on reclassification adjustments on derivative instruments $ 0.2 $ 0.0
[1] Tax expense or benefit related to the periods presented are not material.
XML 17 R64.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES - Leases (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Sep. 27, 2019
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term- operating leases 7 years  
Weighted average remaining lease term-finance leases 4 years 9 months 18 days  
Operating lease expense $ 7.8  
Finance lease cost:    
Amortization of right-of-use assets 0.1  
Interest on lease liabilities 0.1  
Variable lease cost 4.5  
Total lease expense 12.5  
Cash paid for amounts included in the measurement of lease liabilities:    
Operating cash flows for leases 8.8  
Operating leases:    
Operating lease right-of-use assets 114.1  
Long-term lease liabilities 93.7  
Total lease liabilities 118.1  
Finance leases:    
Total lease liabilities $ 13.9  
Weighted average remaining discount rate-operating leases (percent) 4.80%  
Weighted average remaining discount rate-finance leases (percent) 1.50%  
Future Minimum Operating Lease Payments [Abstract]    
Remainder of 2020 $ 21.5  
2021 25.8  
2022 20.3  
2023 15.4  
2024 11.8  
Thereafter 51.4  
Total minimum lease payments 146.2  
Less imputed interest 28.1  
Finance Lease, Liability, Payment, Due [Abstract]    
Remainder of 2020 2.9  
2021 3.5  
2022 2.9  
2023 2.9  
2024 1.1  
Thereafter 1.1  
Total minimum lease payments 14.4  
Less: imputed interest 0.5  
Future Minimum Payments Due under Topic 840 [Abstract]    
2020   $ 32.5
2021   26.3
2022   20.2
2023   14.5
2024   10.9
Thereafter   $ 49.9
Other Assets    
Operating leases:    
Operating lease right-of-use assets 114.1  
Property, plant, and equipment, net    
Finance leases:    
Property, plant, and equipment, net 14.3  
Accrued Expenses    
Operating leases:    
Accrued liabilities 24.4  
Finance leases:    
Accrued liabilities 3.4  
Long-term Lease Liabilities    
Operating leases:    
Long-term lease liabilities 93.7  
Other Long-term Liabilities    
Finance leases:    
Other long-term liabilities $ 10.5  
Minimum    
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term- operating leases 1 year  
Weighted average remaining lease term-finance leases 1 year  
Maximum    
Lessee, Lease, Description [Line Items]    
Weighted average remaining lease term- operating leases 19 years  
Weighted average remaining lease term-finance leases 8 years  
XML 18 var-20200103_htm.xml IDEA: XBRL DOCUMENT 0000203527 2019-09-28 2020-01-03 0000203527 2020-01-31 0000203527 us-gaap:ProductMember 2019-09-28 2020-01-03 0000203527 us-gaap:ProductMember 2018-09-29 2018-12-28 0000203527 us-gaap:ServiceMember 2019-09-28 2020-01-03 0000203527 us-gaap:ServiceMember 2018-09-29 2018-12-28 0000203527 2018-09-29 2018-12-28 0000203527 2020-01-03 0000203527 2019-09-27 0000203527 2018-09-28 0000203527 2018-12-28 0000203527 us-gaap:CommonStockMember 2019-09-27 0000203527 us-gaap:AdditionalPaidInCapitalMember 2019-09-27 0000203527 us-gaap:RetainedEarningsMember 2019-09-27 0000203527 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-27 0000203527 us-gaap:ParentMember 2019-09-27 0000203527 us-gaap:NoncontrollingInterestMember 2019-09-27 0000203527 us-gaap:RetainedEarningsMember 2019-09-28 2020-01-03 0000203527 us-gaap:ParentMember 2019-09-28 2020-01-03 0000203527 us-gaap:NoncontrollingInterestMember 2019-09-28 2020-01-03 0000203527 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-28 2020-01-03 0000203527 us-gaap:CommonStockMember 2019-09-28 2020-01-03 0000203527 us-gaap:AdditionalPaidInCapitalMember 2019-09-28 2020-01-03 0000203527 us-gaap:CommonStockMember 2020-01-03 0000203527 us-gaap:AdditionalPaidInCapitalMember 2020-01-03 0000203527 us-gaap:RetainedEarningsMember 2020-01-03 0000203527 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-03 0000203527 us-gaap:ParentMember 2020-01-03 0000203527 us-gaap:NoncontrollingInterestMember 2020-01-03 0000203527 us-gaap:CommonStockMember 2018-09-28 0000203527 us-gaap:AdditionalPaidInCapitalMember 2018-09-28 0000203527 us-gaap:RetainedEarningsMember 2018-09-28 0000203527 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-28 0000203527 us-gaap:ParentMember 2018-09-28 0000203527 us-gaap:NoncontrollingInterestMember 2018-09-28 0000203527 us-gaap:RetainedEarningsMember 2018-09-29 2018-12-28 0000203527 us-gaap:ParentMember 2018-09-29 2018-12-28 0000203527 us-gaap:NoncontrollingInterestMember 2018-09-29 2018-12-28 0000203527 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-29 2018-12-28 0000203527 us-gaap:CommonStockMember 2018-09-29 2018-12-28 0000203527 us-gaap:AdditionalPaidInCapitalMember 2018-09-29 2018-12-28 0000203527 us-gaap:CommonStockMember 2018-12-28 0000203527 us-gaap:AdditionalPaidInCapitalMember 2018-12-28 0000203527 us-gaap:RetainedEarningsMember 2018-12-28 0000203527 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-28 0000203527 us-gaap:ParentMember 2018-12-28 0000203527 us-gaap:NoncontrollingInterestMember 2018-12-28 0000203527 country:IN 2019-09-28 2020-01-03 0000203527 country:LK 2019-09-28 2020-01-03 0000203527 2020-01-04 2020-01-03 0000203527 2020-10-03 2020-01-03 0000203527 2021-10-02 2020-01-03 0000203527 2022-10-01 2020-01-03 0000203527 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-03 0000203527 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-03 0000203527 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-03 0000203527 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-01-03 0000203527 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember var:MPTCSubordinatedBondsMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember var:MPTCSubordinatedBondsMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember var:MPTCSubordinatedBondsMember 2020-01-03 0000203527 us-gaap:FairValueMeasurementsRecurringMember var:MPTCSubordinatedBondsMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2020-01-03 0000203527 us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-03 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-01-03 0000203527 us-gaap:FairValueMeasurementsRecurringMember 2020-01-03 0000203527 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0000203527 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0000203527 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0000203527 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-27 0000203527 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember var:MPTCSubordinatedBondsMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember var:MPTCSubordinatedBondsMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember var:MPTCSubordinatedBondsMember 2019-09-27 0000203527 us-gaap:FairValueMeasurementsRecurringMember var:MPTCSubordinatedBondsMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2019-09-27 0000203527 us-gaap:FairValueMeasurementsRecurringMember var:APTCSecuritiesMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0000203527 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0000203527 us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0000203527 srt:MinimumMember 2019-09-28 2020-01-03 0000203527 srt:MaximumMember 2019-09-28 2020-01-03 0000203527 var:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0000203527 var:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-28 2020-01-03 0000203527 var:ContingentConsiderationMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-03 0000203527 var:CPTCMember var:TermLoanMember 2020-01-03 0000203527 us-gaap:NotesReceivableMember 2020-01-03 0000203527 us-gaap:NotesReceivableMember 2019-09-27 0000203527 var:OncologySystemsMember 2019-09-27 0000203527 us-gaap:AllOtherSegmentsMember 2019-09-27 0000203527 var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 us-gaap:AllOtherSegmentsMember 2019-09-28 2020-01-03 0000203527 var:OncologySystemsMember 2020-01-03 0000203527 us-gaap:AllOtherSegmentsMember 2020-01-03 0000203527 var:ProtonSolutionsMember 2020-01-03 0000203527 var:ProtonSolutionsMember 2019-09-27 0000203527 us-gaap:TechnologyBasedIntangibleAssetsMember 2020-01-03 0000203527 us-gaap:TechnologyBasedIntangibleAssetsMember 2019-09-27 0000203527 us-gaap:CustomerRelatedIntangibleAssetsMember 2020-01-03 0000203527 us-gaap:CustomerRelatedIntangibleAssetsMember 2019-09-27 0000203527 us-gaap:TradeNamesMember 2020-01-03 0000203527 us-gaap:TradeNamesMember 2019-09-27 0000203527 us-gaap:OtherIntangibleAssetsMember 2020-01-03 0000203527 us-gaap:OtherIntangibleAssetsMember 2019-09-27 0000203527 us-gaap:SegmentContinuingOperationsMember 2019-09-28 2020-01-03 0000203527 us-gaap:SegmentContinuingOperationsMember 2018-09-29 2018-12-28 0000203527 us-gaap:RevolvingCreditFacilityMember 2020-01-03 0000203527 us-gaap:RevolvingCreditFacilityMember 2019-09-27 0000203527 us-gaap:RevolvingCreditFacilityMember 2019-11-01 2019-11-01 0000203527 us-gaap:RevolvingCreditFacilityMember 2019-10-31 0000203527 us-gaap:RevolvingCreditFacilityMember 2019-11-01 0000203527 us-gaap:RevolvingCreditFacilityMember var:MultiCurrencyBorrowingsMember 2019-11-01 0000203527 us-gaap:RevolvingCreditFacilityMember us-gaap:LetterOfCreditMember 2019-10-31 0000203527 us-gaap:RevolvingCreditFacilityMember us-gaap:LetterOfCreditMember 2019-11-01 0000203527 us-gaap:RevolvingCreditFacilityMember var:SwingLineLoansMember 2019-11-01 0000203527 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2019-09-28 2020-01-03 0000203527 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2019-09-28 2020-01-03 0000203527 us-gaap:RevolvingCreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember 2019-09-28 2020-01-03 0000203527 us-gaap:RevolvingCreditFacilityMember var:EurodollarPlus1Member 2019-09-28 2020-01-03 0000203527 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember var:EurodollarPlus1Member 2019-09-28 2020-01-03 0000203527 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember var:EurodollarPlus1Member 2019-09-28 2020-01-03 0000203527 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2019-09-28 2020-01-03 0000203527 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember 2019-09-28 2020-01-03 0000203527 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2019-09-28 2020-01-03 0000203527 var:SumitomoCreditFacilityMember 2020-01-03 0000203527 var:SumitomoCreditFacilityMember 2019-09-28 2020-01-03 0000203527 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-03 0000203527 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0000203527 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2020-01-03 0000203527 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-09-27 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-03 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0000203527 currency:EUR us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-03 0000203527 currency:EUR us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0000203527 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-03 0000203527 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-03 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0000203527 us-gaap:ForeignExchangeForwardMember 2019-09-28 2020-01-03 0000203527 us-gaap:ForeignExchangeForwardMember 2018-09-29 2018-12-28 0000203527 us-gaap:SalesRevenueNetMember 2019-09-28 2020-01-03 0000203527 us-gaap:SalesRevenueNetMember 2018-09-29 2018-12-28 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2020-01-03 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:ShortMember 2019-09-27 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2020-01-03 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:LongMember 2019-09-27 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:NonoperatingIncomeExpenseMember 2019-09-28 2020-01-03 0000203527 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:NonoperatingIncomeExpenseMember 2018-09-29 2018-12-28 0000203527 srt:MinimumMember 2020-01-03 0000203527 srt:MaximumMember 2020-01-03 0000203527 us-gaap:OtherNoncurrentAssetsMember 2020-01-03 0000203527 us-gaap:AccruedLiabilitiesMember 2020-01-03 0000203527 var:LongTermLeaseLiabilitiesMember 2020-01-03 0000203527 us-gaap:PropertyPlantAndEquipmentMember 2020-01-03 0000203527 us-gaap:OtherNoncurrentLiabilitiesMember 2020-01-03 0000203527 us-gaap:EquipmentMember 2020-01-03 0000203527 us-gaap:EquipmentMember 2019-09-27 0000203527 var:BestMedicalInternationalInc.LitigationMember us-gaap:ThreatenedLitigationMember 2018-10-16 2018-10-16 0000203527 var:BestMedicalInternationalInc.LitigationMember us-gaap:ThreatenedLitigationMember 2020-01-03 0000203527 us-gaap:PensionPlansDefinedBenefitMember 2019-09-28 2020-01-03 0000203527 us-gaap:PensionPlansDefinedBenefitMember 2018-09-29 2018-12-28 0000203527 var:November2016Member 2016-11-30 0000203527 var:November2016Member 2020-01-03 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0000203527 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-09-27 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-28 2020-01-03 0000203527 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-09-28 2020-01-03 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-28 2020-01-03 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-28 2020-01-03 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-03 0000203527 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2020-01-03 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-03 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-01-03 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-29 2018-12-28 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-29 2018-12-28 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-29 2018-12-28 0000203527 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-28 0000203527 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-28 0000203527 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-28 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-09-28 2020-01-03 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-29 2018-12-28 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-09-28 2020-01-03 0000203527 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-09-29 2018-12-28 0000203527 var:CostOfRevenuesProductMember 2019-09-28 2020-01-03 0000203527 var:CostOfRevenuesProductMember 2018-09-29 2018-12-28 0000203527 var:CostOfRevenuesServiceMember 2019-09-28 2020-01-03 0000203527 var:CostOfRevenuesServiceMember 2018-09-29 2018-12-28 0000203527 us-gaap:ResearchAndDevelopmentExpenseMember 2019-09-28 2020-01-03 0000203527 us-gaap:ResearchAndDevelopmentExpenseMember 2018-09-29 2018-12-28 0000203527 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-09-28 2020-01-03 0000203527 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-09-29 2018-12-28 0000203527 us-gaap:EmployeeStockOptionMember 2019-09-28 2020-01-03 0000203527 us-gaap:EmployeeStockOptionMember 2018-09-29 2018-12-28 0000203527 var:EmployeeStockPurchasePlanMember 2019-09-28 2020-01-03 0000203527 var:EmployeeStockPurchasePlanMember 2018-09-29 2018-12-28 0000203527 us-gaap:EmployeeStockOptionMember 2020-01-03 0000203527 us-gaap:StockAppreciationRightsSARSMember 2020-01-03 0000203527 us-gaap:StockAppreciationRightsSARSMember 2019-09-28 2020-01-03 0000203527 var:RestrictedStockRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsMember 2020-01-03 0000203527 var:RestrictedStockRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsMember 2019-09-28 2020-01-03 0000203527 var:MMProtonILLCMember us-gaap:LoansReceivableMember 2020-01-03 0000203527 var:MMProtonILLCMember us-gaap:LoansReceivableMember 2019-09-27 0000203527 var:RPTCSecuritiesMember us-gaap:LoansReceivableMember 2020-01-03 0000203527 var:RPTCSecuritiesMember us-gaap:LoansReceivableMember 2019-09-27 0000203527 var:ProtonInternationalMember us-gaap:LoansReceivableMember 2020-01-03 0000203527 var:ProtonInternationalMember us-gaap:LoansReceivableMember 2019-09-27 0000203527 us-gaap:LoansReceivableMember 2020-01-03 0000203527 us-gaap:LoansReceivableMember 2019-09-27 0000203527 var:MPTCSubordinatedRevenueBondsMember 2020-01-03 0000203527 var:MPTCSubordinatedRevenueBondsMember 2019-09-27 0000203527 var:MPTCSubordinatedBondsMember 2020-01-03 0000203527 var:MPTCSubordinatedBondsMember 2019-09-27 0000203527 var:APTCSecuritiesMember 2020-01-03 0000203527 var:APTCSecuritiesMember 2019-09-27 0000203527 var:CPTCMember var:RevolvingLoanMember 2020-01-03 0000203527 var:CPTCMember var:RevolvingLoanMember 2019-09-27 0000203527 var:CPTCMember var:TermLoanMember 2019-09-27 0000203527 var:CPTCMember 2020-01-03 0000203527 var:CPTCMember 2019-09-27 0000203527 var:APTCSecuritiesMember 2017-12-01 2017-12-31 0000203527 var:ProtonCenterMunichMember us-gaap:LoansReceivableMember 2017-07-01 2017-07-31 0000203527 var:RPTCSecuritiesMember 2017-07-31 0000203527 var:RPTCSecuritiesMember 2020-01-03 0000203527 var:RPTCSecuritiesMember 2019-09-27 0000203527 var:MMProtonILLCMember us-gaap:LoansReceivableMember 2015-07-31 0000203527 var:MMProtonILLCMember var:SeniorFirstLienLoanMember 2016-06-30 0000203527 var:MMProtonILLCMember us-gaap:SeniorSubordinatedLoansMember 2015-07-31 0000203527 var:MMProtonILLCMember us-gaap:SeniorSubordinatedLoansMember 2019-05-01 0000203527 var:MMProtonILLCMember us-gaap:SeniorSubordinatedLoansMember 2020-01-03 0000203527 var:NewYorkProtonCenterMember 2020-01-03 0000203527 var:NewYorkProtonCenterMember 2019-09-27 0000203527 var:MPTCSeriesB2BondsMember us-gaap:AvailableforsaleSecuritiesMember 2020-01-03 0000203527 var:MPTCSeriesB2BondsMember srt:ScenarioForecastMember us-gaap:AvailableforsaleSecuritiesMember 2022-01-01 0000203527 var:MPTCSeriesB1BondsMember us-gaap:AvailableforsaleSecuritiesMember 2020-01-03 0000203527 var:MPTCSeriesB1BondsMember srt:ScenarioForecastMember us-gaap:AvailableforsaleSecuritiesMember 2022-01-01 0000203527 var:MarylandProtonTherapyCenterMPTCMember 2020-01-03 0000203527 var:MarylandProtonTherapyCenterMPTCMember 2019-09-27 0000203527 var:CPTCMember var:VarianMedicalSystemsInc.Member 2017-03-31 0000203527 var:CPTCMember 2016-10-01 2017-09-29 0000203527 var:CPTCMember 2017-12-06 0000203527 var:CPTCMember us-gaap:LoansReceivableMember 2017-12-06 0000203527 var:CPTCMember var:TermLoanMember var:VarianMedicalSystemsInc.Member 2017-12-06 0000203527 var:CPTCMember var:TermLoanMember var:TrancheALoansMember var:VarianMedicalSystemsInc.Member 2017-12-06 0000203527 var:CPTCMember var:TermLoanMember var:TrancheBLoansMember var:VarianMedicalSystemsInc.Member 2017-12-06 0000203527 var:CPTCMember var:TermLoanMember var:TrancheCLoansMember var:VarianMedicalSystemsInc.Member 2017-12-06 0000203527 var:CPTCMember var:TermLoanMember var:TrancheDLoansMember var:VarianMedicalSystemsInc.Member 2017-12-06 0000203527 var:CPTCMember var:TermLoanMember 2017-12-06 2017-12-06 0000203527 var:CPTCMember us-gaap:LoansReceivableMember var:RevolvingLoanMember 2019-09-28 2020-01-03 0000203527 var:CPTCMember us-gaap:LoansReceivableMember var:RevolvingLoanMember var:VarianMedicalSystemsInc.Member 2019-09-28 2020-01-03 0000203527 var:CPTCMember var:TermLoanMember var:VarianMedicalSystemsInc.Member 2020-01-03 0000203527 var:CPTCMember var:TermLoanMember var:TrancheBLoansMember var:VarianMedicalSystemsInc.Member 2020-01-03 0000203527 var:CPTCMember var:TermLoanMember var:TrancheALoansMember var:VarianMedicalSystemsInc.Member 2019-09-28 2020-01-03 0000203527 var:CPTCMember var:TermLoanMember var:TrancheDLoansMember var:VarianMedicalSystemsInc.Member 2019-09-28 2020-01-03 0000203527 var:CPTCMember var:TermLoanMember var:TrancheCLoansMember var:VarianMedicalSystemsInc.Member 2019-09-28 2020-01-03 0000203527 var:CPTCMember var:TermLoanMember var:TrancheBLoansMember var:VarianMedicalSystemsInc.Member 2019-09-28 2020-01-03 0000203527 var:MMProtonILLCMember us-gaap:SeniorSubordinatedLoansMember 2015-07-31 2015-07-31 0000203527 us-gaap:OperatingSegmentsMember var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 us-gaap:OperatingSegmentsMember var:OncologySystemsMember 2018-09-29 2018-12-28 0000203527 us-gaap:OperatingSegmentsMember var:ProtonSolutionsMember 2019-09-28 2020-01-03 0000203527 us-gaap:OperatingSegmentsMember var:ProtonSolutionsMember 2018-09-29 2018-12-28 0000203527 us-gaap:OperatingSegmentsMember 2019-09-28 2020-01-03 0000203527 us-gaap:OperatingSegmentsMember 2018-09-29 2018-12-28 0000203527 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2019-09-28 2020-01-03 0000203527 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2018-09-29 2018-12-28 0000203527 us-gaap:CorporateMember 2019-09-28 2020-01-03 0000203527 us-gaap:CorporateMember 2018-09-29 2018-12-28 0000203527 var:HardwareMember var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 var:HardwareMember var:OncologySystemsMember 2018-09-29 2018-12-28 0000203527 var:HardwareMember var:ProtonSolutionsMember 2019-09-28 2020-01-03 0000203527 var:HardwareMember var:ProtonSolutionsMember 2018-09-29 2018-12-28 0000203527 var:HardwareMember us-gaap:AllOtherSegmentsMember 2019-09-28 2020-01-03 0000203527 var:HardwareMember us-gaap:AllOtherSegmentsMember 2018-09-29 2018-12-28 0000203527 var:HardwareMember 2019-09-28 2020-01-03 0000203527 var:HardwareMember 2018-09-29 2018-12-28 0000203527 var:SoftwareMember var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 var:SoftwareMember var:OncologySystemsMember 2018-09-29 2018-12-28 0000203527 var:SoftwareMember var:ProtonSolutionsMember 2019-09-28 2020-01-03 0000203527 var:SoftwareMember var:ProtonSolutionsMember 2018-09-29 2018-12-28 0000203527 var:SoftwareMember 2019-09-28 2020-01-03 0000203527 var:SoftwareMember 2018-09-29 2018-12-28 0000203527 var:ServiceExcludingSoftwareMember var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 var:ServiceExcludingSoftwareMember var:OncologySystemsMember 2018-09-29 2018-12-28 0000203527 var:ServiceExcludingSoftwareMember var:ProtonSolutionsMember 2019-09-28 2020-01-03 0000203527 var:ServiceExcludingSoftwareMember var:ProtonSolutionsMember 2018-09-29 2018-12-28 0000203527 var:ServiceExcludingSoftwareMember 2019-09-28 2020-01-03 0000203527 var:ServiceExcludingSoftwareMember 2018-09-29 2018-12-28 0000203527 srt:AmericasMember var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 srt:AmericasMember var:OncologySystemsMember 2018-09-29 2018-12-28 0000203527 srt:AmericasMember var:ProtonSolutionsMember 2019-09-28 2020-01-03 0000203527 srt:AmericasMember var:ProtonSolutionsMember 2018-09-29 2018-12-28 0000203527 srt:AmericasMember us-gaap:AllOtherSegmentsMember 2019-09-28 2020-01-03 0000203527 srt:AmericasMember us-gaap:AllOtherSegmentsMember 2018-09-29 2018-12-28 0000203527 srt:AmericasMember 2019-09-28 2020-01-03 0000203527 srt:AmericasMember 2018-09-29 2018-12-28 0000203527 us-gaap:EMEAMember var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 us-gaap:EMEAMember var:OncologySystemsMember 2018-09-29 2018-12-28 0000203527 us-gaap:EMEAMember var:ProtonSolutionsMember 2019-09-28 2020-01-03 0000203527 us-gaap:EMEAMember var:ProtonSolutionsMember 2018-09-29 2018-12-28 0000203527 us-gaap:EMEAMember us-gaap:AllOtherSegmentsMember 2019-09-28 2020-01-03 0000203527 us-gaap:EMEAMember us-gaap:AllOtherSegmentsMember 2018-09-29 2018-12-28 0000203527 us-gaap:EMEAMember 2019-09-28 2020-01-03 0000203527 us-gaap:EMEAMember 2018-09-29 2018-12-28 0000203527 srt:AsiaPacificMember var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 srt:AsiaPacificMember var:OncologySystemsMember 2018-09-29 2018-12-28 0000203527 srt:AsiaPacificMember var:ProtonSolutionsMember 2019-09-28 2020-01-03 0000203527 srt:AsiaPacificMember var:ProtonSolutionsMember 2018-09-29 2018-12-28 0000203527 srt:AsiaPacificMember us-gaap:AllOtherSegmentsMember 2019-09-28 2020-01-03 0000203527 srt:AsiaPacificMember us-gaap:AllOtherSegmentsMember 2018-09-29 2018-12-28 0000203527 srt:AsiaPacificMember 2019-09-28 2020-01-03 0000203527 srt:AsiaPacificMember 2018-09-29 2018-12-28 0000203527 srt:NorthAmericaMember var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 srt:NorthAmericaMember var:OncologySystemsMember 2018-09-29 2018-12-28 0000203527 srt:NorthAmericaMember var:ProtonSolutionsMember 2019-09-28 2020-01-03 0000203527 srt:NorthAmericaMember var:ProtonSolutionsMember 2018-09-29 2018-12-28 0000203527 srt:NorthAmericaMember us-gaap:AllOtherSegmentsMember 2019-09-28 2020-01-03 0000203527 srt:NorthAmericaMember us-gaap:AllOtherSegmentsMember 2018-09-29 2018-12-28 0000203527 srt:NorthAmericaMember 2019-09-28 2020-01-03 0000203527 srt:NorthAmericaMember 2018-09-29 2018-12-28 0000203527 var:InternationalExcludingNorthAmericaMember var:OncologySystemsMember 2019-09-28 2020-01-03 0000203527 var:InternationalExcludingNorthAmericaMember var:OncologySystemsMember 2018-09-29 2018-12-28 0000203527 var:InternationalExcludingNorthAmericaMember var:ProtonSolutionsMember 2019-09-28 2020-01-03 0000203527 var:InternationalExcludingNorthAmericaMember var:ProtonSolutionsMember 2018-09-29 2018-12-28 0000203527 var:InternationalExcludingNorthAmericaMember us-gaap:AllOtherSegmentsMember 2019-09-28 2020-01-03 0000203527 var:InternationalExcludingNorthAmericaMember us-gaap:AllOtherSegmentsMember 2018-09-29 2018-12-28 0000203527 var:InternationalExcludingNorthAmericaMember 2019-09-28 2020-01-03 0000203527 var:InternationalExcludingNorthAmericaMember 2018-09-29 2018-12-28 0000203527 var:OncologySystemsMember us-gaap:TransferredAtPointInTimeMember 2019-09-28 2020-01-03 0000203527 var:OncologySystemsMember us-gaap:TransferredAtPointInTimeMember 2018-09-29 2018-12-28 0000203527 us-gaap:AllOtherSegmentsMember us-gaap:TransferredAtPointInTimeMember 2019-09-28 2020-01-03 0000203527 us-gaap:AllOtherSegmentsMember us-gaap:TransferredAtPointInTimeMember 2018-09-29 2018-12-28 0000203527 us-gaap:TransferredAtPointInTimeMember 2019-09-28 2020-01-03 0000203527 us-gaap:TransferredAtPointInTimeMember 2018-09-29 2018-12-28 0000203527 var:OncologySystemsMember us-gaap:TransferredOverTimeMember 2019-09-28 2020-01-03 0000203527 var:OncologySystemsMember us-gaap:TransferredOverTimeMember 2018-09-29 2018-12-28 0000203527 var:ProtonSolutionsMember us-gaap:TransferredOverTimeMember 2019-09-28 2020-01-03 0000203527 var:ProtonSolutionsMember us-gaap:TransferredOverTimeMember 2018-09-29 2018-12-28 0000203527 us-gaap:TransferredOverTimeMember 2019-09-28 2020-01-03 0000203527 us-gaap:TransferredOverTimeMember 2018-09-29 2018-12-28 0000203527 var:EmbolicsMicrospheresBusinessMember 2019-08-01 2019-08-31 0000203527 var:CancerTreatmentServicesInternationalMember 2019-06-01 2019-06-28 0000203527 var:CancerTreatmentServicesInternationalMember 2019-06-28 0000203527 var:CancerTreatmentServicesInternationalMember 2019-09-28 2020-01-03 0000203527 var:EndocareandAliconMember 2019-06-01 2019-06-28 0000203527 var:EndocareandAliconMember 2019-06-28 0000203527 var:EndocareandAliconMember 2019-09-28 2020-01-03 0000203527 var:EndocareandAliconMember 2019-06-29 2019-09-27 0000203527 var:EndocareandAliconMember 2020-01-03 0000203527 var:PrivatelyheldCompanyMember 2019-03-30 2019-06-28 0000203527 var:PrivatelyheldCompanyMember 2019-06-28 0000203527 var:PrivatelyheldSoftwareCompanyMember 2018-09-29 2018-12-28 0000203527 var:PrivatelyheldSoftwareCompanyMember 2019-09-27 shares iso4217:USD iso4217:USD shares var:cancer_center var:specialty_hospital pure iso4217:JPY var:patent iso4217:EUR var:tranche var:segment false 2020 Q1 0000203527 --10-02 90665845 P9M P1Y P1Y P5Y 0 P1Y P6Y6M SUBSEQUENT EVENTS {OPEN} P15M 721900000 17500000 27600000 25700000 6700000 542000000.0 0.0280 10-Q true 2020-01-03 false 1-7598 VARIAN MEDICAL SYSTEMS, INC. DE 94-2359345 3100 Hansen Way, Palo Alto, CA 94304-1038 650 493-4000 Common Stock, $1 par value VAR NYSE Yes Yes Large Accelerated Filer false false false 90665845 421000000.0 400200000 407900000 340800000 828900000 741000000.0 271900000 266600000 190200000 158300000 462100000 424900000 366800000 316100000 67100000 60900000 177000000.0 141100000 12700000 2400000 256800000 204400000 110000000.0 111700000 3000000.0 3900000 4700000 1200000 4400000 23000000.0 112700000 137400000 23800000 33500000 88900000 103900000 700000 700000 88200000 103200000 0.97 1.13 0.96 1.12 90900000 91000000.0 91700000 92000000.0 88900000 103900000 0.0 0.0 0.0 0.0 -200000 -200000 -200000 -100000 -900000 -500000 -700000 -300000 -0.0 -0.0 -100000 0 200000 0.0 600000 0 -700000 0 5100000 -4000000.0 5100000 -3700000 94000000.0 100200000 700000 700000 93300000 99500000 721900000 531400000 47000000.0 46500000 1079200000 1106300000 597400000 551500000 248500000 206200000 2647000000.0 2395400000 330300000 311500000 114100000 612400000 612200000 290900000 300700000 85700000 84700000 370300000 397200000 4450700000 4101700000 215300000 248500000 471200000 459500000 817900000 766000000.0 542000000.0 410000000.0 2046400000 1884000000.0 93700000 453300000 440100000 2593400000 2324100000 1 1 1000000.0 1000000.0 0 0 0 0 0 0 1 1 189000000.0 189000000.0 90700000 90700000 90800000 90800000 90700000 90800000 870400000 845600000 983200000 934000000.0 -97000000.0 -102100000 1847300000 1768300000 10000000.0 9300000 1857300000 1777600000 4450700000 4101700000 88900000 103900000 14900000 10500000 15000000.0 12800000 10200000 4700000 1400000 22000000.0 8800000 0 -2700000 -3700000 -29500000 -2900000 44900000 32400000 -6300000 -8600000 -32700000 13500000 -42100000 -12500000 57400000 47200000 112600000 140900000 22600000 14000000.0 1700000 25500000 9200000 29900000 0 3500000 -15100000 -13100000 43800000 34800000 19700000 22000000.0 3600000 4400000 11000000.0 0 11000000.0 132000000.0 0 -900000 0 103400000 -17200000 -2800000 1700000 198100000 112300000 544100000 516400000 742200000 628700000 90800000 90800000 845600000 934000000.0 -102100000 1768300000 9300000 1777600000 88200000 88200000 700000 88900000 5100000 5100000 5100000 300000 300000 20700000 21000000.0 21000000.0 0 0 3600000 3600000 3600000 14700000 14700000 14700000 400000 400000 7000000.0 39000000.0 46400000 46400000 90700000 90700000 870400000 983200000 -97000000.0 1847300000 10000000.0 1857300000 91200000 91200000 778100000 780400000 -65300000 1584400000 4300000 1588700000 103200000 103200000 700000 103900000 -3700000 -3700000 -3700000 300000 300000 21700000 22000000.0 22000000.0 4400000 4400000 4400000 10500000 10500000 10500000 300000 300000 6600000 27900000 34800000 34800000 0 200000 200000 200000 91200000 91200000 799300000 855500000 -69000000.0 1677000000.0 5000000.0 1682000000.0 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Description of Business</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The long-term growth and value creation strategy of Varian Medical Systems, Inc. (“VMS”) and subsidiaries (collectively, the “Company”) is to transform the Company from the global leader in radiation therapy to the global leader in multi-disciplinary, integrated cancer care solutions that leverages its clinical experience and strengths in technology development and new product innovation. The Company offers solutions in radiation therapy and medical oncology, as well as interventional oncology, an emerging area of cancer care. The Company designs, manufactures, sells and services hardware and software products for treating cancer with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, and offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolization. Software solutions include treatment planning, informatics, clinical knowledge exchange, patient care management, practice management and decision support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices. The Company also develops, designs, manufactures, sells and services proton therapy products and systems for cancer treatment.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company has expanded its services offerings to include clinical practice services that assist within the clinical workflow. These services focus on decision support and/or cancer care knowledge augmentation aimed at facilitating improved accessibility and affordability to care while maintaining a fundamental level of clinical quality. Further, the Company operates ten multi-disciplinary cancer centers and one specialty hospital in India and one multi-disciplinary cancer center in Sri Lanka.</span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Basis of Presentation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of September 27, 2019, was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2019 (the “2019 Annual Report”). </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s financial position as of January 3, 2020, and September 27, 2019, results of operations and statements of comprehensive earnings for the three months ended January 3, 2020, and December 28, 2018, statements of cash flows for the three months ended January 3, 2020, and December 28, 2018, and statements of equity for the three months ended January 3, 2020, and December 28, 2018. The results of operations for the three months ended January 3, 2020, are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Reclassifications</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain reclassifications have been made to the amounts in the prior year in order to conform to the current year's presentation.</span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Fiscal Year</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September 30. Fiscal year 2020 was the 53-week period ending October 2, 2020. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. The fiscal quarter ended January 3, 2020 was a 14-week period, and the fiscal quarter ended December 28, 2018, was a 13-week period.</span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Principles of Consolidation</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Consolidation of Variable Interest Entities</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities, and results of operations of the variable interest entity will be included in the Company’s condensed consolidated financial statements. At January 3, 2020 and September 27, 2019, the Company consolidated its non-controlling interest in a joint venture, included within its Oncology Systems business, related to the Cancer Treatment Services International ("CTSI") operations. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</span></div><div style="text-align:justify;margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Significant Accounting Policies</span></div><div style="margin-top:6pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">With the exception of the change for the accounting of leases as a result of the adoption of Accounting Standard Codification Topic 842, there have been no material changes to the Company's significant accounting policies provided in Note 1, "Summary of Significant Accounting Policies," within Item 8 of the Company's Annual Report on Form 10-K for the year ended September 27, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represents the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate ("IBR"). The Company recognizes operating leases with lease terms of more than twelve months in operating lease right-of-use assets, accrued liabilities, and long-term lease liabilities on its Condensed Consolidated Balance Sheets. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company’s finance leases primarily represent certain sale and leaseback-sublease arrangements. The Company has entered into sale-leaseback arrangements with a third-party finance company for certain equipment and simultaneously subleased the equipment to certain qualified customers. The Company’s leaseback arrangements have been accounted for as finance leases as they meet one or more of the finance lease classification criteria. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company generally does not have adequate information to determine the implicit rate in a lease, therefore the Company uses an estimated IBR. The Company does not maintain a public credit rating and its debt arrangements are unsecured, thus requiring significant judgment to calculate the IBR. The Company uses different data sets to estimate the IBR, including: (i) an estimated indicative credit rating of the Company; (ii) yields on comparable credit rating composite curves; (iii) foreign exchange rates; and (iv) an estimated adjustment for collateral. The Company also applies adjustments to account for considerations related to (i) tenor; and (ii) country credit rating that may not be fully incorporated by the aforementioned data sets. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Certain of the Company’s lease arrangements include variable lease payments. Variable lease payments, not dependent on an index or discount rate, are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments generally include common area maintenance, utilities, maintenance charges, property taxes, insurance, and contingent rent payments. Certain of the Company's arrangements contain clauses that provide for contingent rent payments based on a percentage of revenue share and/or earnings before interest, taxes, depreciation, and amortization. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> </span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company combines lease and non-lease components as a single lease component for both its operating and finance leases. In addition, the Company does not record operating and finance lease assets and liabilities for short-term leases, which have an initial term of twelve months or less.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first quarter of fiscal year 2020, the Company adopted the Financial Accounting Standards Board ("FASB") standard on accounting for leases, "Leases." The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record ROU assets and corresponding lease liabilities on the balance sheet. The Company adopted this standard under the optional transition method, which applies the standard on the effective date, rather than the earliest comparative period presented in the financial statements. The Company elected: (1) the "package of practical expedients," which does not require the Company to reassess its prior conclusions about lease identification, lease classification, and initial direct costs under the new standard; (2) not to separate non-lease components from lease components; and (3) not to recognize ROU assets and lease liabilities for short-term leases. The Company has implemented internal controls and key system functionalities to enable the preparation of financial information. The primary impact for the Company was the balance sheet recognition of ROU assets and lease liabilities for operating leases as a lessee. See Note 8, "Commitments and Contingencies," for more information on the impact of this adoption on the Company's condensed consolidated financial statements. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first quarter of fiscal year 2020, the Company adopted FASB guidance that added the Overnight Index Swap rate based on the Secured Overnight Financing Rate ("SOFR") as a benchmark interest rate for hedge accounting purposes. The amendment recognizes SOFR as a likely LIBOR replacement and supports the marketplace transition by adding the new reference rate as a benchmark interest rate. The Company has not executed interest rate hedges but adopted the amendment prospectively as the Company may consider interest rate hedges in the future. The Company is monitoring the LIBOR to SOFR migration and will coordinate the transition of outstanding LIBOR based debt and any related interest rate derivatives with counterparties when the market is liquid to ensure an orderly and efficient transition.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first quarter of fiscal year 2020, the Company adopted FASB guidance that allows companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The impact of adopting this amendment on the Company's condensed consolidated financial statements was not material.</span></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Recent Accounting Standards or Updates Not Yet Effective</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the current guidance, and improving the consistent application of and simplification of other areas of the guidance. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB amended its guidance for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new standard also requires customers to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. This new standard becomes effective for the Company in the first quarter of fiscal year 2021, with early adoption permitted. This new standard can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">which modifies the disclosure requirements for employers that have sponsor defined benefit pension or other post-retirement plans by removing and adding certain disclosures for these plans. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures. The standard is effective for the Company beginning in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.</span></div>In June 2016, the FASB issued an amendment to its accounting guidance related to the impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses, rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021, with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements. 10 1 1 <div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Basis of Presentation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of September 27, 2019, was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2019 (the “2019 Annual Report”). </span></div>In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s financial position as of January 3, 2020, and September 27, 2019, results of operations and statements of comprehensive earnings for the three months ended January 3, 2020, and December 28, 2018, statements of cash flows for the three months ended January 3, 2020, and December 28, 2018, and statements of equity for the three months ended January 3, 2020, and December 28, 2018. The results of operations for the three months ended January 3, 2020, are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period. <div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Fiscal Year</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September 30. Fiscal year 2020 was the 53-week period ending October 2, 2020. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. The fiscal quarter ended January 3, 2020 was a 14-week period, and the fiscal quarter ended December 28, 2018, was a 13-week period.</span></div> <div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Principles of Consolidation</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation. </span></div>Consolidation of Variable Interest EntitiesFor entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities, and results of operations of the variable interest entity will be included in the Company’s condensed consolidated financial statements. At January 3, 2020 and September 27, 2019, the Company consolidated its non-controlling interest in a joint venture, included within its Oncology Systems business, related to the Cancer Treatment Services International ("CTSI") operations. <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</span></div> <div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Leases</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represents the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate ("IBR"). The Company recognizes operating leases with lease terms of more than twelve months in operating lease right-of-use assets, accrued liabilities, and long-term lease liabilities on its Condensed Consolidated Balance Sheets. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company’s finance leases primarily represent certain sale and leaseback-sublease arrangements. The Company has entered into sale-leaseback arrangements with a third-party finance company for certain equipment and simultaneously subleased the equipment to certain qualified customers. The Company’s leaseback arrangements have been accounted for as finance leases as they meet one or more of the finance lease classification criteria. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company generally does not have adequate information to determine the implicit rate in a lease, therefore the Company uses an estimated IBR. The Company does not maintain a public credit rating and its debt arrangements are unsecured, thus requiring significant judgment to calculate the IBR. The Company uses different data sets to estimate the IBR, including: (i) an estimated indicative credit rating of the Company; (ii) yields on comparable credit rating composite curves; (iii) foreign exchange rates; and (iv) an estimated adjustment for collateral. The Company also applies adjustments to account for considerations related to (i) tenor; and (ii) country credit rating that may not be fully incorporated by the aforementioned data sets. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Certain of the Company’s lease arrangements include variable lease payments. Variable lease payments, not dependent on an index or discount rate, are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments generally include common area maintenance, utilities, maintenance charges, property taxes, insurance, and contingent rent payments. Certain of the Company's arrangements contain clauses that provide for contingent rent payments based on a percentage of revenue share and/or earnings before interest, taxes, depreciation, and amortization. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> </span></div>The Company combines lease and non-lease components as a single lease component for both its operating and finance leases. In addition, the Company does not record operating and finance lease assets and liabilities for short-term leases, which have an initial term of twelve months or less. <div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first quarter of fiscal year 2020, the Company adopted the Financial Accounting Standards Board ("FASB") standard on accounting for leases, "Leases." The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record ROU assets and corresponding lease liabilities on the balance sheet. The Company adopted this standard under the optional transition method, which applies the standard on the effective date, rather than the earliest comparative period presented in the financial statements. The Company elected: (1) the "package of practical expedients," which does not require the Company to reassess its prior conclusions about lease identification, lease classification, and initial direct costs under the new standard; (2) not to separate non-lease components from lease components; and (3) not to recognize ROU assets and lease liabilities for short-term leases. The Company has implemented internal controls and key system functionalities to enable the preparation of financial information. The primary impact for the Company was the balance sheet recognition of ROU assets and lease liabilities for operating leases as a lessee. See Note 8, "Commitments and Contingencies," for more information on the impact of this adoption on the Company's condensed consolidated financial statements. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first quarter of fiscal year 2020, the Company adopted FASB guidance that added the Overnight Index Swap rate based on the Secured Overnight Financing Rate ("SOFR") as a benchmark interest rate for hedge accounting purposes. The amendment recognizes SOFR as a likely LIBOR replacement and supports the marketplace transition by adding the new reference rate as a benchmark interest rate. The Company has not executed interest rate hedges but adopted the amendment prospectively as the Company may consider interest rate hedges in the future. The Company is monitoring the LIBOR to SOFR migration and will coordinate the transition of outstanding LIBOR based debt and any related interest rate derivatives with counterparties when the market is liquid to ensure an orderly and efficient transition.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first quarter of fiscal year 2020, the Company adopted FASB guidance that allows companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The impact of adopting this amendment on the Company's condensed consolidated financial statements was not material.</span></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Recent Accounting Standards or Updates Not Yet Effective</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, the FASB issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the current guidance, and improving the consistent application of and simplification of other areas of the guidance. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB amended its guidance for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new standard also requires customers to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. This new standard becomes effective for the Company in the first quarter of fiscal year 2021, with early adoption permitted. This new standard can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">which modifies the disclosure requirements for employers that have sponsor defined benefit pension or other post-retirement plans by removing and adding certain disclosures for these plans. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.</span></div><div style="text-align:justify;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued guidance</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures. The standard is effective for the Company beginning in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.</span></div>In June 2016, the FASB issued an amendment to its accounting guidance related to the impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses, rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021, with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements. OTHER FINANCIAL INFORMATION <div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Contracts with Customers</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers: </span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unbilled receivables - current</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">315.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">346.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Unbilled receivables - long-term </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred revenues - current</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(817.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(766.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Deferred revenues - long-term </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(78.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(73.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total net unbilled receivables (deferred revenues)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(538.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(457.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;margin-bottom:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets. </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;margin-bottom:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the three months ended January 3, 2020, unbilled receivables decreased by $23.3 million, primarily due to the timing of billings in Oncology Systems, and deferred revenues increased by $57.7 million primarily due to the contractual timing of billings occurring before the revenues were recognized. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the three months ended January 3, 2020 and December 28, 2018, the Company recognized revenues of $314.5 million, and $263.4 million, which were included in the deferred revenues balances at September 27, 2019 and September 28, 2018, respectively. </span></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Unfulfilled Performance Obligations</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table represents the Company's unfulfilled performance obligations as of January 3, 2020, and the estimated revenues expected to be recognized in the future related to these unfulfilled performance obligations: </span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.929%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.724%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Years of Revenue Recognition</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remainder of 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unfulfilled Performance Obligations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,884.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,003.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">787.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,122.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The table above includes both product and service unfulfilled performance obligations, which includes a component of service performance obligations that have not been invoiced. The fiscal years presented reflect management’s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers’ facilities for installation, installation requirements, and availability of products or customer acceptance terms.</span></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's cash, cash equivalents and restricted cash:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">721.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">531.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Restricted cash - current </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Restricted cash - long-term </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total cash, cash equivalents, and restricted cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">544.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;margin-bottom:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets. </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;margin-bottom:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Inventories</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's inventories:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials and parts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">399.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">376.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work-in-process</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">71.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">122.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total inventories</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">597.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">551.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Other Long-Term Liabilities</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's other long-term liabilities:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income taxes payable</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income taxes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred revenues</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Defined benefit pension plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other long-term liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">453.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">440.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Other Income, Net</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's other income, net:</span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:72.122%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.429%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain on equity investments</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net foreign currency exchange gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other income, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> <div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers: </span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unbilled receivables - current</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">315.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">346.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Unbilled receivables - long-term </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred revenues - current</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(817.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(766.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Deferred revenues - long-term </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(78.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(73.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total net unbilled receivables (deferred revenues)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(538.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(457.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;margin-bottom:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets. </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;margin-bottom:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.</span></div> 315800000 346700000 42700000 35100000 817900000 766000000.0 78900000 73100000 538300000 457300000 -23300000 57700000 314500000 263400000 263400000 <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table represents the Company's unfulfilled performance obligations as of January 3, 2020, and the estimated revenues expected to be recognized in the future related to these unfulfilled performance obligations: </span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.929%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.724%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Years of Revenue Recognition</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remainder of 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unfulfilled Performance Obligations</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,884.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,003.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">787.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,122.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 1884100000 2003200000 787700000 2122900000 <div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's cash, cash equivalents and restricted cash:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">721.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">531.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Restricted cash - current </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Restricted cash - long-term </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total cash, cash equivalents, and restricted cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">544.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;margin-bottom:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets. </span></div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets.</span> 721900000 531400000 3700000 4200000 16600000 8500000 742200000 544100000 <div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's inventories:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials and parts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">399.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">376.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Work-in-process</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">71.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">122.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total inventories</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">597.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">551.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 399800000 376500000 75600000 71800000 122000000.0 103200000 597400000 551500000 <div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's other long-term liabilities:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income taxes payable</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred income taxes</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred revenues</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">73.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Defined benefit pension plan</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other long-term liabilities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">453.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">440.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 180800000 180300000 78100000 75300000 78900000 73100000 42500000 42300000 30400000 31100000 42600000 38000000.0 453300000 440100000 <div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's other income, net:</span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:72.122%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.429%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain on equity investments</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net foreign currency exchange gain</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total other income, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 1400000 22000000.0 2400000 1300000 600000 -300000 4400000 23000000.0 FAIR VALUE<div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Assets/Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.198%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.725%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Measurements at January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Quoted Prices in<br/>Active Markets<br/>for Identical<br/>Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Type of Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 1)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 2)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 3)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Available-for-sale securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-1 Bonds </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-2 Bonds </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">APTC securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivative assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:6.75pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets measured at fair value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities measured at fair value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.198%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.725%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Measurements at September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Quoted Prices in Active Markets for Identical Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Significant<br/> Other<br/>Observable<br/> Inputs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Significant Unobservable Inputs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Type of Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 1)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 3)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash equivalents:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Available-for-sale securities:</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> </sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-1 Bonds</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-2 Bonds</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">APTC securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:5.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivative assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:6.75pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets measured at fair value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities measured at fair value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company classifies its money market funds as Level 1 because they have daily liquidity, quoted prices for the underlying investments can be obtained, and there are active markets for the underlying investments. The Company's Level 2 available-for-sale securities consist of bonds for the Maryland Proton Therapy Center ("MPTC") and the Alabama Proton Therapy Center </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">(“APTC”). The observable inputs for these securities are comparable bond issues, broker/dealer quotations for the same or similar investments in active markets, and other observable inputs such as yields, credit risks, default rates, and volatility. The Company's available-for-sale securities are included in other assets on the Company's Condensed Consolidated Balance Sheets, except for amounts related to short-term interest receivable. See Note 14, "Proton Solutions Loans and Investments," for further information about the available-for-sale securities. As of January 3, 2020, and September 27, 2019, the carrying amount of the Company's Level 1 money market funds and Level 2 available-for-sale securities approximated their respective fair values. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads. The Company’s derivative instruments are generally short-term in nature, typically one month to fifteen months in duration.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company generally measures the fair value of its Level 3 contingent consideration liabilities based on Monte Carlo pricing models with key assumptions that include estimated revenues of the acquired business, the probability of completing certain milestone targets during the earn-out period, revenue volatility, and estimated discount rates corresponding to the periods of expected payments. If the estimated revenues or probability of completing certain milestones were to increase or decrease during the respective earn-out period, the fair value of the contingent consideration would increase or decrease, respectively. If the estimated discount rates were to increase or decrease, the fair value of contingent consideration would decrease or increase, respectively. Changes in key assumptions may result in an increase or decrease in the fair value of contingent consideration. The Company's contingent consideration is from its business combinations and is included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the reconciliation for liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:84.549%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent<br/>Consideration</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments due to the effect of foreign exchange</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value recognized in earnings</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no transfers of assets or liabilities between fair value measurement levels during either the three months ended January 3, 2020, or the three months ended December 28, 2018. Transfers between fair value measurement levels are recognized at the end of the reporting period.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Fair Value of Other Financial Instruments</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair values of certain of the Company’s financial instruments, including bank deposits included in cash equivalents, trade and unbilled receivables, net of allowance for doubtful accounts, revolving loan to California Proton Therapy Center ("CPTC"), accounts payable, and short-term borrowings approximate their carrying amounts due to their short maturities.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020, the fair value of the Term Loan (as defined below) with CPTC approximated its carrying value of $44.0 million. The carrying value is based on the present value of expected future cash payments discounted at a rate reflecting the nature and duration of the loans, risks involved with CPTC, and its industry. As a result, the Term Loan is categorized as Level 3 in the fair value hierarchy. See Note 14, "Proton Solutions Loans and Investments," for further information. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's equity investments in privately-held companies were $56.4 million and $64.2 million at January 3, 2020 and September 27, 2019, respectively. </span></div>The fair value of the outstanding long-term notes receivable, including accrued interest, approximated their carrying value of $34.1 million and $33.6 million at January 3, 2020 and September 27, 2019, respectively, because they are based on terms of recent comparable transactions and are categorized as Level 3 in the fair value hierarchy. The fair value is based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks as well as underlying cash flow assumptions. See Note 14, "Proton Solutions Loans and Investments," for information on the long-term notes receivable. <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.198%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.725%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Measurements at January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Quoted Prices in<br/>Active Markets<br/>for Identical<br/>Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Type of Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 1)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 2)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 3)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Available-for-sale securities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-1 Bonds </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-2 Bonds </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">APTC securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivative assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:6.75pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets measured at fair value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities measured at fair value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.198%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.725%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value Measurements at September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Quoted Prices in Active Markets for Identical Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Significant<br/> Other<br/>Observable<br/> Inputs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Significant Unobservable Inputs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Type of Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 1)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 2)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Level 3)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash equivalents:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Available-for-sale securities:</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> </sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-1 Bonds</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-2 Bonds</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">APTC securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:5.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivative assets</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:6.75pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets measured at fair value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent consideration</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities measured at fair value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 17500000 0 0 17500000 0 27600000 0 27600000 0 25700000 0 25700000 0 6700000 0 6700000 0 2300000 0 2300000 17500000 62300000 0 79800000 0 0 84300000 84300000 0 0 84300000 84300000 200000 0 0 200000 0 27100000 0 27100000 0 25100000 0 25100000 0 6600000 0 6600000 0 2800000 0 2800000 200000 61600000 0 61800000 0 0 75300000 75300000 0 0 75300000 75300000 P1M P15M <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the reconciliation for liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:84.549%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Contingent<br/>Consideration</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments due to the effect of foreign exchange</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change in fair value recognized in earnings</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(84.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 75300000 -200000 -8800000 84300000 44000000.0 56400000 64200000 34100000 33600000 RECEIVABLES <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's trade and unbilled receivables, net, and long-term notes receivable: </span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:72.122%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.429%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trade and unbilled receivables, gross</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,174.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,193.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowance for doubtful accounts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(47.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(46.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trade and unbilled receivables, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,127.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,147.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,106.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Long-term </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"> </span></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Long-term notes receivable </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1) (2)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A financing receivable represents a financing arrangement with a contractual right to receive money, on demand or on fixed or determinable dates, and that is recognized as an asset on the Company’s Condensed Consolidated Balance Sheets. The Company’s financing receivables consist of trade receivables with contractual maturities of more than one year and notes receivable. A small portion of the Company's financing trade receivables are included in short-term trade accounts receivable. As of January 3, 2020, and September 27, 2019, the allowance for doubtful accounts is entirely related to short-term trade and unbilled receivables. See Note 14, "Proton Solutions Loans and Investments," for more information on the Company's long-term notes receivable balances.</span></div> <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's trade and unbilled receivables, net, and long-term notes receivable: </span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:72.122%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.429%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trade and unbilled receivables, gross</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,174.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,193.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Allowance for doubtful accounts</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(47.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(46.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trade and unbilled receivables, net</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,127.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,147.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,106.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Long-term </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"> </span></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Long-term notes receivable </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1) (2)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other assets on the Company's Condensed Consolidated Balance Sheets.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.</span></div> 1174700000 1193500000 47000000.0 46500000 1127700000 1147000000.0 1079200000 1106300000 48500000 40700000 34100000 33600000 GOODWILL AND INTANGIBLE ASSETS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the activity of goodwill by reportable operating segment: </span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:70.222%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.771%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:1.0%;"/><td style="width:6.771%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.776%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;"> (1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Business combination</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Measurement period adjustments to business combinations in prior year</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">448.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:12pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt;">The total carrying value of goodwill at both January 3, 2020, and September 27, 2019 is net of $50.5 million of accumulated impairment charges related to the Company recording an impairment charge for the full value of the Proton Solutions operating segment goodwill in fiscal year 2019. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the gross carrying amount and accumulated amortization of the Company's intangible assets: </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:30.554%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.113%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.113%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.967%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.375%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Technologies and patents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(92.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">134.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(85.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer contracts, supplier relationships, and partner relationships</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">93.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">95.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trade names</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible with finite lives</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">408.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(130.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">278.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">408.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(120.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">288.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">In-process research and development with indefinite lives</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(130.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">290.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(120.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">300.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amortization expense for intangible assets was $10.1 million and $4.7 million during the three months ended January 3, 2020 and December 28, 2018, respectively. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions): </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.720%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Years:</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Amortization Expense </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remainder of 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">123.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total remaining amortization for intangible assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">278.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the activity of goodwill by reportable operating segment: </span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:70.222%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.771%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:1.0%;"/><td style="width:6.771%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.776%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;"> (1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Business combination</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Measurement period adjustments to business combinations in prior year</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">448.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div>(1)The total carrying value of goodwill at both January 3, 2020, and September 27, 2019 is net of $50.5 million of accumulated impairment charges related to the Company recording an impairment charge for the full value of the Proton Solutions operating segment goodwill in fiscal year 2019. 447900000 164300000 612200000 300000 0 300000 -100000 0 -100000 448100000 164300000 612400000 50500000 50500000 <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the gross carrying amount and accumulated amortization of the Company's intangible assets: </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:30.554%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.113%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.113%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.967%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.375%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Technologies and patents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(92.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">134.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(85.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer contracts, supplier relationships, and partner relationships</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">93.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">95.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trade names</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible with finite lives</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">408.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(130.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">278.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">408.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(120.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">288.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">In-process research and development with indefinite lives</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(130.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">290.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(120.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">300.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the gross carrying amount and accumulated amortization of the Company's intangible assets: </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:30.554%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.113%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.113%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.967%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.364%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.375%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated Amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Technologies and patents</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(92.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">134.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(85.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer contracts, supplier relationships, and partner relationships</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">93.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">95.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trade names</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible with finite lives</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">408.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(130.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">278.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">408.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(120.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">288.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">In-process research and development with indefinite lives</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(130.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">290.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(120.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">300.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 226400000 92200000 134200000 226400000 85900000 140500000 121100000 28100000 93000000.0 121100000 25700000 95400000 55100000 4100000 51000000.0 55100000 3000000.0 52100000 6100000 6100000 0 6100000 6100000 0 408700000 130500000 278200000 408700000 120700000 288000000.0 12700000 12700000 12700000 12700000 421400000 130500000 290900000 421400000 120700000 300700000 10100000 4700000 <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions): </span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.720%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Years:</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remaining Amortization Expense </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remainder of 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">123.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total remaining amortization for intangible assets</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">278.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 27100000 35600000 33500000 32700000 25700000 123600000 278200000 BORROWINGS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's total short-term borrowings:</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.929%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.724%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except for percentages)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Interest Rate</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Interest Rate</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term borrowings:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revolving Credit Facility<br/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">542.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.80 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">410.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total short-term borrowings</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">542.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">410.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">On November 1, 2019, the Company entered into Amendment No.2 (the "Amendment") to its Credit Agreement dated April 3, 2018, (the "Credit Agreement"), by and among the Company certain lenders party thereto, and Bank of America, N.A., as administrative agent, swing line lender and letter of credit issuer. The Amendment extended the maturity date from April 2023 to November 2024. The Amendment reduced the aggregate principal amount available under Credit Agreement's <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZWQyOTVhZTBkZjQzMDc4ODUwODMxOGU1OTliZWQzL3NlYzo0MWVkMjk1YWUwZGY0MzA3ODg1MDgzMThlNTk5YmVkM182NC9mcmFnOjA0M2QzZjA5NjhjOTRiMDU5ZTQyOTIxOGI3NDVjYjE5L3RleHRyZWdpb246MDQzZDNmMDk2OGM5NGIwNTllNDI5MjE4Yjc0NWNiMTlfMzE1_55cdaafa-b08f-4bc1-91e8-ad78e706c724">five</span>-year revolving credit facility (the "Revolving Credit Facility") from $1.8 billion to $1.2 billion, added a $500 million sub-limit for multi-currency borrowings, increased the letter of credit sub-limit from $50.0 million to $225 million, and reduced the commitment fee. In addition, there is a sub-limit for swing line loans of up to $25 million. Under the Revolving Credit Facility, the Company has the right to (i) request to increase the aggregate commitments by an aggregate amount for all such requests of up to $100.0 million and (ii) request an additional increase in the commitments or establish one or more term loans, provided that, in each case, the lenders are willing to provide such new or increased commitments and certain other conditions are met. The proceeds of the Revolving Credit Facility may be used for working capital, capital expenditures, Company share repurchases, permitted acquisitions and other corporate purposes. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Borrowings under the Revolving Credit Facility accrue interest based on either (i) the Eurodollar Rate plus a margin of 1.000% to 1.375% based on a net leverage ratio involving funded indebtedness and EBITDA, or (ii) a base rate of (a) the federal funds rate plus 0.50%, (b) BofA’s announced prime rate, or (c) the Eurodollar Rate plus 1.00%, whichever is highest, plus a margin of 0.000% to 0.375% based on the same leverage ratio, depending upon instructions from the Company. Borrowings under the Eurodollar Rate have a contract repayment date of twelve months, or less. Borrowings under the base rate can be made on an overnight basis and have a final maturity of five years.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company must pay a commitment fee on the unused portion of the Revolving Credit Facility at a rate from 0.100% to 0.225% based on a net leverage ratio. The Company may prepay, reduce or terminate the commitments without penalty. Swing line loans under the Revolving Credit Facility will bear interest at the base rate plus the then applicable margin for base rate loans.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Credit Agreement provides that certain material domestic subsidiaries must guarantee the Revolving Credit Facility, subject to certain limitations on the amount secured. As of January 3, 2020, no subsidiary guarantees were required to be executed under the Credit Agreement.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Credit Agreement contains provisions that limit the Company's ability to, among other things, incur future indebtedness, contingent obligations or liens, guarantee indebtedness, make certain investments and capital expenditures, sell stock or assets and pay dividends, and consummate certain mergers or acquisitions.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Credit Agreement contains affirmative and negative covenants applicable to the Company and its subsidiaries that are typical for credit facilities of this type, and that are subject to materiality and other qualifications, carve-outs, baskets and exceptions. The Company agreed to maintain a financial covenant which requires a maximum consolidated net leverage ratio. The Company was in compliance with all financial covenants under the Credit Agreement for all periods within these condensed consolidated financial statements. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Other Borrowings</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">VMS’s Japanese subsidiary (“VMS KK”) has an unsecured uncommitted credit agreement with Sumitomo that enables VMS KK to borrow and have outstanding at any given time a maximum of 3.0 billion Japanese Yen (the “Sumitomo Credit Facility”). In February 2019, the Sumitomo Credit Facility was extended and will expire in February 2020. Borrowings under the Sumitomo Credit Facility accrue interest based on the basic loan rate announced by the Bank of Japan plus a margin of 0.5%. As of January 3, 2020, the Company did not have an outstanding principal balance on its Sumitomo Credit Facility.</span></div> <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the Company's total short-term borrowings:</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:44.929%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.724%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except for percentages)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Interest Rate</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted-Average Interest Rate</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Short-term borrowings:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revolving Credit Facility<br/></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">542.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.80 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">410.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.05 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total short-term borrowings</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">542.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">410.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 542000000.0 0.0280 410000000.0 0.0305 542000000.0 410000000.0 1800000000 1200000000 500000000 50000000.0 225000000 25000000 100000000.0 0.01000 0.01375 0.0050 0.0100 0.00000 0.00375 P12M P5Y 0.00100 0.00225 3000000000.0 0.005 DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company measures all derivatives at fair value on the Condensed Consolidated Balance Sheets. The accounting for gains or losses resulting from changes in the fair value of those derivatives depends upon the use of the derivative and whether it qualifies for hedge accounting. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of derivative instruments reported on the Company's Condensed Consolidated Balance Sheets were as follows: </span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.035%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:32.064%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.722%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance Sheet<br/>Location</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:12.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign exchange forward contracts</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign exchange forward contracts</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:17.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total derivatives</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of September 27, 2019, the fair value of the Company's derivatives not designated as hedging instruments were not material.</span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Cash Flow Hedging Activities</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company had the following outstanding foreign currency forward contracts that were entered into to hedge forecasted revenues and designated as cash flow hedges:</span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.783%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.011%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.622%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Notional Value Sold</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Euro</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Japanese Yen</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">133.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the amounts, before tax, recognized in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets:</span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss Recognized in Other Comprehensive Earnings (Loss)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28, 2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency forward contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020, the net unrealized gain on derivatives, before tax, of $1.9 million was included in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets and is expected to be reclassified into net earnings over the next 12 months.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings was as follows: </span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:73.877%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.549%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.260%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location and Amount Recognized in Earnings on Cash Flow Hedging Relationships</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28, 2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="8" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenues </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value and cash flow hedges are recorded</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain on cash flow hedge relationships: </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency forward contracts:</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of gain reclassified from accumulated other comprehensive loss into net earnings </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Balance Sheet Hedging Activities</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company also hedges balance sheet exposures from its various subsidiaries and business units where the U.S. Dollar is the functional currency. For derivative instruments not designated as hedging instruments, changes in their fair values are recognized in other income, net in the Condensed Consolidated Statements of Earnings. Changes in the values of these hedging instruments are offset by changes in the values of foreign-currency-denominated assets and liabilities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The notional amount of the Company's outstanding foreign currency forward contracts relating to balance sheet hedging activities:</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Notional value sold</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">471.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">385.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Notional value purchased</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">116.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings related to the foreign currency forward contracts that are not designated as hedging instruments.</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.497%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.523%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain (Loss) Recognized in Net Earnings on Derivative Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Gain (Loss) Recognized in Net Earnings on Derivative Instruments</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income, net</span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The gains (losses) on these derivative instruments were significantly offset by the gains (losses) resulting from the re-measurement of monetary assets and liabilities denominated in currencies other than the U.S. Dollar functional currency.</span></div> <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of derivative instruments reported on the Company's Condensed Consolidated Balance Sheets were as follows: </span></div><div><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.035%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:32.064%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.722%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance Sheet<br/>Location</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:12.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign exchange forward contracts</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign exchange forward contracts</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:top;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:17.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total derivatives</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 1900000 2800000 400000 0 2300000 2800000 <div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company had the following outstanding foreign currency forward contracts that were entered into to hedge forecasted revenues and designated as cash flow hedges:</span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:69.783%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:11.011%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.622%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Notional Value Sold</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Euro</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Japanese Yen</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">133.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 52900000 76500000 46200000 56700000 99100000 133200000 <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the amounts, before tax, recognized in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets:</span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loss Recognized in Other Comprehensive Earnings (Loss)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28, 2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency forward contracts</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> -100000 0 1900000 <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings was as follows: </span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:73.877%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.549%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.260%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location and Amount Recognized in Earnings on Cash Flow Hedging Relationships</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28, 2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="8" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenues </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value and cash flow hedges are recorded</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain on cash flow hedge relationships: </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency forward contracts:</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:middle;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of gain reclassified from accumulated other comprehensive loss into net earnings </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 828900000 741000000.0 800000 0 <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The notional amount of the Company's outstanding foreign currency forward contracts relating to balance sheet hedging activities:</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Notional value sold</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">471.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">385.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Notional value purchased</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">116.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">52.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/></tr></table></div> 471300000 385000000.0 116300000 52300000 <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings related to the foreign currency forward contracts that are not designated as hedging instruments.</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:63.497%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.523%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain (Loss) Recognized in Net Earnings on Derivative Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amount of Gain (Loss) Recognized in Net Earnings on Derivative Instruments</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income, net</span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> -5000000.0 2800000 COMMITMENTS AND CONTINGENCIES<div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Product Warranty</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table reflects the changes in the Company’s accrued product warranty:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:73.877%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued product warranty, at beginning of period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charged to cost of revenues</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actual product warranty expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued product warranty, at end of period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accrued product warranty was included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets. </span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Leases</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company leases its facilities and certain equipment under operating leases. The Company's operating leases have remaining lease terms ranging from less than one year to 19</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> years.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Facilities primarily include general and administrative o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">ffice space, and space for manufacturing, research and development, and other services.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Equipment primarily includes vehicles and various office equipment. The Company's finance leases primarily relate to its sale and leaseback-subleases arrangements for certain equipment and have a remaining lease terms ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxZWQyOTVhZTBkZjQzMDc4ODUwODMxOGU1OTliZWQzL3NlYzo0MWVkMjk1YWUwZGY0MzA3ODg1MDgzMThlNTk5YmVkM183My9mcmFnOjE0MDM3MGIzM2NjNDQ3Nzk4YTU5YjFhNDczMjcyNWEwL3RleHRyZWdpb246MTQwMzcwYjMzY2M0NDc3OThhNTliMWE0NzMyNzI1YTBfODc5NjA5MzAzODY2Ng_0236a7fb-bdcb-46d8-a9f8-6199192c1233">one</span> year to 8 years. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Lease cost for operating leases is recognized on a straight-line basis over the lease term. Lease cost for finance leases is recognized as amortization of the finance lease ROU asset and interest expense on the finance lease liability over the lease term. The Company also has variable lease cost that primarily relate to its operating leases and include</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> common area maintenance, utilities, maintenance charges, property taxes, insurance, and contingent rent. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the components of the Company's lease cost:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.697%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Variable lease cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:6pt;margin-bottom:6pt;"><span><br/></span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the supplemental cash flow information related to the Company's operating leases:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.697%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">   Operating cash flows for leases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.136%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">114.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">93.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">   Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, plant, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the weighted lease term and discount rate by operating and finance leases:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.136%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average remaining lease term in years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020, the future minimum lease payments are as follows:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:73.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.865%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.112%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Leases</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remainder of 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total minimum lease payments</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease liability</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:6pt;margin-bottom:6pt;"><span><br/></span></div><div style="margin-top:6pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At September 27, 2019, the Company was committed to minimum rentals under non-cancellable operating leases (including rent escalation clauses) for fiscal years 2020 through 2024 and thereafter, as determined under the prior accounting guidance of Accounting Standard Codification 840, as follows: $32.5 million, $26.3 million, $20.2 million, $14.5 million, $10.9 million and $49.9 million, respectively. </span></div><div><span><br/></span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Lessor Arrangements</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company leases some of its equipment to certain customers on operating leases generally over a period of 15 years. As of January 3, 2020,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> the Company had $22.6 million and $6.4 million included in property, plant and equipment and accumulated depreciation, respectively, related to equipment leased to customers. As of September 27, 2019, the Company had $22.5 million and $5.5 million included in property, plant and equipment and accumulated depreciation, respectively, related to equipment </span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">leased to customers. The Company recorded income of $2.5 million and $2.1 million during the three months ended January 3, 2020 and December 28, 2018, respectively, on these equipment leases. </span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Contingencies</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Environmental Remediation Liabilities</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s operations and facilities, past and present, are subject to environmental laws, including laws that regulate the handling, storage, transport and disposal of hazardous substances. Certain of those laws impose cleanup liabilities on the Company in connection with its past and present operations. Those include facilities sold as part of the Company’s electron devices business in 1995 and thin film systems business in 1997. As a result, the Company oversees various environmental cleanup projects and receives reimbursements from third parties for a portion of the costs of its cleanup activities. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020 and September 27, 2019, the Company had accrued $4.7 million and $4.8 million, respectively, net of third parties' indemnification obligations, for environmental remediation liabilities. The Company believes its reserve is adequate; however, as the scope of the Company’s obligations becomes more clearly defined, the Company may modify the reserve, and charge or credit future earnings accordingly. Based on information currently known to management, management believes the costs of these environmental-related matters are not reasonably likely to have a material adverse effect on the consolidated financial statements of the Company in any one fiscal year.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company also reimburses certain third parties for cleanup activities. The amount the Company spent on environmental cleanup costs, third-party claim costs, project management costs and legal costs in the three months January 3, 2020 and December 28, 2018, was not material. </span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Other Matters</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On October 16, 2018, Best Medical International, Inc. sued the Company in U.S. District Court in the District of Delaware, alleging infringement of four patents related to treatment planning. The Company intends to defend the suit vigorously. This lawsuit is in the initial stages, and at this time, the Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure. Therefore, no amounts have been accrued as of January 3, 2020.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations and other legal matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value). A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition to the above, the Company is involved in other legal matters. However, such matters are subject to many uncertainties, and outcomes are not predictable with assurance. The Company is unable to estimate a loss or a range of reasonably possible losses with respect to such matters. There can be no assurances as to whether the Company will become subject to significant additional claims and liabilities with respect to ongoing or future proceedings. If actual liabilities significantly exceed the estimates made, the Company’s consolidated financial position, results of operations or cash flows could be materially adversely affected. Legal expenses relating to legal matters are expensed as incurred.</span></div> <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table reflects the changes in the Company’s accrued product warranty:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:73.877%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.698%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued product warranty, at beginning of period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Charged to cost of revenues</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Actual product warranty expenditures</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued product warranty, at end of period</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 43200000 44800000 20800000 13300000 17800000 11800000 46200000 46300000 P1Y P19Y P8Y <div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the components of the Company's lease cost:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.697%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Variable lease cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:6pt;margin-bottom:6pt;"><span><br/></span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the supplemental cash flow information related to the Company's operating leases:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.697%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">   Operating cash flows for leases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.136%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">114.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">93.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">   Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, plant, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the weighted lease term and discount rate by operating and finance leases:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:85.280%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.136%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average remaining lease term in years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div> 7800000 100000 100000 4500000 12500000 8800000 114100000 24400000 93700000 118100000 14300000 3400000 10500000 13900000 P7Y P4Y9M18D 0.048 0.015 <div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020, the future minimum lease payments are as follows:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:73.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.865%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.112%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Leases</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remainder of 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total minimum lease payments</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease liability</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> <div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020, the future minimum lease payments are as follows:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:73.000%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.865%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.112%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating Leases</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finance leases</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Remainder of 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2021</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2022</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2023</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2024</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Thereafter</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  Total minimum lease payments</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: imputed interest</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total operating lease liability</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 21500000 2900000 25800000 3500000 20300000 2900000 15400000 2900000 11800000 1100000 51400000 1100000 146200000 14400000 28100000 500000 118100000 13900000 32500000 26300000 20200000 14500000 10900000 49900000 P15Y 22600000 6400000 22500000 5500000 2500000 2100000 4700000 4800000 4 0 RETIREMENT PLANSThe Company sponsors multiple defined benefit pension plans for regular full-time employees in Germany, Japan, Switzerland and the United Kingdom. The Company also sponsors a post-retirement benefit plan that provides healthcare benefits to certain eligible retirees in the United States. <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of net periodic benefit costs were as follows:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Defined Benefit Plans</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on plan assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Recognized actuarial loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The components of net periodic benefit costs were as follows:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Defined Benefit Plans</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on plan assets</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service cost</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Recognized actuarial loss</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 2500000 1800000 500000 900000 1900000 1600000 -200000 -200000 -1100000 -600000 2000000.0 1500000 INCOME TAXES <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s effective tax rate was 21.0% and 24.4% for the three months ended January 3, 2020 and December 28, 2018, respectively. The Company’s effective tax rate is lower in the three months ended January 3, 2020 as compared to the year-ago period, primarily because the prior period included the tax effect of a change in law due to the enactment of the Tax Cuts and Jobs Act, which was signed into law on December 22, 2017.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company’s effective income tax rate differs from the U.S. federal statutory rate primarily because the Company’s foreign earnings are taxed at rates that are, on average, lower than the U.S. federal rate, and because the Company’s domestic earnings are subject to state income taxes. The total amount of unrecognized tax benefits did not materially change during the three months ended January 3, 2020; however, the amount of unrecognized tax benefits has increased as a result of positions taken during the current and prior years and has decreased as the result of the expiration of the statutes of limitation in various jurisdictions.</span></div> 0.210 0.244 STOCKHOLDERS’ EQUITY <div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Share Repurchase Program</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. Share repurchases under the Company's authorizations may be made in open market purchases, in privately negotiated transactions (including accelerated share repurchase programs), or under Rule 10b5-1 share repurchase plans, and may be made from time to time in one or more blocks. All shares that were repurchased under the Company's share repurchase programs have been retired. As of January 3, 2020, approximately 1.9 million shares of VMS common stock remained available for repurchase under the November 2016 authorization. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company repurchased shares of VMS common stock during the periods presented as follows:</span></div><div style="margin-top:3pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except per share amounts)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of shares</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average repurchase price per share</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139.67 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108.90 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cost of shares repurchased</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Accumulated Other Comprehensive Loss</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.327%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.626%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(In millions)</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Unrealized Gains<br/>(Losses) Defined<br/>Benefit Pension and<br/>Post-Retirement<br/>Benefit Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net<br/>Unrealized<br/>Gains<br/>Cash Flow<br/>Hedging<br/>Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(61.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(42.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(102.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive earnings (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out of other comprehensive earnings (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax (expense) benefit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(61.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(97.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:52.678%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.624%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Unrealized Gains<br/>(Losses) Defined<br/>Benefit Pension and<br/>Post-Retirement<br/>Benefit Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 28, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(35.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(65.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive earnings (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out of other comprehensive earnings (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 28, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(69.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The amounts reclassified, before taxes, out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings, with line item location, during each period were as follows: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:38.087%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.472%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.528%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.472%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.528%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:1.0%;"/><td style="width:23.513%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive Earnings (Loss) Components</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Line Item in Statements of Earnings</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized loss on defined benefit pension and post-retirement benefit plans</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income, net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized earnings on cash flow hedging instruments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenues</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amounts reclassified out of other comprehensive earnings (loss)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 8000000.0 1900000 <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company repurchased shares of VMS common stock during the periods presented as follows:</span></div><div style="margin-top:3pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except per share amounts)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of shares</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average repurchase price per share</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139.67 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108.90 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cost of shares repurchased</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 300000 300000 139.67 108.90 46400000 34800000 <div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:37.327%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.626%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(In millions)</span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Unrealized Gains<br/>(Losses) Defined<br/>Benefit Pension and<br/>Post-Retirement<br/>Benefit Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net<br/>Unrealized<br/>Gains<br/>Cash Flow<br/>Hedging<br/>Instruments</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(61.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(42.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(102.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive earnings (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out of other comprehensive earnings (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax (expense) benefit</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(61.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(97.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:52.678%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:1.0%;"/><td style="width:12.619%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.624%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Unrealized Gains<br/>(Losses) Defined<br/>Benefit Pension and<br/>Post-Retirement<br/>Benefit Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cumulative<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 28, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(35.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(65.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive earnings (loss) before reclassifications</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amounts reclassified out of other comprehensive earnings (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Tax expense</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at December 28, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(69.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> -61700000 2100000 -42500000 -102100000 0 -100000 5100000 5000000.0 -900000 800000 0 -100000 200000 -200000 0 0 -61000000.0 1400000 -37400000 -97000000.0 -35200000 -30100000 -65300000 0 -4000000.0 -4000000.0 -400000 0 -400000 100000 0 100000 -34900000 -34100000 -69000000.0 <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The amounts reclassified, before taxes, out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings, with line item location, during each period were as follows: </span></div><div><span><br/></span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:38.087%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.472%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.528%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.472%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.528%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td style="width:1.0%;"/><td style="width:23.513%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive Earnings (Loss) Components</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Line Item in Statements of Earnings</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized loss on defined benefit pension and post-retirement benefit plans</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income, net</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized earnings on cash flow hedging instruments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenues</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total amounts reclassified out of other comprehensive earnings (loss)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> -900000 -400000 800000 0 -100000 -400000 EMPLOYEE STOCK PLANS <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of revenues - Product</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of revenues - Service</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, general and administrative</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total share-based compensation expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax benefit for share-based compensation</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="margin-top:12pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of stock options and performance stock options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: </span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee Stock Option Plans</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected dividend</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Weighted average fair value at grant date</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> (1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.42 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.87 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:12pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Excludes the fair value of the market condition based on a relative total shareholder return for the performance stock options granted during the period.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: </span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee Stock Purchase Plan</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected dividend</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average fair value at grant date</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.58 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.82 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The activity for stock options and performance stock options is summarized as follows: </span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:37.238%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.641%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.641%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.641%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.643%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except per share amounts)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of<br/>Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted<br/>Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Aggregate</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Intrinsic</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Value</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;"> (1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97.66 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">131.34 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cancelled or expired</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.35 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82.03 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.01 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercisable at January 3, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82.38 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:12pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of $144.93 as of January 3, 2020, the last trading date of the first quarter of fiscal year 2020, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020, there was $20.7 million of total unrecognized compensation expense related to stock options and performance stock options granted under the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of 2.1 years.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020 there was $0.6 million of total unrecognized compensation expense related to cash-settled stock appreciation rights granted outside the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of 2.2 years.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except per share amounts)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of<br/>Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average<br/>Grant-Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108.35 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140.74 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84.99 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cancelled or expired<br/><br/><br/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117.11 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115.82 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="margin-top:6pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of January 3, 2020, unrecognized compensation expense totaling $43.7 million was related to awards of restricted stock units, deferred stock units and performance units granted under the Company's employee stock plans. This unrecognized share-based compensation expense is expected to be recognized over a weighted average period of 2.0 years.</span></div> <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of revenues - Product</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of revenues - Service</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, general and administrative</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total share-based compensation expense</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income tax benefit for share-based compensation</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 800000 700000 1300000 1100000 1200000 1100000 11600000 7600000 14900000 10500000 2900000 2300000 <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of stock options and performance stock options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: </span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee Stock Option Plans</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected dividend</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:6.75pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Weighted average fair value at grant date</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> (1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.42 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.87 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:12pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Excludes the fair value of the market condition based on a relative total shareholder return for the performance stock options granted during the period.</span></div> P3Y9M18D P3Y9M18D 0.016 0.029 0.260 0.222 0 0 29.42 25.87 <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: </span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee Stock Purchase Plan</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected term (in years)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Risk-free interest rate</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected volatility</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected dividend</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average fair value at grant date</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.58 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.82 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> P0Y6M P0Y6M 0.016 0.025 0.264 0.186 0 0 27.58 22.82 <div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The activity for stock options and performance stock options is summarized as follows: </span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:99.853%;"><tr><td style="width:1.0%;"/><td style="width:37.238%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:12.641%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.641%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.641%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.532%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.643%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Options Outstanding</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except per share amounts)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of<br/>Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted<br/>Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Aggregate</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Intrinsic</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Value</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;"> (1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97.66 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">131.34 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cancelled or expired</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99.35 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercised</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82.03 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101.01 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exercisable at January 3, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82.38 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div>(1)The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of $144.93 as of January 3, 2020, the last trading date of the first quarter of fiscal year 2020, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.. 2200000 97.66 100000 131.34 0 99.35 100000 82.03 2200000 101.01 P4Y7M6D 98000000.0 1100000 82.38 P3Y4M24D 68200000 144.93 20700000 P2Y1M6D 600000 P2Y2M12D <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except per share amounts)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Number of<br/>Shares</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted Average<br/>Grant-Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at September 27, 2019</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108.35 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Granted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140.74 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vested</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84.99 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cancelled or expired<br/><br/><br/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117.11 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance at January 3, 2020</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115.82 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div> 700000 108.35 100000 140.74 100000 84.99 100000 117.11 600000 115.82 43700000 P2Y EARNINGS PER SHARE<div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth the computation of basic and diluted net earnings per share:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except per share amounts)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Net earnings attributable to noncontrolling interests</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings attributable to Varian </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average shares outstanding - basic</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dilutive effect of potential common shares</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings per share attributable to Varian - basic</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.97 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings per share attributable to Varian - diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.96 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.12 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Anti-dilutive employee share-based awards, excluded</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> <div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table sets forth the computation of basic and diluted net earnings per share:</span></div><div style="margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions, except per share amounts)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: Net earnings attributable to noncontrolling interests</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings attributable to Varian </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">103.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average shares outstanding - basic</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">90.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dilutive effect of potential common shares</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings per share attributable to Varian - basic</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.97 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.13 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings per share attributable to Varian - diluted</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.96 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.12 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Anti-dilutive employee share-based awards, excluded</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 88900000 103900000 700000 700000 88200000 103200000 90900000 91000000.0 800000 1000000.0 91700000 92000000.0 0.97 1.13 0.96 1.12 800000 900000 PROTON SOLUTIONS LOANS AND INVESTMENTS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In limited cases, the Company participates, along with other investors and at market terms, in the financing of proton therapy centers. Over time, the Company has divested some of its investments, including investments in CPTC, the New York Proton Center ("NYPC"), the Georgia Proton Treatment Center and the Delray Radiation Therapy Center. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table lists the Company's notes receivable, including accrued interest, senior secured debt, available-for-sale securities, loans outstanding and future commitments for funding the development, construction and operation of various proton therapy centers:</span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.292%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.703%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitment</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;">Notes Receivable and Secured Debt: </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NYPC loan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RPTC senior secured debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton International LLC loan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;">Available-For-Sale Securities: </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-1 Bonds </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-2 Bonds  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">APTC securities </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CPTC Loans and Investment:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Short-term revolving loan </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Term loan </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other assets at January 3, 2020 and September 27, 2019 on the Company's Condensed Consolidated Balance Sheets, except for amounts related to short-term interest receivable.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets. </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(3)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in prepaid and other current assets at January 3, 2020 and other assets at September 27, 2019 on the Company's Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Alabama Proton Therapy Center ("APTC") Securities</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2017, the Company purchased $6.0 million in Subordinate Revenue Bonds, which financed the APTC. The Subordinate Revenue Bonds carry an interest rate of 8.5% and pay interest semi-annually. The Company is scheduled to start receiving annual principal payments on the Subordinate Revenue Bonds beginning on November 1, 2022. The Subordinate Revenue Bonds will mature on October 1, 2047. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At January 3, 2020 and September 27, 2019, the Company had $3.9 million and $2.1 million, respectively, in long-term unbilled receivables from APTC. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Rinecker</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Proton Therapy Center ("RPTC") Senior Secured Debt</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2017, the Company purchased the outstanding senior secured debt related to the RPTC in Munich, Germany for €21.5 million or $24.5 million. By purchasing the senior secured debt, the Company has a right to approximately 77 million Euros in claims against all of RPTC's assets. In September 2017, the management of RPTC filed for bankruptcy in Germany. In January 2018, the final insolvency proceedings commenced, and in December 2019 the center closed for clinical operations and decommissioning began. Upon finalization of bankruptcy proceedings, the Company believes it is probable it will recover the outstanding senior secured debt balance and trade accounts receivable, net. The Company classified its senior secured debt as long-term other assets because it expects the bankruptcy proceedings to be complete in greater than one year.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At January 3, 2020 and September 27, 2019, the Company had $4.2 million and $4.6 million, respectively, in long-term trade receivables, net, from RPTC, which does not include any unbilled receivables.</span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">New York Proton Center ("NYPC") Loan</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In July 2015, the Company committed to loan up to $91.5 million to MM Proton I, LLC. In June 2016, the Company assigned $73.0 million of this loan to Deutsche Bank AG. The remaining balance is comprised of an $18.5 million “Subordinate Loan” with a six-and-a-half-year term at up to 13.5% interest. In December 2019, the interest rate on the loan was reduced to 10%, effective May 1, 2019. As of January 3, 2020, the Subordinate Loan is $32.3 million, including accrued interest. The principal balance and accrued interest on the Subordinate Loan are due in full at maturity in January 2022. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At January 3, 2020 and September 27, 2019, the Company had $18.0 million and $16.6 million, respectively, in trade and unbilled receivables, which included $6.4 million and $6.0 million in unbilled receivables, respectively, from NYPC.</span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Maryland Proton Treatment Center ("MPTC") Securities</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has Subordinate Revenue Bonds ("MPTC Series B-2 Bonds") that carry an interest rate of 8.5% per annum with interest accruing up to the MPTC Series B-2 Bonds face amount of $33.9 million until January 1, 2022 and then will pay cash interest semi-annually. The MPTC Series B-2 Bonds will mature on January 1, 2049. The Company also has Subordinate Revenue Bonds ("MPTC Series B-1 Bonds") that carry an interest rate of 7.5% with interest accruing up to the MPTC Series B-1 Bonds face amount of $32.0 million on January 1, 2022 and then will pay cash interest semi-annually. The MPTC Series B-1 Bonds will mature on January 1, 2048. The MPTC Series B-1 Bonds are senior in right and time to the MPTC Series B-2 Bonds.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At January 3, 2020 and September 27, 2019, the Company had zero net trade and unbilled receivables from MPTC.</span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Variable Interest Entities</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has determined that MM Proton I, LLC and RPTC are variable interest entities and that the Company holds a significant variable interest of each of the entities through its participation in the loan facilities and its agreements to supply and service the proton therapy equipment. The Company has concluded that it is not the primary beneficiary of any of these entities. The Company has no voting rights, has no approval authority or veto rights for these centers' budget, and does not have the power to direct patient recruitment, clinical operations and management of these Centers, which the Company believes are the matters that most significantly affect their economic performance. The Company’s exposure to loss as a result of its </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">involvement with MM Proton I, LLC and RPTC is limited to the carrying amounts of the above-mentioned assets on its Condensed Consolidated Balance Sheets.</span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">California Proton Therapy Center ("CPTC") Loans and Investment</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Between September 2011 and November 2015, the Company, ORIX and J.P. Morgan (the "Lenders”) funded loans (“Original CPTC Loans”) to the Scripps Proton Therapy Center in San Diego, California. ORIX is the loan agent. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2017, California Proton Treatment Center, LLC ("Original CPTC") filed for bankruptcy and concurrently entered into a Debtor-in-Possession Facility (the "DIP Facility") with the Lenders where the Company's pro-rata share of the DIP Facility was $7.3 million. In September 2017, the Lenders and Scripps signed a Transition Agreement to transition the operations of the center from Scripps to Proton Doctors Professional Corporation. As a result of these events, the Company recorded an impairment charge of $51.4 million to its Original CPTC Loans in fiscal year 2017.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to an order of the Bankruptcy Court, the California Proton Treatment Center ("Original CPTC") conducted an auction of the Scripps Proton Therapy Center. On December 6, 2017 (“Closing Date”), the Bankruptcy Court approved the sale of Scripps Proton Therapy Center to California Proton Therapy Center, LLC (“CPTC”), an entity owned by the Lenders. The Lenders purchased all assets and assumed $112.0 million of Original CPTC’s outstanding liabilities. On December 13, 2017, the Bankruptcy Court dismissed the bankruptcy filing of Original CPTC. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On the Closing Date, the Lenders entered into a Credit Agreement with Original CPTC of which the terms of the Original CPTC Loans, DIP Facility and accrued interest (collectively “Former Loans”) have been modified. In addition to the partially satisfied Original CPTC Loans reinstated by the Bankruptcy Court, the Company received a 47.08% equity ownership in CPTC, which it sold for a nominal amount in March 2019. Original CPTC has assigned all its Former Loans to CPTC at an amount of $112.0 million, the partially satisfied loan balance. Per the terms of the Credit Agreement, the Company's portion of the $112.0 million is $53.5 million; the remainder is allocated between ORIX and J.P. Morgan. The $53.5 million is composed of four tranches: Tranche A of $2.0 million, Tranche B of $7.2 million, Tranche C of $15.6 million, and Tranche D of $28.7 million (collectively, the "Term Loan"). The maturity date of the Term Loan is three years from the Closing Date. The Term Loan is secured by the assets of CPTC. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, the Lenders have committed to lend up to $15.0 million in a Revolving Loan with a maturity date of one year from the Closing Date. In the first quarters of fiscal 2019, fiscal 2020 and subsequent to the end of the first quarter of fiscal 2020, as provided in the initial agreement, the Lenders have granted extensions to the term of the Revolving Loan with a current maturity of June 30, 2020. The Company's share of the funding commitment from the Revolving Loan is $7.2 million, and as of January 3, 2020, the Company has funded $5.3 million. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All of the tranches accrue paid-in-kind interest at 7.5% per annum, except the Tranche B and the Revolving Loan, which accrue paid-in-kind interest at 10% per annum. The seniority of these loans is as follows: Revolving Loan, Tranche A, Tranche B, Tranche C and Tranche D. If CPTC is in default, the interest rate of the Tranche A, C and D will increase to 9.5% and the interest rate on the Tranche B and the Revolving Loan will increase to 12.0%.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company believes it is probable that it will collect the amounts owed under the Term Loan and Revolving Loan when due based on CPTC’s current operating plan. This plan includes an increase in patient volume, partnership with a significant clinical partner, and maintenance of its current reimbursement structure. In July 2019, the Centers for Medicare and Medicaid Services ("CMS") proposed an alternative payment model (or “APM”) pilot program for radiation oncology. This proposed APM could materially impact the reimbursement to CPTC for its services. CPTC's inability to execute its operating plan, as well as finalization of the proposed APM as currently drafted could negatively impact CPTC's ability to repay or refinance the debt when it comes due, which may result in an impairment of the loan receivable; this impairment could be material. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At January 3, 2020, and September 27, 2019, the Company had $2.9 million and $2.6 million, respectively, in trade receivables, net, from CPTC.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Further, the Company has determined that CPTC is a variable interest entity because of the Company's participation in the loan facilities, and its operations and maintenance agreement. The Company has no special approval authority or veto rights for CPTC’s budget, and does not have the power to direct patient recruitment, clinical operations and management of CPTC, which the Company believes are the matters that most significantly affect their economic performance. Therefore, the Company does not have majority voting rights and no power to direct activities at CPTC, and as a result it is not the primary beneficiary of CPTC.</span></div> <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table lists the Company's notes receivable, including accrued interest, senior secured debt, available-for-sale securities, loans outstanding and future commitments for funding the development, construction and operation of various proton therapy centers:</span></div><div style="text-align:center;margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.292%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.695%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.703%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitment</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitment</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;">Notes Receivable and Secured Debt: </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NYPC loan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">RPTC senior secured debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton International LLC loan</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;">Available-For-Sale Securities: </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-1 Bonds </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MPTC Series B-2 Bonds  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:11.25pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">APTC securities </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:14pt;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CPTC Loans and Investment:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Short-term revolving loan </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:11.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Term loan </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in other assets at January 3, 2020 and September 27, 2019 on the Company's Condensed Consolidated Balance Sheets, except for amounts related to short-term interest receivable.</span></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets. </span></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:3pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(3)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">Included in prepaid and other current assets at January 3, 2020 and other assets at September 27, 2019 on the Company's Condensed Consolidated Balance Sheets.</span></div> 32300000 0 31800000 0 24000000.0 0 23500000 0 1800000 0 1800000 0 58100000 0 57100000 0 27600000 0 27100000 0 25700000 0 25100000 0 6700000 0 6600000 0 60000000.0 0 58800000 0 5300000 1900000 5300000 1900000 44000000.0 0 44000000.0 0 49300000 1900000 49300000 1900000 6000000.0 0.085 3900000 2100000 21500000 24500000 77000000 4200000 4600000 91500000 73000000.0 18500000 0.135 0.10 32300000 18000000.0 16600000 6400000 6000000.0 0.085 33900000 0.075 32000000.0 0 0 7300000 51400000 112000000.0 0.4708 112000000.0 112000000.0 53500000 53500000 4 2000000.0 7200000 15600000 28700000 P3Y 15000000.0 P1Y 7200000 5300000 0.075 0.10 0.095 0.095 0.095 0.120 2900000 2600000 SEGMENT INFORMATION<div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has two reportable operating segments: Oncology Systems and Proton Solutions. The Company's Interventional Solutions business is reflected in the "Other" category because it does not meet the criteria for a reportable operating segment. The operating segments were determined based on how the Company’s Chief Executive Officer, its Chief Operating Decision Maker (“CODM”), views and evaluates the Company’s operations. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings. </span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Description of Segments</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments such as fixed field intensity-modulated radiation therapy (“IMRT”), image-guided radiation therapy (“IGRT”), volumetric modulated arc therapy ("VMAT"), stereotactic radiosurgery (“SRS”), stereotactic body radiotherapy (“SBRT”) and brachytherapy as well as associated quality assurance equipment. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Oncology Systems’ hardware products include linear accelerators, brachytherapy afterloaders, treatment accessories, artificial intelligence-powered adaptive delivery systems and quality assurance software. The Oncology Systems’ software solutions include treatment planning, informatics, clinical knowledge exchange, patient care management, practice management and decision support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Oncology Systems’ products enable radiation oncology departments in hospitals and clinics to perform conventional radiotherapy treatments and offer advanced treatments such as IMRT, IGRT, VMAT, SRS and SBRT, and treat patients using brachytherapy techniques, which involve the introduction or temporary insertion of radioactive sources. The Oncology Systems' products are also used by surgeons and radiation oncologists to perform stereotactic radiosurgery and by medical oncology departments to manage patient treatments. Oncology Systems’ customers worldwide include university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices, medical oncology practices, radiotherapy centers and cancer care clinics. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Oncology Systems segment offers services ranging from hardware phone support, break/fix repair of linear accelerators, obsolescence protection of hardware, software support, software upgrades, hosting as a service, as well as clinical consulting services. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Oncology Systems segment also provides clinical practice services that assist within the clinical workflow. These services focus on decision support and/or cancer care knowledge augmentation aimed at facilitating improved accessibility and affordability to care while maintaining a fundamental level of clinical quality. Further, the Company operates ten multi-disciplinary cancer centers and one specialty hospital in India and one multi-disciplinary cancer center in Sri Lanka.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Proton Solutions segment develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams, for the treatment of cancer.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Other category primarily includes the Interventional Solutions business, which offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolization. Interventional Solutions also provides software and remote services for post treatment dose calculation for Yttrium-90 microspheres used in selective internal radiation therapy. The Other category also includes assets related to</span><span style="background-color:rgb(255,255,255, 0.0);color:#263238;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> the use of radiation in the heart and other forms of radiosurgery for cardiovascular disease.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following information is provided for the purpose of achieving an understanding of operations but may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company allocates corporate costs to its operating segments based on the relative revenues of Oncology Systems, Proton Solutions and Interventional Solutions. The Company allocates these costs, excluding certain corporate related costs, transactions or adjustments that the Company's CODM considers to be non-operational, such as restructuring and impairment charges, significant litigation charges or benefits and legal costs, and acquisition-related expenses and in process research and development. Although the Company excludes these amounts from segment operating earnings, they are included in the condensed consolidated operating earnings and included in the reconciliation below. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes select financial results for each reportable segment:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenues</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">782.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">702.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total reportable segments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">810.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Company</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Earnings from continuing operations before taxes </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">124.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total reportable segments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">122.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unallocated corporate </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">110.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">111.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income (expense), net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Company</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-align:justify;margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Disaggregation of Revenues </span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company disaggregates its revenues from contracts by major product categories, geographic region, and by timing of revenue recognition for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenues by Product Type</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Total Revenues by Product Type</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Hardware</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">320.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Hardware</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">359.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">347.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Software </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">148.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">131.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Software</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">148.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">131.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">257.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Service</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">321.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">262.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Revenues</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Includes software support agreements that are recorded in revenues from service, and software licenses that are recorded in revenues from product in the Condensed Consolidated Statements of Earnings. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenues by Geographical Region</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.391%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.722%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Total Revenues by Geographical Region</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Americas</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">330.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Americas</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">402.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">350.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EMEA</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">259.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total EMEA</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">272.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">APAC</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">143.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total APAC</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Revenues</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">North America </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">355.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">309.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total North America</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">328.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">427.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">393.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">450.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">412.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">North America primarily includes the United States and Canada.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenues by Timing of Revenue Recognition</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.099%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.722%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Timing of revenue recognition</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Products transferred at a point in time</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">382.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">366.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total products transferred at a point in time</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">400.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">366.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Products and services transferred over time</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">400.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">335.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total products and services transferred over time</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">428.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">374.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 2 10 1 1 <div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes select financial results for each reportable segment:</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:64.228%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:14.520%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.522%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,<br/>2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Revenues</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">782.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">702.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total reportable segments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">810.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Company</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Earnings from continuing operations before taxes </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;border-top:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">  </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">124.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total reportable segments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">122.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unallocated corporate </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operating earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">110.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">111.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income (expense), net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other income, net</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cff0fc;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cff0fc;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:24.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Company</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 782400000 702500000 27600000 38500000 810000000.0 741000000.0 18900000 0 828900000 741000000.0 136400000 124100000 -14300000 -8800000 122100000 115300000 2800000 0 -14900000 -3600000 110000000.0 111700000 -1700000 2700000 4400000 23000000.0 112700000 137400000 <div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company disaggregates its revenues from contracts by major product categories, geographic region, and by timing of revenue recognition for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenues by Product Type</span></div><div style="margin-top:12pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.830%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.721%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"/></span></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Total Revenues by Product Type</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Hardware</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">320.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Hardware</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">359.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">347.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Software </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">148.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">131.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Software</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">148.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">131.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">257.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Service</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">321.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">262.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:24pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Revenues</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Includes software support agreements that are recorded in revenues from service, and software licenses that are recorded in revenues from product in the Condensed Consolidated Statements of Earnings. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenues by Geographical Region</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.391%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.384%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.722%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Total Revenues by Geographical Region</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Americas</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">330.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Americas</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">402.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">350.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EMEA</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">259.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total EMEA</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">272.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">APAC</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">143.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total APAC</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153.8 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Revenues</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">North America </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:3pt double #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">355.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">309.1 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total North America</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">328.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">427.2 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">393.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.7 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">450.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">412.3 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div><div style="text-indent:-18pt;padding-left:36pt;margin-top:6pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt;">North America primarily includes the United States and Canada.</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Revenues by Timing of Revenue Recognition</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:71.099%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.719%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.530%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.722%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Three Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">Timing of revenue recognition</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">January 3,</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 28,</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(In millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2018</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Products transferred at a point in time</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">382.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">366.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">— </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total products transferred at a point in time</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">400.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">366.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Products and services transferred over time</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology Systems</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">400.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">335.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proton Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.6 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.5 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:12pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total products and services transferred over time</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">428.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">374.4 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:18pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828.9 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741.0 </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000;border-bottom:3pt double #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"> </span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr></table></div> 320000000.0 313600000 20100000 33600000 18900000 0 359000000.0 347200000 148800000 131200000 0 0 148800000 131200000 313600000 257700000 7500000 4900000 321100000 262600000 828900000 741000000.0 378900000 330800000 16900000 19600000 6400000 0 402200000 350400000 259800000 234500000 10300000 16500000 2800000 0 272900000 251000000.0 143700000 137200000 400000 2400000 9700000 0 153800000 139600000 828900000 741000000.0 355200000 309100000 16900000 19600000 6400000 0 378500000 328700000 427200000 393400000 10700000 18900000 12500000 0 450400000 412300000 828900000 741000000.0 382000000.0 366600000 18900000 0 400900000 366600000 400400000 335900000 27600000 38500000 428000000.0 374400000 828900000 741000000.0 BUSINESS COMBINATIONS<div style="margin-top:12pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Business Combinations in Fiscal Year 2020</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company completed an acquisition in its Oncology Systems business that was not material in the first quarter of fiscal year 2020. The acquisition was comprised of goodwill and assets acquired. The purchase accounting from this transaction is not yet finalized.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Business Combinations in Fiscal Year 2019</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Assets acquired from Boston Scientific</span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2019, the Company acquired Boston Scientific's embolics microspheres business, for treating arteriovenous malformations and hypervascular tumors, for a purchase price of $90.0 million in cash consideration. The assets from this purchase are included in the Company's Interventional Solutions business, which is included in the Other category. The purchase accounting from this transaction has been finalized. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cancer Treatment Services International </span></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, the Company acquired CTSI, a privately-held company for a purchase price of $277.0 million, consisting of $262.8 million of cash consideration, $8.2 million of contingent consideration, and $6.0 million of other consideration. The undiscounted range of the contingent consideration payments is zero to $58 million and is based on actual revenues over the 18 months following the acquisition date. There have been no changes this quarter to the fair value of the contingent consideration included in the initial purchase price. The Company has included this acquisition in its Oncology Systems business. The purchase accounting from this transaction is not yet finalized. The Company recorded a measurement period adjustment in the first quarter of fiscal year 2020 that was not material. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Endocare and Alicon</span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, the Company acquired Endocare and Alicon for a combined purchase price of $210.0 million consisting of $197.4 million of cash consideration and $12.6 million of contingent consideration. The undiscounted range of the contingent consideration payments is zero to $40 million and is based on actual revenues through March 2020. Due to better than expected actual and projected financial performance for Endocare and Alicon, as well as a change in the expected mix of products, the Company recorded an $8.8 million increase in the fair value of contingent consideration in the first quarter of fiscal year 2020, in addition to a $18.6 million increase in the fair value of the contingent consideration recorded in the fourth quarter of fiscal year 2019. The Company has recorded a total of $40.0 million in contingent consideration related to the Endocare and Alicon acquisitions, which is expected to be paid in fiscal year 2020. These acquisitions are included in the Company's Interventional Solutions business, which is included in the Other category. The purchase accounting from this transaction is not yet finalized. The Company has not recorded any measurement period adjustments this quarter. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other Acquisitions in Fiscal Year 2019</span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the third quarter of fiscal year 2019, the Company purchased a privately-held company for a cash purchase price of $15.2 million, including a holdback of </span><span style="background-color:rgb(255,255,255, 0.0);color:#263238;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">$3.6 million</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and contingent consideration. At the closing date, the value of the contingent consideration was zero because none of the milestones were probable to be achieved however, the Company could potentially pay up to approximately </span><span style="background-color:rgb(255,255,255, 0.0);color:#263238;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">$9 million</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> by 2023 if certain milestones were met plus additional payments for achieving revenue targets through 2035. The acquisition was classified as an asset acquisition. This acquisition is included in the Other category. </span></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first quarter of fiscal year 2019, the Company acquired a privately-held software company for a purchase price of $28.5 million. The acquisition primarily consisted of $21.9 million in goodwill and $6.5 million in finite-lived intangible assets. The Company integrated this acquisition into its Oncology Systems reporting unit. </span></div><div style="margin-top:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Other Information </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount. The Company believes the factors that contributed to goodwill in its completed acquisitions include synergies not available to market participants, as well as the acquisition of a talented workforce.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of assets acquired and liabilities assumed has been determined on a preliminary basis for acquisitions completed in the current year and certain acquisitions in the previous fiscal year. The Company will finalize these amounts as it obtains the </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">information necessary to complete the measurement process. Any changes resulting from facts and circumstances that existed as of the date of a business combination may result in certain adjustments. The Company expects to finalize these amounts no later than one year from the date of each business combination.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The condensed consolidated financial statements include the operating results from the date the above businesses were acquired. Pro forma results of operations for the completed acquisitions have not been presented because the effects were not material to the Company's condensed consolidated financial statements.</span></div>The Company incurred acquisition transaction costs of $3.9 million and $2.4 million during the three months ended January 3, 2020 and December 28, 2018, respectively. 90000000.0 277000000.0 262800000 8200000 6000000.0 0 58000000 P18M 0 210000000.0 197400000 12600000 0 40000000 8800000 18600000 40000000.0 15200000 3600000 0 9000000 28500000 21900000 6500000 3900000 2400000 Tax expense or benefit related to the periods presented are not material. XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY Statement - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Total Varian Stockholders' Equity
Noncontrolling Interests
Beginning balance (in shares) at Sep. 28, 2018   91.2          
Balance at beginning of period at Sep. 28, 2018 $ 1,588.7 $ 91.2 $ 778.1 $ 780.4 $ (65.3) $ 1,584.4 $ 4.3
Net earnings (loss) 103.9     103.2   103.2 0.7
Other comprehensive (loss) earnings (3.7)       (3.7) (3.7)  
Issuance of common stock (in shares)   0.3          
Issuance of common stock 22.0 $ 0.3 21.7     22.0  
Tax withholdings on vesting of equity awards (4.4)   (4.4)     (4.4)  
Share-based compensation expense $ 10.5   10.5     10.5  
Repurchases of common stock (in shares) (0.3) (0.3)          
Repurchases of common stock $ (34.8) $ (0.3) (6.6) (27.9)   (34.8)  
Other (0.2)   0.0 (0.2)   (0.2)  
Ending balance (in shares) at Dec. 28, 2018   91.2          
Balance at end of period at Dec. 28, 2018 $ 1,682.0 $ 91.2 799.3 855.5 (69.0) 1,677.0 5.0
Beginning balance (in shares) at Sep. 27, 2019 90.8 90.8          
Balance at beginning of period at Sep. 27, 2019 $ 1,777.6 $ 90.8 845.6 934.0 (102.1) 1,768.3 9.3
Net earnings (loss) 88.9     88.2   88.2 0.7
Other comprehensive (loss) earnings 5.1       5.1 5.1  
Issuance of common stock (in shares)   0.3          
Issuance of common stock 21.0 $ 0.3 20.7     21.0  
Tax withholdings on vesting of equity awards $ (3.6) $ 0.0 (3.6)     (3.6)  
Tax withholdings on vesting of equity awards (shares) 0.0            
Share-based compensation expense $ 14.7   14.7     14.7  
Repurchases of common stock (in shares) (0.3) (0.4)          
Repurchases of common stock $ (46.4) $ (0.4) (7.0) (39.0)   (46.4)  
Ending balance (in shares) at Jan. 03, 2020 90.7 90.7          
Balance at end of period at Jan. 03, 2020 $ 1,857.3 $ 90.7 $ 870.4 $ 983.2 $ (97.0) $ 1,847.3 $ 10.0
XML 20 R60.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Derivative [Line Items]    
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value and cash flow hedges are recorded $ 828.9 $ 741.0
Amount of gain reclassified from accumulated other comprehensive loss into net earnings 0.6 0.0
Revenues    
Derivative [Line Items]    
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value and cash flow hedges are recorded 828.9 741.0
Amount of gain reclassified from accumulated other comprehensive loss into net earnings $ 0.8 $ 0.0
JSON 21 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "var-20200103.htm": { "axisCustom": 0, "axisStandard": 40, "contextCount": 369, "dts": { "calculationLink": { "local": [ "var-20200103_cal.xml" ] }, "definitionLink": { "local": [ "var-20200103_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "var-20200103.htm" ] }, "labelLink": { "local": [ "var-20200103_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "var-20200103_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml" ] }, "schema": { "local": [ "var-20200103.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd" ] } }, "elementCount": 712, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 16, "http://www.varian.com/20200103": 1, "http://xbrl.sec.gov/dei/2019-01-31": 6, "total": 23 }, "keyCustom": 41, "keyStandard": 438, "memberCustom": 43, "memberStandard": 69, "nsprefix": "var", "nsuri": "http://www.varian.com/20200103", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12bTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.varian.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12bTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104102 - Disclosure - OTHER FINANCIAL INFORMATION", "role": "http://www.varian.com/role/OTHERFINANCIALINFORMATION", "shortName": "OTHER FINANCIAL INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112103 - Disclosure - FAIR VALUE", "role": "http://www.varian.com/role/FAIRVALUE", "shortName": "FAIR VALUE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "var:LoansNotesTradeandOtherReceivablesIncludingFinancingReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117104 - Disclosure - RECEIVABLES", "role": "http://www.varian.com/role/RECEIVABLES", "shortName": "RECEIVABLES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "var:LoansNotesTradeandOtherReceivablesIncludingFinancingReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2120105 - Disclosure - GOODWILL AND INTANGIBLE ASSETS", "role": "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETS", "shortName": "GOODWILL AND INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2126106 - Disclosure - BORROWINGS", "role": "http://www.varian.com/role/BORROWINGS", "shortName": "BORROWINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2130107 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "role": "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2138108 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2144109 - Disclosure - RETIREMENT PLANS", "role": "http://www.varian.com/role/RETIREMENTPLANS", "shortName": "RETIREMENT PLANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2147110 - Disclosure - INCOME TAXES", "role": "http://www.varian.com/role/INCOMETAXES", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2149111 - Disclosure - STOCKHOLDERS' EQUITY", "role": "http://www.varian.com/role/STOCKHOLDERSEQUITY", "shortName": "STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS", "role": "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2155112 - Disclosure - EMPLOYEE STOCK PLANS", "role": "http://www.varian.com/role/EMPLOYEESTOCKPLANS", "shortName": "EMPLOYEE STOCK PLANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2162113 - Disclosure - EARNINGS PER SHARE", "role": "http://www.varian.com/role/EARNINGSPERSHARE", "shortName": "EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "var:ProtonSolutionsLoansandInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2165114 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS", "role": "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTS", "shortName": "PROTON SOLUTIONS LOANS AND INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "var:ProtonSolutionsLoansandInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2169115 - Disclosure - SEGMENT INFORMATION", "role": "http://www.varian.com/role/SEGMENTINFORMATION", "shortName": "SEGMENT INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2174116 - Disclosure - BUSINESS COMBINATIONS", "role": "http://www.varian.com/role/BUSINESSCOMBINATIONS", "shortName": "BUSINESS COMBINATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "2176117 - Disclosure - SUBSEQUENT EVENTS", "role": "http://www.varian.com/role/SUBSEQUENTEVENTS", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": null }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - OTHER FINANCIAL INFORMATION (Tables)", "role": "http://www.varian.com/role/OTHERFINANCIALINFORMATIONTables", "shortName": "OTHER FINANCIAL INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2313302 - Disclosure - FAIR VALUE (Tables)", "role": "http://www.varian.com/role/FAIRVALUETables", "shortName": "FAIR VALUE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2318303 - Disclosure - RECEIVABLES (Tables)", "role": "http://www.varian.com/role/RECEIVABLESTables", "shortName": "RECEIVABLES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS", "role": "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2321304 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)", "role": "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSTables", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2327305 - Disclosure - BORROWINGS (Tables)", "role": "http://www.varian.com/role/BORROWINGSTables", "shortName": "BORROWINGS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2331306 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "role": "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2339307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2345308 - Disclosure - RETIREMENT PLANS (Tables)", "role": "http://www.varian.com/role/RETIREMENTPLANSTables", "shortName": "RETIREMENT PLANS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "var:ShareRepurchasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2350309 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "role": "http://www.varian.com/role/STOCKHOLDERSEQUITYTables", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "var:ShareRepurchasesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2356310 - Disclosure - EMPLOYEE STOCK PLANS (Tables)", "role": "http://www.varian.com/role/EMPLOYEESTOCKPLANSTables", "shortName": "EMPLOYEE STOCK PLANS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2363311 - Disclosure - EARNINGS PER SHARE (Tables)", "role": "http://www.varian.com/role/EARNINGSPERSHARETables", "shortName": "EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "var:ScheduleOfLoansandInvestmentstoFundPTCentersTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2366312 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS (Tables)", "role": "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSTables", "shortName": "PROTON SOLUTIONS LOANS AND INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "var:ScheduleOfLoansandInvestmentstoFundPTCentersTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2370313 - Disclosure - SEGMENT INFORMATION (Tables)", "role": "http://www.varian.com/role/SEGMENTINFORMATIONTables", "shortName": "SEGMENT INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Parenthetical)", "role": "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0ded6a4c3324427c840f467b696666dd_D20190928-20200103", "decimals": "INF", "first": true, "lang": null, "name": "var:NumberofCancerCenters", "reportCount": 1, "unitRef": "cancer_center", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details)", "role": "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - OTHER FINANCIAL INFORMATION - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details)", "role": "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails", "shortName": "OTHER FINANCIAL INFORMATION - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "id3d7c8bbc93040edb4c98da52a81345a_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - OTHER FINANCIAL INFORMATION - Unfulfilled Performance Obligations (Details)", "role": "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnfulfilledPerformanceObligationsDetails", "shortName": "OTHER FINANCIAL INFORMATION - Unfulfilled Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "id3d7c8bbc93040edb4c98da52a81345a_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - OTHER FINANCIAL INFORMATION - Cash, Cash Equivalents and Restricted Cash (Details)", "role": "http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails", "shortName": "OTHER FINANCIAL INFORMATION - Cash, Cash Equivalents and Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "lang": null, "name": "us-gaap:RestrictedCashCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409405 - Disclosure - OTHER FINANCIAL INFORMATION - Components of Inventories (Detail)", "role": "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail", "shortName": "OTHER FINANCIAL INFORMATION - Components of Inventories (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndPurchasedPartsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LiabilityForUncertainTaxPositionsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410406 - Disclosure - OTHER FINANCIAL INFORMATION - Components of Other Long-Term Liabilities (Detail)", "role": "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail", "shortName": "OTHER FINANCIAL INFORMATION - Components of Other Long-Term Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LiabilityForUncertainTaxPositionsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "var:RealizedandUnrealizedGainonInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411407 - Disclosure - OTHER FINANCIAL INFORMATION - Other Income, Net (Details)", "role": "http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails", "shortName": "OTHER FINANCIAL INFORMATION - Other Income, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "var:RealizedandUnrealizedGainonInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "var:ScheduleOfLoansandInvestmentstoFundPTCentersTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414408 - Disclosure - FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)", "role": "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail", "shortName": "FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i24f12232e5884a29a23966f6b75c8526_I20200103", "decimals": "-5", "lang": null, "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "var:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdjustmentsDueToEffectOfForeignExchange", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415409 - Disclosure - FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail)", "role": "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail", "shortName": "FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "var:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdjustmentsDueToEffectOfForeignExchange", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416410 - Disclosure - FAIR VALUE - Additional Information (Detail)", "role": "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "shortName": "FAIR VALUE - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419411 - Disclosure - RECEIVABLES (Details)", "role": "http://www.varian.com/role/RECEIVABLESDetails", "shortName": "RECEIVABLES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2422412 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail)", "role": "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:GoodwillPurchaseAccountingAdjustments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail)", "role": "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424414 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail)", "role": "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i4a34aaaa5a2642e597ad675c9bf67339_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425415 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details)", "role": "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShortTermBorrowings", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2428416 - Disclosure - BORROWINGS - Schedule of Debt (Details)", "role": "http://www.varian.com/role/BORROWINGSScheduleofDebtDetails", "shortName": "BORROWINGS - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShortTermDebtTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "lang": null, "name": "us-gaap:DebtCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i102312bd06ae4f25a98c1f716a59da13_I20191101", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429417 - Disclosure - BORROWINGS - Additional Information (Detail)", "role": "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail", "shortName": "BORROWINGS - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i102312bd06ae4f25a98c1f716a59da13_I20191101", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i2d636e54ff9d4bcfb3fa006f3c875ffb_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432418 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Instruments Reported on the Balance Sheet (Details)", "role": "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Instruments Reported on the Balance Sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i2d636e54ff9d4bcfb3fa006f3c875ffb_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "var:ScheduleofCashFlowHedgingActivitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i75ae828bd8de4336beeb1a682bf7ddf1_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2433419 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedging Activities (Details)", "role": "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedging Activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "var:ScheduleofCashFlowHedgingActivitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i75ae828bd8de4336beeb1a682bf7ddf1_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434420 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Pre-tax amounts Recognized in AOCI on the Balance Sheet (Details)", "role": "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESPretaxamountsRecognizedinAOCIontheBalanceSheetDetails", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Pre-tax amounts Recognized in AOCI on the Balance Sheet (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435421 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail)", "role": "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectivePortionofForeignCurrencyForwardContractsDesignatedasCashFlowHedgesDetail", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "ie5e206481eb349159e9cfd55f6b5d5f8_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i66d1a10b4d0e415fb29032b53f820441_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeAssetNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436422 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail)", "role": "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i66d1a10b4d0e415fb29032b53f820441_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeAssetNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "ie0ef655e0ef04326b2df14cba96612c4_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437423 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail)", "role": "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "ie0ef655e0ef04326b2df14cba96612c4_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440424 - Disclosure - COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail)", "role": "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAccruedProductWarrantyDetail", "shortName": "COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2441425 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details)", "role": "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2442426 - Disclosure - COMMITMENTS AND CONTINGENCIES - Lessor Arrangements (Details)", "role": "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Lessor Arrangements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccrualForEnvironmentalLossContingenciesComponentAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2443427 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail)", "role": "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail", "shortName": "COMMITMENTS AND CONTINGENCIES - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccrualForEnvironmentalLossContingenciesComponentAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "ie3174ca14ce144acbae302a56bd4247d_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2446428 - Disclosure - RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail)", "role": "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail", "shortName": "RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "ie3174ca14ce144acbae302a56bd4247d_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448429 - Disclosure - INCOME TAXES - Additional Information (Detail)", "role": "http://www.varian.com/role/INCOMETAXESAdditionalInformationDetail", "shortName": "INCOME TAXES - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e8248426cae43589df4a855d15a1257_I20161130", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2451430 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Detail)", "role": "http://www.varian.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail", "shortName": "STOCKHOLDERS' EQUITY - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e8248426cae43589df4a855d15a1257_I20161130", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "var:ShareRepurchasesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2452431 - Disclosure - STOCKHOLDERS' EQUITY - Shares Repurchased During Period (Details)", "role": "http://www.varian.com/role/STOCKHOLDERSEQUITYSharesRepurchasedDuringPeriodDetails", "shortName": "STOCKHOLDERS' EQUITY - Shares Repurchased During Period (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "var:ShareRepurchasesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "2", "lang": null, "name": "var:StockRepurchasedDuringPeriodAverageCostPerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2453432 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail)", "role": "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail", "shortName": "STOCKHOLDERS' EQUITY - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8f4b12ad1a83409aa4f6520feaafb559_I20190927", "decimals": "-5", "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2454433 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail)", "role": "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail", "shortName": "STOCKHOLDERS' EQUITY - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i1492a1f2211b478389083df0ec6be4d3_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:OtherOperatingIncomeExpenseNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2457434 - Disclosure - EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail)", "role": "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail", "shortName": "EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i05834d75d2714a9c8971c0b343fae31e_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2458435 - Disclosure - EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail)", "role": "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail", "shortName": "EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i05834d75d2714a9c8971c0b343fae31e_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2459436 - Disclosure - EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail)", "role": "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail", "shortName": "EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i21eca7755d8e4192976b5c64d219b2b5_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2460437 - Disclosure - EMPLOYEE STOCK PLANS - Additional Information (Detail)", "role": "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail", "shortName": "EMPLOYEE STOCK PLANS - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i21eca7755d8e4192976b5c64d219b2b5_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2461438 - Disclosure - EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail)", "role": "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail", "shortName": "EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i0890d4a5507246558e7d0fc33d20755e_I20190927", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2464439 - Disclosure - EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail)", "role": "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail", "shortName": "EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "var:ScheduleOfLoansandInvestmentstoFundPTCentersTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2467440 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS - Loans and Commitments (Details)", "role": "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails", "shortName": "PROTON SOLUTIONS LOANS AND INVESTMENTS - Loans and Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "var:ScheduleOfLoansandInvestmentstoFundPTCentersTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "lang": null, "name": "var:RemainingObligationFundLoan", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i38b116526d514149a440ede4d453fa63_I20180928", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EQUITY Statement", "role": "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF EQUITY Statement", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i38b116526d514149a440ede4d453fa63_I20180928", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "var:ScheduleOfLoansandInvestmentstoFundPTCentersTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "iafa2e73971e0498caed2702bfcbba490_I20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2468441 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS - Additional Information (Detail)", "role": "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "shortName": "PROTON SOLUTIONS LOANS AND INVESTMENTS - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i818a24f42cfb4144ac7b0f17c2225ade_D20171201-20171231", "decimals": "-5", "lang": null, "name": "us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2471442 - Disclosure - SEGMENT INFORMATION - Additional Information (Detail)", "role": "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail", "shortName": "SEGMENT INFORMATION - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2472443 - Disclosure - SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail)", "role": "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail", "shortName": "SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:InterestIncomeExpenseNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2473444 - Disclosure - SEGMENT INFORMATION - Disaggregation of Revenue (Details)", "role": "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails", "shortName": "SEGMENT INFORMATION - Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i923b1f8e45bc4f7491c2aab0fede38fe_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2475445 - Disclosure - BUSINESS COMBINATIONS (Details)", "role": "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails", "shortName": "BUSINESS COMBINATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "var-20200103.htm", "contextRef": "i8e304b1eadf04451877f3c06ff97cf40_D20190928-20200103", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 115, "tag": { "country_IN": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "INDIA", "terseLabel": "India" } } }, "localname": "IN", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail", "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails" ], "xbrltype": "domainItemType" }, "country_LK": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SRI LANKA", "terseLabel": "Sri Lanka" } } }, "localname": "LK", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail", "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Euro Member Countries, Euro", "verboseLabel": "Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails" ], "xbrltype": "domainItemType" }, "currency_JPY": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Japan, Yen", "verboseLabel": "Japan, Yen" } } }, "localname": "JPY", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page.", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r499" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r500" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r501" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r501" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r501" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r502" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r501" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r501" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r501" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r501" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r497" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r498" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.varian.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Americas [Member]", "terseLabel": "Americas" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "APAC" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r153", "r161" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r58", "r119" ], "lang": { "en-US": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "stringItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Currency [Axis]", "terseLabel": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail", "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails", "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail", "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails", "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "North America [Member]", "terseLabel": "North America" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r163", "r250", "r253", "r489", "r490" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail", "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails", "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail", "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails", "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails", "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r164", "r250", "r254", "r491", "r493", "r495" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails", "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r226", "r448" ], "lang": { "en-US": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesDateAxis": { "auth_ref": [ "r242" ], "lang": { "en-US": { "role": { "documentation": "Information by date of execution of accelerated share repurchases.", "label": "Accelerated Share Repurchases, Date [Axis]", "terseLabel": "Accelerated Share Repurchases, Date [Axis]" } } }, "localname": "AcceleratedShareRepurchasesDateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AcceleratedShareRepurchasesDateDomain": { "auth_ref": [ "r242" ], "lang": { "en-US": { "role": { "documentation": "Date upon which the accelerated share repurchase agreement was executed.", "label": "Accelerated Share Repurchases, Date [Domain]", "terseLabel": "Accelerated Share Repurchases, Date [Domain]" } } }, "localname": "AcceleratedShareRepurchasesDateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "verboseLabel": "Long-term notes receivable and Available-for-sale Securities [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails", "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": { "auth_ref": [ "r51" ], "lang": { "en-US": { "role": { "documentation": "Information by type of receivable.", "label": "Receivable Type [Axis]", "terseLabel": "Receivable Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails", "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGross": { "auth_ref": [ "r166" ], "calculation": { "http://www.varian.com/role/RECEIVABLESDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, before Allowance for Credit Loss", "terseLabel": "Trade and unbilled receivables, gross" } } }, "localname": "AccountsReceivableGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r21", "r476" ], "calculation": { "http://www.varian.com/role/RECEIVABLESDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.varian.com/role/RECEIVABLESDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "totalLabel": "Trade and unbilled receivables, net" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r3", "r21", "r166", "r167", "r251" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.varian.com/role/RECEIVABLESDetails_1": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade and unbilled receivables, net of allowance for doubtful accounts of $47.0 and $46.5 at January 3, 2020 and September 27, 2019, respectively", "verboseLabel": "Short-term" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetNoncurrent": { "auth_ref": [ "r21", "r166", "r251", "r465", "r476" ], "calculation": { "http://www.varian.com/role/RECEIVABLESDetails_1": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent.", "label": "Accounts Receivable, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Long-term" } } }, "localname": "AccountsReceivableNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForEnvironmentalLossContingenciesComponentAmount": { "auth_ref": [ "r227" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Recorded amount of the accrual for a material component of an environmental loss contingency.", "label": "Accrual for Environmental Loss Contingencies, Component Amount", "terseLabel": "Amount accrued for environmental remediation expense" } } }, "localname": "AccrualForEnvironmentalLossContingenciesComponentAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesMember": { "auth_ref": [ "r44" ], "lang": { "en-US": { "role": { "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.", "label": "Accrued Liabilities [Member]", "verboseLabel": "Accrued Expenses" } } }, "localname": "AccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r64", "r70", "r73", "r272", "r362" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest.", "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "Net Unrealized Gains (Losses) Defined Benefit Pension and Post-Retirement Benefit Plans", "verboseLabel": "Unrealized loss on defined benefit pension and post-retirement benefit plans" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail", "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r37", "r218" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r62", "r70", "r73", "r362" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.", "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "Cumulative Translation Adjustment" } } }, "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": { "auth_ref": [ "r70", "r361" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.", "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]", "terseLabel": "Net Unrealized Gains Cash Flow Hedging Instruments", "verboseLabel": "Unrealized earnings on cash flow hedging instruments" } } }, "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail", "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income Loss [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r67", "r69", "r70" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income Loss [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r66", "r70", "r73", "r362" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r22" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Capital in excess of par value" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Capital\u00a0in\u00a0Excess of Par Value" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedTerseLabel": "Tax withholdings on vesting of equity awards" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r285", "r287", "r319", "r320" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllOtherSegmentsMember": { "auth_ref": [ "r145", "r146", "r147", "r148", "r149", "r150" ], "lang": { "en-US": { "role": { "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.", "label": "Other Segments [Member]", "terseLabel": "Other" } } }, "localname": "AllOtherSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r287", "r313", "r318" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Total share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r168", "r178", "r180", "r181" ], "calculation": { "http://www.varian.com/role/RECEIVABLESDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "negatedLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r27", "r168", "r178" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r112", "r204", "r210" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets and inventory step-up" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive employee shared based awards, excluded (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r66", "r70", "r73", "r362" ], "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r157", "r458", "r477" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r54" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r405" ], "calculation": { "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets measured at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r170", "r173", "r187" ], "calculation": { "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "terseLabel": "Fair Value", "verboseLabel": "Available-for-sale securities" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableforsaleSecuritiesMember": { "auth_ref": [ "r175" ], "lang": { "en-US": { "role": { "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available-for-sale Securities [Member]", "terseLabel": "Available-for-sale Securities" } } }, "localname": "AvailableforsaleSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r288", "r315" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail", "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r383", "r388" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r333", "r334" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r332" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition-related expenses" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r340", "r341", "r344" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Acquisition purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredOther1": { "auth_ref": [ "r346" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash.", "label": "Business Combination, Consideration Transferred, Other", "terseLabel": "Other consideration" } } }, "localname": "BusinessCombinationConsiderationTransferredOther1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r111", "r348" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "terseLabel": "Change in fair value of contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh": { "auth_ref": [ "r349" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents the amount of any change recognized during the period in the high-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High", "terseLabel": "Undiscounted range of contingent consideration payments, high" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow": { "auth_ref": [ "r349" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents the amount of any change recognized during the period in the low-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, Low", "terseLabel": "Undiscounted range of contingent consideration payments, low" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r339", "r342", "r347" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r339", "r343" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "verboseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r350" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "BUSINESS COMBINATIONS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONS" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r335", "r336" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r1", "r35", "r114" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r109", "r114", "r116" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r109", "r420" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r35" ], "calculation": { "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r403" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months", "terseLabel": "Unrealized loss on derivatives, before tax, expected to be reclassified over the next 12 months" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESPretaxamountsRecognizedinAOCIontheBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r380" ], "lang": { "en-US": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r48", "r225", "r467", "r484" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 8)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r224", "r228" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r19", "r236" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r19" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock of $1 par value: 189.0 shares authorized; 90.7 and 90.8 shares issued and outstanding at January 3, 2020 and September 27, 2019, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Retirement Benefits [Abstract]", "terseLabel": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r76", "r78", "r79" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive earnings attributable to Varian" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r76", "r78", "r356", "r357", "r370" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 }, "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Less: Comprehensive earnings attributable to noncontrolling interests", "verboseLabel": "Less: Net earnings attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r76", "r78", "r355", "r370" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive earnings" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r117", "r358", "r372", "r374" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r247" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of contract balances and changes in contract balances.", "label": "Contract with Customer, Asset and Liability [Table Text Block]", "verboseLabel": "Unbilled Accounts Receivable and Deferred Revenues from Contracts with Customers:" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r244", "r246", "r251" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails": { "order": 1.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, Net, Current", "verboseLabel": "Unbilled receivables - current" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNetNoncurrent": { "auth_ref": [ "r244", "r246", "r251" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails": { "order": 2.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.", "label": "Contract with Customer, Asset, Net, Noncurrent", "terseLabel": "Unbilled receivables - long-term" } } }, "localname": "ContractWithCustomerAssetNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r244", "r245", "r251" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "negatedTotalLabel": "Total net unbilled receivables (deferred revenues)" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r244", "r245", "r251" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails": { "order": 3.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "negatedTerseLabel": "Deferred revenues - current", "verboseLabel": "Deferred revenues" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r244", "r245", "r251" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail": { "order": 6.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 }, "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails": { "order": 4.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "negatedTerseLabel": "Deferred revenues - long-term", "verboseLabel": "Long-term deferred revenues" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail", "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r252" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "verboseLabel": "Recognized revenue included in deferred revenue balance" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r264", "r282", "r492" ], "lang": { "en-US": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "MPTC Series B-1 Bonds" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateMember": { "auth_ref": [ "r147" ], "lang": { "en-US": { "role": { "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.", "label": "Corporate Segment [Member]", "terseLabel": "Unallocated corporate" } } }, "localname": "CorporateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r90" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Total cost of revenues" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Cost of Revenue [Abstract]", "terseLabel": "Cost of revenues:" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail", "http://www.varian.com/role/BORROWINGSScheduleofDebtDetails", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail", "http://www.varian.com/role/BORROWINGSScheduleofDebtDetails", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelatedIntangibleAssetsMember": { "auth_ref": [ "r337" ], "lang": { "en-US": { "role": { "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.", "label": "Customer-Related Intangible Assets [Member]", "verboseLabel": "Customer contracts, supplier relationships, and partner relationships" } } }, "localname": "CustomerRelatedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt, Current", "terseLabel": "Total short-term borrowings" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r235" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "BORROWINGS" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGS" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r14", "r15", "r16", "r459", "r461", "r475" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Line of credit, basis spread on variable rate (as a percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Short-term borrowings:" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r46" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r46", "r120", "r237", "r238", "r239", "r240", "r423", "r424", "r426", "r474" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Credit facility term (in years)" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate", "verboseLabel": "Weighted-Average Interest Rate (as a percent)" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSScheduleofDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtorInPossessionFinancingAmountArranged": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount debtor-in-possession financing arranged (but not necessarily all borrowed).", "label": "Debtor-in-Possession Financing, Amount Arranged", "terseLabel": "Additional financing" } } }, "localname": "DebtorInPossessionFinancingAmountArranged", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r326" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.", "label": "Deferred Income Taxes and Other Tax Liabilities, Noncurrent", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "auth_ref": [ "r17", "r258", "r259", "r263" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "terseLabel": "Defined benefit pension plan" } } }, "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r262" ], "calculation": { "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail": { "order": 5.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)", "negatedLabel": "Recognized actuarial loss" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r270", "r281", "r282" ], "calculation": { "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "terseLabel": "Amortization of prior service cost" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r269", "r280", "r282" ], "calculation": { "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "negatedLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r261", "r268", "r279", "r282" ], "calculation": { "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r266", "r277", "r282" ], "calculation": { "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "totalLabel": "Net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r260", "r267", "r278", "r282" ], "calculation": { "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r112", "r216" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetNotionalAmount": { "auth_ref": [ "r376", "r377", "r379" ], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative asset.", "label": "Derivative Asset, Notional Amount", "verboseLabel": "Notional Value" } } }, "localname": "DerivativeAssetNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r56", "r57", "r415" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESPretaxamountsRecognizedinAOCIontheBalanceSheetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r55", "r59", "r386", "r454" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "terseLabel": "Total derivatives" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r384", "r387", "r393", "r395" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESPretaxamountsRecognizedinAOCIontheBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r404" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESPretaxamountsRecognizedinAOCIontheBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about derivatives and hedging activities.", "label": "Derivative Instruments and Hedging Activities Disclosures [Table]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESPretaxamountsRecognizedinAOCIontheBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r381", "r384", "r393" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectivePortionofForeignCurrencyForwardContractsDesignatedasCashFlowHedgesDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r377", "r379" ], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional value sold" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r122", "r375", "r378", "r379", "r381", "r382", "r389", "r393", "r397", "r398", "r402" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectivePortionofForeignCurrencyForwardContractsDesignatedasCashFlowHedgesDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTermOfContract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Term of Contract", "terseLabel": "Derivative, term of contract" } } }, "localname": "DerivativeTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r381" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r250" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r322" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "EMPLOYEE STOCK PLANS" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANS" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r85", "r125", "r128", "r129", "r130", "r131", "r134", "r471", "r486" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net earnings per share - basic (in dollars per share)", "verboseLabel": "Net earnings per share attributable to Varian - basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r85", "r125", "r128", "r129", "r130", "r131", "r134", "r471", "r486" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net earnings per share - diluted (in dollars per share)", "verboseLabel": "Net earnings per share attributable to Varian - diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r135" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EARNINGSPERSHARE" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r420" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effects of exchange rate changes on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r121", "r324", "r325" ], "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate (as a percent)" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/INCOMETAXESAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r314" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation expense related to outstanding stock awards" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r314" ], "lang": { "en-US": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period unrecognized compensation expense is expected to be recognized, years" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r313" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, Tax Benefit", "negatedLabel": "Income tax benefit for share-based compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r311" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock options", "verboseLabel": "Employee Stock Option Plans" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail", "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Equipment" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r236" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement", "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail", "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r177" ], "lang": { "en-US": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity ownership interest (percent)" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "auth_ref": [ "r176" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "terseLabel": "Equity investments in privately-held companies" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EurodollarMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.", "label": "Eurodollar [Member]", "terseLabel": "Eurodollar" } } }, "localname": "EurodollarMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]", "terseLabel": "Assets/Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r405", "r406", "r407", "r413" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r410", "r413" ], "lang": { "en-US": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r410", "r413" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Reconciliation for Assets Measured and Recorded at Fair Value on Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r405", "r416" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Fair Value of Derivative Instruments Reported on the Balance Sheet" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r264", "r265", "r282", "r406", "r450" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r412", "r413" ], "lang": { "en-US": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r405", "r406", "r408", "r409", "r414" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail", "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r412" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUE" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r264", "r265", "r282", "r406", "r451" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Markets for Identical Instruments" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r264", "r265", "r282", "r406", "r452" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant Other Observable Inputs" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r264", "r265", "r282", "r406", "r453" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r410" ], "lang": { "en-US": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail", "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r411" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in fair value recognized in earnings" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r410" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "negatedPeriodEndLabel": "Contingent Consideration, ending balance", "negatedPeriodStartLabel": "Contingent Consideration, beginning balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r412", "r414" ], "lang": { "en-US": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail", "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r383", "r389", "r399" ], "lang": { "en-US": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r400" ], "lang": { "en-US": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "terseLabel": "Federal Funds Rate" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r432", "r436", "r444" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Interest on lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Finance Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Finance Lease, Liability, Payment, Due [Abstract]" } } }, "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r431", "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails_1": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "totalLabel": "Total lease liabilities" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r431" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r443" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "Finance Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Finance Lease Liability Maturity" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r431" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "totalLabel": "Total minimum lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 6.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due after fifth fiscal year following latest fiscal year.", "label": "Finance Lease, Liability, Payments, Due after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fifth fiscal year following latest fiscal year.", "label": "Finance Lease, Liability, Payments, Due Year Five", "terseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in fourth fiscal year following latest fiscal year.", "label": "Finance Lease, Liability, Payments, Due Year Four", "terseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in third fiscal year following latest fiscal year.", "label": "Finance Lease, Liability, Payments, Due Year Three", "terseLabel": "2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in second fiscal year following latest fiscal year.", "label": "Finance Lease, Liability, Payments, Due Year Two", "terseLabel": "2021" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease, due in remainder of fiscal year following latest fiscal year ended.", "label": "Finance Lease, Liability, Payments, Remainder of Fiscal Year", "terseLabel": "Remainder of 2020" } } }, "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails_1": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: imputed interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r430" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under finance lease.", "label": "Finance Lease, Right-of-Use Asset", "terseLabel": "Property, plant, and equipment, net" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r432", "r436", "r444" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r441", "r444" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average remaining discount rate-finance leases (percent)" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r440", "r444" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term-finance leases" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r179", "r182", "r183", "r184", "r186", "r188", "r189", "r190", "r191" ], "lang": { "en-US": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Major Types of Debt and Equity Securities" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r209" ], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year", "terseLabel": "Remainder of 2020" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r211" ], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "Future amortization expense, fiscal year 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r211" ], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "Future amortization expense, fiscal year 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r211" ], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "Future amortization expense, fiscal year 2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r211" ], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "Future amortization expense, fiscal year 2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r205", "r206", "r209", "r213", "r456" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r209", "r456" ], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Finite lived intangible assets, gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite Lived Intangible Assets [Line Items]", "verboseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r205", "r208" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r209" ], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiscalPeriod": { "auth_ref": [ "r351", "r371", "r373" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.", "label": "Fiscal Period, Policy [Policy Text Block]", "terseLabel": "Fiscal Year" } } }, "localname": "FiscalPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r417", "r418", "r419" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Net foreign currency exchange gain" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "verboseLabel": "Foreign exchange forward contracts" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESPretaxamountsRecognizedinAOCIontheBalanceSheetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [ "r384", "r392" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.", "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments", "terseLabel": "Amount of Gain (Loss) Recognized in Net Earnings on Derivative Instruments" } } }, "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainOnSaleOfInvestments": { "auth_ref": [ "r86", "r87", "r112", "r468", "r487" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale.", "label": "Gain on Sale of Investments", "negatedLabel": "Gain on sale of equity investments" } } }, "localname": "GainOnSaleOfInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r195", "r196" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance, ending", "periodStartLabel": "Balance, beginning", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r198" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Business combination", "verboseLabel": "Goodwill acquired" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r215" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "GOODWILL AND INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETS" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [ "r197", "r200" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "terseLabel": "Accumulated impairment charges" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r199", "r331" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Measurement period adjustments to business combinations in prior year" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r88" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r381", "r396" ], "lang": { "en-US": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r381" ], "lang": { "en-US": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r381" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r89", "r113", "r131", "r354" ], "calculation": { "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "totalLabel": "Net earnings attributable to Varian" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": { "auth_ref": [ "r352", "r355" ], "calculation": { "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Less: Net earnings attributable to noncontrolling interests" } } }, "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r83", "r125", "r457", "r469", "r488" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 }, "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings before taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r355" ], "calculation": { "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r220" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectivePortionofForeignCurrencyForwardContractsDesignatedasCashFlowHedgesDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectivePortionofForeignCurrencyForwardContractsDesignatedasCashFlowHedgesDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r330" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/INCOMETAXES" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r118", "r156", "r328" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Taxes on earnings" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r111" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r111" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Trade and unbilled receivables" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "auth_ref": [ "r111" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Increase (Decrease) in Contract with Customer, Asset", "negatedLabel": "Decrease in unbilled receivables" } } }, "localname": "IncreaseDecreaseInContractWithCustomerAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r111" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenues" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Increase in deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r111" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in assets and liabilities, net of effects of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r111" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r212" ], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "verboseLabel": "In-process research and development with indefinite lives" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InformationByCategoryOfDebtSecurityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by category of debt security, either available-for-sale or held-to-maturity.", "label": "Debt Security Category [Axis]", "terseLabel": "Debt Security Category [Axis]" } } }, "localname": "InformationByCategoryOfDebtSecurityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Total intangible assets" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r203", "r207" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets", "totalLabel": "Total intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r81", "r155", "r422", "r425", "r473" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r472" ], "calculation": { "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "terseLabel": "Interest income (expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r28", "r194" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r2", "r53", "r193" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndPurchasedPartsNetOfReserves": { "auth_ref": [ "r30", "r194" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of items purchased for use as components of a finished product or pieces of machinery and equipment plus any items in their natural and unrefined state. This element may be used when the reporting entity combines raw materials and purchased parts into an aggregate amount.", "label": "Inventory, Raw Materials and Purchased Parts, Net of Reserves", "terseLabel": "Raw materials and parts" } } }, "localname": "InventoryRawMaterialsAndPurchasedPartsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r29", "r194" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r92", "r154" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r442", "r444" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease expense" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r442" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Components of Lease Expense, Supplemental Cash Flow Information and Supplemental Balance Sheet Information" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeFinanceLeaseDescriptionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Lessee, Finance Lease, Description [Abstract]", "terseLabel": "Finance lease cost:" } } }, "localname": "LesseeFinanceLeaseDescriptionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r435" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r434" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r443" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Future Minimum Operating Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "terseLabel": "Remainder of 2020" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r443" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r446" ], "lang": { "en-US": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Term of Contract", "terseLabel": "Lease term" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r43" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r463", "r482" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r45" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r405" ], "calculation": { "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "negatedTotalLabel": "Total liabilities measured at fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "verboseLabel": "Long-term income taxes payable" } } }, "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r16", "r461", "r475" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "terseLabel": "Outstanding principal balance" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Commitment fee" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line Of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r40" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Loan facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r40", "r120" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line Of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationReserve": { "auth_ref": [ "r48", "r225" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.", "label": "Estimated Litigation Liability", "terseLabel": "Estimated litigation accrual" } } }, "localname": "LitigationReserve", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]", "terseLabel": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]", "terseLabel": "Litigation Status [Domain]" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LoansReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An amount of money or property, or a portion thereof, leant to a borrower (debtor) in exchange for a promise to repay the amount borrowed plus interest at a date certain in the future.", "label": "Loans Receivable [Member]", "terseLabel": "Loans Receivable" } } }, "localname": "LoansReceivableMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates an ownership position in, or purchase of, a security.", "label": "Long [Member]", "terseLabel": "Notional Value Purchased" } } }, "localname": "LongMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r46" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r46", "r234" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of another entity's patents that the entity has allegedly infringed.", "label": "Loss Contingency, Patents Allegedly Infringed, Number", "terseLabel": "Number of patents allegedly infringed" } } }, "localname": "LossContingencyPatentsAllegedlyInfringedNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r52", "r462", "r481" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r264" ], "lang": { "en-US": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]", "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]" } } }, "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAccruedProductWarrantyDetail" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r109" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r109" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r109", "r110", "r113" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r74", "r77", "r84", "r113", "r133", "r470", "r485" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net earnings attributable to Varian" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r352" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r381" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r93" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Other income, net", "totalLabel": "Total other income, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing nonoperating income (expense).", "label": "Nonoperating Income (Expense) [Member]", "terseLabel": "Other income, net" } } }, "localname": "NonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NotesAndLoansReceivableGrossCurrent": { "auth_ref": [ "r3", "r4", "r50", "r167" ], "calculation": { "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails": { "order": 1.0, "parentTag": "var_LoansandInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable, classified as current.", "label": "Financing Receivable, before Allowance for Credit Loss, Current", "terseLabel": "Loans", "verboseLabel": "Short-term revolving loan" } } }, "localname": "NotesAndLoansReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableGrossNoncurrent": { "auth_ref": [ "r166" ], "calculation": { "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails": { "order": 2.0, "parentTag": "var_LoansandInvestments", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Financing Receivable, before Allowance for Credit Loss, Noncurrent", "terseLabel": "Modified former loans receivable", "verboseLabel": "Term loan" } } }, "localname": "NotesAndLoansReceivableGrossNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r3", "r4", "r20", "r166", "r167", "r464" ], "calculation": { "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails": { "order": 1.0, "parentTag": "var_NotesLoansandFinancingReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.", "label": "Financing Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Short-term" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "auth_ref": [ "r21" ], "calculation": { "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails": { "order": 2.0, "parentTag": "var_NotesLoansandFinancingReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.", "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Long-term" } } }, "localname": "NotesAndLoansReceivableNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.", "label": "Notes Receivable [Member]", "terseLabel": "Notes Receivable" } } }, "localname": "NotesReceivableMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r21", "r166", "r185" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Financing Receivable, after Allowance for Credit Loss", "verboseLabel": "Long-term notes receivable" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Earnings from continuing operations before taxes", "totalLabel": "Operating earnings" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail", "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r437", "r444" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncome": { "auth_ref": [ "r136", "r445", "r447" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.", "label": "Operating Lease, Lease Income", "terseLabel": "Rental income" } } }, "localname": "OperatingLeaseLeaseIncome", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Future Minimum Operating Lease Payments [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r431" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r431" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "verboseLabel": "Accrued liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r431" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Long-term lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r433", "r439" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows for leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r430" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets", "verboseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r441", "r444" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average remaining discount rate-operating leases (percent)" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r440", "r444" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term- operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]", "terseLabel": "Future Minimum Payments Due under Topic 840 [Abstract]" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r427", "r428" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "terseLabel": "2020" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r427", "r428" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "2024" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r427", "r428" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r427", "r428" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r427", "r428" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "2021" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r427", "r428" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "Thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r153", "r161" ], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]", "terseLabel": "Defined benefit pension and post-retirement benefit plans:" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]", "terseLabel": "Derivative instruments:" } } }, "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax": { "auth_ref": [ "r67", "r71", "r72", "r271" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, after Tax", "terseLabel": "Amortization of prior service cost included in net periodic benefit cost, net of tax benefit of $0.0* and $0.0*, respectively" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax", "terseLabel": "Tax on amortization of prior service cost included in net periodic benefit cost" } } }, "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r70" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Other comprehensive earnings (loss) before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r63", "r67" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "totalLabel": "Derivative instruments" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": { "auth_ref": [ "r63", "r67" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax", "terseLabel": "Change in unrealized loss, net of tax benefit of $0.0* and $0.0, respectively" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r63", "r67", "r385", "r390", "r401" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "terseLabel": "Loss Recognized in Other Comprehensive Earnings (Loss)" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESPretaxamountsRecognizedinAOCIontheBalanceSheetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax", "negatedTerseLabel": "Tax on increase (decrease) in unrealized gain on derivative instruments" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "auth_ref": [ "r67", "r71" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "negatedLabel": "Reclassification adjustments, net of tax benefit of $0.2 and $0.0, respectively", "terseLabel": "Amount of gain reclassified from accumulated other comprehensive loss into net earnings" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectivePortionofForeignCurrencyForwardContractsDesignatedasCashFlowHedgesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax", "verboseLabel": "Tax on reclassification adjustments on derivative instruments" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r61", "r421" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r75", "r78", "r80", "r236" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive (loss) earnings", "totalLabel": "Other comprehensive earnings (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive earnings (loss), net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r65", "r67" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTotalLabel": "Defined benefit pension and post-retirement benefit plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "auth_ref": [ "r67", "r71", "r72", "r271" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax", "negatedLabel": "Amortization of net actuarial loss included in net periodic benefit cost, net of tax expense of $(0.2) and $(0.1), respectively" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax", "terseLabel": "Tax on amortization of net actuarial loss included in net periodic benefit cost" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r68", "r327", "r329" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "negatedLabel": "Tax (expense) benefit" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities", "totalLabel": "Total other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r113" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Long-term Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Other long-term liabilities:" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r93" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r94" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (loss)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "terseLabel": "Other income, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "auth_ref": [ "r17", "r460", "r478" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.", "label": "Other Sundry Liabilities, Noncurrent", "verboseLabel": "Other" } } }, "localname": "OtherSundryLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain": { "auth_ref": [ "r174" ], "lang": { "en-US": { "role": { "documentation": "Provides the categories of debt securities, available-for-sale or held-to-maturity, on which an entity may recognize other than temporary impairments (OTTI) for which a portion related to credit losses has been recognized in earnings and a portion related to all other factors has been recognized in other comprehensive income.", "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]", "terseLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]" } } }, "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale": { "auth_ref": [ "r172" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings and other comprehensive loss (OCI).", "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale", "terseLabel": "Impairment charges" } } }, "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Varian Stockholders' Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r97", "r101", "r123" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r105" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchases of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r105" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedLabel": "Tax withholdings on vesting of equity awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r96", "r98", "r171" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Payments to Acquire Debt Securities, Available-for-sale", "terseLabel": "Payments to acquire available-for-sale securities" } } }, "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r99", "r345" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Cash paid" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r99" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r100" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r284" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for pension and other postretirement benefits.", "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]", "terseLabel": "RETIREMENT PLANS" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANS" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r256", "r273", "r274", "r283" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Defined Benefit Plans" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r288", "r315" ], "lang": { "en-US": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PositionAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by position taken for a security.", "label": "Position [Axis]", "terseLabel": "Position [Axis]" } } }, "localname": "PositionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PositionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates position taken for a security.", "label": "Position [Domain]", "terseLabel": "Position [Domain]" } } }, "localname": "PositionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r18" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock of $1 par value: 1.0 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r33", "r34" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.", "label": "Prepaid Expenses and Other Current Assets [Member]", "terseLabel": "Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r103" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Borrowings under credit facility agreement" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": { "auth_ref": [ "r102", "r316" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.", "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised", "terseLabel": "Proceeds from issuance of common stock to employees" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r104", "r107", "r123" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r103", "r106", "r115" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.", "label": "Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less", "terseLabel": "Net borrowings under the credit facility agreements with maturities less than 90 days" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfOtherInvestments": { "auth_ref": [ "r97" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from the sale of investments classified as other.", "label": "Proceeds from Sale of Other Investments", "terseLabel": "Sale of equity investments" } } }, "localname": "ProceedsFromSaleOfOtherInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r231", "r232", "r466" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "Accrued product warranty, at end of period", "periodStartLabel": "Accrued product warranty, at beginning of period" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAccruedProductWarrantyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r229" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedLabel": "Actual product warranty expenditures" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAccruedProductWarrantyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r74", "r77", "r108", "r157", "r162", "r355", "r359", "r360", "r369", "r370" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings", "totalLabel": "Net earnings", "verboseLabel": "Net earnings" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r36", "r217" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Leased equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment [Member]", "terseLabel": "Property, plant, and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r11", "r219", "r483" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": { "auth_ref": [ "r429" ], "lang": { "en-US": { "role": { "documentation": "Information by property that could be leased or is available for lease.", "label": "Property Subject to or Available for Operating Lease [Axis]", "terseLabel": "Property Subject to or Available for Operating Lease [Axis]" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable": { "auth_ref": [ "r429" ], "lang": { "en-US": { "role": { "documentation": "A listing by major property class of the amount of lessor property under a leasing agreement, and available for lease (not currently under lease), at cost, between the lessor and the lessee as of the balance sheet date.", "label": "Property Subject to or Available for Operating Lease, by Major Property Class [Table]", "terseLabel": "Property Subject to or Available for Operating Lease, by Major Property Class [Table]" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": { "auth_ref": [ "r429" ], "lang": { "en-US": { "role": { "documentation": "A descriptive title of whether the property is subject to or available for operating lease.", "label": "Property Subject to or Available for Operating Lease [Domain]", "terseLabel": "Property Subject to or Available for Operating Lease [Domain]" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property Subject to or Available for Operating Lease [Line Items]", "terseLabel": "Property Subject to or Available for Operating Lease [Line Items]" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReceivableTypeDomain": { "auth_ref": [ "r51" ], "lang": { "en-US": { "role": { "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.", "label": "Receivable [Domain]", "terseLabel": "Receivable [Domain]" } } }, "localname": "ReceivableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails", "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Receivables [Abstract]", "terseLabel": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]", "terseLabel": "Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items]" } } }, "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "auth_ref": [ "r70", "r73" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "negatedLabel": "Amounts reclassified out of other comprehensive earnings (loss)" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]", "terseLabel": "Reclassification Out Of Accumulated Other Comprehensive Income [Table]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Loss)" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r106" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedTerseLabel": "Repayments under credit facility agreement" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r323", "r496" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r1", "r9", "r116" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash - current" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r7", "r12", "r116", "r494" ], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Noncurrent", "terseLabel": "Restricted cash - long-term" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r23", "r241", "r480" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r256", "r257", "r273", "r274", "r283" ], "lang": { "en-US": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r256", "r257", "r273", "r274", "r283" ], "lang": { "en-US": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r248" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Unfulfilled Performance Obligations" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnfulfilledPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnfulfilledPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r249" ], "lang": { "en-US": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Remaining performance obligation, period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnfulfilledPerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r249" ], "lang": { "en-US": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnfulfilledPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnfulfilledPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": { "auth_ref": [ "r249" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]", "verboseLabel": "Schedule of Unfulfilled Performance Obligations" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r82", "r152", "r153", "r160" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 }, "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "netLabel": "Total revenues", "terseLabel": "Revenues", "verboseLabel": "Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value and cash flow hedges are recorded" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectivePortionofForeignCurrencyForwardContractsDesignatedasCashFlowHedgesDetail", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail", "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail", "http://www.varian.com/role/BORROWINGSScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r141" ], "lang": { "en-US": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenues" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectivePortionofForeignCurrencyForwardContractsDesignatedasCashFlowHedgesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r51" ], "lang": { "en-US": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails", "http://www.varian.com/role/RECEIVABLESDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Trade and Unbilled Receivables, Net and Notes Receivable" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RECEIVABLESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r333", "r334" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Cash, Cash Equivalents and Restricted Cash:" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r391" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Amounts Before Tax Included in AOCI on the Balance Sheet" } } }, "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r390" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Earnings (Loss)" } } }, "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r273", "r274", "r275", "r276", "r282" ], "lang": { "en-US": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule Of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r133" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Computation of Basic and Diluted Net Earnings (Loss) Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EARNINGSPERSHARETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r287", "r312", "r318" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r287", "r312", "r318" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Share-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable": { "auth_ref": [ "r321" ], "lang": { "en-US": { "role": { "documentation": "Describes the details pertaining to each employee stock ownership plan.", "label": "Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table]", "terseLabel": "Schedule Of Employee Stock Ownership Plan E S O P Disclosures [Table]" } } }, "localname": "ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r405", "r406" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Assets and Liabilities Measured at Fair Value on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r205", "r208" ], "lang": { "en-US": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule Of Finite Lived Intangible Assets [Table]", "verboseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r205", "r208" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Gross Carrying Amount and Accumulated Amortization of Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r201", "r202" ], "lang": { "en-US": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule Of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r201", "r202" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Activity of Goodwill by Reportable Operating Segment" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r212", "r214" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r8", "r30", "r31", "r32" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "verboseLabel": "Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "auth_ref": [ "r266" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.", "label": "Schedule of Net Benefit Costs [Table Text Block]", "terseLabel": "Schedule of Net Defined Benefit Costs" } } }, "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/RETIREMENTPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r377" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r392", "r394" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "terseLabel": "Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments" } } }, "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Other Income (Expense), Net:" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r233" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Accrued Product Warranty" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r151", "r157", "r158", "r159", "r201" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule Of Segment Reporting Information By Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail", "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r151", "r157", "r158", "r159", "r201" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Operating Results Information for Each Business Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r288", "r315" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r290", "r302", "r304" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Activity Under Employee Stock Plans" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r306" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Option Component of ESPP Shares with Weighted Average Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r306" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Fair Value of Employee Stock Option Plans With Weighted Average Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "auth_ref": [ "r41" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-term Debt [Table Text Block]", "terseLabel": "Schedule of Short-term Borrowings and Long-term Debt" } } }, "localname": "ScheduleOfShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "auth_ref": [ "r363", "r364", "r365", "r366", "r367" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "Schedule of Variable Interest Entities [Table]", "terseLabel": "Schedule Of Variable Interest Entities [Table]" } } }, "localname": "ScheduleOfVariableInterestEntitiesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r208" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentContinuingOperationsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Component of an entity expected to operate in the foreseeable future.", "label": "Continuing Operations [Member]", "terseLabel": "Continuing Operations" } } }, "localname": "SegmentContinuingOperationsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentOperatingActivitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Operations of an entity including continuing and discontinued operations.", "label": "Operating Activities [Domain]", "terseLabel": "Operating Activities [Domain]" } } }, "localname": "SegmentOperatingActivitiesDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r165" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail", "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r91", "r192" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [ "r95" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "verboseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeniorSubordinatedLoansMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A senior subordinated loan takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior subordinated debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors. However senior subordinated loans are junior to Senior Notes and loans and Senior bond holders.", "label": "Senior Subordinated Loans [Member]", "terseLabel": "Senior Subordinated Loans" } } }, "localname": "SeniorSubordinatedLoansMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r111" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r296" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Cancelled or expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r301" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Cancelled or expired (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r299" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r299" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Balance at end of period (in shares)", "periodStartLabel": "Balance at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Balance at end of period (in dollars per share)", "periodStartLabel": "Balance at beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant-Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r300" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r300" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r309" ], "lang": { "en-US": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r310" ], "lang": { "en-US": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail", "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Weighted Average Remaining Term (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r293" ], "lang": { "en-US": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r293" ], "lang": { "en-US": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r297" ], "lang": { "en-US": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Cancelled or expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r297" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Cancelled or expired (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r294" ], "lang": { "en-US": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value at grant date (dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r315" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Balance at end of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r292", "r315" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Balance at end of period (in shares)", "periodStartLabel": "Balance at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r291" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Balance at end of period (in dollars per share)", "periodStartLabel": "Balance at beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r286", "r289" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Equity Award" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail", "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r307", "r317" ], "lang": { "en-US": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r315" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r315" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r305" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Balance at end of period (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "negatedLabel": "Tax withholdings on vesting of equity awards (shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates the sale of a borrowed security or written option.", "label": "Short [Member]", "terseLabel": "Notional Value Sold" } } }, "localname": "ShortMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r13", "r459", "r479" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-term Debt", "terseLabel": "Short-term borrowings" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSScheduleofDebtDetails", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Charged to cost of revenues" } } }, "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAccruedProductWarrantyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r157", "r201", "r221", "r222", "r223", "r489" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r49", "r236" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement", "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail", "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by continuing and discontinuing operations.", "label": "Operating Activities [Axis]", "terseLabel": "Operating Activities [Axis]" } } }, "localname": "StatementOperatingActivitiesSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StockAppreciationRightsSARSMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.", "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Cash-settled Stock Appreciation Rights" } } }, "localname": "StockAppreciationRightsSARSMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r18", "r19", "r236", "r241" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r18", "r19", "r236", "r241", "r295" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r18", "r19", "r236", "r241" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased", "terseLabel": "Number of shares authorized by VMS Board of Directors to be repurchased (in shares)" } } }, "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased", "terseLabel": "Remaining authorization (shares)" } } }, "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r18", "r19", "r236", "r241" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedTerseLabel": "Repurchases of common stock (in shares)", "verboseLabel": "Number of shares (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement", "http://www.varian.com/role/STOCKHOLDERSEQUITYSharesRepurchasedDuringPeriodDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r18", "r19", "r236", "r241" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value", "negatedTerseLabel": "Repurchases of common stock" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r18", "r19", "r236", "r241" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "terseLabel": "Total cost of shares repurchased" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYSharesRepurchasedDuringPeriodDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r19", "r24", "r25", "r169" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Varian stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r352", "r353", "r368" ], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement", "http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r243" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITY" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.", "label": "Stockholders' Equity, Other", "negatedTerseLabel": "Other" } } }, "localname": "StockholdersEquityOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r449" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SUBSEQUENTEVENTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "OTHER FINANCIAL INFORMATION" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r337" ], "lang": { "en-US": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]", "terseLabel": "Technologies and patents" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ThreatenedLitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Risk of loss associated with the outcome of threatened litigation against the entity.", "label": "Threatened Litigation [Member]", "terseLabel": "Threatened Litigation" } } }, "localname": "ThreatenedLitigationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r255" ], "lang": { "en-US": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing of Transfer of Good or Service [Axis]", "terseLabel": "Timing of Transfer of Good or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing of Transfer of Good or Service [Domain]", "terseLabel": "Timing of Transfer of Good or Service [Domain]" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r338" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade names" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r255" ], "lang": { "en-US": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred at Point in Time [Member]", "terseLabel": "Products transferred at a point in time" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r255" ], "lang": { "en-US": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred over Time [Member]", "terseLabel": "Products and Services transferred over time" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r455" ], "lang": { "en-US": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Major Types of Debt and Equity Securities" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r137", "r138", "r139", "r140", "r142", "r143", "r144" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableInterestEntityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Variable Interest Entity [Line Items]", "terseLabel": "Variable Interest Entity [Line Items]" } } }, "localname": "VariableInterestEntityLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r438", "r444" ], "calculation": { "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r131" ], "calculation": { "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Dilutive effect of potential common shares (in shares)" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r127", "r131" ], "calculation": { "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares outstanding - diluted (in shares)", "totalLabel": "Weighted average shares outstanding - diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Shares used in the calculation of net earnings per share:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r126", "r131" ], "calculation": { "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares outstanding - basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS", "http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "var_APTCSecuritiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "APTC Securities [Member]", "label": "APTC Securities [Member]", "terseLabel": "APTC Securities" } } }, "localname": "APTCSecuritiesMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "var_AccountsReceivableFromVariableInterestEntity": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Accounts receivable from variable interest entity.", "label": "Accounts Receivable From Variable Interest Entity", "terseLabel": "Accounts receivable, includes unbilled accounts receivable" } } }, "localname": "AccountsReceivableFromVariableInterestEntity", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "var_AcquisitionrelatedExpenseBenefitandInprocessRD": { "auth_ref": [], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Acquisition-related Expense (Benefit) and In-process R&D", "label": "Acquisition-related Expense (Benefit) and In-process R&D", "terseLabel": "Acquisition-related expenses" } } }, "localname": "AcquisitionrelatedExpenseBenefitandInprocessRD", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS" ], "xbrltype": "monetaryItemType" }, "var_AdditionalLoanFacilityMaximumCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Additional Loan Facility Maximum Commitment Amount", "label": "Additional Loan Facility Maximum Commitment Amount", "terseLabel": "Additional maximum commitment amount" } } }, "localname": "AdditionalLoanFacilityMaximumCommitmentAmount", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "var_AssetAcquisitionConsiderationTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Consideration Transferred", "label": "Asset Acquisition, Consideration Transferred", "terseLabel": "Asset acquisition purchase price" } } }, "localname": "AssetAcquisitionConsiderationTransferred", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "var_AssetAcquisitionContingentConsiderationArrangementsChangeinRangeofOutcomesContingentConsiderationLiabilityValueHigh": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High", "label": "Asset Acquisition, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High", "terseLabel": "Asset acquisition, potential maximum payout of contingent consideration" } } }, "localname": "AssetAcquisitionContingentConsiderationArrangementsChangeinRangeofOutcomesContingentConsiderationLiabilityValueHigh", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "var_AssetAcquisitionContingentConsiderationLiabilityFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Contingent Consideration, Liability, Fair Value", "label": "Asset Acquisition, Contingent Consideration, Liability, Fair Value", "terseLabel": "Asset acquisition, fair value of contingent consideration" } } }, "localname": "AssetAcquisitionContingentConsiderationLiabilityFairValue", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "var_AssetAcquisitionHoldbackAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Asset Acquisition, Holdback Amount", "label": "Asset Acquisition, Holdback Amount", "negatedLabel": "Asset acquisition, holdback amount" } } }, "localname": "AssetAcquisitionHoldbackAmount", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "monetaryItemType" }, "var_BestMedicalInternationalInc.LitigationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Best Medical International, Inc. Litigation [Member]", "label": "Best Medical International, Inc. Litigation [Member]", "terseLabel": "Best Medical International, Inc. Litigation" } } }, "localname": "BestMedicalInternationalInc.LitigationMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_BusinessCombinationContingentConsiderationRevenueProjectionPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Combination, Contingent Consideration, Revenue Projection Period", "label": "Business Combination, Contingent Consideration, Revenue Projection Period", "terseLabel": "Revenue projection period for consideration payments" } } }, "localname": "BusinessCombinationContingentConsiderationRevenueProjectionPeriod", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "durationItemType" }, "var_CPTCMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "CPTC", "label": "C P T C [Member]", "terseLabel": "C P T C" } } }, "localname": "CPTCMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "var_CancerTreatmentServicesInternationalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cancer Treatment Services International [Member]", "label": "Cancer Treatment Services International [Member]", "terseLabel": "Cancer Treatment Services International" } } }, "localname": "CancerTreatmentServicesInternationalMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "domainItemType" }, "var_CashPaidForAmountsIncludedInTheMeasurementForLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cash Paid for Amounts Included in the Measurement for Lease Liabilities", "label": "Cash Paid for Amounts Included in the Measurement for Lease Liabilities [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashPaidForAmountsIncludedInTheMeasurementForLeaseLiabilitiesAbstract", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "stringItemType" }, "var_ClaimsFiledAgainstAssetsofCompanyinBankruptcy": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Claims Filed Against Assets of Company in Bankruptcy", "label": "Claims Filed Against Assets of Company in Bankruptcy", "terseLabel": "Claims filed against assets of Company in bankruptcy" } } }, "localname": "ClaimsFiledAgainstAssetsofCompanyinBankruptcy", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "var_CommitmentsAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commitments and Contingencies [Line Items]", "label": "Commitments And Contingencies [Line Items]", "terseLabel": "Commitments And Contingencies [Line Items]" } } }, "localname": "CommitmentsAndContingenciesLineItems", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "var_CommitmentsAndContingenciesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commitments and Contingencies [Table]", "label": "Commitments And Contingencies [Table]", "terseLabel": "Commitments And Contingencies [Table]" } } }, "localname": "CommitmentsAndContingenciesTable", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "var_ContingentConsiderationLiabilityFairValue": { "auth_ref": [], "calculation": { "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Contingent Consideration Liability, Fair Value", "label": "Contingent Consideration Liability, Fair Value", "negatedTerseLabel": "Contingent consideration" } } }, "localname": "ContingentConsiderationLiabilityFairValue", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "var_ContingentConsiderationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Contingent consideration [member]", "label": "Contingent Consideration [Member]", "terseLabel": "Contingent Consideration" } } }, "localname": "ContingentConsiderationMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "var_CostOfRevenuesProductMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cost of Revenues - Product [Member]", "label": "Cost Of Revenues Product [Member]", "terseLabel": "Cost of revenues - Product" } } }, "localname": "CostOfRevenuesProductMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "var_CostOfRevenuesServiceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cost Of Revenues Service [Member]", "label": "Cost Of Revenues Service [Member]", "terseLabel": "Cost of revenues - Service" } } }, "localname": "CostOfRevenuesServiceMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail" ], "xbrltype": "domainItemType" }, "var_DebtInstrumentContractRepaymentDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Contract Repayment Date", "label": "Debt Instrument, Contract Repayment Date", "terseLabel": "Debt instrument, contract repayment date" } } }, "localname": "DebtInstrumentContractRepaymentDate", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "var_DebtorinPossessionFinancingLiabilitiesAssumedbyLenders": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debtor in Possession, Financing, Liabilities Assumed by Lenders", "label": "Debtor in Possession, Financing, Liabilities Assumed by Lenders", "terseLabel": "Liabilities assumed by lenders" } } }, "localname": "DebtorinPossessionFinancingLiabilitiesAssumedbyLenders", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "var_EmbolicsMicrospheresBusinessMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Embolics Microspheres Business", "label": "Embolics Microspheres Business [Member]", "terseLabel": "Embolics Microspheres Business" } } }, "localname": "EmbolicsMicrospheresBusinessMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "domainItemType" }, "var_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee stock purchase plan.", "label": "Employee Stock Purchase Plan [Member]", "terseLabel": "Employee Stock Purchase Plan" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail" ], "xbrltype": "domainItemType" }, "var_EndocareandAliconMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Endocare and Alicon [Member]", "label": "Endocare and Alicon [Member]", "terseLabel": "Endocare and Alicon" } } }, "localname": "EndocareandAliconMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "domainItemType" }, "var_EurodollarPlus1Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Eurodollar Plus 1% [Member]", "label": "Eurodollar Plus 1% [Member]", "terseLabel": "Eurodollar Rate plus 1%" } } }, "localname": "EurodollarPlus1Member", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdjustmentsDueToEffectOfForeignExchange": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments Due to Effect of Foreign Exchange", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments Due to Effect of Foreign Exchange", "terseLabel": "Adjustments due to the effect of foreign exchange" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdjustmentsDueToEffectOfForeignExchange", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "var_FinancingReceivableStatedRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Stated Rate", "label": "Financing Receivable, Stated Rate", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "FinancingReceivableStatedRate", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "var_FinancingReceivableTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financing Receivable, Term", "label": "Financing Receivable, Term", "terseLabel": "Term (in years)" } } }, "localname": "FinancingReceivableTerm", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "var_HardwareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Hardware [Member]", "label": "Hardware [Member]", "terseLabel": "Hardware" } } }, "localname": "HardwareMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "var_IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Increase (Decrease) In Accrued Liabilities And Other Non-current Liabilities", "label": "Increase (Decrease) In Accrued Liabilities And Other Non-current Liabilities", "terseLabel": "Accrued liabilities and other long-term liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "var_InternationalExcludingNorthAmericaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "International, Excluding North America [Member]", "label": "International, Excluding North America [Member]", "terseLabel": "International" } } }, "localname": "InternationalExcludingNorthAmericaMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "var_LesseeFinanceLeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee Finance Leases", "label": "Lessee Finance Leases [Abstract]", "terseLabel": "Finance leases:" } } }, "localname": "LesseeFinanceLeasesAbstract", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "stringItemType" }, "var_LesseeOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee Operating Leases", "label": "Lessee Operating Leases [Abstract]", "terseLabel": "Operating leases:" } } }, "localname": "LesseeOperatingLeasesAbstract", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "stringItemType" }, "var_LoanFacilityMaximumLendingCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Loan Facility Maximum Lending Commitment", "label": "Loan Facility Maximum Lending Commitment", "terseLabel": "Maximum lending commitment" } } }, "localname": "LoanFacilityMaximumLendingCommitment", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "var_LoansNotesTradeandOtherReceivablesIncludingFinancingReceivablesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loans, Notes, Trade and Other Receivables, Including Financing Receivables Disclosure [Text Block]", "label": "Loans, Notes, Trade and Other Receivables, Including Financing Receivables Disclosure [Text Block]", "terseLabel": "RECEIVABLES" } } }, "localname": "LoansNotesTradeandOtherReceivablesIncludingFinancingReceivablesDisclosureTextBlock", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/RECEIVABLES" ], "xbrltype": "textBlockItemType" }, "var_LoansandInvestments": { "auth_ref": [], "calculation": { "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Loans and Investments", "label": "Loans and Investments", "totalLabel": "Loans and Investments" } } }, "localname": "LoansandInvestments", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "var_LongTermLeaseLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long-term Lease Liabilities", "label": "Long-term Lease Liabilities [Member]", "terseLabel": "Long-term Lease Liabilities" } } }, "localname": "LongTermLeaseLiabilitiesMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails" ], "xbrltype": "domainItemType" }, "var_MMProtonILLCMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MM Proton I, LLC [Member]", "label": "MM Proton I, LLC [Member]", "terseLabel": "NYPC loan" } } }, "localname": "MMProtonILLCMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "var_MPTCSeriesB1BondsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MPTC Series B-1 Bonds [Member]", "label": "MPTC Series B-1 Bonds [Member]", "terseLabel": "MPTC Series B-1 Bonds" } } }, "localname": "MPTCSeriesB1BondsMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_MPTCSeriesB2BondsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MPTC Series B-2 Bonds [Member]", "label": "MPTC Series B-2 Bonds [Member]", "terseLabel": "MPTC Series B-2 Bonds" } } }, "localname": "MPTCSeriesB2BondsMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_MPTCSubordinatedBondsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MPTC Subordinated Bonds [Member]", "label": "MPTC Subordinated Bonds [Member]", "terseLabel": "MPTC Series B-2 Bonds" } } }, "localname": "MPTCSubordinatedBondsMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "var_MPTCSubordinatedRevenueBondsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MPTC Subordinated Revenue Bonds [Member]", "label": "MPTC Subordinated Revenue Bonds [Member]", "terseLabel": "MPTC Series B-1 Bonds" } } }, "localname": "MPTCSubordinatedRevenueBondsMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "var_MarylandProtonTherapyCenterMPTCMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Maryland Proton Therapy Center (MPTC) [Member]", "label": "Maryland Proton Therapy Center (MPTC) [Member]", "verboseLabel": "MPTC loans (1)" } } }, "localname": "MarylandProtonTherapyCenterMPTCMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_MaximumLendingCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum Lending Commitment", "label": "Maximum Lending Commitment", "terseLabel": "Maximum lending commitment" } } }, "localname": "MaximumLendingCommitment", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "var_MultiCurrencyBorrowingsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Multi-currency Borrowings", "label": "Multi-currency Borrowings [Member]", "terseLabel": "Multi-currency Borrowings" } } }, "localname": "MultiCurrencyBorrowingsMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Net Income (Loss) Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest", "label": "Net Income (Loss) Including Portion Attributable to Noncontrolling Interest Excluding Redeemable Noncontrolling Interest", "terseLabel": "Net earnings (loss)" } } }, "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement" ], "xbrltype": "monetaryItemType" }, "var_NewYorkProtonCenterMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "New York Proton Center [Member]", "label": "New York Proton Center [Member]", "terseLabel": "New York Proton Center" } } }, "localname": "NewYorkProtonCenterMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_NoteReceivableDefaultInterestRatePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Note Receivable, Default Interest Rate, Percent", "label": "Note Receivable, Default Interest Rate, Percent", "terseLabel": "Interest receivable, default rate (percent)" } } }, "localname": "NoteReceivableDefaultInterestRatePercent", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "var_NotesLoansandFinancingReceivableNet": { "auth_ref": [], "calculation": { "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Notes, Loans and Financing Receivable, Net", "label": "Notes, Loans and Financing Receivable, Net", "totalLabel": "Notes receivable and secured debt" } } }, "localname": "NotesLoansandFinancingReceivableNet", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "var_November2016Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "November 2016 [Member]", "label": "November 2016 [Member]", "terseLabel": "November 2016" } } }, "localname": "November2016Member", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_NumberofCancerCenters": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Cancer Centers", "label": "Number of Cancer Centers", "verboseLabel": "Number of cancer centers" } } }, "localname": "NumberofCancerCenters", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail", "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails" ], "xbrltype": "integerItemType" }, "var_NumberofSpecialtyHospitals": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Specialty Hospitals", "label": "Number of Specialty Hospitals", "verboseLabel": "Number of specialty hospitals" } } }, "localname": "NumberofSpecialtyHospitals", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail", "http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails" ], "xbrltype": "integerItemType" }, "var_NumberofTranches": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Tranches", "label": "Number of Tranches", "terseLabel": "Number of Tranches" } } }, "localname": "NumberofTranches", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "var_OncologySystemsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Oncology Systems", "label": "Oncology Systems [Member]", "terseLabel": "Oncology Systems" } } }, "localname": "OncologySystemsMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "var_OtherFinancialInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Financial Information [Abstract]", "label": "Other Financial Information [Abstract]", "terseLabel": "Other Financial Information [Abstract]" } } }, "localname": "OtherFinancialInformationAbstract", "nsuri": "http://www.varian.com/20200103", "xbrltype": "stringItemType" }, "var_PaidinkindInterestReceivablePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Paid-in-kind Interest Receivable, Percent", "label": "Paid-in-kind Interest Receivable, Percent", "terseLabel": "Paid-in-kind interest receivable (percent)" } } }, "localname": "PaidinkindInterestReceivablePercent", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "var_PaymentstoAcquireSeniorSecuredDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payments to Acquire Senior Secured Debt", "label": "Payments to Acquire Senior Secured Debt", "terseLabel": "Payments to acquire outstanding senior debt" } } }, "localname": "PaymentstoAcquireSeniorSecuredDebt", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "var_PercentageAddedToEurodollarBaseRateBeforeMargin": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage added to Eurodollar base rate before margin.", "label": "Percentage Added To Eurodollar Base Rate Before Margin", "terseLabel": "Percentage added to Eurodollar base rate before margin (as a percent)" } } }, "localname": "PercentageAddedToEurodollarBaseRateBeforeMargin", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "var_PrivatelyheldCompanyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Privately-held Company [Member]", "label": "Privately-held Company [Member]", "terseLabel": "Privately-held Company" } } }, "localname": "PrivatelyheldCompanyMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "domainItemType" }, "var_PrivatelyheldSoftwareCompanyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Privately-held Software Company [Member]", "label": "Privately-held Software Company [Member]", "terseLabel": "Privately-held Software Company" } } }, "localname": "PrivatelyheldSoftwareCompanyMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BUSINESSCOMBINATIONSDetails" ], "xbrltype": "domainItemType" }, "var_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization", "terseLabel": "Accumulated amortization on equipment leased to customers, included in PP&E" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "var_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization", "terseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "var_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization", "terseLabel": "Equipment leased to customers included in PP&E" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "var_ProtonCenterMunichMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Proton Center, Munich [Member]", "label": "Proton Center, Munich [Member]", "terseLabel": "Proton Center, Munich" } } }, "localname": "ProtonCenterMunichMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_ProtonInternationalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Proton International [Member]", "label": "Proton International [Member]", "terseLabel": "Proton International LLC loan" } } }, "localname": "ProtonInternationalMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "var_ProtonSolutionsLoansandInvestmentsTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Proton Solutions Loans and Investments [Text Block]", "label": "Proton Solutions Loans and Investments [Text Block]", "terseLabel": "PROTON SOLUTIONS LOANS AND INVESTMENTS" } } }, "localname": "ProtonSolutionsLoansandInvestmentsTextBlock", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTS" ], "xbrltype": "textBlockItemType" }, "var_ProtonSolutionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Proton Solutions [Member]", "label": "Proton Solutions [Member]", "terseLabel": "Proton Solutions" } } }, "localname": "ProtonSolutionsMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail", "http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail", "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails", "http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail" ], "xbrltype": "domainItemType" }, "var_RPTCSecuritiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "RPTC Securities [Member]", "label": "RPTC Securities [Member]", "terseLabel": "RPTC senior secured debt", "verboseLabel": "RPTC Securities" } } }, "localname": "RPTCSecuritiesMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "var_RealizedandUnrealizedGainonInvestments": { "auth_ref": [], "calculation": { "http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Realized and Unrealized Gain on Investments", "label": "Realized and Unrealized Gain on Investments", "terseLabel": "Gain on equity investments" } } }, "localname": "RealizedandUnrealizedGainonInvestments", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "var_RemainingObligationFundLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Remaining Obligation Fund Loan", "label": "Remaining Obligation Fund Loan", "verboseLabel": "Commitment" } } }, "localname": "RemainingObligationFundLoan", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "var_RemainingObligationtoFundBond": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Remaining Obligation to Fund Bond", "label": "Remaining Obligation to Fund Bond", "terseLabel": "Commitment" } } }, "localname": "RemainingObligationtoFundBond", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "var_RestrictedStockRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restricted Stock, Restricted Stock Units, Deferred Stock Units And Performance Units [Member]", "label": "Restricted Stock Restricted Stock Units Deferred Stock Units And Performance Units [Member]", "terseLabel": "Restricted stocks, restricted stock units, deferred stock units and performance units" } } }, "localname": "RestrictedStockRestrictedStockUnitsDeferredStockUnitsAndPerformanceUnitsMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_RevolvingLoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revolving Loan [Member]", "label": "Revolving Loan [Member]", "terseLabel": "Revolving Loan" } } }, "localname": "RevolvingLoanMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "var_ScheduleOfLoansandInvestmentstoFundPTCentersTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule Of Loans and Investments to Fund PT Centers [Table Text Block]", "label": "Schedule Of Loans and Investments to Fund PT Centers [Table Text Block]", "terseLabel": "Schedule of Loans and Investments to Fund PT Centers" } } }, "localname": "ScheduleOfLoansandInvestmentstoFundPTCentersTableTextBlock", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSTables" ], "xbrltype": "textBlockItemType" }, "var_ScheduleofCashFlowHedgingActivitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Cash Flow Hedging Activities [Table Text Block]", "label": "Schedule of Cash Flow Hedging Activities [Table Text Block]", "terseLabel": "Schedule of Cash Flow Hedging Activities" } } }, "localname": "ScheduleofCashFlowHedgingActivitiesTableTextBlock", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" ], "xbrltype": "textBlockItemType" }, "var_SeniorFirstLienLoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior First Lien Loan [Member]", "label": "Senior First Lien Loan [Member]", "terseLabel": "Senior First Lien Loan" } } }, "localname": "SeniorFirstLienLoanMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_ServiceExcludingSoftwareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Service, Excluding Software [Member]", "label": "Service, Excluding Software [Member]", "terseLabel": "Service" } } }, "localname": "ServiceExcludingSoftwareMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "var_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]", "verboseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail" ], "xbrltype": "stringItemType" }, "var_ShareRepurchasesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Repurchases [Table Text Block]", "label": "Share Repurchases [Table Text Block]", "terseLabel": "Schedule of Share Repurchases" } } }, "localname": "ShareRepurchasesTableTextBlock", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYTables" ], "xbrltype": "textBlockItemType" }, "var_ShareholdersEquityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Shareholders Equity [Line Items]", "label": "Shareholders Equity [Line Items]", "terseLabel": "Stockholders\u2019 equity and noncontrolling interests [Line Items]" } } }, "localname": "ShareholdersEquityLineItems", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "var_ShareholdersEquityTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Shareholders Equity [Table]", "label": "Shareholders Equity [Table]", "terseLabel": "Shareholders Equity [Table]" } } }, "localname": "ShareholdersEquityTable", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "var_SoftwareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Software [Member]", "label": "Software [Member]", "terseLabel": "Software" } } }, "localname": "SoftwareMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "var_StockRepurchasedDuringPeriodAverageCostPerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock Repurchased During Period, Per Share", "label": "Stock Repurchased During Period, Average Cost Per Share", "terseLabel": "Average repurchase price per share (in dollars per share)" } } }, "localname": "StockRepurchasedDuringPeriodAverageCostPerShare", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/STOCKHOLDERSEQUITYSharesRepurchasedDuringPeriodDetails" ], "xbrltype": "perShareItemType" }, "var_SumitomoCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sumitomo credit facility.", "label": "Sumitomo Credit Facility [Member]", "terseLabel": "Sumitomo Credit Facility" } } }, "localname": "SumitomoCreditFacilityMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_SwingLineLoansMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Swing line loans.", "label": "Swing Line Loans [Member]", "terseLabel": "Swing Line Loans" } } }, "localname": "SwingLineLoansMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/BORROWINGSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_TermLoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Term Loan", "label": "Term Loan [Member]", "terseLabel": "Term Loan" } } }, "localname": "TermLoanMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail", "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails" ], "xbrltype": "domainItemType" }, "var_TrancheALoansMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tranche A loans.", "label": "Tranche A Loans [Member]", "terseLabel": "Tranche A loan" } } }, "localname": "TrancheALoansMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_TrancheBLoansMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tranche B loans.", "label": "Tranche B Loans [Member]", "terseLabel": "Tranche B loan" } } }, "localname": "TrancheBLoansMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_TrancheCLoansMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tranche C Loans [Member]", "label": "Tranche C Loans [Member]", "terseLabel": "Tranche C Loans" } } }, "localname": "TrancheCLoansMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_TrancheDLoansMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tranche D Loans [Member]", "label": "Tranche D Loans [Member]", "terseLabel": "Tranche D Loans" } } }, "localname": "TrancheDLoansMember", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "var_UnbilledReceivablesfromVariableInterestEntity": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Unbilled Receivables from Variable Interest Entity", "label": "Unbilled Receivables from Variable Interest Entity", "terseLabel": "Unbilled receivables from variable interest entity" } } }, "localname": "UnbilledReceivablesfromVariableInterestEntity", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "var_VarianMedicalSystemsInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Varian Medical Systems, Inc. [Member]", "label": "Varian Medical Systems, Inc. [Member]", "terseLabel": "Varian Medical Systems, Inc." } } }, "localname": "VarianMedicalSystemsInc.Member", "nsuri": "http://www.varian.com/20200103", "presentation": [ "http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail" ], "xbrltype": "domainItemType" } }, "unitCount": 11 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3098-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r124": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=118952077&loc=SL77927221-108306" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8615-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8654-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8657-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8660-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8663-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8672-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=SL6284422-111562" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27340-111563" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "8B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=SL6284393-111563" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r215": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r224": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB TOPIC 5.Y.Q2)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r235": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653" }, "r243": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929" }, "r322": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e39076-109324" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5227-128473" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5291-111683" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5710-111685" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5728-111685" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759159-111685" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5747-111685" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6228884-111685" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-02(b))", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-02)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-03(b))", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-03)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=118875152&loc=SL5864739-113975" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061190-113977" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994" }, "r404": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=84164653&loc=d3e41551-112718" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888421&loc=SL77919311-209978" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919359-209981" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919372-209981" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r449": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(9))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117420044&loc=d3e19393-158473" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=116631420&loc=SL116631458-115580" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r497": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r498": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r499": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a),(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r500": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r501": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r502": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3151-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" } }, "version": "2.1" } XML 22 R43.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OTHER FINANCIAL INFORMATION - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Dec. 28, 2018
Sep. 28, 2018
Other Financial Information [Abstract]        
Cash and cash equivalents $ 721.9 $ 531.4    
Restricted cash - current 3.7 4.2    
Restricted cash - long-term 16.6 8.5    
Total cash, cash equivalents, and restricted cash $ 742.2 $ 544.1 $ 628.7 $ 516.4
XML 23 R47.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities $ 60.0 $ 58.8
Fair Value, Measurements, Recurring    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Derivative assets 2.3 2.8
Total assets measured at fair value 79.8 61.8
Contingent consideration (84.3) (75.3)
Total liabilities measured at fair value (84.3) (75.3)
Fair Value, Measurements, Recurring | MPTC Series B-1 Bonds    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 27.6 27.1
Fair Value, Measurements, Recurring | MPTC Series B-2 Bonds    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 25.7 25.1
Fair Value, Measurements, Recurring | APTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 6.7 6.6
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Derivative assets 0.0 0.0
Total assets measured at fair value 17.5 0.2
Contingent consideration 0.0 0.0
Total liabilities measured at fair value 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments | MPTC Series B-1 Bonds    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments | MPTC Series B-2 Bonds    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 0.0 0.0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments | APTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Derivative assets 2.3 2.8
Total assets measured at fair value 62.3 61.6
Contingent consideration 0.0 0.0
Total liabilities measured at fair value 0.0 0.0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs | MPTC Series B-1 Bonds    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 27.6 27.1
Fair Value, Measurements, Recurring | Significant Other Observable Inputs | MPTC Series B-2 Bonds    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 25.7 25.1
Fair Value, Measurements, Recurring | Significant Other Observable Inputs | APTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 6.7 6.6
Fair Value, Measurements, Recurring | Significant Unobservable Inputs    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Derivative assets 0.0 0.0
Total assets measured at fair value 0.0 0.0
Contingent consideration (84.3) (75.3)
Total liabilities measured at fair value (84.3) (75.3)
Fair Value, Measurements, Recurring | Significant Unobservable Inputs | MPTC Series B-1 Bonds    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs | MPTC Series B-2 Bonds    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 0.0 0.0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs | APTC Securities    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Available-for-sale securities 0.0 0.0
Money Market Funds | Fair Value, Measurements, Recurring    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Cash equivalents 17.5 0.2
Money Market Funds | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Instruments    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Cash equivalents 17.5 0.2
Money Market Funds | Fair Value, Measurements, Recurring | Significant Other Observable Inputs    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Cash equivalents 0.0 0.0
Money Market Funds | Fair Value, Measurements, Recurring | Significant Unobservable Inputs    
Assets/Liabilities Measured at Fair Value on a Recurring Basis    
Cash equivalents $ 0.0 $ 0.0
XML 24 R71.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period $ 1,777.6 $ 1,588.7
Balance at end of period 1,857.3 1,682.0
Net Unrealized Gains (Losses) Defined Benefit Pension and Post-Retirement Benefit Plans    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period (61.7) (35.2)
Other comprehensive earnings (loss) before reclassifications 0.0 0.0
Amounts reclassified out of other comprehensive earnings (loss) 0.9 0.4
Tax (expense) benefit (0.2) (0.1)
Balance at end of period (61.0) (34.9)
Net Unrealized Gains Cash Flow Hedging Instruments    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period 2.1  
Other comprehensive earnings (loss) before reclassifications (0.1)  
Amounts reclassified out of other comprehensive earnings (loss) (0.8)  
Tax (expense) benefit 0.2  
Balance at end of period 1.4  
Cumulative Translation Adjustment    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period (42.5) (30.1)
Other comprehensive earnings (loss) before reclassifications 5.1 (4.0)
Amounts reclassified out of other comprehensive earnings (loss) 0.0 0.0
Tax (expense) benefit 0.0 0.0
Balance at end of period (37.4) (34.1)
Accumulated Other Comprehensive Loss    
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]    
Balance at beginning of period (102.1) (65.3)
Other comprehensive earnings (loss) before reclassifications 5.0 (4.0)
Amounts reclassified out of other comprehensive earnings (loss) 0.1 0.4
Tax (expense) benefit 0.0 (0.1)
Balance at end of period $ (97.0) $ (69.0)
XML 25 R81.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION - Additional Information (Detail)
 3 Months Ended
Jan. 03, 2020
segment
specialty_hospital
cancer_center
Segment Reporting Information [Line Items]  
Number of segments | segment 2
India  
Segment Reporting Information [Line Items]  
Number of cancer centers 10
Number of specialty hospitals | specialty_hospital 1
Sri Lanka  
Segment Reporting Information [Line Items]  
Number of cancer centers 1
XML 26 R75.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Jan. 03, 2020
USD ($)
$ / shares
shares
Number of Shares  
Balance at beginning of period (in shares) | shares 2.2
Granted (in shares) | shares 0.1
Cancelled or expired (in shares) | shares 0.0
Exercised (in shares) | shares (0.1)
Balance at end of period (in shares) | shares 2.2
Exercisable (in shares) | shares 1.1
Weighted Average Exercise Price  
Balance at beginning of period (in dollars per share) $ 97.66
Granted (in dollars per share) 131.34
Cancelled or expired (in dollars per share) 99.35
Exercised (in dollars per share) 82.03
Balance at end of period (in dollars per share) 101.01
Exercisable (in dollars per share) $ 82.38
Weighted Average Remaining Term (in years)  
Balance at end of period (in years) 4 years 7 months 6 days
Exercisable (in years) 3 years 4 months 24 days
Aggregate Intrinsic Value  
Balance at end of period | $ $ 98.0
Exercisable | $ $ 68.2
Share price (in dollars per share) $ 144.93
XML 27 R79.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
PROTON SOLUTIONS LOANS AND INVESTMENTS - Loans and Commitments (Details) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Dec. 06, 2017
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Available-for-sale securities $ 60.0 $ 58.8  
Commitment 0.0 0.0  
Loans Receivable      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Notes receivable and secured debt 58.1 57.1  
Commitment 0.0 0.0  
NYPC loan | Loans Receivable      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Long-term 32.3 31.8  
Commitment 0.0 0.0  
RPTC senior secured debt | Loans Receivable      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Short-term 24.0 23.5  
Commitment 0.0 0.0  
Proton International LLC loan | Loans Receivable      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Long-term 1.8 1.8  
Commitment 0.0 0.0  
MPTC Series B-1 Bonds      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Available-for-sale securities 27.6 27.1  
Commitment 0.0 0.0  
MPTC Series B-2 Bonds      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Available-for-sale securities 25.7 25.1  
Commitment 0.0 0.0  
APTC Securities      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Available-for-sale securities 6.7 6.6  
Commitment 0.0 0.0  
C P T C      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Loans and Investments 49.3 49.3  
Commitment 1.9 1.9  
C P T C | Loans Receivable      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Term loan     $ 112.0
C P T C | Revolving Loan      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Short-term revolving loan 5.3 5.3  
Commitment 1.9 1.9  
C P T C | Term Loan      
Long-term notes receivable and Available-for-sale Securities [Line Items]      
Term loan 44.0 44.0  
Commitment $ 0.0 $ 0.0  
XML 28 R56.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
BORROWINGS - Additional Information (Detail)
 3 Months Ended
Nov. 01, 2019
USD ($)
Jan. 03, 2020
JPY (¥)
Oct. 31, 2019
USD ($)
Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Credit facility term (in years) 5 years    
Loan facility, maximum borrowing capacity $ 1,200,000,000   $ 1,800,000,000
Additional maximum commitment amount 100,000,000.0    
Revolving Credit Facility | Minimum      
Line Of Credit Facility [Line Items]      
Commitment fee   0.10%  
Revolving Credit Facility | Maximum      
Line Of Credit Facility [Line Items]      
Commitment fee   0.225%  
Eurodollar | Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Debt instrument, contract repayment date   12 months  
Eurodollar | Revolving Credit Facility | Minimum      
Line Of Credit Facility [Line Items]      
Line of credit, basis spread on variable rate (as a percent)   1.00%  
Eurodollar | Revolving Credit Facility | Maximum      
Line Of Credit Facility [Line Items]      
Line of credit, basis spread on variable rate (as a percent)   1.375%  
Eurodollar Rate plus 1% | Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Percentage added to Eurodollar base rate before margin (as a percent)   1.00%  
Eurodollar Rate plus 1% | Revolving Credit Facility | Minimum      
Line Of Credit Facility [Line Items]      
Line of credit, basis spread on variable rate (as a percent)   0.00%  
Eurodollar Rate plus 1% | Revolving Credit Facility | Maximum      
Line Of Credit Facility [Line Items]      
Line of credit, basis spread on variable rate (as a percent)   0.375%  
Federal Funds Rate | Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Line of credit, basis spread on variable rate (as a percent)   0.50%  
Sumitomo Credit Facility      
Line Of Credit Facility [Line Items]      
Loan facility, maximum borrowing capacity | ¥   ¥ 3,000,000,000.0  
Outstanding principal balance | ¥   ¥ 0  
Line of credit, basis spread on variable rate (as a percent)   0.50%  
Multi-currency Borrowings | Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Loan facility, maximum borrowing capacity 500,000,000    
Letter of Credit | Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Loan facility, maximum borrowing capacity 225,000,000   $ 50,000,000.0
Swing Line Loans | Revolving Credit Facility      
Line Of Credit Facility [Line Items]      
Loan facility, maximum borrowing capacity $ 25,000,000    
EXCEL 29 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 30 R52.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Finite Lived Intangible Assets [Line Items]    
Finite lived intangible assets, gross $ 408.7 $ 408.7
Accumulated Amortization (130.5) (120.7)
Net Carrying Amount 278.2 288.0
In-process research and development with indefinite lives 12.7 12.7
Total intangible assets 421.4 421.4
Total intangible assets, net 290.9 300.7
Technologies and patents    
Finite Lived Intangible Assets [Line Items]    
Finite lived intangible assets, gross 226.4 226.4
Accumulated Amortization (92.2) (85.9)
Net Carrying Amount 134.2 140.5
Customer contracts, supplier relationships, and partner relationships    
Finite Lived Intangible Assets [Line Items]    
Finite lived intangible assets, gross 121.1 121.1
Accumulated Amortization (28.1) (25.7)
Net Carrying Amount 93.0 95.4
Trade names    
Finite Lived Intangible Assets [Line Items]    
Finite lived intangible assets, gross 55.1 55.1
Accumulated Amortization (4.1) (3.0)
Net Carrying Amount 51.0 52.1
Other    
Finite Lived Intangible Assets [Line Items]    
Finite lived intangible assets, gross 6.1 6.1
Accumulated Amortization (6.1) (6.1)
Net Carrying Amount $ 0.0 $ 0.0
XML 31 R33.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES (Tables)
 3 Months Ended
Jan. 03, 2020
Commitments and Contingencies Disclosure [Abstract]  
Accrued Product Warranty
The following table reflects the changes in the Company’s accrued product warranty:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Accrued product warranty, at beginning of period$43.2  $44.8  
Charged to cost of revenues20.8  13.3  
Actual product warranty expenditures(17.8) (11.8) 
Accrued product warranty, at end of period$46.2  $46.3  
Components of Lease Expense, Supplemental Cash Flow Information and Supplemental Balance Sheet Information
The following table summarizes the components of the Company's lease cost:
Three Months Ended
(In millions)January 3, 2020
Operating lease cost$7.8  
Finance lease cost:
Amortization of right-of-use assets0.1  
Interest on lease liabilities0.1  
Variable lease cost4.5  
Total lease cost$12.5  

The following table summarizes the supplemental cash flow information related to the Company's operating leases:
Three Months Ended
(In millions)January 3, 2020
Cash paid for amounts included in the measurement of lease liabilities:
   Operating cash flows for leases$8.8  
The following table summarizes supplemental balance sheet information related to the Company's operating and finance leases:
(In millions)January 3, 2020
Operating leases:
Operating right-of-use assets$114.1  
Accrued liabilities$24.4  
Long-term lease liabilities93.7  
   Total lease liabilities$118.1  
Finance leases:
Property, plant, and equipment, net$14.3  
Accrued liabilities$3.4  
Other long-term liabilities10.5
Total lease liabilities$13.9  

The following table summarizes the weighted lease term and discount rate by operating and finance leases:
January 3, 2020
Weighted average remaining lease term in years
Operating leases7.0
Finance leases4.8
Weighted average discount rate
Operating leases4.8 %
Finance leases1.5 %
Future Minimum Operating Lease Payments
As of January 3, 2020, the future minimum lease payments are as follows:
(In millions)Operating LeasesFinance leases
Remainder of 2020$21.5  $2.9  
202125.8  3.5  
202220.3  2.9  
202315.4  2.9  
202411.8  1.1  
Thereafter51.4  1.1  
  Total minimum lease payments$146.2  $14.4  
Less: imputed interest28.1  0.5  
Total operating lease liability$118.1  $13.9  
Finance Lease Liability Maturity
As of January 3, 2020, the future minimum lease payments are as follows:
(In millions)Operating LeasesFinance leases
Remainder of 2020$21.5  $2.9  
202125.8  3.5  
202220.3  2.9  
202315.4  2.9  
202411.8  1.1  
Thereafter51.4  1.1  
  Total minimum lease payments$146.2  $14.4  
Less: imputed interest28.1  0.5  
Total operating lease liability$118.1  $13.9  
XML 32 R37.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EARNINGS PER SHARE (Tables)
 3 Months Ended
Jan. 03, 2020
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Net Earnings (Loss) Per Share
The following table sets forth the computation of basic and diluted net earnings per share:
 Three Months Ended
(In millions, except per share amounts)January 3,
2020		December 28,
2018
Net earnings$88.9  $103.9  
Less: Net earnings attributable to noncontrolling interests0.7  0.7  
Net earnings attributable to Varian $88.2  $103.2  
Denominator:
Weighted average shares outstanding - basic90.9  91.0  
Dilutive effect of potential common shares0.8  1.0  
Weighted average shares outstanding - diluted91.7  92.0  
Net earnings per share attributable to Varian - basic$0.97  $1.13  
Net earnings per share attributable to Varian - diluted$0.96  $1.12  
Anti-dilutive employee share-based awards, excluded0.8  0.9  
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
INCOME TAXES
 3 Months Ended
Jan. 03, 2020
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The Company’s effective tax rate was 21.0% and 24.4% for the three months ended January 3, 2020 and December 28, 2018, respectively. The Company’s effective tax rate is lower in the three months ended January 3, 2020 as compared to the year-ago period, primarily because the prior period included the tax effect of a change in law due to the enactment of the Tax Cuts and Jobs Act, which was signed into law on December 22, 2017.

The Company’s effective income tax rate differs from the U.S. federal statutory rate primarily because the Company’s foreign earnings are taxed at rates that are, on average, lower than the U.S. federal rate, and because the Company’s domestic earnings are subject to state income taxes. The total amount of unrecognized tax benefits did not materially change during the three months ended January 3, 2020; however, the amount of unrecognized tax benefits has increased as a result of positions taken during the current and prior years and has decreased as the result of the expiration of the statutes of limitation in various jurisdictions.
XML 34 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
BORROWINGS
 3 Months Ended
Jan. 03, 2020
Debt Disclosure [Abstract]  
BORROWINGS BORROWINGS
The following table summarizes the Company's total short-term borrowings:
January 3, 2020September 27, 2019
(In millions, except for percentages)AmountWeighted-Average Interest RateAmountWeighted-Average Interest Rate
Short-term borrowings:
Revolving Credit Facility
$542.0  2.80 %$410.0  3.05 %
Total short-term borrowings$542.0  $410.0  

On November 1, 2019, the Company entered into Amendment No.2 (the "Amendment") to its Credit Agreement dated April 3, 2018, (the "Credit Agreement"), by and among the Company certain lenders party thereto, and Bank of America, N.A., as administrative agent, swing line lender and letter of credit issuer. The Amendment extended the maturity date from April 2023 to November 2024. The Amendment reduced the aggregate principal amount available under Credit Agreement's five-year revolving credit facility (the "Revolving Credit Facility") from $1.8 billion to $1.2 billion, added a $500 million sub-limit for multi-currency borrowings, increased the letter of credit sub-limit from $50.0 million to $225 million, and reduced the commitment fee. In addition, there is a sub-limit for swing line loans of up to $25 million. Under the Revolving Credit Facility, the Company has the right to (i) request to increase the aggregate commitments by an aggregate amount for all such requests of up to $100.0 million and (ii) request an additional increase in the commitments or establish one or more term loans, provided that, in each case, the lenders are willing to provide such new or increased commitments and certain other conditions are met. The proceeds of the Revolving Credit Facility may be used for working capital, capital expenditures, Company share repurchases, permitted acquisitions and other corporate purposes.

Borrowings under the Revolving Credit Facility accrue interest based on either (i) the Eurodollar Rate plus a margin of 1.000% to 1.375% based on a net leverage ratio involving funded indebtedness and EBITDA, or (ii) a base rate of (a) the federal funds rate plus 0.50%, (b) BofA’s announced prime rate, or (c) the Eurodollar Rate plus 1.00%, whichever is highest, plus a margin of 0.000% to 0.375% based on the same leverage ratio, depending upon instructions from the Company. Borrowings under the Eurodollar Rate have a contract repayment date of twelve months, or less. Borrowings under the base rate can be made on an overnight basis and have a final maturity of five years.
The Company must pay a commitment fee on the unused portion of the Revolving Credit Facility at a rate from 0.100% to 0.225% based on a net leverage ratio. The Company may prepay, reduce or terminate the commitments without penalty. Swing line loans under the Revolving Credit Facility will bear interest at the base rate plus the then applicable margin for base rate loans.
The Credit Agreement provides that certain material domestic subsidiaries must guarantee the Revolving Credit Facility, subject to certain limitations on the amount secured. As of January 3, 2020, no subsidiary guarantees were required to be executed under the Credit Agreement.
The Credit Agreement contains provisions that limit the Company's ability to, among other things, incur future indebtedness, contingent obligations or liens, guarantee indebtedness, make certain investments and capital expenditures, sell stock or assets and pay dividends, and consummate certain mergers or acquisitions.
The Credit Agreement contains affirmative and negative covenants applicable to the Company and its subsidiaries that are typical for credit facilities of this type, and that are subject to materiality and other qualifications, carve-outs, baskets and exceptions. The Company agreed to maintain a financial covenant which requires a maximum consolidated net leverage ratio. The Company was in compliance with all financial covenants under the Credit Agreement for all periods within these condensed consolidated financial statements.
Other Borrowings
VMS’s Japanese subsidiary (“VMS KK”) has an unsecured uncommitted credit agreement with Sumitomo that enables VMS KK to borrow and have outstanding at any given time a maximum of 3.0 billion Japanese Yen (the “Sumitomo Credit Facility”). In February 2019, the Sumitomo Credit Facility was extended and will expire in February 2020. Borrowings under the Sumitomo Credit Facility accrue interest based on the basic loan rate announced by the Bank of Japan plus a margin of 0.5%. As of January 3, 2020, the Company did not have an outstanding principal balance on its Sumitomo Credit Facility.
XML 35 R10.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OTHER FINANCIAL INFORMATION
 3 Months Ended
Jan. 03, 2020
Other Financial Information [Abstract]  
OTHER FINANCIAL INFORMATION OTHER FINANCIAL INFORMATION 
Contracts with Customers
The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers:
(In millions)January 3,
2020		September 27,
2019
Unbilled receivables - current$315.8  $346.7  
Unbilled receivables - long-term (1)
42.7  35.1  
Deferred revenues - current(817.9) (766.0) 
Deferred revenues - long-term (2)
(78.9) (73.1) 
Total net unbilled receivables (deferred revenues)$(538.3) $(457.3) 
(1)Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2)Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.
During the three months ended January 3, 2020, unbilled receivables decreased by $23.3 million, primarily due to the timing of billings in Oncology Systems, and deferred revenues increased by $57.7 million primarily due to the contractual timing of billings occurring before the revenues were recognized.
During the three months ended January 3, 2020 and December 28, 2018, the Company recognized revenues of $314.5 million, and $263.4 million, which were included in the deferred revenues balances at September 27, 2019 and September 28, 2018, respectively.
Unfulfilled Performance Obligations
The following table represents the Company's unfulfilled performance obligations as of January 3, 2020, and the estimated revenues expected to be recognized in the future related to these unfulfilled performance obligations:
Fiscal Years of Revenue Recognition
(In millions)Remainder of 202020212022Thereafter
Unfulfilled Performance Obligations$1,884.1  $2,003.2  $787.7  $2,122.9  
The table above includes both product and service unfulfilled performance obligations, which includes a component of service performance obligations that have not been invoiced. The fiscal years presented reflect management’s best estimate of when the Company will transfer control to the customer and may change based on timing of shipment, readiness of customers’ facilities for installation, installation requirements, and availability of products or customer acceptance terms.
Cash, Cash Equivalents, and Restricted Cash
The following table summarizes the Company's cash, cash equivalents and restricted cash:
(In millions)January 3,
2020		September 27,
2019
Cash and cash equivalents$721.9  $531.4  
Restricted cash - current (1)
3.7  4.2  
Restricted cash - long-term (2)
16.6  8.5  
  Total cash, cash equivalents, and restricted cash$742.2  $544.1  
(1)Included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets.
(2)Included in other assets on the Company's Condensed Consolidated Balance Sheets.
Inventories
The following table summarizes the Company's inventories:
(In millions)January 3,
2020		September 27,
2019
Raw materials and parts$399.8  $376.5  
Work-in-process75.6  71.8  
Finished goods122.0  103.2  
Total inventories$597.4  $551.5  
Other Long-Term Liabilities
The following table summarizes the Company's other long-term liabilities:
(In millions)January 3,
2020		September 27,
2019
Income taxes payable$180.8  $180.3  
Deferred income taxes78.1  75.3  
Deferred revenues78.9  73.1  
Contingent consideration42.5  42.3  
Defined benefit pension plan30.4  31.1  
Other42.6  38.0  
Total other long-term liabilities$453.3  $440.1  
Other Income, Net
The following table summarizes the Company's other income, net:
Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Gain on equity investments$1.4  $22.0  
Net foreign currency exchange gain2.4  1.3  
Other income (loss)0.6  (0.3) 
Total other income, net$4.4  $23.0  
XML 36 R78.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Earnings Per Share [Abstract]    
Net earnings $ 88.9 $ 103.9
Less: Net earnings attributable to noncontrolling interests 0.7 0.7
Net earnings attributable to Varian $ 88.2 $ 103.2
Weighted average shares outstanding - basic (in shares) 90.9 91.0
Dilutive effect of potential common shares (in shares) 0.8 1.0
Weighted average shares outstanding - diluted (in shares) 91.7 92.0
Net earnings per share attributable to Varian - basic (in dollars per share) $ 0.97 $ 1.13
Net earnings per share attributable to Varian - diluted (in dollars per share) $ 0.96 $ 1.12
Anti-dilutive employee shared based awards, excluded (in shares) 0.8 0.9
XML 37 R70.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY - Shares Repurchased During Period (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Equity [Abstract]    
Number of shares (in shares) 0.3 0.3
Average repurchase price per share (in dollars per share) $ 139.67 $ 108.90
Total cost of shares repurchased $ 46.4 $ 34.8
XML 38 R80.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
PROTON SOLUTIONS LOANS AND INVESTMENTS - Additional Information (Detail)
€ in Millions, $ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 06, 2017
USD ($)
tranche
Jul. 31, 2015
USD ($)
Dec. 31, 2017
USD ($)
Jul. 31, 2017
USD ($)
Jul. 31, 2017
EUR (€)
Jan. 03, 2020
USD ($)
Sep. 29, 2017
USD ($)
Jan. 01, 2022
USD ($)
Sep. 27, 2019
USD ($)
May 01, 2019
Mar. 31, 2017
USD ($)
Jun. 30, 2016
USD ($)
Variable Interest Entity [Line Items]                        
Fair Value           $ 60.0     $ 58.8      
APTC Securities                        
Variable Interest Entity [Line Items]                        
Payments to acquire available-for-sale securities     $ 6.0                  
Interest rate (as a percent)           8.50%            
Unbilled receivables from variable interest entity           $ 3.9     2.1      
Fair Value           6.7     6.6      
RPTC Securities                        
Variable Interest Entity [Line Items]                        
Claims filed against assets of Company in bankruptcy | €         € 77.0              
Accounts receivable, includes unbilled accounts receivable           4.2     4.6      
New York Proton Center                        
Variable Interest Entity [Line Items]                        
Unbilled receivables from variable interest entity           6.4     6.0      
Accounts receivable, includes unbilled accounts receivable           18.0     16.6      
MPTC loans (1)                        
Variable Interest Entity [Line Items]                        
Accounts receivable, includes unbilled accounts receivable           0.0     0.0      
C P T C                        
Variable Interest Entity [Line Items]                        
Accounts receivable, includes unbilled accounts receivable           2.9     2.6      
Impairment charges             $ 51.4          
Liabilities assumed by lenders $ 112.0                      
Equity ownership interest (percent) 47.08%                      
Varian Medical Systems, Inc. | C P T C                        
Variable Interest Entity [Line Items]                        
Additional financing                     $ 7.3  
Loans Receivable | Proton Center, Munich                        
Variable Interest Entity [Line Items]                        
Payments to acquire outstanding senior debt       $ 24.5 € 21.5              
Loans Receivable | NYPC loan                        
Variable Interest Entity [Line Items]                        
Maximum lending commitment   $ 91.5                    
Long-term           32.3     31.8      
Loans Receivable | C P T C                        
Variable Interest Entity [Line Items]                        
Modified former loans receivable $ 112.0                      
Revolving Loan | C P T C                        
Variable Interest Entity [Line Items]                        
Loans           5.3     5.3      
Senior First Lien Loan | NYPC loan                        
Variable Interest Entity [Line Items]                        
Maximum lending commitment                       $ 73.0
Senior Subordinated Loans | NYPC loan                        
Variable Interest Entity [Line Items]                        
Interest rate (as a percent)   13.50%               10.00%    
Maximum lending commitment   $ 18.5                    
Long-term           32.3            
Term (in years)   6 years 6 months                    
Term Loan | C P T C                        
Variable Interest Entity [Line Items]                        
Modified former loans receivable           $ 44.0     $ 44.0      
Credit facility term (in years) 3 years                      
Term Loan | Varian Medical Systems, Inc. | C P T C                        
Variable Interest Entity [Line Items]                        
Modified former loans receivable $ 53.5                      
Number of Tranches | tranche 4                      
Paid-in-kind interest receivable (percent)           7.50%            
Term Loan | Varian Medical Systems, Inc. | C P T C | Tranche A loan                        
Variable Interest Entity [Line Items]                        
Modified former loans receivable $ 2.0                      
Interest receivable, default rate (percent)           9.50%            
Term Loan | Varian Medical Systems, Inc. | C P T C | Tranche B loan                        
Variable Interest Entity [Line Items]                        
Modified former loans receivable 7.2                      
Paid-in-kind interest receivable (percent)           10.00%            
Interest receivable, default rate (percent)           12.00%            
Term Loan | Varian Medical Systems, Inc. | C P T C | Tranche C Loans                        
Variable Interest Entity [Line Items]                        
Modified former loans receivable 15.6                      
Interest receivable, default rate (percent)           9.50%            
Term Loan | Varian Medical Systems, Inc. | C P T C | Tranche D Loans                        
Variable Interest Entity [Line Items]                        
Modified former loans receivable $ 28.7                      
Interest receivable, default rate (percent)           9.50%            
Available-for-sale Securities | MPTC Series B-1 Bonds                        
Variable Interest Entity [Line Items]                        
Interest rate (as a percent)           7.50%            
Available-for-sale Securities | MPTC Series B-2 Bonds                        
Variable Interest Entity [Line Items]                        
Interest rate (as a percent)           8.50%            
Forecast | Available-for-sale Securities | MPTC Series B-1 Bonds                        
Variable Interest Entity [Line Items]                        
Fair Value               $ 32.0        
Forecast | Available-for-sale Securities | MPTC Series B-2 Bonds                        
Variable Interest Entity [Line Items]                        
Fair Value               $ 33.9        
Revolving Loan | Loans Receivable | C P T C                        
Variable Interest Entity [Line Items]                        
Credit facility term (in years)           1 year            
Maximum lending commitment           $ 15.0            
Revolving Loan | Loans Receivable | Varian Medical Systems, Inc. | C P T C                        
Variable Interest Entity [Line Items]                        
Maximum lending commitment           $ 7.2            
XML 39 R84.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
BUSINESS COMBINATIONS (Details) - USD ($)
 1 Months Ended 3 Months Ended
Aug. 31, 2019
Jun. 28, 2019
Jan. 03, 2020
Sep. 27, 2019
Jun. 28, 2019
Dec. 28, 2018
Business Acquisition [Line Items]            
Change in fair value of contingent consideration     $ 8,800,000     $ 0
Goodwill acquired     300,000      
Acquisition-related expenses     3,900,000     2,400,000
Embolics Microspheres Business            
Business Acquisition [Line Items]            
Cash paid $ 90,000,000.0          
Cancer Treatment Services International            
Business Acquisition [Line Items]            
Cash paid   $ 262,800,000        
Acquisition purchase price   277,000,000.0        
Contingent consideration   8,200,000     $ 8,200,000  
Other consideration   6,000,000.0        
Undiscounted range of contingent consideration payments, low   0        
Undiscounted range of contingent consideration payments, high   $ 58,000,000        
Revenue projection period for consideration payments   18 months        
Change in fair value of contingent consideration     0      
Endocare and Alicon            
Business Acquisition [Line Items]            
Cash paid   $ 197,400,000        
Acquisition purchase price   210,000,000.0        
Contingent consideration   12,600,000 40,000,000.0   12,600,000  
Undiscounted range of contingent consideration payments, low   0        
Undiscounted range of contingent consideration payments, high   40,000,000        
Change in fair value of contingent consideration     $ 8,800,000 $ 18,600,000    
Privately-held Company            
Business Acquisition [Line Items]            
Asset acquisition purchase price         15,200,000  
Asset acquisition, holdback amount         (3,600,000)  
Asset acquisition, fair value of contingent consideration   $ 0     0  
Asset acquisition, potential maximum payout of contingent consideration         $ 9,000,000  
Privately-held Software Company            
Business Acquisition [Line Items]            
Acquisition purchase price           28,500,000
Goodwill acquired           $ 21,900,000
Intangible assets       $ 6,500,000    
XML 40 R74.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail) - $ / shares
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Employee Stock Purchase Plan    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Expected term (in years) 6 months 6 months
Risk-free interest rate 1.60% 2.50%
Expected volatility 26.40% 18.60%
Expected dividend 0.00% 0.00%
Weighted average fair value at grant date (dollars per share) $ 27.58 $ 22.82
Employee Stock Option Plans    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Expected term (in years) 3 years 9 months 18 days 3 years 9 months 18 days
Risk-free interest rate 1.60% 2.90%
Expected volatility 26.00% 22.20%
Expected dividend 0.00% 0.00%
Weighted average fair value at grant date (dollars per share) $ 29.42 $ 25.87
XML 41 R57.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Instruments Reported on the Balance Sheet (Details) - Foreign exchange forward contracts - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Designated as Hedging Instrument    
Derivatives, Fair Value [Line Items]    
Total derivatives $ 2.3 $ 2.8
Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets    
Derivatives, Fair Value [Line Items]    
Total derivatives 1.9 2.8
Derivatives Not Designated as Hedging Instrument | Prepaid Expenses and Other Current Assets    
Derivatives, Fair Value [Line Items]    
Total derivatives $ 0.4 $ 0.0
XML 43 R53.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Finite-Lived Intangible Assets [Line Items]    
Amortization of intangible assets and inventory step-up $ 10.2 $ 4.7
Continuing Operations    
Finite-Lived Intangible Assets [Line Items]    
Amortization of intangible assets and inventory step-up $ 10.1 $ 4.7
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 3 Months Ended
Jan. 03, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Fair Value of Derivative Instruments Reported on the Balance Sheet
The fair value of derivative instruments reported on the Company's Condensed Consolidated Balance Sheets were as follows:

January 3,
2020		September 27, 2019
(In millions)Balance Sheet
Location		Fair Value
Derivatives designated as hedging instruments:  
Foreign exchange forward contractsPrepaid expenses and other current assets$1.9  $2.8  
Derivatives not designated as hedging instruments:  
Foreign exchange forward contractsPrepaid expenses and other current assets0.4  —  
Total derivatives $2.3  $2.8  
Schedule of Cash Flow Hedging Activities
The Company had the following outstanding foreign currency forward contracts that were entered into to hedge forecasted revenues and designated as cash flow hedges:
January 3, 2020September 27, 2019
(In millions)Notional Value Sold
Euro$52.9  $76.5  
Japanese Yen46.2  56.7  
$99.1  $133.2  
Amounts Before Tax Included in AOCI on the Balance Sheet
The following table presents the amounts, before tax, recognized in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets:
Loss Recognized in Other Comprehensive Earnings (Loss)
Three Months Ended
(In millions)January 3, 2020December 28, 2018
Foreign currency forward contracts$(0.1) $—  
Schedule of Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Earnings (Loss)
The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings was as follows:
Location and Amount Recognized in Earnings on Cash Flow Hedging Relationships
Three Months Ended
January 3, 2020December 28, 2018
(In millions)Revenues  
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value and cash flow hedges are recorded$828.9  $741.0  
Gain on cash flow hedge relationships:
Foreign currency forward contracts:
Amount of gain reclassified from accumulated other comprehensive loss into net earnings $0.8  $—  
Schedule of Notional Amounts of Outstanding Derivative Positions
The notional amount of the Company's outstanding foreign currency forward contracts relating to balance sheet hedging activities:
(In millions)January 3,
2020		September 27,
2019
Notional value sold$471.3  $385.0  
Notional value purchased$116.3  $52.3  
Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments
The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings related to the foreign currency forward contracts that are not designated as hedging instruments.
Location of Gain (Loss) Recognized in Net Earnings on Derivative InstrumentsAmount of Gain (Loss) Recognized in Net Earnings on Derivative Instruments
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Other income, net$(5.0) $2.8  
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EMPLOYEE STOCK PLANS (Tables)
 3 Months Ended
Jan. 03, 2020
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation Expense
The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Cost of revenues - Product$0.8  $0.7  
Cost of revenues - Service1.3  1.1  
Research and development1.2  1.1  
Selling, general and administrative11.6  7.6  
Total share-based compensation expense$14.9  $10.5  
Income tax benefit for share-based compensation$(2.9) $(2.3) 
Fair Value of Employee Stock Option Plans With Weighted Average Assumptions
The fair value of stock options and performance stock options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 Three Months Ended
January 3,
2020		December 28,
2018
Employee Stock Option Plans  
Expected term (in years)3.83.8
Risk-free interest rate1.6 %2.9 %
Expected volatility26.0 %22.2 %
Expected dividend— %— %
Weighted average fair value at grant date (1)
$29.42  $25.87  
(1)Excludes the fair value of the market condition based on a relative total shareholder return for the performance stock options granted during the period.
Option Component of ESPP Shares with Weighted Average Assumptions
The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 Three Months Ended
January 3,
2020		December 28,
2018
Employee Stock Purchase Plan  
Expected term (in years)0.50.5
Risk-free interest rate1.6 %2.5 %
Expected volatility26.4 %18.6 %
Expected dividend— %— %
Weighted average fair value at grant date$27.58  $22.82  
Activity Under Employee Stock Plans
The activity for stock options and performance stock options is summarized as follows: 
 Options Outstanding
(In millions, except per share amounts)Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Term (in years)
Aggregate
Intrinsic
Value (1)
Balance at September 27, 20192.2  $97.66    
Granted0.1  131.34    
Cancelled or expired—  99.35    
Exercised(0.1) 82.03    
Balance at January 3, 20202.2  $101.01  4.6$98.0  
Exercisable at January 3, 20201.1  $82.38  3.4$68.2  
(1)The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of $144.93 as of January 3, 2020, the last trading date of the first quarter of fiscal year 2020, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date..
Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units
The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:
(In millions, except per share amounts)Number of
Shares		Weighted Average
Grant-Date Fair
Value
Balance at September 27, 20190.7  $108.35  
Granted0.1  140.74  
Vested(0.1) 84.99  
Cancelled or expired


(0.1) 117.11  
Balance at January 3, 20200.6  $115.82  
XML 46 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
 3 Months Ended
Jan. 03, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company measures all derivatives at fair value on the Condensed Consolidated Balance Sheets. The accounting for gains or losses resulting from changes in the fair value of those derivatives depends upon the use of the derivative and whether it qualifies for hedge accounting.
The fair value of derivative instruments reported on the Company's Condensed Consolidated Balance Sheets were as follows:

January 3,
2020		September 27, 2019
(In millions)Balance Sheet
Location		Fair Value
Derivatives designated as hedging instruments:  
Foreign exchange forward contractsPrepaid expenses and other current assets$1.9  $2.8  
Derivatives not designated as hedging instruments:  
Foreign exchange forward contractsPrepaid expenses and other current assets0.4  —  
Total derivatives $2.3  $2.8  
As of September 27, 2019, the fair value of the Company's derivatives not designated as hedging instruments were not material.
Cash Flow Hedging Activities
The Company had the following outstanding foreign currency forward contracts that were entered into to hedge forecasted revenues and designated as cash flow hedges:
January 3, 2020September 27, 2019
(In millions)Notional Value Sold
Euro$52.9  $76.5  
Japanese Yen46.2  56.7  
$99.1  $133.2  
The following table presents the amounts, before tax, recognized in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets:
Loss Recognized in Other Comprehensive Earnings (Loss)
Three Months Ended
(In millions)January 3, 2020December 28, 2018
Foreign currency forward contracts$(0.1) $—  
As of January 3, 2020, the net unrealized gain on derivatives, before tax, of $1.9 million was included in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets and is expected to be reclassified into net earnings over the next 12 months.
The effect of cash flow hedge accounting on the Condensed Consolidated Statements of Earnings was as follows:
Location and Amount Recognized in Earnings on Cash Flow Hedging Relationships
Three Months Ended
January 3, 2020December 28, 2018
(In millions)Revenues  
Total amounts of income and expense line items presented in the Condensed Consolidated Statements of Earnings in which the effects of fair value and cash flow hedges are recorded$828.9  $741.0  
Gain on cash flow hedge relationships:
Foreign currency forward contracts:
Amount of gain reclassified from accumulated other comprehensive loss into net earnings $0.8  $—  
Balance Sheet Hedging Activities
The Company also hedges balance sheet exposures from its various subsidiaries and business units where the U.S. Dollar is the functional currency. For derivative instruments not designated as hedging instruments, changes in their fair values are recognized in other income, net in the Condensed Consolidated Statements of Earnings. Changes in the values of these hedging instruments are offset by changes in the values of foreign-currency-denominated assets and liabilities.

The notional amount of the Company's outstanding foreign currency forward contracts relating to balance sheet hedging activities:
(In millions)January 3,
2020		September 27,
2019
Notional value sold$471.3  $385.0  
Notional value purchased$116.3  $52.3  

The following table presents the gains (losses) recognized in the Condensed Consolidated Statements of Earnings related to the foreign currency forward contracts that are not designated as hedging instruments.
Location of Gain (Loss) Recognized in Net Earnings on Derivative InstrumentsAmount of Gain (Loss) Recognized in Net Earnings on Derivative Instruments
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Other income, net$(5.0) $2.8  
The gains (losses) on these derivative instruments were significantly offset by the gains (losses) resulting from the re-measurement of monetary assets and liabilities denominated in currencies other than the U.S. Dollar functional currency.
XML 47 R11.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE
 3 Months Ended
Jan. 03, 2020
Fair Value Disclosures [Abstract]  
FAIR VALUE FAIR VALUE
Assets/Liabilities Measured at Fair Value on a Recurring Basis
In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
 Fair Value Measurements at January 3, 2020
Quoted Prices in
Active Markets
for Identical
Instruments		Significant
Other
Observable
Inputs		Significant
Unobservable
Inputs		Total
Type of Instruments(Level 1)(Level 2)(Level 3)Balance
(In millions)    
Assets:    
Cash equivalents:
Money market funds$17.5  $—  $—  $17.5  
Available-for-sale securities:
MPTC Series B-1 Bonds —  27.6  —  27.6  
MPTC Series B-2 Bonds —  25.7  —  25.7  
APTC securities—  6.7  —  6.7  
Derivative assets—  2.3  —  2.3  
Total assets measured at fair value$17.5  $62.3  $—  $79.8  
Liabilities:            
Contingent consideration$—  $—  $(84.3) $(84.3) 
Total liabilities measured at fair value$—  $—  $(84.3) $(84.3) 


Fair Value Measurements at September 27, 2019
Quoted Prices in Active Markets for Identical InstrumentsSignificant
Other
Observable
Inputs		Significant Unobservable InputsTotal
Type of Instruments(Level 1)(Level 2)(Level 3)Balance
(In millions)
Assets:
Cash equivalents:
Money market funds$0.2  $—  $—  $0.2  
Available-for-sale securities:
MPTC Series B-1 Bonds—  27.1  —  27.1  
MPTC Series B-2 Bonds—  25.1  —  25.1  
APTC securities—  6.6  —  6.6  
Derivative assets—  2.8  —  2.8  
Total assets measured at fair value$0.2  $61.6  $—  $61.8  
Liabilities:
Contingent consideration$—  $—  $(75.3) $(75.3) 
Total liabilities measured at fair value$—  $—  $(75.3) $(75.3) 

The Company classifies its money market funds as Level 1 because they have daily liquidity, quoted prices for the underlying investments can be obtained, and there are active markets for the underlying investments. The Company's Level 2 available-for-sale securities consist of bonds for the Maryland Proton Therapy Center ("MPTC") and the Alabama Proton Therapy Center
(“APTC”). The observable inputs for these securities are comparable bond issues, broker/dealer quotations for the same or similar investments in active markets, and other observable inputs such as yields, credit risks, default rates, and volatility. The Company's available-for-sale securities are included in other assets on the Company's Condensed Consolidated Balance Sheets, except for amounts related to short-term interest receivable. See Note 14, "Proton Solutions Loans and Investments," for further information about the available-for-sale securities. As of January 3, 2020, and September 27, 2019, the carrying amount of the Company's Level 1 money market funds and Level 2 available-for-sale securities approximated their respective fair values.
The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads. The Company’s derivative instruments are generally short-term in nature, typically one month to fifteen months in duration.

The Company generally measures the fair value of its Level 3 contingent consideration liabilities based on Monte Carlo pricing models with key assumptions that include estimated revenues of the acquired business, the probability of completing certain milestone targets during the earn-out period, revenue volatility, and estimated discount rates corresponding to the periods of expected payments. If the estimated revenues or probability of completing certain milestones were to increase or decrease during the respective earn-out period, the fair value of the contingent consideration would increase or decrease, respectively. If the estimated discount rates were to increase or decrease, the fair value of contingent consideration would decrease or increase, respectively. Changes in key assumptions may result in an increase or decrease in the fair value of contingent consideration. The Company's contingent consideration is from its business combinations and is included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets.
The following table presents the reconciliation for liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):
(In millions)Contingent
Consideration
Balance at September 27, 2019$(75.3) 
Adjustments due to the effect of foreign exchange(0.2) 
Change in fair value recognized in earnings(8.8) 
Balance at January 3, 2020$(84.3) 
There were no transfers of assets or liabilities between fair value measurement levels during either the three months ended January 3, 2020, or the three months ended December 28, 2018. Transfers between fair value measurement levels are recognized at the end of the reporting period.
Fair Value of Other Financial Instruments
The fair values of certain of the Company’s financial instruments, including bank deposits included in cash equivalents, trade and unbilled receivables, net of allowance for doubtful accounts, revolving loan to California Proton Therapy Center ("CPTC"), accounts payable, and short-term borrowings approximate their carrying amounts due to their short maturities.
As of January 3, 2020, the fair value of the Term Loan (as defined below) with CPTC approximated its carrying value of $44.0 million. The carrying value is based on the present value of expected future cash payments discounted at a rate reflecting the nature and duration of the loans, risks involved with CPTC, and its industry. As a result, the Term Loan is categorized as Level 3 in the fair value hierarchy. See Note 14, "Proton Solutions Loans and Investments," for further information.
The Company's equity investments in privately-held companies were $56.4 million and $64.2 million at January 3, 2020 and September 27, 2019, respectively.
The fair value of the outstanding long-term notes receivable, including accrued interest, approximated their carrying value of $34.1 million and $33.6 million at January 3, 2020 and September 27, 2019, respectively, because they are based on terms of recent comparable transactions and are categorized as Level 3 in the fair value hierarchy. The fair value is based on the income approach by using the discounted cash flow model with key assumptions that include discount rates corresponding to the terms and risks as well as underlying cash flow assumptions. See Note 14, "Proton Solutions Loans and Investments," for information on the long-term notes receivable.
XML 48 R19.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY
 3 Months Ended
Jan. 03, 2020
Equity [Abstract]  
STOCKHOLDERS’ EQUITY STOCKHOLDERS’ EQUITY
Share Repurchase Program
In November 2016, the VMS Board of Directors authorized the repurchase of an additional 8.0 million shares of VMS common stock commencing on January 1, 2017. Share repurchases under the Company's authorizations may be made in open market purchases, in privately negotiated transactions (including accelerated share repurchase programs), or under Rule 10b5-1 share repurchase plans, and may be made from time to time in one or more blocks. All shares that were repurchased under the Company's share repurchase programs have been retired. As of January 3, 2020, approximately 1.9 million shares of VMS common stock remained available for repurchase under the November 2016 authorization.
The Company repurchased shares of VMS common stock during the periods presented as follows:
Three Months Ended
(In millions, except per share amounts)January 3,
2020		December 28,
2018
Number of shares0.3  0.3  
Average repurchase price per share$139.67  $108.90  
Total cost of shares repurchased$46.4  $34.8  
Accumulated Other Comprehensive Loss
The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:
(In millions)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans		Net
Unrealized
Gains
Cash Flow
Hedging
Instruments		Cumulative
Translation
Adjustment		Accumulated
Other
Comprehensive
Loss
Balance at September 27, 2019$(61.7) $2.1  $(42.5) $(102.1) 
Other comprehensive earnings (loss) before reclassifications—  (0.1) 5.1  5.0  
Amounts reclassified out of other comprehensive earnings (loss)0.9  (0.8) —  0.1  
Tax (expense) benefit(0.2) 0.2  —  —  
Balance at January 3, 2020$(61.0) $1.4  $(37.4) $(97.0) 

(In millions)Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans		Cumulative
Translation
Adjustment		Accumulated
Other
Comprehensive Loss
Balance at September 28, 2018$(35.2) $(30.1) $(65.3) 
Other comprehensive earnings (loss) before reclassifications—  (4.0) (4.0) 
Amounts reclassified out of other comprehensive earnings (loss)0.4  —  0.4  
Tax expense(0.1) —  (0.1) 
Balance at December 28, 2018$(34.9) $(34.1) $(69.0) 

The amounts reclassified, before taxes, out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings, with line item location, during each period were as follows: 

(In millions)Three Months Ended
Comprehensive Earnings (Loss) ComponentsJanuary 3,
2020		December 28,
2018		Line Item in Statements of Earnings
Unrealized loss on defined benefit pension and post-retirement benefit plans$(0.9) $(0.4) Other income, net
Unrealized earnings on cash flow hedging instruments0.8  —  Revenues
Total amounts reclassified out of other comprehensive earnings (loss)$(0.1) $(0.4)  
XML 49 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OTHER FINANCIAL INFORMATION (Tables)
 3 Months Ended
Jan. 03, 2020
Other Financial Information [Abstract]  
Unbilled Accounts Receivable and Deferred Revenues from Contracts with Customers:
The following table provides the Company's unbilled receivables and deferred revenues from contracts with customers:
(In millions)January 3,
2020		September 27,
2019
Unbilled receivables - current$315.8  $346.7  
Unbilled receivables - long-term (1)
42.7  35.1  
Deferred revenues - current(817.9) (766.0) 
Deferred revenues - long-term (2)
(78.9) (73.1) 
Total net unbilled receivables (deferred revenues)$(538.3) $(457.3) 
(1)Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2)Included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets.
Schedule of Unfulfilled Performance Obligations
The following table represents the Company's unfulfilled performance obligations as of January 3, 2020, and the estimated revenues expected to be recognized in the future related to these unfulfilled performance obligations:
Fiscal Years of Revenue Recognition
(In millions)Remainder of 202020212022Thereafter
Unfulfilled Performance Obligations$1,884.1  $2,003.2  $787.7  $2,122.9  
Cash, Cash Equivalents and Restricted Cash:
The following table summarizes the Company's cash, cash equivalents and restricted cash:
(In millions)January 3,
2020		September 27,
2019
Cash and cash equivalents$721.9  $531.4  
Restricted cash - current (1)
3.7  4.2  
Restricted cash - long-term (2)
16.6  8.5  
  Total cash, cash equivalents, and restricted cash$742.2  $544.1  
(1)Included in prepaid expenses and other current assets on the Company's Condensed Consolidated Balance Sheets.
(2)Included in other assets on the Company's Condensed Consolidated Balance Sheets.
Inventories
The following table summarizes the Company's inventories:
(In millions)January 3,
2020		September 27,
2019
Raw materials and parts$399.8  $376.5  
Work-in-process75.6  71.8  
Finished goods122.0  103.2  
Total inventories$597.4  $551.5  
Other long-term liabilities:
The following table summarizes the Company's other long-term liabilities:
(In millions)January 3,
2020		September 27,
2019
Income taxes payable$180.8  $180.3  
Deferred income taxes78.1  75.3  
Deferred revenues78.9  73.1  
Contingent consideration42.5  42.3  
Defined benefit pension plan30.4  31.1  
Other42.6  38.0  
Total other long-term liabilities$453.3  $440.1  
Other Income (Expense), Net:
The following table summarizes the Company's other income, net:
Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Gain on equity investments$1.4  $22.0  
Net foreign currency exchange gain2.4  1.3  
Other income (loss)0.6  (0.3) 
Total other income, net$4.4  $23.0  
XML 50 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION
 3 Months Ended
Jan. 03, 2020
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
The Company has two reportable operating segments: Oncology Systems and Proton Solutions. The Company's Interventional Solutions business is reflected in the "Other" category because it does not meet the criteria for a reportable operating segment. The operating segments were determined based on how the Company’s Chief Executive Officer, its Chief Operating Decision Maker (“CODM”), views and evaluates the Company’s operations. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on operating earnings.
Description of Segments
The Oncology Systems segment designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments such as fixed field intensity-modulated radiation therapy (“IMRT”), image-guided radiation therapy (“IGRT”), volumetric modulated arc therapy ("VMAT"), stereotactic radiosurgery (“SRS”), stereotactic body radiotherapy (“SBRT”) and brachytherapy as well as associated quality assurance equipment.
The Oncology Systems’ hardware products include linear accelerators, brachytherapy afterloaders, treatment accessories, artificial intelligence-powered adaptive delivery systems and quality assurance software. The Oncology Systems’ software solutions include treatment planning, informatics, clinical knowledge exchange, patient care management, practice management and decision support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices.
Oncology Systems’ products enable radiation oncology departments in hospitals and clinics to perform conventional radiotherapy treatments and offer advanced treatments such as IMRT, IGRT, VMAT, SRS and SBRT, and treat patients using brachytherapy techniques, which involve the introduction or temporary insertion of radioactive sources. The Oncology Systems' products are also used by surgeons and radiation oncologists to perform stereotactic radiosurgery and by medical oncology departments to manage patient treatments. Oncology Systems’ customers worldwide include university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices, medical oncology practices, radiotherapy centers and cancer care clinics.
The Oncology Systems segment offers services ranging from hardware phone support, break/fix repair of linear accelerators, obsolescence protection of hardware, software support, software upgrades, hosting as a service, as well as clinical consulting services.

The Oncology Systems segment also provides clinical practice services that assist within the clinical workflow. These services focus on decision support and/or cancer care knowledge augmentation aimed at facilitating improved accessibility and affordability to care while maintaining a fundamental level of clinical quality. Further, the Company operates ten multi-disciplinary cancer centers and one specialty hospital in India and one multi-disciplinary cancer center in Sri Lanka.
The Proton Solutions segment develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams, for the treatment of cancer.
The Other category primarily includes the Interventional Solutions business, which offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolization. Interventional Solutions also provides software and remote services for post treatment dose calculation for Yttrium-90 microspheres used in selective internal radiation therapy. The Other category also includes assets related to the use of radiation in the heart and other forms of radiosurgery for cardiovascular disease.
The following information is provided for the purpose of achieving an understanding of operations but may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.
The Company allocates corporate costs to its operating segments based on the relative revenues of Oncology Systems, Proton Solutions and Interventional Solutions. The Company allocates these costs, excluding certain corporate related costs, transactions or adjustments that the Company's CODM considers to be non-operational, such as restructuring and impairment charges, significant litigation charges or benefits and legal costs, and acquisition-related expenses and in process research and development. Although the Company excludes these amounts from segment operating earnings, they are included in the condensed consolidated operating earnings and included in the reconciliation below.
The following table summarizes select financial results for each reportable segment:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Revenues  
Oncology Systems$782.4  $702.5  
Proton Solutions27.6  38.5  
Total reportable segments810.0  741.0  
Other 18.9  —  
Total Company$828.9  $741.0  
Earnings from continuing operations before taxes       
Oncology Systems$136.4  $124.1  
Proton Solutions(14.3) (8.8) 
Total reportable segments122.1  115.3  
Other2.8  —  
Unallocated corporate (14.9) (3.6) 
Operating earnings110.0  111.7  
Interest income (expense), net(1.7) 2.7  
Other income, net4.4  23.0  
Total Company$112.7  $137.4  
Disaggregation of Revenues
The Company disaggregates its revenues from contracts by major product categories, geographic region, and by timing of revenue recognition for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.
Revenues by Product Type
Three Months Ended
Total Revenues by Product TypeJanuary 3,December 28,
(In millions)20202018
Hardware
Oncology Systems$320.0  $313.6  
Proton Solutions20.1  33.6  
Other18.9  —  
Total Hardware359.0  347.2  
Software (1)
Oncology Systems148.8  131.2  
Proton Solutions—  —  
Total Software148.8  131.2  
Service
Oncology Systems313.6  257.7  
Proton Solutions7.5  4.9  
Total Service321.1  262.6  
Total Revenues$828.9  $741.0  
(1) Includes software support agreements that are recorded in revenues from service, and software licenses that are recorded in revenues from product in the Condensed Consolidated Statements of Earnings.
Revenues by Geographical Region
Three Months Ended
Total Revenues by Geographical RegionJanuary 3,December 28,
(In millions)20202018
Americas
Oncology Systems$378.9  $330.8  
Proton Solutions16.9  19.6  
Other6.4  —  
Total Americas402.2  350.4  
EMEA
Oncology Systems259.8  234.5  
Proton Solutions10.3  16.5  
Other2.8  —  
Total EMEA272.9  251.0  
APAC
Oncology Systems143.7  137.2  
Proton Solutions0.4  2.4  
Other9.7  —  
Total APAC153.8  139.6  
Total Revenues$828.9  $741.0  
North America (1)
Oncology Systems$355.2  $309.1  
Proton Solutions16.9  19.6  
Other6.4  —  
Total North America378.5  328.7  
International
Oncology Systems427.2  393.4  
Proton Solutions10.7  18.9  
Other12.5  —  
Total International450.4  412.3  
Total Revenues$828.9  $741.0  
(1)North America primarily includes the United States and Canada.
Revenues by Timing of Revenue Recognition
Three Months Ended
Timing of revenue recognitionJanuary 3,December 28,
(In millions)20202018
Products transferred at a point in time
Oncology Systems$382.0  $366.6  
Other18.9  —  
Total products transferred at a point in time400.9  366.6  
Products and services transferred over time
Oncology Systems400.4  335.9  
Proton Solutions27.6  38.5  
Total products and services transferred over time428.0  374.4  
Total Revenues$828.9  $741.0  
XML 51 R65.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES - Lessor Arrangements (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Sep. 27, 2019
Property Subject to or Available for Operating Lease [Line Items]      
Lease term 15 years    
Rental income $ 2.5 $ 2.1  
Equipment      
Property Subject to or Available for Operating Lease [Line Items]      
Equipment leased to customers included in PP&E 22.6    
Accumulated amortization on equipment leased to customers, included in PP&E $ 6.4    
Leased equipment     $ 22.5
Accumulated depreciation     $ 5.5
XML 52 R61.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail) - Derivatives Not Designated as Hedging Instrument - Foreign exchange forward contracts - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Notional Value Sold    
Derivative [Line Items]    
Notional Value $ 471.3 $ 385.0
Notional Value Purchased    
Derivative [Line Items]    
Notional Value $ 116.3 $ 52.3
XML 53 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 3 Months Ended
Jan. 03, 2020
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business
The long-term growth and value creation strategy of Varian Medical Systems, Inc. (“VMS”) and subsidiaries (collectively, the “Company”) is to transform the Company from the global leader in radiation therapy to the global leader in multi-disciplinary, integrated cancer care solutions that leverages its clinical experience and strengths in technology development and new product innovation. The Company offers solutions in radiation therapy and medical oncology, as well as interventional oncology, an emerging area of cancer care. The Company designs, manufactures, sells and services hardware and software products for treating cancer with radiotherapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, and offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolization. Software solutions include treatment planning, informatics, clinical knowledge exchange, patient care management, practice management and decision support for comprehensive cancer clinics, radiotherapy centers and medical oncology practices. The Company also develops, designs, manufactures, sells and services proton therapy products and systems for cancer treatment.

The Company has expanded its services offerings to include clinical practice services that assist within the clinical workflow. These services focus on decision support and/or cancer care knowledge augmentation aimed at facilitating improved accessibility and affordability to care while maintaining a fundamental level of clinical quality. Further, the Company operates ten multi-disciplinary cancer centers and one specialty hospital in India and one multi-disciplinary cancer center in Sri Lanka.
Basis of Presentation
The condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of September 27, 2019, was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America. These condensed consolidated financial statements and the accompanying notes are unaudited and should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 27, 2019 (the “2019 Annual Report”).

In the opinion of management, the condensed consolidated financial statements herein include adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s financial position as of January 3, 2020, and September 27, 2019, results of operations and statements of comprehensive earnings for the three months ended January 3, 2020, and December 28, 2018, statements of cash flows for the three months ended January 3, 2020, and December 28, 2018, and statements of equity for the three months ended January 3, 2020, and December 28, 2018. The results of operations for the three months ended January 3, 2020, are not necessarily indicative of the operating results to be expected for the full fiscal year or any future period.
Reclassifications
Certain reclassifications have been made to the amounts in the prior year in order to conform to the current year's presentation.
Fiscal Year
The fiscal years of the Company as reported are the 52- or 53-week periods ending on the Friday nearest September 30. Fiscal year 2020 was the 53-week period ending October 2, 2020. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. The fiscal quarter ended January 3, 2020 was a 14-week period, and the fiscal quarter ended December 28, 2018, was a 13-week period.
Principles of Consolidation
The condensed consolidated financial statements include those of VMS and its wholly-owned and majority-owned or controlled subsidiaries. Intercompany balances, transactions and stock holdings have been eliminated in consolidation.
Consolidation of Variable Interest Entities
For entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities, and results of operations of the variable interest entity will be included in the Company’s condensed consolidated financial statements. At January 3, 2020 and September 27, 2019, the Company consolidated its non-controlling interest in a joint venture, included within its Oncology Systems business, related to the Cancer Treatment Services International ("CTSI") operations.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Significant Accounting Policies
With the exception of the change for the accounting of leases as a result of the adoption of Accounting Standard Codification Topic 842, there have been no material changes to the Company's significant accounting policies provided in Note 1, "Summary of Significant Accounting Policies," within Item 8 of the Company's Annual Report on Form 10-K for the year ended September 27, 2019.

Leases

The Company determines if an arrangement is or contains a lease at the inception of an arrangement. The Company's operating lease right-of-use ("ROU") assets represents the right to use an underlying asset over the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. ROU assets may also include initial direct costs incurred and prepaid lease payments, less lease incentives. Lease liabilities and their corresponding ROU assets are recognized based on the present value of lease payments over the lease term, discounted using the Company's incremental borrowing rate ("IBR"). The Company recognizes operating leases with lease terms of more than twelve months in operating lease right-of-use assets, accrued liabilities, and long-term lease liabilities on its Condensed Consolidated Balance Sheets.

The Company’s finance leases primarily represent certain sale and leaseback-sublease arrangements. The Company has entered into sale-leaseback arrangements with a third-party finance company for certain equipment and simultaneously subleased the equipment to certain qualified customers. The Company’s leaseback arrangements have been accounted for as finance leases as they meet one or more of the finance lease classification criteria. The Company recognizes finance leases with lease terms of more than twelve months in property, plant, and equipment, net, accrued liabilities, and other long-term liabilities on its Condensed Consolidated Balance Sheets.

For purposes of calculating lease liabilities and the corresponding ROU assets, the Company's lease term may include options to extend or terminate the lease when it is reasonably certain that it will exercise that option.

The Company generally does not have adequate information to determine the implicit rate in a lease, therefore the Company uses an estimated IBR. The Company does not maintain a public credit rating and its debt arrangements are unsecured, thus requiring significant judgment to calculate the IBR. The Company uses different data sets to estimate the IBR, including: (i) an estimated indicative credit rating of the Company; (ii) yields on comparable credit rating composite curves; (iii) foreign exchange rates; and (iv) an estimated adjustment for collateral. The Company also applies adjustments to account for considerations related to (i) tenor; and (ii) country credit rating that may not be fully incorporated by the aforementioned data sets.

Certain of the Company’s lease arrangements include variable lease payments. Variable lease payments, not dependent on an index or discount rate, are expensed as incurred and are not included within the ROU asset and lease liability calculation. Variable lease payments generally include common area maintenance, utilities, maintenance charges, property taxes, insurance, and contingent rent payments. Certain of the Company's arrangements contain clauses that provide for contingent rent payments based on a percentage of revenue share and/or earnings before interest, taxes, depreciation, and amortization.

The Company combines lease and non-lease components as a single lease component for both its operating and finance leases. In addition, the Company does not record operating and finance lease assets and liabilities for short-term leases, which have an initial term of twelve months or less.

Recently Adopted Accounting Pronouncements
In the first quarter of fiscal year 2020, the Company adopted the Financial Accounting Standards Board ("FASB") standard on accounting for leases, "Leases." The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record ROU assets and corresponding lease liabilities on the balance sheet. The Company adopted this standard under the optional transition method, which applies the standard on the effective date, rather than the earliest comparative period presented in the financial statements. The Company elected: (1) the "package of practical expedients," which does not require the Company to reassess its prior conclusions about lease identification, lease classification, and initial direct costs under the new standard; (2) not to separate non-lease components from lease components; and (3) not to recognize ROU assets and lease liabilities for short-term leases. The Company has implemented internal controls and key system functionalities to enable the preparation of financial information. The primary impact for the Company was the balance sheet recognition of ROU assets and lease liabilities for operating leases as a lessee. See Note 8, "Commitments and Contingencies," for more information on the impact of this adoption on the Company's condensed consolidated financial statements.
In the first quarter of fiscal year 2020, the Company adopted FASB guidance that added the Overnight Index Swap rate based on the Secured Overnight Financing Rate ("SOFR") as a benchmark interest rate for hedge accounting purposes. The amendment recognizes SOFR as a likely LIBOR replacement and supports the marketplace transition by adding the new reference rate as a benchmark interest rate. The Company has not executed interest rate hedges but adopted the amendment prospectively as the Company may consider interest rate hedges in the future. The Company is monitoring the LIBOR to SOFR migration and will coordinate the transition of outstanding LIBOR based debt and any related interest rate derivatives with counterparties when the market is liquid to ensure an orderly and efficient transition.
In the first quarter of fiscal year 2020, the Company adopted FASB guidance that allows companies to reclassify disproportionate tax effects in accumulated other comprehensive income caused by the Tax Cuts and Jobs Act to retained earnings. The impact of adopting this amendment on the Company's condensed consolidated financial statements was not material.
Recent Accounting Standards or Updates Not Yet Effective
In December 2019, the FASB issued guidance which simplifies the accounting for income taxes by removing certain exceptions to the current guidance, and improving the consistent application of and simplification of other areas of the guidance. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.
In August 2018, the FASB amended its guidance for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new standard also requires customers to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement. This new standard becomes effective for the Company in the first quarter of fiscal year 2021, with early adoption permitted. This new standard can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.

In August 2018, the FASB issued guidance which modifies the disclosure requirements for employers that have sponsor defined benefit pension or other post-retirement plans by removing and adding certain disclosures for these plans. The standard is effective for the Company beginning in the first quarter of fiscal year 2022. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.

In August 2018, the FASB issued guidance which changed the disclosure requirements for fair value measurements by removing, adding and modifying certain disclosures. The standard is effective for the Company beginning in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is evaluating the impact of adopting this guidance to its condensed consolidated financial statements.
In June 2016, the FASB issued an amendment to its accounting guidance related to the impairment of financial instruments. The amendment adds a new impairment model that is based on expected losses, rather than incurred losses. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021, with early adoption permitted beginning in the first quarter of fiscal year 2020. The Company is evaluating the impact of adopting this amendment to its condensed consolidated financial statements.
XML 55 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Cover Page - shares
 3 Months Ended
Jan. 03, 2020
Jan. 31, 2020
Cover page.    
Title of 12(b) Security Common Stock, $1 par value  
Entity Incorporation, State or Country Code DE  
Document Transition Report false  
Document Quarterly Report true  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jan. 03, 2020  
Entity File Number 1-7598  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q1  
Entity Address, Address Line One 3100 Hansen Way,  
Entity Address, City or Town Palo Alto,  
Entity Address, State or Province CA  
Trading Symbol VAR  
Entity Registrant Name VARIAN MEDICAL SYSTEMS, INC.  
City Area Code 650  
Local Phone Number 493-4000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company false  
Entity Central Index Key 0000203527  
Current Fiscal Year End Date --10-02  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   90,665,845
Entity Tax Identification Number 94-2359345  
Entity Address, Postal Zip Code 94304-1038  
Security Exchange Name NYSE  
XML 56 R69.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY - Additional Information (Detail) - November 2016 - shares
Jan. 03, 2020
Nov. 30, 2016
Stockholders’ equity and noncontrolling interests [Line Items]    
Number of shares authorized by VMS Board of Directors to be repurchased (in shares)   8,000,000.0
Remaining authorization (shares) 1,900,000  
XML 57 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Current assets:    
Cash and cash equivalents $ 721.9 $ 531.4
Trade and unbilled receivables, net of allowance for doubtful accounts of $47.0 and $46.5 at January 3, 2020 and September 27, 2019, respectively 1,079.2 1,106.3
Inventories 597.4 551.5
Prepaid expenses and other current assets 248.5 206.2
Total current assets 2,647.0 2,395.4
Property, plant and equipment, net   311.5
Property, plant and equipment, net 330.3  
Operating lease right-of-use assets 114.1  
Goodwill 612.4 612.2
Intangible assets 290.9 300.7
Deferred tax assets 85.7 84.7
Other assets 370.3 397.2
Total assets 4,450.7 4,101.7
Current liabilities:    
Accounts payable 215.3 248.5
Accrued liabilities 471.2 459.5
Deferred revenues 817.9 766.0
Short-term borrowings 542.0 410.0
Total current liabilities 2,046.4 1,884.0
Long-term lease liabilities 93.7  
Other long-term liabilities 453.3 440.1
Total liabilities 2,593.4 2,324.1
Commitments and contingencies (Note 8)
Equity:    
Preferred stock of $1 par value: 1.0 shares authorized; none issued and outstanding 0.0 0.0
Common stock of $1 par value: 189.0 shares authorized; 90.7 and 90.8 shares issued and outstanding at January 3, 2020 and September 27, 2019, respectively 90.7 90.8
Capital in excess of par value 870.4 845.6
Retained earnings 983.2 934.0
Accumulated other comprehensive loss (97.0) (102.1)
Total Varian stockholders' equity 1,847.3 1,768.3
Noncontrolling interest 10.0 9.3
Total equity 1,857.3 1,777.6
Total liabilities and equity $ 4,450.7 $ 4,101.7
XML 58 R42.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OTHER FINANCIAL INFORMATION - Unfulfilled Performance Obligations (Details)
$ in Millions
Jan. 03, 2020
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-04  
Revenue from Contract with Customer [Abstract]  
Unfulfilled Performance Obligations $ 1,884.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation, period 9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-10-03  
Revenue from Contract with Customer [Abstract]  
Unfulfilled Performance Obligations $ 2,003.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-10-02  
Revenue from Contract with Customer [Abstract]  
Unfulfilled Performance Obligations $ 787.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01  
Revenue from Contract with Customer [Abstract]  
Unfulfilled Performance Obligations $ 2,122.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation, period
XML 59 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 60 R46.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OTHER FINANCIAL INFORMATION - Other Income, Net (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Other Financial Information [Abstract]    
Gain on equity investments $ 1.4 $ 22.0
Net foreign currency exchange gain 2.4 1.3
Other income (loss) 0.6 (0.3)
Total other income, net $ 4.4 $ 23.0
XML 61 R59.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Pre-tax amounts Recognized in AOCI on the Balance Sheet (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Unrealized loss on derivatives, before tax, expected to be reclassified over the next 12 months $ 1.9  
Foreign exchange forward contracts    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Loss Recognized in Other Comprehensive Earnings (Loss) $ (0.1) $ 0.0
XML 62 R55.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
BORROWINGS - Schedule of Debt (Details) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Short-term borrowings:    
Short-term borrowings $ 542.0 $ 410.0
Total short-term borrowings $ 542.0 $ 410.0
Revolving Credit Facility    
Short-term borrowings:    
Weighted-Average Interest Rate (as a percent) 2.80% 3.05%
Short-term borrowings $ 542.0 $ 410.0
XML 63 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 64 R51.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Sep. 27, 2019
Goodwill [Roll Forward]    
Balance, beginning $ 612.2  
Business combination 0.3  
Measurement period adjustments to business combinations in prior year (0.1)  
Balance, ending 612.4  
Oncology Systems    
Goodwill [Roll Forward]    
Balance, beginning 447.9  
Business combination 0.3  
Measurement period adjustments to business combinations in prior year (0.1)  
Balance, ending 448.1  
Other    
Goodwill [Roll Forward]    
Balance, beginning 164.3  
Business combination 0.0  
Measurement period adjustments to business combinations in prior year 0.0  
Balance, ending 164.3  
Proton Solutions    
Goodwill [Roll Forward]    
Accumulated impairment charges $ 50.5 $ 50.5
XML 65 R72.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items]    
Revenues $ 828.9 $ 741.0
Operating earnings 110.0 111.7
Unrealized loss on defined benefit pension and post-retirement benefit plans    
Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items]    
Other income, net (0.9) (0.4)
Reclassification out of Accumulated Other Comprehensive Income    
Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items]    
Operating earnings (0.1) (0.4)
Reclassification out of Accumulated Other Comprehensive Income | Unrealized earnings on cash flow hedging instruments    
Reclassification Adjustment Out Of Accumulated Comprehensive Income [Line Items]    
Revenues $ 0.8 $ 0.0
XML 66 R82.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Segment Reporting Information [Line Items]    
Revenues $ 828.9 $ 741.0
Earnings from continuing operations before taxes 110.0 111.7
Interest income (expense), net (1.7) 2.7
Other income, net 4.4 23.0
Earnings before taxes 112.7 137.4
Unallocated corporate    
Segment Reporting Information [Line Items]    
Earnings from continuing operations before taxes (14.9) (3.6)
Operating Segments    
Segment Reporting Information [Line Items]    
Revenues 810.0 741.0
Earnings from continuing operations before taxes 122.1 115.3
Operating Segments | Oncology Systems    
Segment Reporting Information [Line Items]    
Revenues 782.4 702.5
Earnings from continuing operations before taxes 136.4 124.1
Operating Segments | Proton Solutions    
Segment Reporting Information [Line Items]    
Revenues 27.6 38.5
Earnings from continuing operations before taxes (14.3) (8.8)
Operating Segments | Other    
Segment Reporting Information [Line Items]    
Revenues 18.9 0.0
Earnings from continuing operations before taxes $ 2.8 $ 0.0
XML 67 R76.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EMPLOYEE STOCK PLANS - Additional Information (Detail)
$ in Millions
 3 Months Ended
Jan. 03, 2020
USD ($)
Stock options  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Unrecognized compensation expense related to outstanding stock awards $ 20.7
Weighted average period unrecognized compensation expense is expected to be recognized, years 2 years 1 month 6 days
Restricted stocks, restricted stock units, deferred stock units and performance units  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Unrecognized compensation expense related to outstanding stock awards $ 43.7
Weighted average period unrecognized compensation expense is expected to be recognized, years 2 years
Cash-settled Stock Appreciation Rights  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Unrecognized compensation expense related to outstanding stock awards $ 0.6
Weighted average period unrecognized compensation expense is expected to be recognized, years 2 years 2 months 12 days
XML 68 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS
 3 Months Ended
Jan. 03, 2020
Retirement Benefits [Abstract]  
RETIREMENT PLANS RETIREMENT PLANSThe Company sponsors multiple defined benefit pension plans for regular full-time employees in Germany, Japan, Switzerland and the United Kingdom. The Company also sponsors a post-retirement benefit plan that provides healthcare benefits to certain eligible retirees in the United States.
The components of net periodic benefit costs were as follows:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Defined Benefit Plans  
Service cost$2.5  $1.8  
Interest cost0.5  0.9  
Expected return on plan assets(1.9) (1.6) 
Amortization of prior service cost(0.2) (0.2) 
Recognized actuarial loss1.1  0.6  
Net periodic benefit cost$2.0  $1.5  
XML 69 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND INTANGIBLE ASSETS
 3 Months Ended
Jan. 03, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS GOODWILL AND INTANGIBLE ASSETS
The following table summarizes the activity of goodwill by reportable operating segment: 
(In millions)Oncology SystemsOther
Total (1)
Balance at September 27, 2019$447.9  $164.3  $612.2  
Business combination0.3  —  0.3  
Measurement period adjustments to business combinations in prior year(0.1) —  (0.1) 
Balance at January 3, 2020$448.1  $164.3  $612.4  
(1)The total carrying value of goodwill at both January 3, 2020, and September 27, 2019 is net of $50.5 million of accumulated impairment charges related to the Company recording an impairment charge for the full value of the Proton Solutions operating segment goodwill in fiscal year 2019.
The following table summarizes the gross carrying amount and accumulated amortization of the Company's intangible assets: 
January 3, 2020September 27, 2019
(In millions)Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Technologies and patents$226.4  $(92.2) $134.2  $226.4  $(85.9) $140.5  
Customer contracts, supplier relationships, and partner relationships121.1  (28.1) 93.0  121.1  (25.7) 95.4  
Trade names55.1  (4.1) 51.0  55.1  (3.0) 52.1  
Other6.1  (6.1) —  6.1  (6.1) —  
Total intangible with finite lives408.7  (130.5) 278.2  408.7  (120.7) 288.0  
In-process research and development with indefinite lives12.7  —  12.7  12.7  —  12.7  
Total intangible assets$421.4  $(130.5) $290.9  $421.4  $(120.7) $300.7  
Amortization expense for intangible assets was $10.1 million and $4.7 million during the three months ended January 3, 2020 and December 28, 2018, respectively.
As of January 3, 2020, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions):
Fiscal Years:Remaining Amortization Expense  
Remainder of 2020$27.1  
202135.6  
202233.5  
202332.7  
202425.7  
Thereafter123.6  
Total remaining amortization for intangible assets$278.2  
XML 70 R30.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND INTANGIBLE ASSETS (Tables)
 3 Months Ended
Jan. 03, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Activity of Goodwill by Reportable Operating Segment
The following table summarizes the activity of goodwill by reportable operating segment: 
(In millions)Oncology SystemsOther
Total (1)
Balance at September 27, 2019$447.9  $164.3  $612.2  
Business combination0.3  —  0.3  
Measurement period adjustments to business combinations in prior year(0.1) —  (0.1) 
Balance at January 3, 2020$448.1  $164.3  $612.4  
(1)The total carrying value of goodwill at both January 3, 2020, and September 27, 2019 is net of $50.5 million of accumulated impairment charges related to the Company recording an impairment charge for the full value of the Proton Solutions operating segment goodwill in fiscal year 2019.
Schedule of Indefinite-Lived Intangible Assets
The following table summarizes the gross carrying amount and accumulated amortization of the Company's intangible assets: 
January 3, 2020September 27, 2019
(In millions)Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Technologies and patents$226.4  $(92.2) $134.2  $226.4  $(85.9) $140.5  
Customer contracts, supplier relationships, and partner relationships121.1  (28.1) 93.0  121.1  (25.7) 95.4  
Trade names55.1  (4.1) 51.0  55.1  (3.0) 52.1  
Other6.1  (6.1) —  6.1  (6.1) —  
Total intangible with finite lives408.7  (130.5) 278.2  408.7  (120.7) 288.0  
In-process research and development with indefinite lives12.7  —  12.7  12.7  —  12.7  
Total intangible assets$421.4  $(130.5) $290.9  $421.4  $(120.7) $300.7  
Gross Carrying Amount and Accumulated Amortization of Intangible Assets
The following table summarizes the gross carrying amount and accumulated amortization of the Company's intangible assets: 
January 3, 2020September 27, 2019
(In millions)Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Technologies and patents$226.4  $(92.2) $134.2  $226.4  $(85.9) $140.5  
Customer contracts, supplier relationships, and partner relationships121.1  (28.1) 93.0  121.1  (25.7) 95.4  
Trade names55.1  (4.1) 51.0  55.1  (3.0) 52.1  
Other6.1  (6.1) —  6.1  (6.1) —  
Total intangible with finite lives408.7  (130.5) 278.2  408.7  (120.7) 288.0  
In-process research and development with indefinite lives12.7  —  12.7  12.7  —  12.7  
Total intangible assets$421.4  $(130.5) $290.9  $421.4  $(120.7) $300.7  
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
As of January 3, 2020, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions):
Fiscal Years:Remaining Amortization Expense  
Remainder of 2020$27.1  
202135.6  
202233.5  
202332.7  
202425.7  
Thereafter123.6  
Total remaining amortization for intangible assets$278.2  
XML 71 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS (Tables)
 3 Months Ended
Jan. 03, 2020
Retirement Benefits [Abstract]  
Schedule of Net Defined Benefit Costs
The components of net periodic benefit costs were as follows:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Defined Benefit Plans  
Service cost$2.5  $1.8  
Interest cost0.5  0.9  
Expected return on plan assets(1.9) (1.6) 
Amortization of prior service cost(0.2) (0.2) 
Recognized actuarial loss1.1  0.6  
Net periodic benefit cost$2.0  $1.5  
XML 72 R38.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
PROTON SOLUTIONS LOANS AND INVESTMENTS (Tables)
 3 Months Ended
Jan. 03, 2020
Receivables [Abstract]  
Schedule of Loans and Investments to Fund PT Centers
The following table lists the Company's notes receivable, including accrued interest, senior secured debt, available-for-sale securities, loans outstanding and future commitments for funding the development, construction and operation of various proton therapy centers:
January 3, 2020September 27, 2019
(In millions)BalanceCommitment BalanceCommitment
Notes Receivable and Secured Debt: (1)
NYPC loan$32.3  $—  $31.8  $—  
RPTC senior secured debt24.0  —  23.5  —  
Proton International LLC loan1.8  —  1.8  —  
$58.1  $—  $57.1  $—  
Available-For-Sale Securities: (1)
MPTC Series B-1 Bonds  $27.6  $—  $27.1  $—  
MPTC Series B-2 Bonds   25.7  —  25.1  —  
APTC securities  6.7  —  6.6  —  
$60.0  $—  $58.8  $—  
CPTC Loans and Investment:
Short-term revolving loan (2)
$5.3  $1.9  $5.3  $1.9  
Term loan (3)
44.0  —  44.0  —  
$49.3  $1.9  $49.3  $1.9  
(1)Included in other assets at January 3, 2020 and September 27, 2019 on the Company's Condensed Consolidated Balance Sheets, except for amounts related to short-term interest receivable.
(2)Included in prepaid and other current assets on the Company's Condensed Consolidated Balance Sheets.
(3)Included in prepaid and other current assets at January 3, 2020 and other assets at September 27, 2019 on the Company's Condensed Consolidated Balance Sheets.
XML 73 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RECEIVABLES (Tables)
 3 Months Ended
Jan. 03, 2020
Receivables [Abstract]  
Schedule of Trade and Unbilled Receivables, Net and Notes Receivable
The following table summarizes the Company's trade and unbilled receivables, net, and long-term notes receivable:
(In millions)January 3,
2020		September 27,
2019
Trade and unbilled receivables, gross$1,174.7  $1,193.5  
Allowance for doubtful accounts(47.0) (46.5) 
Trade and unbilled receivables, net$1,127.7  $1,147.0  
Short-term$1,079.2  $1,106.3  
Long-term (1)
$48.5  $40.7  
Long-term notes receivable (1) (2)
$34.1  $33.6  
(1)Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2)Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.
XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 369 479 1 true 115 0 false 11 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.varian.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS Sheet http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEARNINGS CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS Statements 2 false false R3.htm 1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS Sheet http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS Statements 3 false false R4.htm 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Parenthetical) Sheet http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSParenthetical CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Parenthetical) Statements 4 false false R5.htm 1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 5 false false R6.htm 1005006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.varian.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 6 false false R7.htm 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EQUITY Statement Sheet http://www.varian.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITYStatement CONDENSED CONSOLIDATED STATEMENTS OF EQUITY Statement Statements 8 false false R9.htm 2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 2104102 - Disclosure - OTHER FINANCIAL INFORMATION Sheet http://www.varian.com/role/OTHERFINANCIALINFORMATION OTHER FINANCIAL INFORMATION Notes 10 false false R11.htm 2112103 - Disclosure - FAIR VALUE Sheet http://www.varian.com/role/FAIRVALUE FAIR VALUE Notes 11 false false R12.htm 2117104 - Disclosure - RECEIVABLES Sheet http://www.varian.com/role/RECEIVABLES RECEIVABLES Notes 12 false false R13.htm 2120105 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETS GOODWILL AND INTANGIBLE ASSETS Notes 13 false false R14.htm 2126106 - Disclosure - BORROWINGS Sheet http://www.varian.com/role/BORROWINGS BORROWINGS Notes 14 false false R15.htm 2130107 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Sheet http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES Notes 15 false false R16.htm 2138108 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.varian.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 16 false false R17.htm 2144109 - Disclosure - RETIREMENT PLANS Sheet http://www.varian.com/role/RETIREMENTPLANS RETIREMENT PLANS Notes 17 false false R18.htm 2147110 - Disclosure - INCOME TAXES Sheet http://www.varian.com/role/INCOMETAXES INCOME TAXES Notes 18 false false R19.htm 2149111 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.varian.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS' EQUITY Notes 19 false false R20.htm 2155112 - Disclosure - EMPLOYEE STOCK PLANS Sheet http://www.varian.com/role/EMPLOYEESTOCKPLANS EMPLOYEE STOCK PLANS Notes 20 false false R21.htm 2162113 - Disclosure - EARNINGS PER SHARE Sheet http://www.varian.com/role/EARNINGSPERSHARE EARNINGS PER SHARE Notes 21 false false R22.htm 2165114 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS Sheet http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTS PROTON SOLUTIONS LOANS AND INVESTMENTS Notes 22 false false R23.htm 2169115 - Disclosure - SEGMENT INFORMATION Sheet http://www.varian.com/role/SEGMENTINFORMATION SEGMENT INFORMATION Notes 23 false false R24.htm 2174116 - Disclosure - BUSINESS COMBINATIONS Sheet http://www.varian.com/role/BUSINESSCOMBINATIONS BUSINESS COMBINATIONS Notes 24 false false R25.htm 2176117 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.varian.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 25 false false R26.htm 2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 26 false false R27.htm 2305301 - Disclosure - OTHER FINANCIAL INFORMATION (Tables) Sheet http://www.varian.com/role/OTHERFINANCIALINFORMATIONTables OTHER FINANCIAL INFORMATION (Tables) Tables http://www.varian.com/role/OTHERFINANCIALINFORMATION 27 false false R28.htm 2313302 - Disclosure - FAIR VALUE (Tables) Sheet http://www.varian.com/role/FAIRVALUETables FAIR VALUE (Tables) Tables http://www.varian.com/role/FAIRVALUE 28 false false R29.htm 2318303 - Disclosure - RECEIVABLES (Tables) Sheet http://www.varian.com/role/RECEIVABLESTables RECEIVABLES (Tables) Tables http://www.varian.com/role/RECEIVABLES 29 false false R30.htm 2321304 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETS 30 false false R31.htm 2327305 - Disclosure - BORROWINGS (Tables) Sheet http://www.varian.com/role/BORROWINGSTables BORROWINGS (Tables) Tables http://www.varian.com/role/BORROWINGS 31 false false R32.htm 2331306 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Sheet http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) Tables http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES 32 false false R33.htm 2339307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://www.varian.com/role/COMMITMENTSANDCONTINGENCIES 33 false false R34.htm 2345308 - Disclosure - RETIREMENT PLANS (Tables) Sheet http://www.varian.com/role/RETIREMENTPLANSTables RETIREMENT PLANS (Tables) Tables http://www.varian.com/role/RETIREMENTPLANS 34 false false R35.htm 2350309 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.varian.com/role/STOCKHOLDERSEQUITYTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.varian.com/role/STOCKHOLDERSEQUITY 35 false false R36.htm 2356310 - Disclosure - EMPLOYEE STOCK PLANS (Tables) Sheet http://www.varian.com/role/EMPLOYEESTOCKPLANSTables EMPLOYEE STOCK PLANS (Tables) Tables http://www.varian.com/role/EMPLOYEESTOCKPLANS 36 false false R37.htm 2363311 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.varian.com/role/EARNINGSPERSHARETables EARNINGS PER SHARE (Tables) Tables http://www.varian.com/role/EARNINGSPERSHARE 37 false false R38.htm 2366312 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS (Tables) Sheet http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSTables PROTON SOLUTIONS LOANS AND INVESTMENTS (Tables) Tables http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTS 38 false false R39.htm 2370313 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.varian.com/role/SEGMENTINFORMATIONTables SEGMENT INFORMATION (Tables) Tables http://www.varian.com/role/SEGMENTINFORMATION 39 false false R40.htm 2403401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details) Sheet http://www.varian.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdjustmentsfromAmountsPreviouslyReportedDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details) Details 40 false false R41.htm 2406402 - Disclosure - OTHER FINANCIAL INFORMATION - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details) Sheet http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnbilledReceivablesandDeferredRevenuesfromContractswithCustomersDetails OTHER FINANCIAL INFORMATION - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details) Details 41 false false R42.htm 2407403 - Disclosure - OTHER FINANCIAL INFORMATION - Unfulfilled Performance Obligations (Details) Sheet http://www.varian.com/role/OTHERFINANCIALINFORMATIONUnfulfilledPerformanceObligationsDetails OTHER FINANCIAL INFORMATION - Unfulfilled Performance Obligations (Details) Details 42 false false R43.htm 2408404 - Disclosure - OTHER FINANCIAL INFORMATION - Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.varian.com/role/OTHERFINANCIALINFORMATIONCashCashEquivalentsandRestrictedCashDetails OTHER FINANCIAL INFORMATION - Cash, Cash Equivalents and Restricted Cash (Details) Details 43 false false R44.htm 2409405 - Disclosure - OTHER FINANCIAL INFORMATION - Components of Inventories (Detail) Sheet http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofInventoriesDetail OTHER FINANCIAL INFORMATION - Components of Inventories (Detail) Details 44 false false R45.htm 2410406 - Disclosure - OTHER FINANCIAL INFORMATION - Components of Other Long-Term Liabilities (Detail) Sheet http://www.varian.com/role/OTHERFINANCIALINFORMATIONComponentsofOtherLongTermLiabilitiesDetail OTHER FINANCIAL INFORMATION - Components of Other Long-Term Liabilities (Detail) Details 45 false false R46.htm 2411407 - Disclosure - OTHER FINANCIAL INFORMATION - Other Income, Net (Details) Sheet http://www.varian.com/role/OTHERFINANCIALINFORMATIONOtherIncomeNetDetails OTHER FINANCIAL INFORMATION - Other Income, Net (Details) Details 46 false false R47.htm 2414408 - Disclosure - FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.varian.com/role/FAIRVALUEAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetail FAIR VALUE - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 47 false false R48.htm 2415409 - Disclosure - FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail) Sheet http://www.varian.com/role/FAIRVALUEReconciliationforAssetsandLiabilitiesMeasuredandRecordedatFairValueonRecurringBasisDetail FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail) Details 48 false false R49.htm 2416410 - Disclosure - FAIR VALUE - Additional Information (Detail) Sheet http://www.varian.com/role/FAIRVALUEAdditionalInformationDetail FAIR VALUE - Additional Information (Detail) Details 49 false false R50.htm 2419411 - Disclosure - RECEIVABLES (Details) Sheet http://www.varian.com/role/RECEIVABLESDetails RECEIVABLES (Details) Details http://www.varian.com/role/RECEIVABLESTables 50 false false R51.htm 2422412 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail) Sheet http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSActivityofGoodwillbyReportableOperatingSegmentDetail GOODWILL AND INTANGIBLE ASSETS - Activity of Goodwill by Reportable Operating Segment (Detail) Details 51 false false R52.htm 2423413 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail) Sheet http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSGrossCarryingAmountandAccumulatedAmortizationofIntangibleAssetsDetail GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Detail) Details 52 false false R53.htm 2424414 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail) Sheet http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSAdditionalInformationDetail GOODWILL AND INTANGIBLE ASSETS - Additional Information (Detail) Details 53 false false R54.htm 2425415 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details) Sheet http://www.varian.com/role/GOODWILLANDINTANGIBLEASSETSFutureAmortizationExpenseDetails GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details) Details 54 false false R55.htm 2428416 - Disclosure - BORROWINGS - Schedule of Debt (Details) Sheet http://www.varian.com/role/BORROWINGSScheduleofDebtDetails BORROWINGS - Schedule of Debt (Details) Details 55 false false R56.htm 2429417 - Disclosure - BORROWINGS - Additional Information (Detail) Sheet http://www.varian.com/role/BORROWINGSAdditionalInformationDetail BORROWINGS - Additional Information (Detail) Details 56 false false R57.htm 2432418 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Instruments Reported on the Balance Sheet (Details) Sheet http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESDerivativeInstrumentsReportedontheBalanceSheetDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Derivative Instruments Reported on the Balance Sheet (Details) Details 57 false false R58.htm 2433419 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedging Activities (Details) Sheet http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESCashFlowHedgingActivitiesDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedging Activities (Details) Details 58 false false R59.htm 2434420 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Pre-tax amounts Recognized in AOCI on the Balance Sheet (Details) Sheet http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESPretaxamountsRecognizedinAOCIontheBalanceSheetDetails DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Pre-tax amounts Recognized in AOCI on the Balance Sheet (Details) Details 59 false false R60.htm 2435421 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail) Sheet http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectivePortionofForeignCurrencyForwardContractsDesignatedasCashFlowHedgesDetail DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effective Portion of Foreign Currency Forward Contracts Designated as Cash Flow Hedges (Detail) Details 60 false false R61.htm 2436422 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail) Sheet http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESOutstandingForeignCurrencyForwardContractsthatWereEnteredintotoHedgeBalanceSheetExposuresDetail DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Foreign Currency Forward Contracts that Were Entered into to Hedge Balance Sheet Exposures (Detail) Details 61 false false R62.htm 2437423 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail) Sheet http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESGainsLossesRelatedtoForeignCurrencyForwardExchangeContractsthatareNotDesignatedasHedgingInstrumentsDetail DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail) Details http://www.varian.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables 62 false false R63.htm 2440424 - Disclosure - COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail) Sheet http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAccruedProductWarrantyDetail COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail) Details 63 false false R64.htm 2441425 - Disclosure - COMMITMENTS AND CONTINGENCIES - Leases (Details) Sheet http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLeasesDetails COMMITMENTS AND CONTINGENCIES - Leases (Details) Details 64 false false R65.htm 2442426 - Disclosure - COMMITMENTS AND CONTINGENCIES - Lessor Arrangements (Details) Sheet http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESLessorArrangementsDetails COMMITMENTS AND CONTINGENCIES - Lessor Arrangements (Details) Details 65 false false R66.htm 2443427 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Sheet http://www.varian.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetail COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) Details 66 false false R67.htm 2446428 - Disclosure - RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail) Sheet http://www.varian.com/role/RETIREMENTPLANSScheduleofNetPeriodicBenefitCostsDetail RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail) Details 67 false false R68.htm 2448429 - Disclosure - INCOME TAXES - Additional Information (Detail) Sheet http://www.varian.com/role/INCOMETAXESAdditionalInformationDetail INCOME TAXES - Additional Information (Detail) Details 68 false false R69.htm 2451430 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Detail) Sheet http://www.varian.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetail STOCKHOLDERS' EQUITY - Additional Information (Detail) Details 69 false false R70.htm 2452431 - Disclosure - STOCKHOLDERS' EQUITY - Shares Repurchased During Period (Details) Sheet http://www.varian.com/role/STOCKHOLDERSEQUITYSharesRepurchasedDuringPeriodDetails STOCKHOLDERS' EQUITY - Shares Repurchased During Period (Details) Details 70 false false R71.htm 2453432 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail) Sheet http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAccumulatedOtherComprehensiveEarningsLossandRelatedTaxEffectsDetail STOCKHOLDERS' EQUITY - Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects (Detail) Details 71 false false R72.htm 2454433 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail) Sheet http://www.varian.com/role/STOCKHOLDERSEQUITYScheduleofAmountsReclassifiedOutofOtherComprehensiveEarningsDetail STOCKHOLDERS' EQUITY - Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Detail) Details 72 false false R73.htm 2457434 - Disclosure - EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail) Sheet http://www.varian.com/role/EMPLOYEESTOCKPLANSNetShareBasedCompensationExpenseDetail EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail) Details 73 false false R74.htm 2458435 - Disclosure - EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail) Sheet http://www.varian.com/role/EMPLOYEESTOCKPLANSFairValuewithWeightedAverageAssumptionsDetail EMPLOYEE STOCK PLANS - Fair Value with Weighted Average Assumptions (Detail) Details 74 false false R75.htm 2459436 - Disclosure - EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail) Sheet http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityUnderEmployeeStockPlansDetail EMPLOYEE STOCK PLANS - Activity Under Employee Stock Plans (Detail) Details 75 false false R76.htm 2460437 - Disclosure - EMPLOYEE STOCK PLANS - Additional Information (Detail) Sheet http://www.varian.com/role/EMPLOYEESTOCKPLANSAdditionalInformationDetail EMPLOYEE STOCK PLANS - Additional Information (Detail) Details 76 false false R77.htm 2461438 - Disclosure - EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail) Sheet http://www.varian.com/role/EMPLOYEESTOCKPLANSActivityforRestrictedStockRestrictedStockUnitsDeferredStockUnitsandPerformanceUnitsDetail EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail) Details 77 false false R78.htm 2464439 - Disclosure - EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail) Sheet http://www.varian.com/role/EARNINGSPERSHAREComputationofNetBasicandDilutedEarningsPerShareDetail EARNINGS PER SHARE - Computation of Net Basic and Diluted Earnings Per Share (Detail) Details 78 false false R79.htm 2467440 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS - Loans and Commitments (Details) Sheet http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSLoansandCommitmentsDetails PROTON SOLUTIONS LOANS AND INVESTMENTS - Loans and Commitments (Details) Details 79 false false R80.htm 2468441 - Disclosure - PROTON SOLUTIONS LOANS AND INVESTMENTS - Additional Information (Detail) Sheet http://www.varian.com/role/PROTONSOLUTIONSLOANSANDINVESTMENTSAdditionalInformationDetail PROTON SOLUTIONS LOANS AND INVESTMENTS - Additional Information (Detail) Details 80 false false R81.htm 2471442 - Disclosure - SEGMENT INFORMATION - Additional Information (Detail) Sheet http://www.varian.com/role/SEGMENTINFORMATIONAdditionalInformationDetail SEGMENT INFORMATION - Additional Information (Detail) Details 81 false false R82.htm 2472443 - Disclosure - SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail) Sheet http://www.varian.com/role/SEGMENTINFORMATIONOperatingResultsInformationforEachReportableSegmentDetail SEGMENT INFORMATION - Operating Results Information for Each Reportable Segment (Detail) Details 82 false false R83.htm 2473444 - Disclosure - SEGMENT INFORMATION - Disaggregation of Revenue (Details) Sheet http://www.varian.com/role/SEGMENTINFORMATIONDisaggregationofRevenueDetails SEGMENT INFORMATION - Disaggregation of Revenue (Details) Details 83 false false R84.htm 2475445 - Disclosure - BUSINESS COMBINATIONS (Details) Sheet http://www.varian.com/role/BUSINESSCOMBINATIONSDetails BUSINESS COMBINATIONS (Details) Details http://www.varian.com/role/BUSINESSCOMBINATIONS 84 false false All Reports Book All Reports var-20200103.htm ex101rsuagreement.htm exhibit311-2020q1.htm exhibit312-2020q1.htm exhibit321-2020q1.htm exhibit322-2020q1.htm var-20200103.xsd var-20200103_cal.xml var-20200103_def.xml var-20200103_lab.xml var-20200103_pre.xml http://xbrl.sec.gov/currency/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true XML 75 R25.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SUBSEQUENT EVENTS
 3 Months Ended
Jan. 03, 2020
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS {OPEN}
XML 76 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EARNINGS PER SHARE
 3 Months Ended
Jan. 03, 2020
Earnings Per Share [Abstract]  
EARNINGS PER SHARE EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted net earnings per share:
 Three Months Ended
(In millions, except per share amounts)January 3,
2020		December 28,
2018
Net earnings$88.9  $103.9  
Less: Net earnings attributable to noncontrolling interests0.7  0.7  
Net earnings attributable to Varian $88.2  $103.2  
Denominator:
Weighted average shares outstanding - basic90.9  91.0  
Dilutive effect of potential common shares0.8  1.0  
Weighted average shares outstanding - diluted91.7  92.0  
Net earnings per share attributable to Varian - basic$0.97  $1.13  
Net earnings per share attributable to Varian - diluted$0.96  $1.12  
Anti-dilutive employee share-based awards, excluded0.8  0.9  
XML 77 R40.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Adjustments from Amounts Previously Reported (Details)
 3 Months Ended
Jan. 03, 2020
cancer_center
specialty_hospital
India  
Segment Reporting Information [Line Items]  
Number of cancer centers 10
Number of specialty hospitals | specialty_hospital 1
Sri Lanka  
Segment Reporting Information [Line Items]  
Number of cancer centers 1
XML 78 R44.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OTHER FINANCIAL INFORMATION - Components of Inventories (Detail) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Other Financial Information [Abstract]    
Raw materials and parts $ 399.8 $ 376.5
Work-in-process 75.6 71.8
Finished goods 122.0 103.2
Total inventories $ 597.4 $ 551.5
XML 79 R48.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE - Reconciliation for Assets and Liabilities Measured and Recorded at Fair Value on Recurring Basis (Detail)
$ in Millions
 3 Months Ended
Jan. 03, 2020
USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Adjustments due to the effect of foreign exchange $ (0.2)
Fair Value, Measurements, Recurring | Contingent Consideration  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Contingent Consideration, beginning balance (75.3)
Change in fair value recognized in earnings (8.8)
Contingent Consideration, ending balance $ (84.3)
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RETIREMENT PLANS - Schedule of Net Periodic Benefit Costs (Detail) - Defined Benefit Plans - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Defined Benefit Plan Disclosure [Line Items]    
Service cost $ 2.5 $ 1.8
Interest cost 0.5 0.9
Expected return on plan assets (1.9) (1.6)
Amortization of prior service cost (0.2) (0.2)
Recognized actuarial loss 1.1 0.6
Net periodic benefit cost $ 2.0 $ 1.5
XML 81 R63.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES - Accrued Product Warranty (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]    
Accrued product warranty, at beginning of period $ 43.2 $ 44.8
Charged to cost of revenues 20.8 13.3
Actual product warranty expenditures (17.8) (11.8)
Accrued product warranty, at end of period $ 46.2 $ 46.3
XML 82 R3.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Statement of Comprehensive Income [Abstract]    
Net earnings $ 88.9 $ 103.9
Defined benefit pension and post-retirement benefit plans:    
Amortization of prior service cost included in net periodic benefit cost, net of tax benefit of $0.0* and $0.0*, respectively [1] (0.2) (0.2)
Amortization of net actuarial loss included in net periodic benefit cost, net of tax expense of $(0.2) and $(0.1), respectively 0.9 0.5
Defined benefit pension and post-retirement benefit plans 0.7 0.3
Derivative instruments:    
Change in unrealized loss, net of tax benefit of $0.0* and $0.0, respectively [1] (0.1) 0.0
Reclassification adjustments, net of tax benefit of $0.2 and $0.0, respectively (0.6) 0.0
Derivative instruments (0.7) 0.0
Currency translation adjustment 5.1 (4.0)
Other comprehensive earnings (loss) 5.1 (3.7)
Comprehensive earnings 94.0 100.2
Less: Comprehensive earnings attributable to noncontrolling interests 0.7 0.7
Comprehensive earnings attributable to Varian 93.3 99.5
Tax on amortization of prior service cost included in net periodic benefit cost [1] $ 0.0 $ 0.0
[1] Tax expense or benefit related to the periods presented are not material.
XML 83 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Cash flows from operating activities:    
Net earnings $ 88.9 $ 103.9
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Share-based compensation expense 14.9 10.5
Depreciation 15.0 12.8
Amortization of intangible assets and inventory step-up 10.2 4.7
Gain on sale of equity investments (1.4) (22.0)
Change in fair value of contingent consideration 8.8 0.0
Other, net 2.7 3.7
Changes in assets and liabilities, net of effects of acquisitions:    
Trade and unbilled receivables 29.5 2.9
Inventories (44.9) (32.4)
Prepaid expenses and other assets 6.3 8.6
Accounts payable (32.7) 13.5
Accrued liabilities and other long-term liabilities (42.1) (12.5)
Deferred revenues 57.4 47.2
Net cash provided by operating activities 112.6 140.9
Cash flows from investing activities:    
Purchases of property, plant and equipment (22.6) (14.0)
Acquisitions, net of cash acquired (1.7) (25.5)
Sale of equity investments 9.2 29.9
Other, net 0.0 (3.5)
Net cash used in investing activities (15.1) (13.1)
Cash flows from financing activities:    
Repurchases of common stock (43.8) (34.8)
Proceeds from issuance of common stock to employees 19.7 22.0
Tax withholdings on vesting of equity awards (3.6) (4.4)
Borrowings under credit facility agreement 11.0 0.0
Repayments under credit facility agreement (11.0)  
Net borrowings under the credit facility agreements with maturities less than 90 days 132.0 0.0
Other (0.9) 0.0
Net cash provided by (used in) financing activities 103.4 (17.2)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash (2.8) 1.7
Net increase in cash, cash equivalents, and restricted cash 198.1 112.3
Cash, cash equivalents, and restricted cash at beginning of period 544.1 516.4
Cash, cash equivalents, and restricted cash at end of period $ 742.2 $ 628.7
XML 84 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
BUSINESS COMBINATIONS
 3 Months Ended
Jan. 03, 2020
Business Combinations [Abstract]  
BUSINESS COMBINATIONS BUSINESS COMBINATIONS
Business Combinations in Fiscal Year 2020
The Company completed an acquisition in its Oncology Systems business that was not material in the first quarter of fiscal year 2020. The acquisition was comprised of goodwill and assets acquired. The purchase accounting from this transaction is not yet finalized.

Business Combinations in Fiscal Year 2019
Assets acquired from Boston Scientific
In August 2019, the Company acquired Boston Scientific's embolics microspheres business, for treating arteriovenous malformations and hypervascular tumors, for a purchase price of $90.0 million in cash consideration. The assets from this purchase are included in the Company's Interventional Solutions business, which is included in the Other category. The purchase accounting from this transaction has been finalized.

Cancer Treatment Services International
In June 2019, the Company acquired CTSI, a privately-held company for a purchase price of $277.0 million, consisting of $262.8 million of cash consideration, $8.2 million of contingent consideration, and $6.0 million of other consideration. The undiscounted range of the contingent consideration payments is zero to $58 million and is based on actual revenues over the 18 months following the acquisition date. There have been no changes this quarter to the fair value of the contingent consideration included in the initial purchase price. The Company has included this acquisition in its Oncology Systems business. The purchase accounting from this transaction is not yet finalized. The Company recorded a measurement period adjustment in the first quarter of fiscal year 2020 that was not material.

Endocare and Alicon
In June 2019, the Company acquired Endocare and Alicon for a combined purchase price of $210.0 million consisting of $197.4 million of cash consideration and $12.6 million of contingent consideration. The undiscounted range of the contingent consideration payments is zero to $40 million and is based on actual revenues through March 2020. Due to better than expected actual and projected financial performance for Endocare and Alicon, as well as a change in the expected mix of products, the Company recorded an $8.8 million increase in the fair value of contingent consideration in the first quarter of fiscal year 2020, in addition to a $18.6 million increase in the fair value of the contingent consideration recorded in the fourth quarter of fiscal year 2019. The Company has recorded a total of $40.0 million in contingent consideration related to the Endocare and Alicon acquisitions, which is expected to be paid in fiscal year 2020. These acquisitions are included in the Company's Interventional Solutions business, which is included in the Other category. The purchase accounting from this transaction is not yet finalized. The Company has not recorded any measurement period adjustments this quarter.

Other Acquisitions in Fiscal Year 2019
In the third quarter of fiscal year 2019, the Company purchased a privately-held company for a cash purchase price of $15.2 million, including a holdback of $3.6 million and contingent consideration. At the closing date, the value of the contingent consideration was zero because none of the milestones were probable to be achieved however, the Company could potentially pay up to approximately $9 million by 2023 if certain milestones were met plus additional payments for achieving revenue targets through 2035. The acquisition was classified as an asset acquisition. This acquisition is included in the Other category.
In the first quarter of fiscal year 2019, the Company acquired a privately-held software company for a purchase price of $28.5 million. The acquisition primarily consisted of $21.9 million in goodwill and $6.5 million in finite-lived intangible assets. The Company integrated this acquisition into its Oncology Systems reporting unit.
Other Information
The excess of purchase price over the fair value amounts assigned to the assets acquired and liabilities assumed represents the goodwill amount. The Company believes the factors that contributed to goodwill in its completed acquisitions include synergies not available to market participants, as well as the acquisition of a talented workforce.

The fair value of assets acquired and liabilities assumed has been determined on a preliminary basis for acquisitions completed in the current year and certain acquisitions in the previous fiscal year. The Company will finalize these amounts as it obtains the
information necessary to complete the measurement process. Any changes resulting from facts and circumstances that existed as of the date of a business combination may result in certain adjustments. The Company expects to finalize these amounts no later than one year from the date of each business combination.

The condensed consolidated financial statements include the operating results from the date the above businesses were acquired. Pro forma results of operations for the completed acquisitions have not been presented because the effects were not material to the Company's condensed consolidated financial statements.
The Company incurred acquisition transaction costs of $3.9 million and $2.4 million during the three months ended January 3, 2020 and December 28, 2018, respectively.
XML 85 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EMPLOYEE STOCK PLANS
 3 Months Ended
Jan. 03, 2020
Share-based Payment Arrangement [Abstract]  
EMPLOYEE STOCK PLANS EMPLOYEE STOCK PLANS
The table below summarizes the share-based compensation expense recognized for employee stock awards and employee stock purchase plan shares:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Cost of revenues - Product$0.8  $0.7  
Cost of revenues - Service1.3  1.1  
Research and development1.2  1.1  
Selling, general and administrative11.6  7.6  
Total share-based compensation expense$14.9  $10.5  
Income tax benefit for share-based compensation$(2.9) $(2.3) 

The fair value of stock options and performance stock options granted was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 Three Months Ended
January 3,
2020		December 28,
2018
Employee Stock Option Plans  
Expected term (in years)3.83.8
Risk-free interest rate1.6 %2.9 %
Expected volatility26.0 %22.2 %
Expected dividend— %— %
Weighted average fair value at grant date (1)
$29.42  $25.87  
(1)Excludes the fair value of the market condition based on a relative total shareholder return for the performance stock options granted during the period.

The option component of employee stock purchase plan shares was estimated at the date of grant using the Black-Scholes model with the following weighted average assumptions: 
 Three Months Ended
January 3,
2020		December 28,
2018
Employee Stock Purchase Plan  
Expected term (in years)0.50.5
Risk-free interest rate1.6 %2.5 %
Expected volatility26.4 %18.6 %
Expected dividend— %— %
Weighted average fair value at grant date$27.58  $22.82  
The activity for stock options and performance stock options is summarized as follows: 
 Options Outstanding
(In millions, except per share amounts)Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Term (in years)
Aggregate
Intrinsic
Value (1)
Balance at September 27, 20192.2  $97.66    
Granted0.1  131.34    
Cancelled or expired—  99.35    
Exercised(0.1) 82.03    
Balance at January 3, 20202.2  $101.01  4.6$98.0  
Exercisable at January 3, 20201.1  $82.38  3.4$68.2  
(1)The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of VMS common stock of $144.93 as of January 3, 2020, the last trading date of the first quarter of fiscal year 2020, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date..
As of January 3, 2020, there was $20.7 million of total unrecognized compensation expense related to stock options and performance stock options granted under the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of 2.1 years.
As of January 3, 2020 there was $0.6 million of total unrecognized compensation expense related to cash-settled stock appreciation rights granted outside the Company's employee stock plans. This unrecognized compensation expense is expected to be recognized over a weighted average period of 2.2 years.
The activity for restricted stock, restricted stock units, deferred stock units and performance units is summarized as follows:
(In millions, except per share amounts)Number of
Shares		Weighted Average
Grant-Date Fair
Value
Balance at September 27, 20190.7  $108.35  
Granted0.1  140.74  
Vested(0.1) 84.99  
Cancelled or expired


(0.1) 117.11  
Balance at January 3, 20200.6  $115.82  

As of January 3, 2020, unrecognized compensation expense totaling $43.7 million was related to awards of restricted stock units, deferred stock units and performance units granted under the Company's employee stock plans. This unrecognized share-based compensation expense is expected to be recognized over a weighted average period of 2.0 years.
XML 86 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE (Tables)
 3 Months Ended
Jan. 03, 2020
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis
In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
 Fair Value Measurements at January 3, 2020
Quoted Prices in
Active Markets
for Identical
Instruments		Significant
Other
Observable
Inputs		Significant
Unobservable
Inputs		Total
Type of Instruments(Level 1)(Level 2)(Level 3)Balance
(In millions)    
Assets:    
Cash equivalents:
Money market funds$17.5  $—  $—  $17.5  
Available-for-sale securities:
MPTC Series B-1 Bonds —  27.6  —  27.6  
MPTC Series B-2 Bonds —  25.7  —  25.7  
APTC securities—  6.7  —  6.7  
Derivative assets—  2.3  —  2.3  
Total assets measured at fair value$17.5  $62.3  $—  $79.8  
Liabilities:            
Contingent consideration$—  $—  $(84.3) $(84.3) 
Total liabilities measured at fair value$—  $—  $(84.3) $(84.3) 


Fair Value Measurements at September 27, 2019
Quoted Prices in Active Markets for Identical InstrumentsSignificant
Other
Observable
Inputs		Significant Unobservable InputsTotal
Type of Instruments(Level 1)(Level 2)(Level 3)Balance
(In millions)
Assets:
Cash equivalents:
Money market funds$0.2  $—  $—  $0.2  
Available-for-sale securities:
MPTC Series B-1 Bonds—  27.1  —  27.1  
MPTC Series B-2 Bonds—  25.1  —  25.1  
APTC securities—  6.6  —  6.6  
Derivative assets—  2.8  —  2.8  
Total assets measured at fair value$0.2  $61.6  $—  $61.8  
Liabilities:
Contingent consideration$—  $—  $(75.3) $(75.3) 
Total liabilities measured at fair value$—  $—  $(75.3) $(75.3) 
Reconciliation for Assets Measured and Recorded at Fair Value on Recurring Basis
The following table presents the reconciliation for liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3):
(In millions)Contingent
Consideration
Balance at September 27, 2019$(75.3) 
Adjustments due to the effect of foreign exchange(0.2) 
Change in fair value recognized in earnings(8.8) 
Balance at January 3, 2020$(84.3) 
XML 87 R49.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE - Additional Information (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Sep. 27, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Equity investments in privately-held companies $ 56.4 $ 64.2
Notes Receivable    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Long-term 34.1 33.6
C P T C | Term Loan    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Modified former loans receivable $ 44.0 $ 44.0
Minimum    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative, term of contract 1 month  
Maximum    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Derivative, term of contract 15 months  
XML 88 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OTHER FINANCIAL INFORMATION - Unbilled Receivables and Deferred Revenues from Contracts with Customers (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Sep. 27, 2019
Other Financial Information [Abstract]      
Unbilled receivables - current $ 315.8   $ 346.7
Unbilled receivables - long-term 42.7   35.1
Deferred revenues - current (817.9)   (766.0)
Deferred revenues - long-term (78.9)   (73.1)
Total net unbilled receivables (deferred revenues) (538.3)   $ (457.3)
Decrease in unbilled receivables 23.3    
Increase in deferred revenue 57.7    
Recognized revenue included in deferred revenue balance $ 314.5 $ 263.4  
XML 89 R45.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
OTHER FINANCIAL INFORMATION - Components of Other Long-Term Liabilities (Detail) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Other Financial Information [Abstract]    
Long-term income taxes payable $ 180.8 $ 180.3
Deferred income taxes 78.1 75.3
Long-term deferred revenues 78.9 73.1
Contingent consideration 42.5 42.3
Defined benefit pension plan 30.4 31.1
Other 42.6 38.0
Total other long-term liabilities $ 453.3 $ 440.1
XML 90 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Revenues:    
Total revenues $ 828.9 $ 741.0
Cost of revenues:    
Total cost of revenues 462.1 424.9
Gross margin 366.8 316.1
Operating expenses:    
Research and development 67.1 60.9
Selling, general and administrative 177.0 141.1
Acquisition-related expenses 12.7 2.4
Total operating expenses 256.8 204.4
Operating earnings 110.0 111.7
Interest income 3.0 3.9
Interest expense (4.7) (1.2)
Other income, net 4.4 23.0
Earnings before taxes 112.7 137.4
Taxes on earnings 23.8 33.5
Net earnings 88.9 103.9
Less: Net earnings attributable to noncontrolling interests 0.7 0.7
Net earnings attributable to Varian $ 88.2 $ 103.2
Net earnings per share - basic (in dollars per share) $ 0.97 $ 1.13
Net earnings per share - diluted (in dollars per share) $ 0.96 $ 1.12
Shares used in the calculation of net earnings per share:    
Weighted average shares outstanding - basic (in shares) 90.9 91.0
Weighted average shares outstanding - diluted (in shares) 91.7 92.0
Product    
Revenues:    
Total revenues $ 421.0 $ 400.2
Cost of revenues:    
Total cost of revenues 271.9 266.6
Service    
Revenues:    
Total revenues 407.9 340.8
Cost of revenues:    
Total cost of revenues $ 190.2 $ 158.3
XML 91 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 47.0 $ 46.5
Preferred stock, par value (in dollars per share) $ 1 $ 1
Preferred stock, shares authorized (in shares) 1,000,000.0 1,000,000.0
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 1 $ 1
Common stock, shares authorized (in shares) 189,000,000.0 189,000,000.0
Common stock, shares issued (in shares) 90,700,000 90,800,000
Common stock, shares outstanding (in shares) 90,700,000 90,800,000
XML 92 R66.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES - Additional Information (Detail)
Oct. 16, 2018
patent
Jan. 03, 2020
USD ($)
Sep. 27, 2019
USD ($)
Commitments And Contingencies [Line Items]      
Amount accrued for environmental remediation expense   $ 4,700,000 $ 4,800,000
Threatened Litigation | Best Medical International, Inc. Litigation      
Commitments And Contingencies [Line Items]      
Number of patents allegedly infringed | patent 4    
Estimated litigation accrual   $ 0  
XML 93 R62.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Gains (Losses) Related to Foreign Currency Forward Exchange Contracts that are Not Designated as Hedging Instruments (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Derivatives Not Designated as Hedging Instrument | Foreign exchange forward contracts | Other income, net    
Derivative [Line Items]    
Amount of Gain (Loss) Recognized in Net Earnings on Derivative Instruments $ (5.0) $ 2.8
XML 94 R54.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
GOODWILL AND INTANGIBLE ASSETS - Future Amortization Expense (Details) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Goodwill and Intangible Assets Disclosure [Abstract]    
Remainder of 2020 $ 27.1  
Future amortization expense, fiscal year 2021 35.6  
Future amortization expense, fiscal year 2022 33.5  
Future amortization expense, fiscal year 2023 32.7  
Future amortization expense, fiscal year 2024 25.7  
Thereafter 123.6  
Net Carrying Amount $ 278.2 $ 288.0
XML 95 R50.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RECEIVABLES (Details) - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Trade and unbilled receivables, gross $ 1,174.7 $ 1,193.5
Allowance for doubtful accounts (47.0) (46.5)
Trade and unbilled receivables, net 1,127.7 1,147.0
Short-term 1,079.2 1,106.3
Long-term 48.5 40.7
Notes Receivable    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Long-term notes receivable $ 34.1 $ 33.6
XML 96 R58.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Cash Flow Hedging Activities (Details) - Cash Flow Hedging - Designated as Hedging Instrument - Foreign exchange forward contracts - USD ($)
$ in Millions
Jan. 03, 2020
Sep. 27, 2019
Derivative [Line Items]    
Notional value sold $ 99.1 $ 133.2
Euro    
Derivative [Line Items]    
Notional value sold 52.9 76.5
Japan, Yen    
Derivative [Line Items]    
Notional value sold $ 46.2 $ 56.7
XML 97 R73.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EMPLOYEE STOCK PLANS - Net Share-Based Compensation Expense (Detail) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense $ 14.9 $ 10.5
Income tax benefit for share-based compensation (2.9) (2.3)
Cost of revenues - Product    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense 0.8 0.7
Cost of revenues - Service    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense 1.3 1.1
Research and development    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense 1.2 1.1
Selling, general and administrative    
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]    
Total share-based compensation expense $ 11.6 $ 7.6
XML 98 R83.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 03, 2020
Dec. 28, 2018
Disaggregation of Revenue [Line Items]    
Revenues $ 828.9 $ 741.0
Products transferred at a point in time    
Disaggregation of Revenue [Line Items]    
Revenues 400.9 366.6
Products and Services transferred over time    
Disaggregation of Revenue [Line Items]    
Revenues 428.0 374.4
Americas    
Disaggregation of Revenue [Line Items]    
Revenues 402.2 350.4
EMEA    
Disaggregation of Revenue [Line Items]    
Revenues 272.9 251.0
APAC    
Disaggregation of Revenue [Line Items]    
Revenues 153.8 139.6
North America    
Disaggregation of Revenue [Line Items]    
Revenues 378.5 328.7
International    
Disaggregation of Revenue [Line Items]    
Revenues 450.4 412.3
Hardware    
Disaggregation of Revenue [Line Items]    
Revenues 359.0 347.2
Software    
Disaggregation of Revenue [Line Items]    
Revenues 148.8 131.2
Service    
Disaggregation of Revenue [Line Items]    
Revenues 321.1 262.6
Oncology Systems | Products transferred at a point in time    
Disaggregation of Revenue [Line Items]    
Revenues 382.0 366.6
Oncology Systems | Products and Services transferred over time    
Disaggregation of Revenue [Line Items]    
Revenues 400.4 335.9
Oncology Systems | Americas    
Disaggregation of Revenue [Line Items]    
Revenues 378.9 330.8
Oncology Systems | EMEA    
Disaggregation of Revenue [Line Items]    
Revenues 259.8 234.5
Oncology Systems | APAC    
Disaggregation of Revenue [Line Items]    
Revenues 143.7 137.2
Oncology Systems | North America    
Disaggregation of Revenue [Line Items]    
Revenues 355.2 309.1
Oncology Systems | International    
Disaggregation of Revenue [Line Items]    
Revenues 427.2 393.4
Oncology Systems | Hardware    
Disaggregation of Revenue [Line Items]    
Revenues 320.0 313.6
Oncology Systems | Software    
Disaggregation of Revenue [Line Items]    
Revenues 148.8 131.2
Oncology Systems | Service    
Disaggregation of Revenue [Line Items]    
Revenues 313.6 257.7
Proton Solutions | Products and Services transferred over time    
Disaggregation of Revenue [Line Items]    
Revenues 27.6 38.5
Proton Solutions | Americas    
Disaggregation of Revenue [Line Items]    
Revenues 16.9 19.6
Proton Solutions | EMEA    
Disaggregation of Revenue [Line Items]    
Revenues 10.3 16.5
Proton Solutions | APAC    
Disaggregation of Revenue [Line Items]    
Revenues 0.4 2.4
Proton Solutions | North America    
Disaggregation of Revenue [Line Items]    
Revenues 16.9 19.6
Proton Solutions | International    
Disaggregation of Revenue [Line Items]    
Revenues 10.7 18.9
Proton Solutions | Hardware    
Disaggregation of Revenue [Line Items]    
Revenues 20.1 33.6
Proton Solutions | Software    
Disaggregation of Revenue [Line Items]    
Revenues 0.0 0.0
Proton Solutions | Service    
Disaggregation of Revenue [Line Items]    
Revenues 7.5 4.9
Other | Products transferred at a point in time    
Disaggregation of Revenue [Line Items]    
Revenues 18.9 0.0
Other | Americas    
Disaggregation of Revenue [Line Items]    
Revenues 6.4 0.0
Other | EMEA    
Disaggregation of Revenue [Line Items]    
Revenues 2.8 0.0
Other | APAC    
Disaggregation of Revenue [Line Items]    
Revenues 9.7 0.0
Other | North America    
Disaggregation of Revenue [Line Items]    
Revenues 6.4 0.0
Other | International    
Disaggregation of Revenue [Line Items]    
Revenues 12.5 0.0
Other | Hardware    
Disaggregation of Revenue [Line Items]    
Revenues $ 18.9 $ 0.0
XML 99 R77.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EMPLOYEE STOCK PLANS - Activity for Restricted Stock, Restricted Stock Units, Deferred Stock Units and Performance Units (Detail)
shares in Millions
 3 Months Ended
Jan. 03, 2020
$ / shares
shares
Number of Shares  
Balance at beginning of period (in shares) | shares 0.7
Granted (in shares) | shares 0.1
Vested (in shares) | shares (0.1)
Cancelled or expired (in shares) | shares (0.1)
Balance at end of period (in shares) | shares 0.6
Weighted Average Grant-Date Fair Value  
Balance at beginning of period (in dollars per share) | $ / shares $ 108.35
Granted (in dollars per share) | $ / shares 140.74
Vested (in dollars per share) | $ / shares 84.99
Cancelled or expired (in dollars per share) | $ / shares 117.11
Balance at end of period (in dollars per share) | $ / shares $ 115.82
XML 100 R16.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
COMMITMENTS AND CONTINGENCIES
 3 Months Ended
Jan. 03, 2020
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
Product Warranty
The following table reflects the changes in the Company’s accrued product warranty:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Accrued product warranty, at beginning of period$43.2  $44.8  
Charged to cost of revenues20.8  13.3  
Actual product warranty expenditures(17.8) (11.8) 
Accrued product warranty, at end of period$46.2  $46.3  
Accrued product warranty was included in accrued liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets.
Leases
The Company leases its facilities and certain equipment under operating leases. The Company's operating leases have remaining lease terms ranging from less than one year to 19 years. Facilities primarily include general and administrative office space, and space for manufacturing, research and development, and other services. Equipment primarily includes vehicles and various office equipment. The Company's finance leases primarily relate to its sale and leaseback-subleases arrangements for certain equipment and have a remaining lease terms ranging from one year to 8 years.

Lease cost for operating leases is recognized on a straight-line basis over the lease term. Lease cost for finance leases is recognized as amortization of the finance lease ROU asset and interest expense on the finance lease liability over the lease term. The Company also has variable lease cost that primarily relate to its operating leases and include common area maintenance, utilities, maintenance charges, property taxes, insurance, and contingent rent.

The following table summarizes the components of the Company's lease cost:
Three Months Ended
(In millions)January 3, 2020
Operating lease cost$7.8  
Finance lease cost:
Amortization of right-of-use assets0.1  
Interest on lease liabilities0.1  
Variable lease cost4.5  
Total lease cost$12.5  

The following table summarizes the supplemental cash flow information related to the Company's operating leases:
Three Months Ended
(In millions)January 3, 2020
Cash paid for amounts included in the measurement of lease liabilities:
   Operating cash flows for leases$8.8  
The following table summarizes supplemental balance sheet information related to the Company's operating and finance leases:
(In millions)January 3, 2020
Operating leases:
Operating right-of-use assets$114.1  
Accrued liabilities$24.4  
Long-term lease liabilities93.7  
   Total lease liabilities$118.1  
Finance leases:
Property, plant, and equipment, net$14.3  
Accrued liabilities$3.4  
Other long-term liabilities10.5
Total lease liabilities$13.9  

The following table summarizes the weighted lease term and discount rate by operating and finance leases:
January 3, 2020
Weighted average remaining lease term in years
Operating leases7.0
Finance leases4.8
Weighted average discount rate
Operating leases4.8 %
Finance leases1.5 %

As of January 3, 2020, the future minimum lease payments are as follows:
(In millions)Operating LeasesFinance leases
Remainder of 2020$21.5  $2.9  
202125.8  3.5  
202220.3  2.9  
202315.4  2.9  
202411.8  1.1  
Thereafter51.4  1.1  
  Total minimum lease payments$146.2  $14.4  
Less: imputed interest28.1  0.5  
Total operating lease liability$118.1  $13.9  

At September 27, 2019, the Company was committed to minimum rentals under non-cancellable operating leases (including rent escalation clauses) for fiscal years 2020 through 2024 and thereafter, as determined under the prior accounting guidance of Accounting Standard Codification 840, as follows: $32.5 million, $26.3 million, $20.2 million, $14.5 million, $10.9 million and $49.9 million, respectively.

Lessor Arrangements
The Company leases some of its equipment to certain customers on operating leases generally over a period of 15 years. As of January 3, 2020, the Company had $22.6 million and $6.4 million included in property, plant and equipment and accumulated depreciation, respectively, related to equipment leased to customers. As of September 27, 2019, the Company had $22.5 million and $5.5 million included in property, plant and equipment and accumulated depreciation, respectively, related to equipment
leased to customers. The Company recorded income of $2.5 million and $2.1 million during the three months ended January 3, 2020 and December 28, 2018, respectively, on these equipment leases.
Contingencies
Environmental Remediation Liabilities
The Company’s operations and facilities, past and present, are subject to environmental laws, including laws that regulate the handling, storage, transport and disposal of hazardous substances. Certain of those laws impose cleanup liabilities on the Company in connection with its past and present operations. Those include facilities sold as part of the Company’s electron devices business in 1995 and thin film systems business in 1997. As a result, the Company oversees various environmental cleanup projects and receives reimbursements from third parties for a portion of the costs of its cleanup activities.

As of January 3, 2020 and September 27, 2019, the Company had accrued $4.7 million and $4.8 million, respectively, net of third parties' indemnification obligations, for environmental remediation liabilities. The Company believes its reserve is adequate; however, as the scope of the Company’s obligations becomes more clearly defined, the Company may modify the reserve, and charge or credit future earnings accordingly. Based on information currently known to management, management believes the costs of these environmental-related matters are not reasonably likely to have a material adverse effect on the consolidated financial statements of the Company in any one fiscal year.
The Company also reimburses certain third parties for cleanup activities. The amount the Company spent on environmental cleanup costs, third-party claim costs, project management costs and legal costs in the three months January 3, 2020 and December 28, 2018, was not material.
Other Matters
On October 16, 2018, Best Medical International, Inc. sued the Company in U.S. District Court in the District of Delaware, alleging infringement of four patents related to treatment planning. The Company intends to defend the suit vigorously. This lawsuit is in the initial stages, and at this time, the Company is unable to predict the ultimate outcome of this matter or estimate a range of possible exposure. Therefore, no amounts have been accrued as of January 3, 2020.
From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations and other legal matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value). A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. 
In addition to the above, the Company is involved in other legal matters. However, such matters are subject to many uncertainties, and outcomes are not predictable with assurance. The Company is unable to estimate a loss or a range of reasonably possible losses with respect to such matters. There can be no assurances as to whether the Company will become subject to significant additional claims and liabilities with respect to ongoing or future proceedings. If actual liabilities significantly exceed the estimates made, the Company’s consolidated financial position, results of operations or cash flows could be materially adversely affected. Legal expenses relating to legal matters are expensed as incurred.
XML 101 R12.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RECEIVABLES
 3 Months Ended
Jan. 03, 2020
Receivables [Abstract]  
RECEIVABLES RECEIVABLES
The following table summarizes the Company's trade and unbilled receivables, net, and long-term notes receivable:
(In millions)January 3,
2020		September 27,
2019
Trade and unbilled receivables, gross$1,174.7  $1,193.5  
Allowance for doubtful accounts(47.0) (46.5) 
Trade and unbilled receivables, net$1,127.7  $1,147.0  
Short-term$1,079.2  $1,106.3  
Long-term (1)
$48.5  $40.7  
Long-term notes receivable (1) (2)
$34.1  $33.6  
(1)Included in other assets on the Company's Condensed Consolidated Balance Sheets.
(2)Balances include accrued interest and are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.
A financing receivable represents a financing arrangement with a contractual right to receive money, on demand or on fixed or determinable dates, and that is recognized as an asset on the Company’s Condensed Consolidated Balance Sheets. The Company’s financing receivables consist of trade receivables with contractual maturities of more than one year and notes receivable. A small portion of the Company's financing trade receivables are included in short-term trade accounts receivable. As of January 3, 2020, and September 27, 2019, the allowance for doubtful accounts is entirely related to short-term trade and unbilled receivables. See Note 14, "Proton Solutions Loans and Investments," for more information on the Company's long-term notes receivable balances.
XML 102 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION (Tables)
 3 Months Ended
Jan. 03, 2020
Segment Reporting [Abstract]  
Operating Results Information for Each Business Segment
The following table summarizes select financial results for each reportable segment:
 Three Months Ended
(In millions)January 3,
2020		December 28,
2018
Revenues  
Oncology Systems$782.4  $702.5  
Proton Solutions27.6  38.5  
Total reportable segments810.0  741.0  
Other 18.9  —  
Total Company$828.9  $741.0  
Earnings from continuing operations before taxes       
Oncology Systems$136.4  $124.1  
Proton Solutions(14.3) (8.8) 
Total reportable segments122.1  115.3  
Other2.8  —  
Unallocated corporate (14.9) (3.6) 
Operating earnings110.0  111.7  
Interest income (expense), net(1.7) 2.7  
Other income, net4.4  23.0  
Total Company$112.7  $137.4  
Schedule of Disaggregation of Revenue
The Company disaggregates its revenues from contracts by major product categories, geographic region, and by timing of revenue recognition for each of its reportable operating segments, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. See details in the tables below.
Revenues by Product Type
Three Months Ended
Total Revenues by Product TypeJanuary 3,December 28,
(In millions)20202018
Hardware
Oncology Systems$320.0  $313.6  
Proton Solutions20.1  33.6  
Other18.9  —  
Total Hardware359.0  347.2  
Software (1)
Oncology Systems148.8  131.2  
Proton Solutions—  —  
Total Software148.8  131.2  
Service
Oncology Systems313.6  257.7  
Proton Solutions7.5  4.9  
Total Service321.1  262.6  
Total Revenues$828.9  $741.0  
(1) Includes software support agreements that are recorded in revenues from service, and software licenses that are recorded in revenues from product in the Condensed Consolidated Statements of Earnings.
Revenues by Geographical Region
Three Months Ended
Total Revenues by Geographical RegionJanuary 3,December 28,
(In millions)20202018
Americas
Oncology Systems$378.9  $330.8  
Proton Solutions16.9  19.6  
Other6.4  —  
Total Americas402.2  350.4  
EMEA
Oncology Systems259.8  234.5  
Proton Solutions10.3  16.5  
Other2.8  —  
Total EMEA272.9  251.0  
APAC
Oncology Systems143.7  137.2  
Proton Solutions0.4  2.4  
Other9.7  —  
Total APAC153.8  139.6  
Total Revenues$828.9  $741.0  
North America (1)
Oncology Systems$355.2  $309.1  
Proton Solutions16.9  19.6  
Other6.4  —  
Total North America378.5  328.7  
International
Oncology Systems427.2  393.4  
Proton Solutions10.7  18.9  
Other12.5  —  
Total International450.4  412.3  
Total Revenues$828.9  $741.0  
(1)North America primarily includes the United States and Canada.
Revenues by Timing of Revenue Recognition
Three Months Ended
Timing of revenue recognitionJanuary 3,December 28,
(In millions)20202018
Products transferred at a point in time
Oncology Systems$382.0  $366.6  
Other18.9  —  
Total products transferred at a point in time400.9  366.6  
Products and services transferred over time
Oncology Systems400.4  335.9  
Proton Solutions27.6  38.5  
Total products and services transferred over time428.0  374.4  
Total Revenues$828.9  $741.0  
XML 103 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
BORROWINGS (Tables)
 3 Months Ended
Jan. 03, 2020
Debt Disclosure [Abstract]  
Schedule of Short-term Borrowings and Long-term Debt
The following table summarizes the Company's total short-term borrowings:
January 3, 2020September 27, 2019
(In millions, except for percentages)AmountWeighted-Average Interest RateAmountWeighted-Average Interest Rate
Short-term borrowings:
Revolving Credit Facility
$542.0  2.80 %$410.0  3.05 %
Total short-term borrowings$542.0  $410.0  
XML 104 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY (Tables)
 3 Months Ended
Jan. 03, 2020
Equity [Abstract]  
Schedule of Share Repurchases
The Company repurchased shares of VMS common stock during the periods presented as follows:
Three Months Ended
(In millions, except per share amounts)January 3,
2020		December 28,
2018
Number of shares0.3  0.3  
Average repurchase price per share$139.67  $108.90  
Total cost of shares repurchased$46.4  $34.8  
Schedule of Accumulated Other Comprehensive Earnings (Loss) and Related Tax Effects
The changes in accumulated other comprehensive loss by component and related tax effects are summarized as follows:
(In millions)
Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans		Net
Unrealized
Gains
Cash Flow
Hedging
Instruments		Cumulative
Translation
Adjustment		Accumulated
Other
Comprehensive
Loss
Balance at September 27, 2019$(61.7) $2.1  $(42.5) $(102.1) 
Other comprehensive earnings (loss) before reclassifications—  (0.1) 5.1  5.0  
Amounts reclassified out of other comprehensive earnings (loss)0.9  (0.8) —  0.1  
Tax (expense) benefit(0.2) 0.2  —  —  
Balance at January 3, 2020$(61.0) $1.4  $(37.4) $(97.0) 

(In millions)Net Unrealized Gains
(Losses) Defined
Benefit Pension and
Post-Retirement
Benefit Plans		Cumulative
Translation
Adjustment		Accumulated
Other
Comprehensive Loss
Balance at September 28, 2018$(35.2) $(30.1) $(65.3) 
Other comprehensive earnings (loss) before reclassifications—  (4.0) (4.0) 
Amounts reclassified out of other comprehensive earnings (loss)0.4  —  0.4  
Tax expense(0.1) —  (0.1) 
Balance at December 28, 2018$(34.9) $(34.1) $(69.0) 
Schedule of Amounts Reclassified Out of Other Comprehensive Earnings (Loss)
The amounts reclassified, before taxes, out of other comprehensive earnings (loss) into the Condensed Consolidated Statements of Earnings, with line item location, during each period were as follows: 

(In millions)Three Months Ended
Comprehensive Earnings (Loss) ComponentsJanuary 3,
2020		December 28,
2018		Line Item in Statements of Earnings
Unrealized loss on defined benefit pension and post-retirement benefit plans$(0.9) $(0.4) Other income, net
Unrealized earnings on cash flow hedging instruments0.8  —  Revenues
Total amounts reclassified out of other comprehensive earnings (loss)$(0.1) $(0.4)  

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�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